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Abstract
The communication between neurons and other cells at chemical synapses, via the 
release of neurotransmitters, is a tightly regulated process. Regulation of the synaptic 
vesicle cycle, responsible for the release of neurotransmitters, controls the level of 
synaptic transmission. The identities of proteins involved in this regulation are gradually 
being elucidated using both in vitro and in vivo systems.
In C. elegans adults the single Rho GTPase orthologue, RHO-1, stimulates 
neurotransmitter release at excitatory synapses at the neuromuscular junction. 
Expression of constitutively active RHO-1 increases release, whilst inhibition of 
endogenous RHO-1 by C3 transferase decreases release. RHO-1 stimulates release via 
„two pathways, one that is dependent upon the diacylglycerol binding protein UNC-13 
and the other that is independent of UNC-13. This thesis explores the upstream 
regulation of RHO-1.
Data presented here suggests that one of the pathways acting upstream of RHO-1 in 
acetylcholine-releasing motor neurons depends upon Gcn2 (GPA-12), which acts via the 
single C.elegans RGS RhoGEF, (RHGF-1). Constitutively active GPA-12 has the same 
effect as constitutively active RHO-1, inducing the accumulation of diacylglycerol and the 
neuromodulator UNC-13 at release sites, and increased ACh release. All these effects 
are suppressed by mutation of RHGF-1. GPA-12 acts entirely in an UNC-13 dependent 
manner, suggesting the probability of other upstream pathways also stimulating RHO-1 
to control neurotransmitter release.
3
Published Papers
Hiley E., McMullan, R. and Nurrish, S. J. (2006) The Ga12-RGS RhoGEF-RhoA 
signalling pathway regulates neurotransmitter release in C. elegans. EMBO J, internet 
access only.
McMullan, R., Hiley, E., Morrison, P. and Nurrish, S.J. (2006) Rho is a presynaptic 
activator of neurotransmitter release at pre-existing synapses in C. elegans. Genes Dev, 
20, 65-76
4
Acknowledgements
I would like to thank my father, Robin Hiley, my mother, Carolyn Hiley, my sister, 
Charlotte Hiley, my granny Margaret Whitcher, my boyfriend, Richard Hobbs, and all my 
friends for their help and support during my PhD. I would particularly like to thank my 
father and sister for their extremely useful proof reading. I would like to thank my 
supervisor, Dr. Stephen Nurrish, for his guidance, and all members past and present of 
the Nurrish laboratory and the Laboratory for Molecular and Cell Biology, for their 
continuing help throughout my studies.
5
Table of Contents
Declaration...............................................................................................................................2
Abstract...................................................................................................................................... 3
Published Papers......................................................................................................................4
Acknowledgements................................................................................................................. 5
List of Figures and Tables.................................................................................................... 15
Abbreviations.......................................................................................................................... 20
1. Introduction....................................................................................................................... 23
1.1. The nervous system..................................................................................................... 23
1.1.1. Cells within the nervous system...........................................................................23
1.1.2. Organisation of the nervous system.................................................................... 24
1.1.3. Synapses................................................................................................................ 25
1.1.4. Neurotransmitters..................................................................................................25
1.1.5. The importance of the precise regulation of the synapse.................................. 27
1.1.6. The synaptic vesicle cycle.....................................................................................28
1.2. Caenorhabditis elegans as a model system...............................................................30
1.3. The nervous system of C. elegans.............................................................................. 30
1.4. Neurotransmitters in C. elegans...................................................................................31
1.5. Behaviours in C. elegans..............................................................................................32
1.5.1. Locomotion............................................................................................................. 33
1.5.1.1. Regulation of locomotion............................................................................... 35
1.5.2. Feeding: Pharyngeal pumping and the peristalsis cycle.....................................37
1.5.2.1. Neuronal regulation of feeding.......................................................................38
1.5.3. Defecation: Defecation Motor Programme (DMP).............................................. 40
1.5.3.1. Regulation of defecation.................................................................................41
1.6. The synaptic vesicle cycle in C. elegans.................................................................... 43
1.6.1. Synaptic vesicle docking and priming................................................................ 44
1.6.1.1. RAB-3.............................................................................................................. 45
1.6.1.2. AEX-3.............................................................................................................. 45
1.6.1.3. RAB-27............................................................................................................46
6
1.6.1.4. UNC-10............................................................................................................47
1.6.1.5. UNC-18............................................................................................................47
1.6.1.6. The SNAREs...................................................................................................48
1.6.1.7. UNC-13............................................................................................................50
1.6.1.8. TOM-1.............................................................................................................. 52
1.6.1.9. Separation of docking and priming................................................................53
1.6.2. Fusion.....................................................................................................................54
1.6.3. Endocytosis and vesicle recycling........................................................................54
1.6.3.1. SNT-1.............................................................................................................. 55
1.6.3.2. UNC-11............................................................................................................56
1.6.3.3. Dynamin...........................................................................................................56
1.6.3.4. UNC-26............................................................................................................56
1.7. Regulation of ACh release at the neuromuscular junction........................................57
1.7.1. Regulation of DAG levels and UNC-13 control ACh release..............................57
1.7.2. Heterotrimeric G proteins regulate DAG levels and ACh release....................... 58
1.7.3. Gaq (EGL-30)........................................................................................................ 60
1.7.4. Ga0 (GOA-1)...........................................................................................................63
1.7.5. Antagonism between the regulation of ACh release by EGL-30 and GOA-1... 65
1.7.6. EAT-16 is a negative regulator of EGL-30.......................................................... 65
1.7.7. EGL-10 is a negative regulator of GOA-1........................................................... 67
1.7.8. GPB-2 is required by EAT-16 and EGL-10......................................................... 68
1.7.9. DGK-1 regulates DAG levels and ACh release...................................................69
1.7.10. RHO-1 negatively regulates DGK-1 in the control of ACh release...................72
1.7.11. GSA-1 (Gas): a third G protein regulating ACh release................................... 74
1.7.12. RIC-8 regulates GSA-1 and EGL-30.................................................................. 77
1.7.13. KIN-2.....................................................................................................................78
1.8. Rho GTPases............................................................................................................... 78
1.9. The cellular effects of Rho GTPases........................................................................... 80
1.9.1. The cytoskeleton.................................................................................................... 80
1.9.2. Gene transcription................................................................................................. 80
1.9.3. Enzyme activity.......................................................................................................81
1.9.4. Phagocytosis..........................................................................................................81
1.9.5. The cell cycle..........................................................................................................82
7
1.9.6. Cell polarity............................................................................................................. 82
1.9.7. Vesicle transport.................................................................................................... 83
1.10. The roles of Rho GTPases in the nervous system...................................................83
1.11. The roles of Rho GTPases in C. elegans................................................................. 85
1.11.1. RHO-1 controls embryonic cytokinesis and elongation.....................................85
1.11.2. RHO-1, CDC-42 and CED-10 regulate cell migration........................................86
1.11.3. RHO-1 controls neuronal morphogenesis......................................................... 86
1.11.4. RHO-1 and CDC-42 control polarity.................................................................. 86
1.11.5. CED-10 controls cell corpse phagocytosis........................................................ 87
1.11.6. The three Rac proteins are redundantly involved in axon pathfinding............. 87
1.12. RhoGEFs are the major activators of Rho GTPases.............................................. 87
1.13. RGS RhoGEFs mediate signalling from heterotrimeric G proteins to Rho 
GTPases...............................................................................................................................91
1.14. RHGF-1 and GPA-12 in C. elegans..........................................................................93
1.15. The hypothesis for this thesis....................................................................................94
1.16. The aims of this study.................................................................................................95
2. Materials and Methods.................................................................................................... 96
2.1. Worm Stocks................................................................................................................. 96
2.2. Freezing and defrosting worms....................................................................................96
2.3. Crossing worms............................................................................................................ 96
2.4. Microinjection of worms................................................................................................97
2.5. DNA isolation from worms............................................................................................97
2.6. RNA isolation from worms............................................................................................98
2.7. Pharyngeal pumping assays........................................................................................ 98
2.8. Defecation assays.........................................................................................................99
2.9. Embryonic arrest assays..............................................................................................99
2.10. Aldicarb assays......................................................................................................... 100
2.11. Levamisole assays................................................................................................... 100
8
2.12. Phorbol esters pre-treatment...................................................................................100
2.13. Aldicarb assay screening for rescue of mutation nz90.......................................... 101
2.14. Feeding RNAi............................................................................................................ 101
2.15. Single Nucleotide Polymorphism (SNP) mapping..................................................102
2.16. Confocal microscopy: Examining the gross neuronal morphology...................... 102
2.17. Confocal microscopy: Counting UNC-13 and SNB-1 puncta................................ 103
2.18. Polymerase Chain Reaction (PCR)......................................................................... 103
2.19. Polymerase chain reaction for sub-cloning.............................................................104
2.20. Single worm PCR for screening progeny when crossing strains..........................105
2.21. RT PCR from RNA extract....................................................................................... 106
2.22. Restriction digestion and ligation of DNA............................................................... 107
2.23. Transformation of bacteria....................................................................................... 108
2.24. Isolation of plasmid DNA from bacteria.................................................................. 108
2.25. DNA sequencing.......................................................................................................109
2.26. Sequencing the gpa-12 (pk322) deletion................................................................ 109
2.27. Sequencing the rhgf-1 deletion mutant gk217........................................................109
2.28. Sequencing the rfigf-1 deletion mutant ok880....................................................... 110
2.29. Making constitutively active gpa-12 cDNA under neuronal promoter................... 110
2.30. Making rhgf-1 complete cDNA under neuronal promoter......................................111
2.31. Preparation of cosmids and fosmids....................................................................... 112
2.32. Making T02B5.1 genomic construct........................................................................ 113
2.33. Amplifying T02B5.3 genomic sequence..................................................................113
2.34. Sequencing genes in nz90 .......................................................................................113
2.35. Solutions and buffers................................................................................................ 114
2.36. Strains........................................................................................................................117
2.37. Oligos........................................................................................................................ 124
9
2.38. Plasmids.................................................................................................................. 133
3. Results: Regulation of Acetylcholine Release by Gai2 .......................................... 136
3.1. Introduction..................................................................................................................136
3.2. Deletion of almost the entire gpa-12 gene had no effect upon ACh release.........136
3.3. Over expression of constitutively active GPA-12 increased ACh release............. 138
3.4. Loss or gain of GPA-12 had no effect upon the muscle.......................................... 140
3.5. Gross neuronal morphology of animals with GPA-12 (Q205L) was unchanged ..142
3.6. Expression of GPA-12 (Q205L) in cholinergic motor neurons increased ACh 
release................................................................................................................................. 144
3.7. Inhibition of RHO-1 suppressed GPA-12 (Q205L) mediated ACh release............ 146
3.8. Loss of GPA-12 had no effect upon RHO-1 (G14V) mediated ACh release......... 147
3.9. Loss of GPA-12 had no effect upon the increase in ACh release in DGK-1 mutant 
animals................................................................................................................................ 150
3.10. GPA-12 (Q205L) increased UNC-13 puncta in the dorsal nerve cord.................151
3.11. UNC-13 puncta in GPA-12 (Q205L) animals occurred at synapses.................... 154
3.12. Non-DAG binding UNC-13S suppressed GPA-12 (Q205L) mediated increase in 
ACh release........................................................................................................................ 157
3.13. Non-DAG binding UNC-13S partially suppressed RHO-1 (G14V) mediated 
increase in ACh release (in collaboration with Dr. R McMullan).....................................157
3.14. Non-DAG binding UNC-13S is not relocalised upon GPA-12 (Q205L) expression 
..............................................................................................................................................159
3.15. GPA-12 had no effect upon synapse number or size.............................................161
3.16. Expression of GPA-12 (Q205L) in the motor neurons during early development 
affected neuronal wiring.....................................................................................................165
3.17. Other phenotypes associated with expression of GPA-12 (Q205L)..................... 167
3.18. Mutation of TPA-1 did not suppress GPA-12 (Q205L) mediated increase in ACh 
release................................................................................................................................. 169
10
3.19. PKC-1 mutation did not suppress GPA-12 (Q205L) mediated increase in ACh 
release................................................................................................................................. 170
3.20. PKC-1 did not suppress GPA-12 (Q205L) mediated reduction in pharyngeal 
pumping, increase in length of defecation cycle or growth arrest...................................171
3.21. Discussion and conclusions..................................................................................... 174
3.21.1. Neurotransmitter release in C. elegans is controlled by G protein coupled 
pathways..........................................................................................................................174
3.21.2. GPA-12 regulates neurotransmitter release.................................................... 175
3.21.3. GPA-12 acts upstream of RHO-1 and DGK-1 to regulate release................176
3.21.4. GPA-12 recruits UNC-13 to synapses in a DAG-dependent manner 177
3.21.5. GPA-12 activates one of multiple RHO-1 pathways controlling ACh release 
......................................................................................................................................... 178
3.21.6. Possible long term effects of constitutively active GPA-12............................179
3.21.7. Leakiness of the hs::GPA-12 (Q205L) construct............................................ 179
3.21.8. GPA-12 regulates feeding but not ACh release through TPA-1.................... 180
3.21.9. PKC-1 has no role in GPA-12 regulation of ACh release or feeding 180
3.21.10. GPA-12 controls neuronal wiring during development................................. 181
3.21.11. GPA-12 pathways are not active under basal laboratory conditions 182
4. Results: The Guanine Nucleotide Exchange Factor linking GPA-12 and RHO-1 
....................................................................................................................................... 184
4.1. Introduction..................................................................................................................184
4.2. rhgf-1 cDNA has an additional exon at 5’ end..........................................................184
4.3. Mutation of RHGF-1 had a small effect upon ACh release.....................................185
4.4. Mutation of RHGF-1 had no effect upon the muscle................................................187
4.5. Mutation of RHGF-1 suppressed GPA-12 (Q205L) mediated aldicarb 
hypersensitivity..................................................................................................................188
4.6. RHO-1 acted downstream of RHGF-1 ...................................................................... 191
4.7. RHGF-1 was required in cholinergic motor neurons to mediate GPA-12 (Q205L) 
induced hypersensitivity to aldicarb.................................................................................. 193
4.8. Expression of RHGF-1 in cholinergic motor neurons was sufficient to increase 
ACh release.......................................................................................................................193
11
4.9. RHO-1 was required for RHGF-1 to increase aldicarb sensitivity...........................196
4.10. Mutation of GPA-12 partially suppressed high level neuronal RHGF-1 mediated 
aldicarb hypersensitivity.....................................................................................................196
4.11. RHGF-1 was needed for GPA-12 (Q205L) induced UNC-13 relocalisation 199
4.12. Mutation of RHGF-1 had no effect upon synapse number or size........................202
4.13. RHGF-1 expression did not cause or suppress GPA-12 (Q205L) mediated 
neuronal wiring defects..................................................................................................... 206
4.14. GPA-12 (Q205L) induced reduction of pharyngeal pumping, growth arrest or 
lengthening of the defecation cycle did not need RHGF-1............................................. 209
4.15. An additional deletion mutation in RHGF-1............................................................212
4.16. Other RhoGEFs in the nervous system.................................................................. 214
4.17. Discussion and conclusions.....................................................................................215
4.17.1. RHGF-1 is required for GPA-12 to stimulate neurotransmitter release 215
4.17.2. RHGF-1 is needed only within the cholinergic motor neurons to stimulate
neurotransmitter release................................................................................................218
4.17.3. Mutation rhgf-1 (ok880) does not completely suppress GPA-12 (Q205L) 
mediated ACh release................................................................................................... 219
4.17.4. RHGF-1 is not involved in neuronal wiring...................................................... 220
4.17.5. RHGF-1 is not involved in the regulation of pharyngeal pumping or the 
length of the defecation cycle by GPA-12.................................................................... 221
4.17.6. Mutation rhgf-1 (gk217) is not the cause of aldicarb resistance....................221
4.17.7. Other RhoGEFs regulate ACh release.............................................................222
5. Results: Identification of a New Mutation Affecting Acetylcholine Release 223
5.1. Introduction..................................................................................................................223
5.2. An additional mutation in strain VC430 causes strong aldicarb resistance........... 223
5.3. Mutation nz90 caused resistance to trichlorfon....................................................... 224
5.4. Levamisole sensitivity was unchanged in nz90 mutant animals............................. 226
5.5. Treatment with phorbol esters caused aldicarb hypersensitivity in nz90 mutant 
animals................................................................................................................................227
12
5.6. Mutation nz90 did not affect neuronal wiring.............................................................228
5.7. Mutation nz90 caused no defect in the defecation cycle.......................................229
5.8. UNC-13 localisation is changed in nz90 mutant animals......................................230
5.9. Mutation nz90 caused a decrease in the number of SNB-1 puncta.....................231
5.10. Partial co-localisation of UNC-13 and SNB-1 was observed in nz90 mutant 
animals................................................................................................................................ 234
5.11. No defects in the post-synaptic compartment have been identified in nz90 
mutant animals...................................................................................................................236
5.12. snip-SNP mapping of mutation nz90.......................................................................236
5.13. Mutation nz90 lies within a small region in the centre of chromosome V ............ 239
5.14. Cosmid and fosmid rescue of nz90 aldicarb resistance........................................243
5.15. Rescuing cosmid T02B5 encodes 4 genes............................................................245
5.16. T02B5.1 and T02B5.3 encode predicted carboxylesterases................................ 246
5.17. RNAi of T02B5.1 and T02B5.3 had no effect upon aldicarb sensitivity............... 248
5.18. Over expression of T02B5.1 and T02B5.3 in wild type animals had no effect... 250
5.19. Discussion and conclusions.....................................................................................251
5.19.1. Strain VC430 contains an additional mutation reducing aldicarb sensitivity 
.........................................................................................................................................251
5.19.2. Mutation nz90 alters the synapse.................................................................... 251
5.19.3. SNB-1 localisation defects in synaptogenesis mutants................................. 252
5.19.4. SNB-1 specific localisation............................................................................... 254
5.19.5. Mutation nz90 may have an indirect effect upon the cholinergic motor 
neurons............................................................................................................................254
5.19.6. nz90 might be a mutation in T02B5.1 or T02B5.3.......................................... 255
5.19.7. T02B5.1 and T02B5.3 encode predicted carboxylesterases..........................257
5.19.8. Neuroligins.......................................................................................................... 257
5.19.9. T02B5.3 homologues are expressed in neurons............................................ 261
5.19.10. Identifying mutation nz90 ................................................................................. 261
6. Summary, conclusions and future work...................................................................... 262
13
6.1. Summary of results.................................................................................................... 262
6.2. The release of ACh in C. elegans is a model system used to identify candidate 
proteins involved in human behaviours and diseases.................................................... 263
6.3. What acts upstream of GPA-12 to regulate neurotransmission?............................263
6.3.1. Potential neurotransmitters and neuromodulators regulating the Gai2/ RHGF-
1 pathway........................................................................................................................ 264
6.3.2. Potential GPCRs upstream of GPA-12..............................................................265
6.4. Are there any other proteins acting downstream of GPA-12?................................ 266
6.4.1. PLC-1....................................................................................................................267
6.4.2. TPA-1....................................................................................................................267
6.5. Does the Gai2 pathway regulate the Gaq and/ or Goto pathways to regulate ACh 
release?............................................................................................................................... 268
6.6. Is GPA-12 acting in cells other than the cholinergic motor neurons?....................268
6.7. Other upstream activators of RHO-1.........................................................................269
7. References....................................................................................................................... 271
8. Appendix...........................................................................................................................306
8.1. Sequence of gpa-12 deletion mutant pk322.............................................................306
8.2. Sequence of rhgf-1 deletion mutant ok880............................................................... 309
8.3. Sequence of rhgf-1 deletion mutant gk217............................................................... 326
8.4. Sequencing of genes T02B5.1, T02B5.3 and T02B5.4........................................... 343
8.5. snip-SNPs: location, primer sequences and name..................................................348
14
List of Figures and Tables
Figure 1.1 Structure of a neuron.....................................................................................24
Table 1.1. Small molecule neurotransmitters in mammals......................................... 26
Table 1.2. Effects of drugs upon synapses...................................................................28
Figure 1.2 The synaptic vesicle cycle............................................................................ 29
Figure 1.3 Sinusoidal locomotion....................................................................................34
Figure 1.4 Reciprocal relaxation and contraction of muscles by motor neurons
facilitate locomotion......................................................................................35
Figure 1.5 Structure of pharynx...................................................................................... 37
Figure 1.6 Feeding is mediated by pumping and isthmus peristalsis..........................39
Figure 1.7 Defecation cycle.............................................................................................40
Figure 1.8 The synaptic vesicle cycle in C. elegans..................................................... 44
Figure 1.9 The SNARE complex.....................................................................................49
Figure 1.10 UNC-13 isoforms............................................................................................50
Figure 1.11 Cycle of activation of heterotrimeric G proteins.......................................... 60
Figure 1.12 EGL-30 and EGL-8 stimulate ACh release..................................................62
Figure 1.13 GOA-1 negatively regulates ACh release.................................................... 64
Figure 1.14 EAT-16 negatively regulates EGL-30...........................................................66
Figure 1.15 EGL-10 negatively regulates GOA-1 to control ACh release..................... 68
Figure 1.16 DGK-1 negatively regulates ACh release.................................................... 71
Figure 1.17 RHO-1 stimulates ACh release.....................................................................73
Figure 1.18 GSA-1 regulates ACh release by the production of cAMP.........................76
Figure 1.19 Rho GTPases are molecular switches..........................................................79
Table 1.3. Enzymes regulated by Rho GTPases.......................................................... 81
Table 1.4. DH-PH containing RhoGEFs in C. elegans.................................................90
Figure 1.20 The RGS RhoGEF family...............................................................................92
Figure 1.21 The Ga 12/ RGS RhoGEF/ Rho pathway is conserved in C. elegans,
Drosophila and mammals............................................................................ 94
Figure 2.1. Principle of SMART™ RACE RT PCR........................................................ 107
Figure 3.1. Amino Acid sequence alignment of GPA-12 and human Gai2................137
Figure 3.2. Structure of gpa-12 (pk322) deletion and aldicarb sensitivity of mutant
animals......................................................................................................... 138
15
Figure 3.3.
Figure 3.4.
Figure 3.5. 
Figure 3.6. 
Figure 3.7.
Figure 3.8. 
Figure 3.9.
Figure 3.10.
Figure 3.11.
Table 3.1. 
Figure 3.12.
Figure 3.13. 
Figure 3.14.
Figure 3.15.
Figure 3.16.
Table 3.2. 
Figure 3.17. 
Figure 3.18. 
Table 3.3. 
Figure 3.19. 
Figure 3.20.
Figure 3.21.
Structure of hs::GPA-12 (Q205L) transgene and sensitivity to aldicarb of
transgenic animals...................................................................................... 139
Aldicarb sensitivity of hs::GPA-12 (Q205L) animals 24 hours after
heatshock.....................................................................................................140
Levamisole sensitivity of gpa-12 (pk322) and hs::GPA-12 (Q205L)......141
Gross neuronal morphology of heatshock induced GPA-12 (Q205L)... 143 
Structure of p.unc-17::gpa-12 (Q205L) transgene and aldicarb sensitivity
of transgenic animals..................................................................................145
Gross morphology of p.unc-17::gpa-12 (Q205L) animals.........................146
Aldicarb sensitivity of hs::C3T co-expressed with hs::GPA-12 (Q205L)
..................................................................................................................... 148
Aldicarb sensitivity of hs::RHO-1 (G14V) expression in presence of gpa-
12 (pk322) mutation....................................................................................149
Aldicarb sensitivity of dgk-1 (sy428); gpa-12 (pk322) double mutant
animals.........................................................................................................150
Quantification of UNC-13S puncta............................................................151
UNC-13S::YFP localisation in hs::GPA-12 (Q205L) and gpa-12 (pk322)
mutant animals............................................................................................152
Graph of UNC-13S puncta......................................................................... 153
Co-localisation of UNC-13S and SNB-1 in hs::GPA-12 (Q205L) animals
..................................................................................................................... 155
Aldicarb sensitivity of hs::GPA-12 (Q205L) animals expressing UNC-13
(H173K)........................................................................................................156
Aldicarb sensitivity of animals expressing RHO-1 (G14V) and UNC-13
(H173K)........................................................................................................158
Quantification of UNC-13S (H173K) puncta.............................................159
UNC-13 (H173K) localisation in hs::GPA-12 (Q205L) animals...............160
SNB-1 ::CFP localisation.............................................................................162
Quantification of SNB-1 ::CFP puncta number and size...........................163
Graphs of SNB-1 puncta number and size...............................................164
Structure of p.acr-2::gpa-12 (Q205L) construct and sensitivity to aldicarb
of transgenic animals.................................................................................. 165
Gross neuronal morphology of p.acr-2::gpa-12 (Q205L)..........................166
16
Table 3.4.
Figure 3.22. 
Figure 3.23.
Figure 3.24.
Table 3.5. 
Figure 3.25.
Figure 3.26.
Figure 3.27.
Figure 4.1. 
Figure 4.2. 
Figure 4.3. 
Figure 4.4. 
Figure 4.5. 
Figure 4.6.
Figure 4.7.
Figure 4.8.
Figure 4.9. 
Figure 4.10.
Figure 4.11.
Figure 4.12.
Figure 4.13.
Quantification of pharyngeal pumping rate and length of defecation cycle
..................................................................................................................... 167
Graphs of pharyngeal pumping and defecation........................................ 168
Aldicarb sensitivity of tpa-1 (pk1585) mutants with hs::GPA-12 (Q205L)
..................................................................................................................... 169
Aldicarb sensitivity of pkc-1 (ok563) mutant animals with hs::GPA-12
(Q205L)........................................................................................................170
Quantification of pharyngeal pumping and defecation cycle.................... 171
Rate of pharyngeal pumping and defecation cycle length in pkc-1
(ok563) mutant with hs::GPA-12 (Q205L).................................................172
Growth of hs::GPA-12 (Q205L) animals with tpa-1 (pk1585) or pkc-1
(ok563) mutations....................................................................................... 173
Three G-protein coupled pathways regulate neurotransmitter release at
neuromuscular junction.............................................................................. 175
rhgf-1 gene includes one new exon...........................................................185
Deletion mutation rhgf-1 (ok880)...............................................................186
Aldicarb sensitivity of rhgf-1 (ok880) mutant animals.............................. 187
Levamisole sensitivity of rhgf-1 (ok880) mutant animals.........................188
Aldicarb sensitivity of hs::GPA-12 with rhgf-1 (ok880) mutation 189
Aldicarb sensitivity of neuronal GPA-12 (Q205L) with rhgf-1 (ok880)
mutation.......................................................................................................190
Aldicarb sensitivity of animals expressing RHO-1 (G14V) with rhgf-1
(ok880) mutation........................................................................................ 192
Aldicarb sensitivity of animals expressing wild type RHGF-1 in
cholinergic motor neurons with hs::GPA-12 (Q205L).............................. 194
Aldicarb sensitivity of neuronal RHGF-1 expressed at high levels 195
Aldicarb sensitivity of animals expressing C3 transferase and high levels
of neuronal RHGF-1................................................................................... 197
Aldicarb sensitivity of high levels of neuronal RHGF-1 in gpa-12 (pk322)
mutant animals............................................................................................198
Aldicarb sensitivity of animals expressing high level neuronal RHGF-1
with and without hs::GPA-12 (Q205L)...................................................... 199
UNC-13 localisation in rhgf-1 (ok880) mutants with hs::gpa-12 (Q205L) 
 200
17
Figure 4.14. 
Table 4.1.
Figure 4.15.
Table 4.2.
Figure 4.16.
Figure 4.17.
Figure 4.18.
Table 4.3.
Figure 4.19.
Figure 4.20. 
Figure 4.21. 
Figure 4.22.
Figure 4.23. 
Figure 4.24. 
Figure 4.25. 
Figure 5.1. 
Figure 5.2. 
Figure 5.3. 
Figure 5.4. 
Figure 5.5. 
Figure 5.6. 
Figure 5.7. 
Figure 5.8. 
Figure 5.9. 
Table 5.1.
Graph showing quantification of UNC-13S puncta.................................. 201
Quantification of UNC-13 puncta in animals with hs::GPA-12 and rhgf-1
(ok880) mutation........................................................................................ 202
SNB-1 localisation in rhgf-1 (ok880) mutant animals with hs::GPA-12
(Q205L)........................................................................................................203
Quantification of number and size of SNB-1 puncta in rhgf-1 (ok880)
mutant animals............................................................................................204
Graphs of SNB-1 puncta number and size in rhgf-1 (ok880) mutant
animals with and without hs::GPA-12 (Q205L)........................................205
Gross morphology of the cholinergic motor neurons in animals
expressing RHGF-1 under acr-2 promoter.............................................. 207
Cholinergic motor neurons in rhgf-1 (ok880) mutant animals expressing
p.acr-2::gpa-12 (Q205L)............................................................................ 208
Quantification of pharyngeal pumping rate and length of defecation cycle
.....................................................................................................................209
Rate of pharyngeal pumping and length of defecation cycle in hs::GPA-
12 (Q205L) animals with mutation rhgf-1 (ok880)................................... 210
Growth of hs::GPA-12 (Q205L) animals with rhgf-1 (ok880) mutation.. 211
Structure of rhgf-1 (gk217) deletion mutant............................................. 212
Aldicarb sensitivity of rhgf-1 (gk217) with and without wild type RHGF-1
.....................................................................................................................213
Levamisole sensitivity of rhgf-1 (gk217) mutant animals........................ 214
Aldicarb sensitivity of other predicted RhoGEFs......................................215
RHGF-1 mediates the activation of RHO-1 by GPA-12...........................217
Aldicarb sensitivity of rhgf-1 (gk217) and nz90 mutations...................... 224
Chemical structure of ACh, aldicarb and trichlorfon................................ 225
Trichlorfon sensitivity of animals with nz90 mutation............................... 226
Levamisole sensitivity of nz90 mutant animals........................................227
Aldicarb sensitivity after treatment with phorbol esters............................228
The gross neuronal morphology of nz90 mutant animals....................... 229
Length of defecation cycle in nz90 mutant animals................................. 230
UNC-13S puncta in nz90 mutant animals.................................................232
Number of SNB-1 puncta in nz90 mutant animals.................................. 233
UNC-13S and SNB-1 puncta in nz90 mutant animals.............................234
18
Figure 5.10. Co-localisation of UNC-13S::YFP and SNB-1 ::CFP............................. 235
Figure 5.11. snip-SNP locations.................................................................................. 237
Figure 5.12. Analysis of 8 snip-SNPs on all chromosomes....................................... 238
Figure 5.13. Repeated analysis of snip-SNPs on chromosomes IV and V ............. 240
Figure 5.14. Gel showing snip-SNP pkP5129 using individual animals................... 241
Figure 5.15. Mutation nz90 lies between positions 5.85 and 6.41 on chromosome V
242
Figure 5.16. Cosmids and Fosmids covering the location of nz90 determined by snip-
SNP mapping.......................................................................................... 243
Figure 5.17. Aldicarb sensitivities of nz90 animals injected with cosmids and fosmids
244
Figure 5.18. T02B5 encodes 4 genes......................................................................... 245
Figure 5.19. Aldicarb sensitivity of nz90 mutant animals expressing individual genes
on cosmid T02B5..................................................................................... 246
Figure 5.20. Amino acid line-up between T02B5.1 and T02B5.3............................. 247
Figure 5.21. Aldicarb sensitivity after RNAi knockdown of T02B5.1, T02B5.3 and egl-
8....................................................................................................................... 249
Figure 5.22. Aldicarb sensitivity of wild type animals with cosmid T02B5 or genes
T02B5.1 or T02B5.3............................................................................... 250
Figure 5.23. Regulation of synaptogenesis by neuroligins and neurexins.............. 259
Figure 5.24. Putative role of neuroligins and neurexins in modulation of synaptic
strength.................................................................................................... 260
19
Abbreviations
aBoc -  anterior body contraction 
ACh -  acetylcholine 
AChR -  acetylcholine receptor 
ADP -  adenosine diphosphate 
ATP -  adenosine triphosphate 
bp -  base pair
C. elegans - Caenorhabditis elegans 
C1 - protein kinase C conserved region 1 
Ca2+ - calcium
cAMP -  cyclic adenosine monophosphate
CarbE - carboxylesterase
CDM -  CED-5/ Dock 180/ Myoblast city
cDNA -  copy DNA
CFP -  cyan fluorescent protein
CNS -  central nervous system
C-terminus -  carboxyl-terminus
CZH -  CDM-zizimim homology
DAG -  diacylglycerol
DGK -  diacylglycerol kinase
DH -  Dbl (diffuse B-cell lymphoma) homology
DMP -  defecation motor programme
DNA -  deoxyribonucleic acid
Drosophila -  Drosophila melanogaster
dsRNA -  double stranded ribonucleic acid
E. coli -  Escherichia coli
EAT -  feeding defective
EGL -  egg laying defective
EM -  electron microscopy
Emc -  enteric muscle contraction
EPSC -  excitatory post-synaptic current
ER -  endoplasmic reticulum
Exp -  expulsion
20
Flp -  FMRF-amide like peptides
FMRF -  phenylalanine-methionine-arginine-phenylalanine 
G -  glycine
GABA -  gamma-aminobutyric acid
GAP -  GTPase activating protein
GDI -  guanine nucleotide dissociation inhibitor
GDP -  guanosine diphosphate
GEF -  guanine nucleotide exchange factor
GFP -  green fluorescent protein
GGL- Gy-subunit like domain
GPCR -  G protein coupled receptor
GTP -  guanosine triphosphate
GTPase -  guanosine triphosphatase
hs -  heatshock
ins -  insulin related gene
IP3 -  inositol trisphosphate
IPTG -  isopropyl pD-thiogalactopyranoside
JNK -  jun kinase
kb -  kilo base pair
L -  leucine
L1 -  larval stage 1
L4 -  larval stage 4
LARG -  leukaemia associated RhoGEF
LSD -  lysergic acid diethylamide
MAPKKK -  MAP kinase kinase kinase
MHD2 -  Munc homology domain
NGF -  neuronal growth factor
NLP -  neuropeptide-like
NMJ -  neuromuscular junction
NSM -  neurosecretory motor neuron
N-terminus -  amino-terminus
OD -  optical density
PA -  phosphatidic acid
pBoc -  posterior body contraction
21
PCR -  polymerase chain reaction
PDZ -  Postsynaptic density protein/ Discs large/ Zonula occludens
PH -  pleckstrin homology
PIP -  phosphatidylinositol phosphate
PIP2 -  phosphatidylinositol bisphosphate
PKA -  protein kinase A
PKC -  protein kinase C
PLC -  phospholipase C
PMA -  phorbol-12-myristate-13-acetate
Q -  glutamine
RGS -  regulator of G-protein signalling
RIC -  resistant to inhibitors of acetylcholinesterases
RNA -  ribonucleic acid
RNAi -  RNA interference
ROS -  reactive oxygen species
RT PCT -  reverse transcriptase polymerase chain reaction 
SEM -  standard error of the mean 
siRNA -  short interfering ribonucleic acid
SNARE -  soluble N-ethylmaleimide sensitive factor attachment protein receptor
SNP -  single nucleotide polymorphism
SRE -  serum response element
SRF -  serum response factor
TCF -  ternary complex factor
TMP -  trimethylpsoralen
UNC -  uncoordinated
UV -  ultra violet
V -  valine
W.T. -  wild type
YFP -  yellow fluorescent protein
22
1. Introduction
The nervous system provides an important method of communication between cells and 
other systems. Defects in the nervous system are associated with numerous different 
human diseases, and many addictive recreational drugs affect the nervous system. 
Therefore, understanding the nervous system and the methods of communication will 
help the designing and development of treatments for diseases of the nervous system 
and drug dependencies.
1.1. The nervous system
1.1.1. Cells within the nervous system
In mammals, the nervous system is composed of two types of cells. The first are the 
cells that transmit signals, called neurons. They encode information either electrically or 
biochemically and carry it long distances in a short period of time. The second are the 
glial cells, which provide support for the neurons. They isolate neurons from each other, 
control their access to other substances in the organism and provide structural support. 
They are also important in the initial organisation and wiring of the nervous system and 
have been shown to have a role in the pathfinding of some neurons.
Neurons, the signal transducers of the nervous system, are extremely diverse but have 
three common features (Figure 1.1). Typically, they have a cell body, which contains 
important organelles including the nucleus. Branch-like processes emanate from the cell 
body called dendrites. These are responsible for receiving signals from the external 
environment and other cells, and transmitting the signal to the cell body. An additional, 
often longer process called the axon extends from the cell body. This is responsible for 
the transmission of the signal from the cell body to the target cell. The axon can branch 
considerably providing multiple axon terminals for the signal transmission. In mammals, 
neurons are typically polarized, the signal input occurs at the dendrites travelling through 
the cell body to provide the output from the axon (Figure 1.1).
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Direction of signal 
transmission
Dendrites
Cell Body
Axon
Axon termini
Figure 1.1
A neuron is composed of three basic structures: the dendrites, the cell body and 
the axon.
Structure of a neuron
1.1.2. Organisation of the nervous system
Neurons can be divided into three general classes. The sensory neurons are found 
throughout the organism and are responsible for the detection of external stimuli. The 
second class is the motor neurons, which are responsible for initiating a response by the 
organism by transmitting signals to muscle cells or glands. The third class is the 
interneurons, these transmit signals between other neurons. In vertebrates, the majority 
of the nervous system is contained within the central nervous system (CNS), which in
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humans is composed of the brain and the spinal cord. Additional peripheral nervous 
systems exist, extending from the CNS to various parts of the body as nerve trunks 
consisting of multiple axonal processes and glial cells.
1.1.3. Synapses
The specialised points at which neurons transmit signals to adjacent cells are called 
synapses. The neuron releasing the signal is called the pre-synaptic neuron. The cell 
receiving the signal is called the post-synaptic cell. There are two common types of 
synapse. The first are chemical synapses in which a chemical messenger called a 
neurotransmitter is released by the pre-synaptic neuron. There is no direct contact 
between the cells but they are in extremely close proximity. The neurotransmitter 
diffuses across the space between the cells called the synaptic cleft. It then interacts 
with receptors in the membrane of the post-synaptic cell thereby transmitting the signal. 
The neurotransmitter within the synaptic cleft is removed by three mechanisms. It can be 
taken up by the pre-synaptic cell and recycled, ready for another round of release in 
response to another action potential. Alternatively, neurotransmitters can be degraded 
by enzymes within the synaptic cleft, ending stimulation of the post-synaptic cell, or the 
neurotransmitter can be taken up by the glial or post-synaptic cell.
The second types of synapse are electrical synapses, also called gap junctions. They 
occur between two neurons that reside far more closely together than the cells at a 
chemical synapse. Channels form within the membrane of both the pre-synaptic and 
post-synaptic neurons allowing an electrical connection between the cells. These 
channels are called connexons and are made from multiple protein subunits called 
connexins (Bennett and Zukin, 2004; Gibson et al., 2005). Ions and other small 
molecules can pass between the neurons within the connexon channel transmitting the 
signal between cells. Signals can be transmitted far more quickly at gap junctions than 
chemical synapses.
1.1.4. Neurotransmitters
Neurotransmitters released by the pre-synaptic neuron at chemical synapses can be 
broadly classified into two groups: (1) small molecules including monoamines and amino
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acids, (2) larger peptide neuromodulators. Common small molecule neurotransmitters 
include acetylcholine (ACh), the amino acid derived dopamine, serotonin and histamine, 
and the amino acids glutamate and gamma-aminobutyric acid (GABA) (Table 1.1) 
Larger peptide neuromodulators are also used in neurotransmission and include 
enkephalins and endorphins, which are responsible for the response to pain.
Amino Acids
Aspartate 
Glutamate 
y-aminobutyric acid 
Glycine
Excitatory role within brain.
Most abundant fast excitatory neurotransmitter within brain. 
Chief inhibitory neurotransmitter in vertebrate nervous system. 
Inhibitory neurotransmitter.
Acetylcholines
ACh Excitatory neurotransmitter and longer-term neuromodulator.
Monoamines
Derived from tyrosine and phenylalanine
Dopamine
Norepinephrine
Epinephrine
Neurotransmitter and neurohormone. 
Neurotransmitter and hormone. 
Neurotransmitter and hormone.
Derived from tryptop lan
Serotonin Neurotransmitter and possible mitogen.
Derived from histidine
Histamine Neurotransmitter, involved in immune response and 
chemotaxis.
Table 1.1. Small molecule neurotransmitters in mammals
There are three classes of small molecule neurotransmitters: amino acids, 
acetylcholines and monoamines. Many have other functions aside from the role of 
a neurotransmitter.
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Classically, to be considered a neurotransmitter a molecule must be: synthesised within 
the neuron itself, found at the pre-synaptic membrane, released into the synaptic cleft 
causing a change in the post-synaptic membrane, and removed from the synaptic cleft 
by either recycling into the pre-synaptic neuron or glial cell, or by degradation. The effect 
of the molecule should be identical whether it has been released endogenously by the 
neuron or has been added exogenously in the form of a drug. Some neurotransmitters 
also function as neurohormones acting over long distances to modulate many cells.
1.1.5. The importance of the precise regulation of the synapse
The regulation of signalling at the synapse is an extremely important process which, 
when disrupted, can cause a variety of diseases. For example, a reduction in the level of 
release of the neurotransmitter dopamine is associated with Parkinson’s disease, which 
is characterised by tremors and rigidity. The bacterium Clostridium tetani, which causes 
tetanus, produces a neurotoxin that disrupts synaptic transmission resulting in a loss of 
muscular control, which can lead to the fatal cessation of breathing.
Various recreational drugs have effects upon the synapses. They often do not directly 
affect the release of neurotransmitters but instead interact with their receptors. Some 
drugs are receptor agonists, stimulating the receptor in the absence of the 
neurotransmitter. Others are antagonists that prevent receptor stimulation even in the 
presence of the appropriate neurotransmitter. Examples of some recreational drugs and 
their effects are given in table 1.2.
Alteration of synaptic regulation can also be used to treat behavioural disorders in 
humans. Mis-regulation of the neurotransmitter serotonin is hypothesised to be one 
cause of depression. The drug Prozac, which has successfully been used in the 
treatment of depression, affects the levels of serotonin at the synapse. It acts by 
preventing the re-uptake of serotonin from the synaptic cleft, thus increasing the 
stimulation of the post-synaptic cell.
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Recreational
Drugs
Effect on synapse Resulting behaviour
Nicotine ACh receptor agonist. Short-term exposure: nausea, and 
cramps.
Long-term exposure: relaxation and 
alertness.
Alcohol GABA agonist.
Reduces flow of Ca2+ into cells. 
Increases glutamate-binding 
sites.
Low dose: excitatory. 
High dose: inhibitory.
Cocaine Blocks reuptake of dopamine and 
norepinephrine.
Confidence, reduced desire for food 
and sleep.
Opiates Endorphin agonist. Pain suppression and euphoria.
LSD Serotonin receptor agonist. Visual hallucinations.
Table 1.2. Effects of drugs upon synapses
Drugs have both excitatory and inhibitory effects upon synapses.
1.1.6. The synaptic vesicle cycle
Neurotransmitters are stored in synaptic vesicles at the pre-synaptic termini. Fusion of 
these vesicles with the plasma membrane allows release of the contained 
neurotransmitter into the synaptic cleft, where it diffuses across to the post-synaptic 
plasma membrane and stimulates cell surface receptors (Figure 1.2).
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Taken from Sudhof 2004.
The release of neurotransmitters by the pre-synaptic neuron is stimulated by 
depolarisation of the membrane. Depolarisation causes an influx of calcium (Ca2+) ions 
through voltage-gated ion channels. These mediate fusion of the synaptic vesicle and 
plasma membranes, facilitating exocytosis of the contained neurotransmitter (Sudhof,
2004). The synaptic vesicles undergo a series of sequential steps to ensure the
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continuous availability of neurotransmitter for release (Figure 1.2) ((Sudhof, 2004) and 
references therein). Firstly the neurotransmitter is actively transported into the vesicles 
(step 1), which then cluster in close proximity to the active zone (step 2) (the area of the 
plasma membrane at which neurotransmitter release occurs). The vesicles then dock at 
the active zone (step 3) and undergo a priming step converting them into a state 
competent for Ca2+ mediated fusion (step 4). After fusion and release of the 
neurotransmitter into the synaptic cleft (step 5), the vesicles endocytose and recycle 
(steps 6-9). Three mechanisms of vesicle recycling have been described. The first 
involves the reacidification and neurotransmitter filling of the vesicles without undocking 
from the plasma membrane, called “kiss and stay”. These vesicles are immediately 
ready for another round of priming and fusion. Secondly, the vesicles undock and 
recycle locally by re-acidification and neurotransmitter filling, called “kiss and run”. The 
final method is for the vesicles to undergo clathrin-mediated endocytosis and either 
directly reacidify and refill with neurotransmitter, or first pass via an endosomal 
intermediate.
1.2. Caenorhabditis elegans as a model system
The nematode worm Caenorhabditis elegans (C. elegans) has been used as a model 
genetic organism for over 30 years (Brenner, 1974). Several features of the nematode 
make it an ideal system for studying development, the nervous system and behaviour. It 
is entirely transparent, therefore cells, including the neurons can easily be visualised in a 
living animal. There is a high level of conservation between the nervous systems of 
mammals and C. elegans, including the conserved use of the neurotransmitters 
glutamate, ACh and GABA, and the neuromodulators serotonin and dopamine. It is easy 
to genetically manipulate and cultivate C. elegans in a laboratory environment. Extensive 
studies have revealed the cellular anatomy of the 959 somatic cells comprising the 
animal as well as their lineage. Recently, the entire genome has been sequenced 
providing valuable information for genetic studies.
1.3. The nervous system of C. elegans
The nervous system of C. elegans is relatively simple comprising of just 302 neurons. In 
comparison, there are over 100 billion neurons within the human brain alone, and tens of
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thousands of neurons in Drosophila melanogaster (Williams and Herrup, 1988). In C. 
elegans, there are about 5000 chemical synapses, 600 gap junctions (electrical 
synapses) and 2000 neuromuscular junctions (NMJs, specialised chemical synapses 
occurring between neurons and muscles) (White et al., 1986). There may be just 302 
neurons but there are 118 different functional classes. There are 39 classes of sensory 
neurons, of which 21 have terminals at the tip of the head, 27 classes are motor neurons 
and the remainder are interneurons (White et al., 1986). The connectivity of the entire 
nervous system has been meticulously mapped with all contacts from each individual 
neuron defined (White et al., 1986). Laser ablation can be used to kill individual neurons, 
facilitating the study of specific neurons (Sulston and White, 1980). The measurement of 
currents within neurons and muscles in the living animal by electrophysiological 
techniques provides a further method to explore neuronal function and the effects of 
genetic mutations upon the nervous system (Lockery and Goodman, 1998; Richmond et 
al., 1999; Richmond and Jorgensen, 1999).
1.4. Neurotransmitters in C. elegans
The nervous system in C. elegans uses many of the classical neurotransmitters found in 
vertebrates, including ACh, GABA, serotonin, dopamine and glutamate. Additionally they 
use the invertebrate specific neurotransmitters octopamine and tyramine (Horvitz et al., 
1982; Lewis et al., 1980; Sulston et al., 1975). Serotonin, dopamine, octopamine and 
tyramine have neuromodulator roles in C. elegans regulating the release of the 
neurotransmitters at synapses. The specific neurotransmitters used by many neurons in 
C. elegans have been assigned.
Neuropeptides are the largest family of signalling molecules in the vertebrate nervous 
system. Over 109 genes are predicted to encode neuropeptides in C. elegans (Li, 2005). 
These include FMRFamide-related peptides (flp), insulin-related genes (ins) and 
neuropeptide-like genes (nip) that encode non-insulin and non-FMRFamide-related 
peptides (Li, 2005). The roles of neuropeptides in neurotransmission are increasingly 
being assigned and have been associated with a wide variety of behaviours. The ins 
gene DAF-28 has been shown to have a role in dauer formation (Li et al., 2003). The 
FMRFamide-related peptides have roles in locomotion, egg-laying and pharyngeal 
pumping (Li, 2005; Nelson et al., 1998; Rogers et al., 2001; Waggoner et al., 2000).
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1.5. Behaviours in C. elegans
Despite the small number of neurons, C. elegans has a widely varied set of responses 
and behaviours. They can be broadly grouped into four classes. The first is locomotion, 
which, being the most easily observed is the most studied behaviour (discussed in 
section 1.5.1). The second is sensory input. C. elegans can respond to a wide variety of 
sensory inputs including taste (Dusenbery, 1974; Ward, 1973), smell (Bargmann et al., 
1990; Barnes and Hekimi, 1997; Troemel et al., 1995), temperature (Hedgecock and 
Russell, 1975), touch (Kaplan and Horvitz, 1993) and osmotic cues (Bargmann et al., 
1990; Troemel et al., 1995). Mutants affecting all of these sensory behaviours have been 
extensively studied. The third class of behaviour is survival, including essential feeding 
and defecation (discussed in section 1.5.2). Reproduction is the final class including the 
behaviour of egg laying. More complex behaviours are also observed including social 
feeding, learning and memory and dauer formation (de Bono and Maricq, 2005; 
Geanacopoulos, 2004).
The behaviours of C. elegans are mediated by innate motor programmes controlling the 
muscles of the animal. There are at least six different programmes controlling largely 
differing groups of neurons and muscles. First, the locomotory programme, which 
involves the body wall muscles and a network of interneurons and motor neurons 
(Chalfie et al., 1985). The second motor programme controls egg-laying and involves a 
different specific set of motor neurons (Waggoner et al., 1998). Third is the rhythmic 
behaviour of defecation, which is controlled by a combination of contraction of the body 
wall muscles and the enteric muscles, and is regulated by another specific set of motor 
neurons (Liu and Thomas, 1994). Fourth is another rhythmic behaviour regulated by 
separate motor neurons, the pumping of the pharynx, facilitating feeding (Avery and 
Horvitz, 1987; Avery and Horvitz, 1989). Fifth is the apparent exploratory behaviour in 
which animals continuously move their head. This movement is mediated by muscles in 
the head and is controlled by a defined group of neurons in the head (Hart et al., 1995). 
The final programme regulates the complex male mating behaviour (Emmons and 
Lipton, 2003).
The behaviours of locomotion, pharyngeal pumping and defecation have been studied in 
this thesis and will be further described. The behaviours of sensory input, male mating
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behaviour, and egg-laying are all reviewed in Wormbook (Bargmann,; Barr and Garcia,; 
Goodman,; Schafer). Social feeding, adaptation and learning are all reviewed in de 
Bono and Marciq 2005.
1.5.1. Locomotion
The locomotion of C. elegans is limited to movement between the dorsal and ventral axis 
of the animal. Only the head is able to move in all orientations due to a different pattern 
of connection between the neurons and muscles. The locomotory circuit involves 95 
body-wall muscles innervated by multiple motor neurons. The animal moves in a 
sinusoidal wave pattern achieved through the contraction and relaxation of opposing 
dorsal and ventral body wall muscles (Figures 1.3 and 1.4) (Niebur and Erdos, 1993). 
The dorsal and ventral body wall muscles are regulated by different motor neurons.
There are three classes of motor neurons A, B and D which are further subdivided into 
those forming NMJs on the dorsal (DA, DB and DD) or ventral (VA, VB and VD) side of 
the animal, although the cell bodies for all these motor neurons lie within the ventral 
nerve cord (White et al., 1986). There are multiple members of each class sequentially 
laid out along the ventral nerve cord. Classes A and B are excitatory cholinergic neurons 
releasing ACh at the NMJ, class B controlling forward locomotion and class A controlling 
reverse locomotion. Class D are inhibitory GABAergic neurons releasing GABA at the 
NMJ (Mclntire et al., 1993b).
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IFigure 1.3 Sinusoidal locomotion
Animals move with a sinusoidal wave pattern of locomotion.
The red line indicates one body bend used as a measure of the rate of locomotion.
The class A and B motor neurons form characteristic dyadic synapses, being pre- 
synaptic with the muscle cell and with a dendrite from the D class motor neuron that 
forms NMJs on the opposite side of the animal (Figure 1.4) (White et al., 1986). Thus, 
upon stimulation, the cholinergic neurons send excitatory messages to both the muscle 
causing contraction and the D type motor neuron. This stimulates the D type motor 
neuron to release GABA onto the opposing muscle causing relaxation. The 
simultaneous activation of the VA and DD motor neurons, and the DA and VD motor 
neurons causes opposing muscle cell contraction and relaxation, creating body bends. 
The importance of co-ordinated opposing muscle contraction and relaxation is 
exemplified by the failure of GABA defective animals to undergo the escape response, 
elicited by wild type animals (a rapid reversal followed by resumption of forward 
locomotion) upon mechanostimulation, instead simply shrinking in size (Mclntire et al., 
1993a).
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Figure 1.4 Reciprocal relaxation and contraction of muscles by motor 
neurons facilitate locomotion
VA and DA are excitatory cholinergic motor neurons. DD and VD are inhibitory 
GABAergic neurons. Reciprocal contraction and relaxation of the muscles creates 
a body bend facilitating locomotion.
Taken from Siefert et al 2006.
The mechanism of transmission of the signal along the animal from anterior to posterior 
mediating forward locomotion and posterior to anterior mediating reverse locomotion has 
not yet been defined. It is hypothesised that the A and D stimulated neurons will transmit 
the excitatory signal to the adjacent A and D neurons to pass on the wave of opposing 
body wall muscle contraction and relaxation. The motor neurons may form a gap 
junction to transmit the signal to the neighbouring motor neuron. The interneurons are 
responsible for controlling the direction of locomotion providing excitatory or inhibitory 
signals to the motor neuron circuits controlling forward (B type motor neurons) and 
reverse locomotion (A type motor neurons).
1.5.1.1. Regulation of locomotion
The locomotion of the animal is regulated by a variety of different sensory inputs such as 
taste, smell, touch, osmolarity, and temperature. The locomotory response to touch is
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relatively simple, the animal reverses and moves away in another direction (Chalfie and 
Sulston, 1981; Chalfie et al., 1985). Responses to other cues in gradients such as smell 
and taste involve more complex locomotion including multiple turns and pirouettes with 
continued sensory input constantly changing the locomotion. These sensory and 
mechanosensory cues affect the direction of movement of the animal.
The speed of locomotion can also be regulated, as determined by counting the rate of 
body bends. One body bend is defined as half a sinusoidal wave, the region just behind 
the pharynx moves from the maximum amplitude of one bend to the maximum amplitude 
of the opposing bend (Figure 1.3) (Hart (ed.)). The feeding state of adult animals alters 
the locomotory rate; animals that are well fed have a lower rate of body bends and move 
more slowly, whilst those that are starved have a higher rate of body bends and move 
more quickly (de Bono and Bargmann, 1998; Sawin et al., 2000). The previous feeding 
state of an animal also determines the locomotory response to food. Animals that have 
been food-deprived exhibit a dramatic slowing when they contact food, whilst well-fed 
animals that have been without food for a short period of time undergo a less significant 
slowing of locomotion upon contact with food (Sawin et al., 2000). These responses to 
the presence of food are regulated by two different neuromodulators; the response after 
long-term absence of food is controlled by serotonin, whilst the response after short-term 
absence of food is controlled by dopamine (Sawin et al., 2000).
During the process of molting, which facilitates the transfer between larval stages during 
development, the locomotion of an animal is altered (Cassada and Russell, 1975). 
Molting is accomplished in three stages: firstly, apolysis when the old cuticle separates 
from the hypodermis, secondly the formation of the new cuticle from the hypodermis, 
and thirdly shedding of the old cuticle called ecdysis (White 1988). Immediately before 
apolysis animals enter a period of lethargus lasting approximately two hours (Kramer, 
1997). Initially, the animals cease moving and connections between the hypodermis and 
cuticle are broken (Kramer, 1997). This is followed by movement of the animal around its 
longitudinal axis, which further facilitates the loosening of the cuticle (Kramer, 1997). The 
animal can then undergo the formation of the new cuticle and ecdysis during which 
locomotion is restored and the animal pushes out of the old cuticle via its head (Kramer, 
1997).
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1.5.2. Feeding: Pharyngeal pumping and the peristalsis cycle
The natural habitat for C. elegans is in the soil, feeding upon bacteria. Feeding is 
mediated by the pharynx, a muscular structure consisting of eight different muscle types 
that can be divided into three functional compartments (Figure 1.5). The most anterior 
compartment, containing muscles pm1 through pm4, is called the corpus. This is 
responsible for the uptake and retention of bacteria. The second adjacent compartment, 
consisting of muscle pm5, is called the isthmus. The flow of bacteria through the pharynx 
is regulated by the isthmus. The third posterior compartment, including muscles pm6 
through pm8, is called the terminal bulb or the grinder. This is responsible for the 
grinding up of bacteria before the products enter the intestine.
Figure 1.5 Structure of pharynx
The pharynx is divided into three sub-sections: the corpus, which is responsible for 
bacterial intake, the isthmus, which is responsible for regulating bacteria flow 
through the pharynx, and the terminal bulb, which grinds up the bacteria.
Taken from Altun, 2005.
Two different motions within the pharynx are required for normal feeding. The first is 
pumping of the pharynx, and the second is isthmus peristalsis (Albertson and Thomson, 
1976; Avery and Horvitz, 1989). Pumping of the pharynx is achieved by a near- 
simultaneous contraction of the muscles within the corpus, the anterior isthmus and the 
terminal bulb (Figure 1.6 A). This is immediately followed by a near-simultaneous 
relaxation of the same muscles. Contraction of the corpus and anterior isthmus opens
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the lumen of the pharynx allowing bacteria to enter as far as the isthmus. The posterior 
isthmus fails to contract preventing the bacteria travelling further into the pharynx. The 
near-simultaneous contraction of the terminal bulb breaks up bacteria already residing 
there, pushing the resulting debris into the intestine (Doncaster, 1962). Relaxation of 
these muscles closes the pharynx retaining bacteria within the lumen and returns the 
grinder in the terminal bulb to the resting position. The second motion, isthmus 
peristalsis, now occurs. The posterior isthmus undergoes a wave of peristaltic 
contraction that transfers the bacteria trapped within the anterior isthmus into the 
posterior region and the terminal bulb ready for grinding (Doncaster, 1962) (Figure 1.6 
B). These motions are not always consecutive, typically every fourth pump is followed by 
isthmus peristalsis (Avery and Horvitz, 1987).
1.5.2.1. Neuronal regulation of feeding
The pharyngeal nervous system, composed of 20 neurons, is responsible for efficient 
feeding (Albertson and Thomson, 1976). It forms an entirely separate nervous system 
capable of independent function from the 282 neurons in the rest of the nervous system. 
Loss of connection between the two systems, by killing the two neurons that form gap 
junctions between the systems, has very little effect upon the function of either nervous 
system. The loss of the pharyngeal nervous system does not prevent pumping of the 
pharynx, however successful feeding is severely reduced (Avery and Horvitz, 1989). 
Three major differences occur, regulated by three different neurons: relaxation of the 
pharynx after contraction is delayed in the absence of the pharyngeal nervous system, 
which is regulated by neuron M3; the speed of pumping is reduced, controlled by MC, 
and there is no isthmus peristalsis stimulated by M4. Feeding is almost normal in 
animals that possess the same three neurons (M3, MC and M4) alone in their 
pharyngeal nervous system (Avery, 1993; Raizen et al., 1995). These neurons are 
therefore essential and sufficient for normal feeding, executing the principle function of 
the nervous system. The other neurons may be responsible for the regulation of feeding 
via these three neurons. A defined role has been assigned to one other class of 
pharyngeal neurons, the NSM (neurosecretory motor neuron) neurons. These neurons 
are involved in the communication of the presence or absence of food to the rest of the 
animal. The presence or absence of food has effects other than the regulation of the 
pharynx, such as controlling the speed of locomotion (Sawin et al., 2000).
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Figure 1.6 Feeding is mediated by pumping and isthmus peristalsis
(A) In a resting state bacteria previously ingested are in the terminal bulb. 
Contraction of the corpus and anterior isthmus opens the lumen allowing bacteria 
to enter the pharynx. Contraction of the terminal bulb grinds up the bacteria within 
the terminal bulb. Relaxation of the same muscles causes closing of the lumen 
retaining some bacteria and transfer of the bacteria debris from the terminal bulb 
into the intestine.
(B) Contraction of the posterior isthmus pushes the retained bacteria within the 
anterior isthmus and corpus into the terminal bulb ready for grinding upon another 
wave of pumping.
Adapted from Riddle et al 1997.
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1.5.3. Defecation: Defecation Motor Programme (DMP)
Defecation is an extremely tightly regulated rhythmic behaviour. The adult 
hermaphrodite defecates approximately once every 50 seconds when well fed (Croll and 
Smith, 1978; Liu and Thomas, 1994; Thomas, 1990). The defecation motor programme 
(DMP) has been extensively studied and can be divided into three phases: posterior 
body contraction (pBoc), anterior body contraction (aBoc) and enteric muscle contraction 
(Emc) causing expulsion (Exp) (Figure 1.7).
The DMP lasts approximately 5 seconds, followed by 45 seconds of intercycle before the 
next DMP begins. The initial contraction of the posterior dorsal and ventral body wall 
muscles drives the contents of the intestine forwards (pBoc). This is followed by 
contraction of the anterior dorsal and ventral body wall muscles and movement of the 
pharynx backwards into the gut (aBoc). This pressurises the intestine, so upon 
contraction of the enteric muscles, the anus opens and the gut contents are expelled 
(Exp).
Figure 1.7 Defecation cycle
The defecation motor programme consists of three phases: posterior body 
contraction (pBoc), anterior body contraction (aBoc), and enteric muscle 
contraction (Emc) resulting in expulsion (Exp).
Taken from de Bono and Marciq 2005.
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1.5.3.1. Regulation of defecation
Two different types of regulation of the defecation cycle have been identified: the control 
of individual steps, or regulation of the entire cycle length retaining all steps. The 
neurotransmitter GABA is required for enteric muscle contraction. Mutations that disrupt 
the production (mutation of unc-25, a glutamic acid decarboxylase) or transport 
(mutation of unc-47, a vesicular GABA transporter) of GABA result in a constipated 
phenotype, caused by a failure of enteric muscle contraction and thus expulsion 
(Thomas, 1990). This was the first instance in which GABA was identified to have an 
excitatory role. It activates a cation-selective channel, EXP-1, which is expressed in the 
enteric muscles (Beg and Jorgensen, 2003; Thomas, 1990). Other neurotransmitters, 
such as serotonin, have a role in regulation of defecation. Exposure to exogenous 
serotonin inhibits enteric muscle contraction causing constipation, although a direct 
effect upon the enteric muscles has not yet been proved (Segalat et al., 1995).
The length of the defecation cycle is regulated in alternative ways. The inositol 
trisphosphate (IP3) receptor (ITR-1) is involved in the regulation of the DMP cycle length 
(Dal Santo et al., 1999). Loss of ITR-1 in the intestinal cells causes an extreme increase 
in cycle time with no defecation observed over 10-20 minutes, conversely over 
expression of ITR-1 produces a shortened DMP cycle length (Dal Santo et al., 1999). 
ITR-1 is a Ca2+ channel localized to the endoplasmic reticulum, thus binding of IP3 to 
ITR-1 causes a change in Ca2+ levels (Dal Santo et al., 1999). The importance of Ca2+ 
was confirmed through observations of Ca2+ level fluctuations coinciding with the length 
of the DMP (Dal Santo et al., 1999). Subsequent studies have determined that loss of 
IRI-1, a protein that interacts with ITR-1 and is co-expressed in the intestine, causes an 
increase in the length and variability of defecation cycle time (Walker et al., 2004). These 
experiments implicate a role for IP3 signalling in the intestinal cells in the regulation of 
the defecation cycle.
Loss-of-function mutations of two phospholipase C (PLC) enzymes, EGL-8 (a PLC-p 
type PLC) and PLC-3 (a PLC-y type PLC), which catalyse the hydrolysis of 
phosphatidylinositol bisphosphate (PIP2) to IP3 and diacylglycerol (DAG), increase the 
length of the defecation cycle (Espelt et al., 2005). However, subsequent studies have 
suggested that only PLC-3 is responsible for producing the IP3 required to bind to ITR-1
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(Espelt et al., 2005). The proteins VAV-1 (a RhoGEF), RHO-1 (RhoA homologue), CED- 
10 (Rac homologue), MIG-2 (Rac homologue) and PPK-1 (phosphatidylinositol 4- 
phosphate 5-kinase) are all also predicted to have roles in regulating the length of the 
DMP (Norman et al., 2005). VAV-1 activates PLC-3 in other systems, suggesting VAV-1, 
RHO-1, CED-10 and MIG-2 could be regulating PLC-3 to control the DMP cycle length 
(Branicky and Hekimi, 2006).
The Exp phase of the defecation cycle is controlled by the nervous system. Mutations of 
proteins involved in general neurotransmission cause defects in the Exp phase 
including; the voltage gated ion channels UNC-2 and UNC-36 (Mathews et al., 2003), 
the DAG-binding protein UNC-13 (Branicky and Hekimi, 2006) and the syntaxin 
homologue UNC-64 (Richmond et al., 2001; Saifee et al., 1998). The Emc phase 
immediately preceeding Exp is also regulated by the nervous system. Serotonin, acting 
via Ga0, inhibits enteric muscle contraction and thus inhibits and Emc and Exp phases of 
the defecation cycle (Segalat et al., 1995).
Animals that migrate off the bacterial food lawn suspend the DMP cycle. When they 
return to food and restart pharyngeal pumping the DMP is reinitiated at the point in the 
cycle at which it was suspended. The phase of the defecation cycle is retained in the 
absence of food (Liu and Thomas, 1994). Conversely, a light touch causes the DMP 
cycle to be reset. Thus, regulation of the phase of the DMP cycle appears to be 
independent of the feeding status of the animal but is dependent upon mechanosensory 
inputs.
The motor programmes controlling defecation and pharyngeal pumping are regulated 
independently but can in some circumstances be interlinked. Mutations lowering the rate 
of pharyngeal pumping such as eat-2 have no effect upon the defecation cycle.
However, a reduction in food concentration results in an increase in DMP cycle time (Liu 
and Thomas, 1994). Conversely, mutations that prevent the expulsion step of the DMP 
and thus cause severe constipation have no effect upon the rate of pharyngeal pumping. 
They continue to feed at a normal rate until the pressure in the gut forces the anus open 
allowing almost the entire contents to be expelled. These mutants are viable and fertile 
but have small and scrawny phenotypes associated with malnourishment (Avery, 1993).
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1.6. The synaptic vesicle cycle in C. elegans
The genes and proteins involved in the regulation of the synaptic vesicle cycle in C. 
elegans have been elucidated through studies of the NMJ. Defects in synaptic 
transmission at the NMJ can be easily observed as defects in the behaviours of 
locomotion, egg laying, pharyngeal pumping and defecation. Genetic screens and 
studies initially focused upon changes in locomotion, due to the ease with which 
defective mutants can be identified. Subsequently, additional techniques to study 
release have been developed including pharmacological effects, electrophysiological 
analysis and electron microscopy (EM). The drug aldicarb, an inhibitor of ACh esterase, 
is commonly used to determine the rates of ACh release at the NMJ. Exposure to 
aldicarb causes a toxic accumulation of ACh in the synaptic cleft that leads to 
hypercontraction of the muscles including the pharynx and body wall muscles, causing 
paralysis and starvation, a reduced growth rate and eventual death of the animal 
(Cambon et al., 1979; Miller et al., 1996; Nguyen etal., 1995; Risheretal., 1987). Two 
different aldicarb assays are performed: the acute aldicarb assay that measures the rate 
of paralysis upon exposure to a single aldicarb concentration over a time period of 100- 
200 minutes (Lackner et al., 1999; Nurrish et al., 1999), and the chronic assay that 
measures the rate of death upon exposure to a range of aldicarb concentrations over a 
time period of 4-21 days (Miller et al., 1996; Miller et al., 1999). The rate of ACh release 
is directly correlated with the rate of paralysis in the acute assay (Lackner et al., 1999; 
Nurrish et al., 1999) and death in the chronic assay (Miller et al., 1996; Miller et al., 
1999). The roles of proteins in the various steps of the synaptic vesicle cycle are 
discussed below (Figure 1.8).
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Figure 1.8 The synaptic vesicle cycle in C. elegans
Many proteins with roles in the various steps of the synaptic vesicle cycle have 
been identified in C. elegans. Many proteins (indicated by *) are predicted to have 
roles in multiple steps.
1.6.1. Synaptic vesicle docking and priming
The process of synaptic vesicle docking is the least understood phase of the synaptic 
vesicle cycle. EM studies of both vertebrate synapses and the NMJ in C. elegans and 
Xenopus show a pool of vesicles that are in contact with the plasma membrane but have 
not undergone fusion (Buchanan et al., 1989; Jorgensen et al., 1995; Takahashi et al., 
1987). These vesicles are said to be docked. Vesicles that are docked either undergo 
fusion with the plasma membrane or detach before fusion (Murthy and Stevens, 1999; 
Zenisek et al., 2000). Docked vesicles undergo a priming step before fusing with the 
membrane. The proteins involved in the docking process are not known, but a few 
contenders have been identified.
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1.6.1.1. RAB-3
The small GTPase Rab3 is a likely candidate for a role in docking. In C. elegans RAB-3 
is associated with synaptic vesicles (Nonet et al., 1997). Synaptic vesicles in rab-3 
mutants have a dispersed localisation as opposed to the clustering observed in wild type 
animals. The mutants also exhibit a slight defect in locomotion, resistance in the acute 
aldicarb assay and have a subtle synaptic defect as determined by electrophysiological 
recordings (Mahoney et al., 2006; Nonet et al., 1997). The lack of severe phenotypes in 
rab-3 mutants suggests other proteins are also involved in docking. There are four Rab3 
isoforms in mammals. Knockout of all four isoforms in mice is lethal due to respiratory 
failure (Schluter et al., 2004). Examination of synapse and brain structure in the 
quadruple knockout revealed no defects, and analysis of cultured hippocampal neurons 
identified no defect in the spontaneous or sucrose-evoked release, suggesting Rab3 is 
not required for synaptic vesicle exocytosis, and thus has no role in synaptic vesicle 
docking, priming or vesicle endocytosis and trafficking (Schluter et al., 2004). A defect in 
the probability of neurotransmitter release was identified, which is caused by a change in 
the level of Ca2+ required to stimulate fusion (Schluter et al., 2006; Schluter et al., 2004).
1.6.1.2. AEX-3
The small GTPase RAB-3 exists in two forms, an inactive GDP-bound form and an 
active GTP-bound form. Guanine nucleotide exchange factors, GEFs, catalyse the 
conversion of the inactive GDP-bound form to the active GTP-bound form (further 
discussed in sections 1.14 and 1.18). RAB-3 is activated by the GEF AEX-3, resulting in 
its recruitment to synaptic vesicles (Iwasaki et al., 1997; Iwasaki and Toyonaga, 2000). 
aex-3 mutants have a locomotory defect and are resistant to aldicarb, similar 
phenotypes to those observed in rab-3 mutants . However, aex-3 mutants exhibit far 
more severe locomotory defects and stronger aldicarb resistance than rab-3 mutants, 
and show defects in the defecation motor programme not present in rab-3 mutants 
(Iwasaki et al., 1997; Iwasaki and Toyonaga, 2000). This suggests AEX-3 has additional 
roles in the regulation of neurotransmission aside from the activation of RAB-3.
An interaction between AEX-3 and a novel protein CAB-1 has been identified in yeast 
two hybrid and in vitro experiments (Iwasaki and Toyonaga, 2000). cab-1 mutant
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animals have defecation defects and are resistant to aldicarb, mimicking aex-3 mutant 
animals (Iwasaki and Toyonaga, 2000). Animals with mutations in both rab-3 and cab-1 
exhibit stronger aldicarb resistance than either mutation alone, suggesting CAB-1 could 
be a RAB-3 independent downstream target of AEX-3 in the regulation of 
neurotransmission (Iwasaki and Toyonaga, 2000).
1.6.1.3. RAB-27
Another Rab small GTPase, RAB-27 (also called AEX-6) is activated by the GEF AEX-3 
(Mahoney et al., 2006). rab-27 mutant animals have neurotransmission defects; they are 
slightly resistant to the ACh esterase inhibitor aldicarb, indicating a decrease in ACh 
release at the NMJ (Mahoney et al., 2006). Double mutant animals with mutations in 
both rab-3 and rab-27 have more a severe aldicarb resistance than the single mutants 
alone, which is comparable with aex-3 mutants (Mahoney et al., 2006). This is consistent 
with AEX-3 activating both RAB-3 and RAB-27 to regulate neurotransmission. 
Electrophysiology of the mutants supports the theory that AEX-3 is regulating both RAB-
3 and RAB-27 with aex-3 and rab-3; rab-27 double mutants having a similar reduction in 
the evoked response (Mahoney et al., 2006).
In vertebrates, the Rab effector rabphilin binds to both Rab3 and Rab27 (Fukuda, 2003; 
Fukuda, 2004; Fukuda, 2005). In C. elegans, the rabphilin homologue RBF-1 has been 
shown to only bind to RAB-27 in vitro, suggesting RBF-1 is only an effector for RAB-27 
(Fukuda, 2003; Fukuda, 2004). In vivo data also suggests RBF-1 is a specific effector of 
RAB-27. Firstly, RBF-1 is mislocalised in aex-3 and rab-27 mutant animals but not rab-3 
mutants. Secondly, genetic epistasis studies show rab-3; rbf-1 double mutants have 
more severe phenotypes than the single mutants, whilst rab-27; rbf-1 double mutants 
have no enhanced neurotransmission defect when compared to rab-27 single mutants 
(Mahoney et al., 2006). In C. elegans RBF-1 potentiates SNARE function through the 
homologue of the SNARE SNAP-25, RIC-4 (Staunton et al., 2001), whilst in vertebrates 
rabphilin regulates dense core vesicle docking by binding SNAP-25 (Tsuboi and Fukuda, 
2005). It is therefore hypothesised that RAB-27 regulates neurotransmission by 
controlling SNARE function through its effector RBF-1 (Rabphilin) and the t-SNARE RIC-
4 (SNAP-25) (Mahoney et al., 2006).
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1.6.1.4. UNC-10
Another protein potentially involved in RAB-3 mediated regulation of neurotransmission 
is UNC-10, the homologue of the mammalian protein Rim which interacts with Rab3 
(Wang et al., 1997). unc-10 mutants were originally identified in a screen looking for 
defects in movement, the mutants exhibit a sluggish locomotion (Brenner, 1974). The 
protein localises to a subdomain of the presynaptic terminal, placing it in the correct 
location for a role in vesicle docking. The mutants have been further characterised and 
have a decreased sensitivity to aldicarb suggesting a decrease in ACh release (Nguyen 
et al., 1995). EM analysis of animals containing a mutation of unc-10 has revealed a 
decrease in synaptic vesicle density at the synapse, resembling rab-3 mutants. Further 
detailed analysis of the vesicles has shown that in rab-3 mutants the reduction in vesicle 
density is caused by the dispersal of vesicles, whilst in unc-10 mutants there is a 
reduction in the total number of synaptic vesicles (Nonet et al., 1997). This is 
inconsistent with UNC-10 simply having a role in synaptic vesicle docking, suggesting a 
possible role for UNC-10 in vesicle trafficking. The phenotypes of unc-10 mutants are 
more severe than rab-3, which suggests that UNC-10 may have multiple roles in 
synaptic vesicle function and cycling whilst RAB-3 is only involved in the docking phase 
(Nonet et al., 1997). Expression of a constitutively open and active form of the SNARE 
protein UNC-64 (syntaxin) rescues the loss of synaptic function in unc-10 mutants 
supporting the idea that UNC-10 has a role in steps other than docking (Koushika et al., 
2001).
1.6.1.5. UNC-18
Another candidate to facilitate synaptic vesicle docking is UNC-18. Mutants are resistant 
to aldicarb and have a locomotion defect (Brenner, 1974; Hosono et al., 1992). 
Electrophysiological recordings have determined that there is an 80% loss of synaptic 
activity in unc-18 mutants (Weimer et al., 2003). The mammalian homologue; Munc-18, 
is also important for synaptic function, Munc-18 mice exhibit severe synaptic defects, 
with a complete loss in synaptic activity and the death of neurons, although the initial 
wiring of the nervous system is unaffected (Verhage et al., 2000). These data suggest a 
role for UNC-18 in synaptic activity. Munc18 and UNC-18 both bind to the SNARE 
protein syntaxin in vitro (Toonen and Verhage, 2003), and various experiments have
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implicated a role for UNC-18 in syntaxin localisation or stabilisation in cell culture and in 
vivo in mice and yeast (Bryant and James, 2001; Rowe et al., 2001; Voets et al., 2001). 
However, analysis of C. elegans unc-18 mutant animals has revealed no difference in 
the localisation of UNC-64 (syntaxin) and furthermore, over expression of constitutively 
open UNC-64 is unable to rescue the loss of synaptic activity in unc-18 mutant animals 
(Weimer et al., 2003). This suggests that the loss of synaptic activity in unc-18 mutant 
animals is not caused by a loss of UNC-64 (Weimer et al., 2003). EM analysis of unc-18 
mutants has revealed a reduction in the number of docked vesicles at the synapse, 
suggesting the role of UNC-18 could be at the docking phase of the synaptic vesicle 
cycle (Weimer et al., 2003). In Drosophila, over expression of the UNC-18 homologue, 
rop, causes a decrease in synaptic release, providing evidence for UNC-18 having both 
a positive and negative impact upon neurotransmission (Schulze et al., 1994).
1.6.1.6. The SNAREs
Docked vesicles at the plasma membrane are next primed, transferring them into a state 
competent for immediate fusion upon the appropriate Ca2+ stimulus. The main process 
that occurs is the formation of the SNARE (soluble NSF attachment protein receptor) 
complex between the SNARE proteins within the plasma membrane (t-SNAREs), 
syntaxin (UNC-64) and SNAP-25 (RIC-4), and the SNARE protein in the vesicle 
membrane (v-SNARE) synaptobrevin (SNB-1) (Chen et al., 2001). The SNARE complex 
consists of a very stable four helical bundle; two helices are from the t-SNARE SNAP-25 
and the other two are from the t-SNARE syntaxin and the v-SNARE synaptobrevin 
(Figure 1.9) (Sollner et al., 1993).
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Figure 1.9 The SNARE complex
The SNARE proteins form a very tight four alpha helical bundle. 
Syntaxin is shown in red.
Synaptobrevin is shown in blue.
SNAP-25 is shown in green.
Taken from Toonen and Verhage 2003.
The formation of the SNARE complex at the synapse brings the synaptic vesicle into 
close apposition with the plasma membrane. In mammals, the importance of the SNARE 
complex has been exemplified by the observation of a correlation between the size of 
the ready releasable pool of synaptic vesicles (vesicles that are docked and primed at 
the membrane) and the level of SNARE complex formation (Lonart and Sudhof, 2000).
In C. elegans loss-of-function mutations in the SNARE proteins, snb-1 (synaptobrevin) 
and unc-64 (syntaxin) lead to embryonic arrest at larval stage 1 (L1) limiting the 
characterisation of the role of these proteins (Nonet et al., 1998; Saifee et al., 1998). 
Hypomorphic mutations in snb-1 have shown a role for SNB-1 in synaptic transmission; 
the animals are resistant to aldicarb (Nonet et al., 1998). Non-null mutations in ric-4 also 
result in aldicarb resistance (Nguyen et al., 1995), and a reduction-of-function mutation 
in unc-64 causes aldicarb resistance and lethargic locomotion (Hawasli et al., 2004). All 
this data supports the hypothesis for a role of these SNARE proteins in 
neurotransmission.
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1.6.1.7. UNC-13
A key regulator in the priming process is the protein UNC-13. There are three predicted 
isoforms of UNC-13 expressed in C. elegans (Figure 1.10) (Kohn et al., 2000). All three 
isoforms contain C1 and C2 domains, which are regulatory domains originally found in 
protein kinase C (Kohn et al., 2000). C1 domains bind to DAG (Burns and Bell, 1991), 
and C2 domains bind to Ca2+ and phospholipids (Kaibuchi et al., 1989). These C1 and 
C2 domains enable UNC-13 to bind to DAG and to phospholipids in a Ca2+ dependent 
manner (Ahmed et al., 1992; Kazanietz et al., 1995; Maruyama and Brenner, 1991). The 
C-terminus, conserved in all three isoforms, is called the R region and contains one C1 
domain and two C2 domains (Kohn et al., 2000). The smallest isoform (called UNC-13S) 
contains the R region and a small additional N terminal region called the M region 
(Figure 1.10) (Kohn et al., 2000). The other two isoforms contain another region N 
terminal to the R region called the L region (Kohn et al., 2000). The L region contains a 
C2 domain at the N terminus. The medium length isoform is composed of the L and R 
regions, whilst the longest isoform (UNC-13L) contains all three regions; R, M and L 
(Kohn et al., 2000). The mammalian Munc13-1 shows the strongest homology to the 
isoform containing the L and R regions; the R region is 50% identical and the L region is 
30% identical (Kohn et al., 2000). Two other Munc-13 isoforms, Munc13-2 and Munc13- 
3 have been predicted, both of which contain an N terminus differing from the L region 
that lacks a C2 domain (Kohn et al., 2000).
UNC-13 L/M/R  
(UNC-13L) M
UNC-13 U R  
(UNC-13M)
UNC-13 M/R
M R(UNC-13S)
Figure 1.10 UNC-13 isoforms
There are three isoforms composed of different combinations of three regions; L, 
M and R. All isoforms contain a C1 domain and multiple C2 domains. Alternative 
nomenclature show in brackets 
C1 domain □  C2 domain H
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UNC-13 is expressed in neurons in a punctate distribution, showing enrichment at 
synapses (Kohn et al., 2000). UNC-13 is an essential protein; an unc-13 null mutation is 
lethal (Kohn et al., 2000). Reduction-of-function mutations in unc-13 causes paralysis 
and resistance to aldicarb, although the animals exhibit a normal response to the 
muscular ACh receptor agonist levamisole indicating a pre as opposed to post-synaptic 
role in regulating ACh release (Brenner, 1974; Nguyen et al., 1995; Rose and Baillie, 
1980). Electrophysiological analysis of the evoked and endogenous responses shows 
defects in unc-13 mutants. The evoked response is completely lost in the severe 
reduction-of-function mutant unc-13 (s69) which is paralyzed (Richmond et al., 1999). 
Synaptic vesicles are seen to accumulate at the synapse in this mutant although they 
are fusion incompetent. Similar synaptic vesicle priming defects are seen in Drosophila 
Dunc-13 mutants and mouse Munc13-1 mutants (Aravamudan et al., 1999; Augustin et 
al., 1999).
In mammals, Munc13 interacts with the N-terminal of syntaxin, suggesting a possible 
mechanism for the regulation of synaptic vesicle priming by Munc13 (Betz et al., 1997). 
This interaction is conserved in C. elegans (Madison et al., 2005). UNC-64 (syntaxin) 
exists in two conformations: the closed conformation, which is unable to form part of the 
SNARE complex, and the open conformation, which can form the SNARE complex, unc- 
64 mutants, constitutively in the open conformation, have been previously reported to 
restore the stimulus-evoked response in unc-13 mutants suggesting an interaction 
between UNC-13 and UNC-64 mediates vesicle priming (Richmond et al., 2001). 
However, recent results suggest that there is only a small rescue in the stimulus-evoked 
response of unc-13 mutants by open unc-64 (McEwen et al., 2006). Other 
measurements for determining the level of synaptic transmission, such as 
electrophysiological measurement of the rate of endogenous EPSCs (excitatory post- 
synaptic currents) and locomotory body bend assays, in the unc-13; unc-64 open 
conformation double mutants have been recorded, and suggest that significant defects 
in synaptic transmission remain in these double mutant animals (McEwen et al., 2006).
Another protein that has been shown to interact with Munc13 is Rim (UNC-10) 
(Andrews-Zwilling et al., 2006; Betz et al., 2001). The interaction between Munc13-1 and 
Rim is thought to facilitate the recruitment of Munc13-1 to the active site at the synapse, 
where it can then participate in neurotransmission (Andrews-Zwilling et al., 2006).
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Evidence for the conservation of this interaction in C. elegans has not been obtained 
thus far. However, examination of the roles of UNC-10 and UNC-13 in synaptic vesicle 
localisation at the synapse in C. elegans has determined that UNC-10 and UNC-13 
localise vesicles to separate sites and UNC-10 recruits vesicles in an UNC-13 
independent manner (Weimer et al., 2006).
1.6.1.8. TOM-1
The protein tomosyn (TOM-1) contains a SNARE motif homologous to synaptobrevin 
and forms an inhibitory complex with the SNAREs syntaxin and SNAP-25 (Fujita et al., 
1998; Hatsuzawa et al., 2003; Pobbati et al., 2004; Widberg et al., 2003). Mutation of 
tom-1 causes an increase in the evoked response, indicating an increase in primed 
vesicles, and an observed increase in the abundance of UNC-13 at release sites, 
suggesting TOM-1 negatively regulates neurotransmitter release (Gracheva et al., 2006; 
McEwen et al., 2006). Mutation of tom-1 was able to increase synaptic transmission in 
the absence of UNC-13 even though UNC-13 recruitment was observed in tom-1 
mutants containing UNC-13, thus TOM-1 does not require UNC-13 to regulate 
neurotransmission (McEwen et al., 2006). TOM-1 binds to the open form of UNC-64, 
suggesting that its inhibitory effect upon neurotransmission could be achieved by 
sequestering open UNC-64, and preventing the formation of the SNARE complex. As 
discussed above expression of a constitutively active form of unc-64 (syntaxin) partially 
rescues the evoked response in unc-13 mutant animals (McEwen et al., 2006). The 
evoked response is more substantially rescued by open UNC-64 in unc-13; tom-1 
double mutants, suggesting both TOM-1 and UNC-13 regulate release by UNC-64 
(McEwen et al., 2006). The ability of TOM-1 to regulate release in the absence of UNC- 
13 suggests that open UNC-64 is present in the absence of UNC-13, thus UNC-13 is not 
essential for the formation of the open conformation of UNC-64 (McEwen et al., 2006). 
This suggests that both UNC-13 and TOM-1 positively and negatively regulate 
neurotransmission through the regulation of UNC-64 respectively.
In mammals, the affinity of tomosyn for syntaxin is regulated by phosphorylation. The 
protein Rho kinase, which is activated by Rho, phosphorylates syntaxin (Sakisaka et al.,
2004). Tomosyn has an increased affinity for phosphorylated syntaxin, thus 
phosphorylation by Rho kinase will increase the interaction between tomosyn and
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syntaxin (Sakisaka et al., 2004). This modification of syntaxin by Rho kinase provides a 
possible mechanism by which the inhibitory interaction between tomosyn and syntaxin at 
the synapse could be regulated.
1.6.1.9. Separation of docking and priming
The separation of the docking and priming steps of the synaptic vesicle cycle is 
controversial. The roles of some proteins in the two steps are debated. The SNARE 
proteins in mammals are thought not to be involved in the docking phase. Injection of the 
Clostridium botulinum neurotoxins, which cleave the SNARE complex (Humeau et al., 
2000; Schiavo et al., 2000), into the synaptic terminal of giant squid synapses inhibits 
neurotransmission but does not lead to a loss of vesicles from the active zone (O'Connor 
et al., 1997). In C. elegans the discovery that the Rab GEF AEX-3 activates both RAB-3 
and RAB-27 to regulate vesicle docking, and RAB-27 acts via its effector RBF-1 
controlling SNARE function through RIC-4 (SNAP-25) supports the idea that the 
SNAREs are involved in synaptic vesicle docking (Mahoney et al., 2006).
It has previously been reported that unc-13 mutant animals exhibit a reduction in 
synaptic vesicle exocytosis but do not show a change in the percentage of vesicles at 
the plasma membrane at the EM level (Richmond et al., 1999). New advances in EM in 
C. elegans, which reduce the contraction of the membrane upon freezing, reveal that 
there is a reduction in the number of vesicles in close proximity to the plasma membrane 
in unc-13 mutant animals, suggesting unc-13 is involved in the docking step of the 
synaptic vesicle cycle (Jorgensen et al., 2006). This reduction in the number of docked 
vesicles is rescued by the expression of a constitutively open form of UNC-64 
(Jorgensen et al., 2006).
UNC-18, a protein previously shown to be involved in the docking of synaptic vesicles, 
binds to UNC-64 (Weimer et al., 2003). In mammals, the interaction between Munc18 
and syntaxin is thought to be required for either the conversion of syntaxin from the 
closed conformation to the open conformation or stabilise the open conformation or both 
to facilitate SNARE complex formation (Dulubova et al., 1999). It was previously 
published that expression of mutant unc-64, in the constitutively open conformation, was 
unable to rescue the paralysis or the evoked and endogenous responses in unc-18
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mutants (Weimer et al., 2003). However, further experiments have shown that the 
docking defects in unc-18 mutants are rescued by expression of the constitutively open 
unc-64 mutant (Jorgensen et al., 2006). This suggests that UNC-64 and possibly the 
SNARE complex are involved in the docking step of the cycle.
1.6.2. Fusion
The fusion of synaptic vesicles occurs in response to a rise in the concentration of Ca2+ 
at the synapse. Many proteins have been identified as potential components of 
voltage-gated Ca2+ channels thought to be responsible for the influx of Ca2+ at the 
synapse. These include UNC-2, EGL-19 and UNC-36 (Lee et al., 1997; Richmond et al., 
2001; Schafer et al., 1996). Studies of the v-SNARE, synaptotagmin, in mammals and 
Drosophila show it may also have a role in Ca2+ sensing (Bai et al., 2002; Fernandez- 
Chacon et al., 2001; Geppert et al., 1994; Gerber et al., 2002; Littleton et al., 1994; 
Littleton et al., 1993; Sutton et al., 1995). In C. elegans snt-1 (synaptotagmin) mutants 
are severely uncoordinated and exhibit synaptic transmission defects, and EM 
experiments suggest the primary defect is in endocytosis, which is also dependent upon 
Ca2+ (Jorgensen et al., 1995; Nonet et al., 1993). Fusion of the synaptic vesicle with the 
plasma membrane occurs microseconds after the influx of Ca2+. It is thought to be 
mediated by the neuronal SNARE complex consisting of SNB-1, UNC-64 and RIC-4. In 
C. elegans null mutations in snb-1 and unc-64 cause embryonic arrest suggesting an 
essential role in neurotransmitter release. In mammalian systems, disruption of any of 
the SNAREs, such as cleavage by treatment with Botulinum neurotoxins, inhibits fusion 
and a null mutation in syntaxin in Drosophila also inhibits fusion (Aravamudan et al., 
1999; Chen et al., 1999; Chen et al., 2001; Xu et al., 1999). Expression of only the 
SNARE proteins in reconstituted vesicles facilitates synaptic fusion supporting the 
essential and sufficient role for SNAREs in vesicle fusion (Weber et al., 1998).
1.6.3. Endocytosis and vesicle recycling
After fusion, synaptic vesicles are recycled by endocytosis and filled with 
neurotransmitter, providing a quick source of vesicles to maintain high levels of 
neurotransmitter release as required. Clathrin-mediated endocytosis is thought to be the 
main method of vesicle retrieval. The vesicles are initially recruited for endocytosis by
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adaptor proteins that bind clathrin, facilitating budding and fission by the small GTPase 
dynamin.
1.6.3.1. SNT-1
Mutation of snt-1 causes an uncoordinated locomotion and impaired synaptic 
transmission (Nonet et al., 1993). The loss of synaptotagmin in both mice and 
Drosophila is lethal; there is a selective loss of synchronous release but no loss of 
asynchronous and spontaneous mini release (Geppert et al., 1994; Littleton et al., 1993). 
A role for synaptotagmin in Ca2+ sensing to mediate fast neurotransmitter release in 
Drosophila and mice has been proposed (Geppert et al., 1994; Littleton et al., 1993).
In C. elegans, EM analysis of the synapse has shown a reduction in the number of 
vesicles and trapping of SNB-1 in the plasma membrane in snt-1 mutants, suggesting 
SNT-1 has a role in endocytosis in addition to the role of a Ca2+ sensor in exocytosis 
(Jorgensen et al., 1995). In Drosophila, EM analysis of synaptotagmin (syt) mutant 
animals has revealed a reduction in the number of synaptic vesicles (52% reduction), 
although also a more significant reduction in the number of docked vesicles (76% 
reduction), suggesting synaptotagmin has a role in vesicle cycling and possibly vesicle 
docking (Reist et al., 1998). The clathrin adaptor protein AP-2 has been shown to 
interact with synaptotagmin in numerous systems (Fukuda et al., 1995; Haucke and De 
Camilli, 1999; Haucke et al., 2000; Zhang et al., 1994), suggesting AP-2 may be 
interacting with SNT-1 to facilitate vesicle endocytosis. There is very little evidence for 
this in C. elegans since knockdown of the two subunits (a-adaptin and p-adaptin) of AP- 
2 cause embryonic lethality and knockdown of a third (a2) and mutation of a fourth (p2) 
cause a dumpy morphology (Grant and Hirsh, 1999; Harris et al., 2001). It has been 
reported but unpublished that mutation of \i2 not only causes a dumpy morphology, but it 
also causes a reduction in synaptic vesicles (Davis et al., 1999). In vitro experiments 
have confirmed that the synaptotagmin-AP2 interaction is required to facilitate receptor- 
mediated endocytosis although a role in the endocytosis of synaptic vesicles has not 
thus far been shown (Haucke et al., 2000).
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1.6.3.2. UNC-11
Mutation in a second clathrin adaptor protein UNC-11 (AP180) causes a defect in 
synaptic transmission and the mis-localisation of SNB-1 (Dittman and Kaplan, 2006; 
Nonet et al., 1999). No defect in endocytosis is observed; the pool of vesicles is 
maintained, although they are larger than in wild type animals (Nonet et al., 1999). The 
binding of clathrin to the vesicles via the adaptor proteins and the conversion of the 
bound clathrin from a flat hexagonal matrix to the cage structure is thought to induce the 
budding of the vesicles from the membrane (Kirchhausen, 2000). The unusually large 
vesicles observed in unc-11 mutants could be due to a defect in the formation of the 
clathrin cages which have been shown to be regulated by the mammalian homologue 
AP180 (Ahle and Ungewickell, 1986).
1.6.3.3. Dynamin
The small GTPase dynamin is responsible for the fission step in which the clathrin 
coated pits separate from the plasma membrane to become vesicles (Sweitzer and 
Hinshaw, 1998). The activity of dynamin is closely regulated. Mutations in two proteins 
known to interact with dynamin cause defects in synaptic transmission and more 
specifically a reduction in the number of synaptic vesicles, EHS-1 (Eps15) and UNC-57 
(endophilin) (Salcini et al., 2001; Schuske et al., 2003). The role of UNC-57 in the 
regulation of dynamin has not been confirmed. Mutation of unc-57 causes the 
accumulation of clathrin-coated and uncoated invaginated pits at the synapse, 
suggesting a defect in endocytosis (Schuske et al., 2003).
1.6.3.4. UNC-26
The phosphoinositide phosphatase UNC-26 (synaptojanin) is mis-localised in unc-57 
mutant animals; it is diffusely spread in the neuron as opposed to being localised to the 
synapse (Schuske et al., 2003). Synaptojanin has a role in vesicle endocytosis; 
synaptojanin-1 mutant mice have defects in the uncoating of synaptic vesicles (Cremona 
et al., 1999). Mutation of unc-26 in C. elegans causes synaptic transmission defects 
resulting from multiple defects in synaptic vesicle endocytosis and recycling including 
synaptic vesicle budding and uncoating after fission, supporting the hypothesis UNC-26
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plays a role in synaptic vesicle endocytosis (Harris et al., 2000). Mutation of unc-57 
cause the same defects in synaptic transmission as unc-26 mutants and double mutants 
of both genes do not show any higher severity of defects (Harris et al., 2000; Schuske et 
al., 2003), suggesting UNC-57 may recruit UNC-26 to the synapse to facilitate vesicle 
fission. After fission, vesicles undergo an uncoating of clathrin before beginning another 
round of the synaptic cycle.
1.7. Regulation of ACh release at the neuromuscular junction
In the genetic model system C. elegans, the control of ACh release at the NMJ has been 
the most studied example of the regulation of the synaptic vesicle cycle, as defects in 
the release of ACh have clear phenotypes. The loss of pharyngeal pumping causes 
death and locomotory defects are easily observed. Simple pharmacological assays have 
been developed to easily assay the rate of ACh release using the drugs aldicarb or 
trichlorfon, and assay the sensitivity of the ACh receptors in the muscle using the drug 
levamisole. Analysis of the genes involved in the regulation of the speed of locomotion 
and the release of ACh in C. elegans provides a model to identify the proteins involved 
in the regulation of neurotransmitter secretion.
1.7.1. Regulation of DAG levels and UNC-13 control ACh release
In C. elegans the DAG-binding protein UNC-13 is required for synaptic transmission; null 
mutants are dead and reduction-of-function mutants are paralyzed with the evoked 
response being completely lost (Brenner, 1974; Kohn et al., 2000; Nguyen et al., 1995; 
Richmond et al., 1999). In mice, the mammalian homologues of UNC-13, Munc13-1 and 
Munc13-2, and in flies, the Drosophila homologue, Dunc13, are required for 
neurotransmitter release (Aravamudan et al., 1999; Augustin et al., 1999). The step in 
the synaptic vesicle cycle at which UNC-13 is required is currently under debate. 
Previous experiments have observed clustering of vesicles at the membrane in unc-13 
null mutants suggesting a defect in the priming step after docking (Richmond et al., 
1999). However, different EM techniques have suggested that there may be a defect in 
synaptic vesicle docking in UNC-13 mutants (Weimer et al., 2006). In C. elegans UNC- 
13 interacts with UNC-64 (syntaxin) (Madison et al., 2005), an interaction that has been 
shown to be conserved in mammals (Betz et al., 1997{Brose, 2000 #135)}. Experiments
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using mouse adrenal chromaffin cells have demonstrated that the minimal protein 
domain within Munc13-1 required to mediate synaptic vesicle priming includes the 
domain that binds to syntaxin (Stevens et al., 2005). Furthermore, point mutations that 
prevent the interaction between Munc13-1 and syntaxin prevent vesicle priming 
(Stevens et al., 2005). In C. elegans mutations in the MHD2 (Munc homology domain) of 
UNC-13, which disrupt the interaction between UNC-13 and UNC-64, reduce the evoked 
and endogenous responses (Madison et al., 2005). However, no reduction in the pool of 
fusion competent vesicles was observed suggesting that the UNC-13/ UNC-64 
interaction is involved in vesicle fusion as opposed to priming or docking (Madison et al., 
2005). unc-64 mutants that are constitutively in the open conformation partially rescue 
the paralysis and evoked release in unc-13 null animals (Richmond et al., 2001). This 
suggests that at least one role for UNC-13 is to interact with the SNARE UNC-64 
(syntaxin) converting it to the open conformation required for SNARE complex formation 
to mediate synaptic transmission. However, the conformation of UNC-64 is also 
potentially regulated by TOM-1, suggesting UNC-13 is not essential to facilitate the 
conversion of UNC-64 to the open conformation (McEwen et al., 2006).
Phorbol esters, functional analogues of the lipid second messenger DAG, bind to the 
zinc finger-like C1 domains of numerous proteins including UNC-13. Phorbol esters 
increase the synaptic efficacy of many neurons (Majewski and lannazzo, 1998), and 
increase the release of ACh at the NMJ in C. elegans (Lackner et al., 1999; Miller et al., 
1999). The increase in neurotransmission by phorbol esters is mediated by UNC-13. 
Non-DAG binding forms of both Munc13-1 (H567K) and UNC-13 (H173K) prevent the 
ability of phorbol esters to increase synaptic transmission (Lackner et al., 1999; Nurrish 
et al., 1999; Rhee et al., 2002). Thus, DAG binding to UNC-13 is required to increase 
neurotransmitter release. Regulation of DAG could therefore provide a mechanism for 
the regulation of synaptic transmission.
1.7.2. Heterotrimeric G proteins regulate DAG levels and ACh release
A wide variety of neurotransmitters and hormones act via seven transmembrane G 
protein coupled receptors (GPCRs) to both stimulate and inhibit synaptic release 
(Dohlman et al., 1991; Nicoll et al., 1990). The G-proteins have a, p and y subunits 
(McCudden et al., 2005). The a subunit binds to GTP or GDP. When the a  subunit is
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bound to GDP the subunits form an inactive trimeric conformation, bound to the 
receptor, sequestering the a  subunit at the plasma membrane (Figure 1.11). Upon 
stimulation, the receptor acts as a guanine nucleotide exchange factor (GEF) and 
catalyses the replacement of the bound GDP by GTP at the a  subunit (McCudden et al.,
2005). This causes dissociation of the trimeric complex allowing the GTP bound a  
subunit, and the 0 and y subunits to separate (Figure 1.11). The a subunit diffuses away 
in the membrane and activates downstream effectors (McCudden et al., 2005), whilst the 
0-Y  subunits activate separate effectors (Birnbaumer, 1992) (Figure 1.11). The intrinsic 
hydrolytic activity of the a  subunit converts the bound GTP to GDP causing the 
reformation of the trimeric complex and inactivation of the downstream effectors and 
pathways. GTPase activating proteins (GAPs) catalyse the intrinsic hydrolysis of GTP to 
GDP quickening the “switching off” of the downstream signalling pathways.
Three heterotrimeric G proteins have been identified in the regulation of ACh release at 
the NMJ in C. elegans. These proteins and the components of their downstream 
pathways have been identified in genetic screens looking at changes in locomotion, egg- 
laying and the effects of the drug aldicarb (Brenner, 1974; Lackner et al., 1999; Miller et 
al., 1996; Miller et al., 1999; Nguyen et al., 1995; Nurrish et al., 1999; Sieburth et al.,
2005).
Two competing heterotrimeric G protein coupled pathways involving the academy 
Ga subunits EGL-30 (Gaq) and GOA-1 (Ga0) have been identified to regulate ACh 
release via DAG and UNC-13 (Lackner et al., 1999; Miller et al., 1999; Nurrish et al., 
1999). A third G protein, Gas appears to act downstream of DAG to regulate ACh 
release (Reynolds et al., 2005; Schade et al., 2005).
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Figure 1.11 Cycle of activation of heterotrimeric G proteins
Trimeric G proteins are composed of three subunits, a, p and y, which cycle
between existing in a complex or independently.
(1) In the inactive conformation, the GaPy subunits are associated with the seven- 
transmembrane receptor.
(2) Ligand (*) binding to the receptor stimulates its GEF activity replacing GDP for 
GTP on the a subunit and activating it.
(3) Active GTP-Ga dissociates from the Gpy subunits and both the a and py 
subunits bind to their effectors (E) stimulating downstream pathways.
(4) RGS proteins (GAPs) catalyse the intrinsic GTPase activity of the Ga subunit 
hydrolysing GTP to GDP.
(5) The inactive Ga-GDP subunit reforms the complex with Gpy subunits and 
rebinds to the receptor.
Taken from Bastiani and Mendel 2006.
1.7.3. Gaq (EGL-30)
EGL-30, the homologue of Gaq, has been associated with movement. Null mutations of 
egl-30 show strong paralysis and are larval lethal, but hypomorphic mutations are viable 
and cause a sluggish locomotion. Over expression in the motor neurons or gain-of- 
function mutations of EGL-30 cause a hyperactive loopy locomotion (Brundage et al., 
1996; Lackner et al., 1999). A screen looking for mutants showing resistance to aldicarb
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isolated egl-30 alleles, suggesting a role for EGL-30 in ACh release at the NMJ (Miller et 
al., 1996). In mammals, Gaq activates the enzyme phospholipase C (PLC) (Singer et al.,
1997). This catalyses the conversion of phosphatidylinositol bisphosphate (PIP2) into the 
small signalling molecules, membrane bound DAG and inositol trisphosphate (IP3) 
(Berridge, 1998; Malenka et al., 1986; Shapira et al., 1987). EGL-30 activates the PLCp 
homologue EGL-8 (Brundage et al., 1996), and mutations of both genes cause a similar 
sluggish locomotion, aldicarb resistance and reduction in neurotransmitter release 
(Lackner et al., 1999; Miller et al., 1996; Miller et al., 1999). This suggests that EGL-30 is 
activating EGL-8, leading to the production of DAG and IP3, and stimulating the release 
of ACh. egl-30 null mutants are lethal whilst egl-8 null mutants are viable, suggesting 
some additional EGL-8-independent roles for EGL-30. The paralysis and lethality of egl- 
30 null mutations can be rescued by treatment with phorbol esters; the resulting animals 
exhibit hyperactivity and an increased sensitivity to aldicarb (Reynolds et al., 2005). This 
suggests that the production of DAG, downstream of EGL-30, stimulates ACh release 
(Figure 1.12).
As discussed above, (sections 1.6.1.7 and 1.7.1) the DAG-binding protein UNC-13 is 
involved in the regulation of synaptic transmission. Expression of a constitutively 
membrane-bound form of UNC-13 rescues the sluggish locomotion and aldicarb 
resistance of egl-8 mutants (Lackner et al., 1999). The binding of proteins to DAG often 
promotes membrane association, mediating the specific effects of the protein. In 
mammals, phorbol esters promote the membrane recruitment of Munc13-1 suggesting 
DAG may be recruiting UNC-13 to the membrane to mediate ACh release at the NMJ in 
C. elegans (Betz et al., 1998). Stimulation of ACh release by the muscarinic agonist 
arecoline, which acts via EGL-30, causes the recruitment of the short UNC-13 isoform to 
sites of release, and this is blocked in a non-DAG binding UNC-13 mutant (UNC- 
13S(H173K)) (Lackner et al., 1999). This suggests EGL-30 stimulates ACh release via 
EGL-8 and a spatially localised increase in DAG as detected by a change in GFP tagged 
UNC-13S localisation (Figure 1.12).
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Figure 1.12 EGL-30 and EGL-8 stimulate ACh release
EGL-30 activates the enzyme EGL-8 that converts PIP2 into DAG leading to the 
recruitment of UNC-13 to release sites and ACh release.
Adapted from (Lackner et al., 1999).
Proteins stimulating ACh release are shown in blue.
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1.7.4. Ga0 (GOA-1)
A second G protein involved in the regulation of ACh release is GOA-1 (Ga0) (Hajdu- 
Cronin et al., 1999; Mendel et al., 1995; Miller et al., 1999; Nurrish et al., 1999; Segalat 
et al., 1995). goa-1 mutant animals display hyperactive locomotion, whilst animals over 
expressing wild type and constitutively active GOA-1 exhibit lethargic locomotion 
(Mendel et al., 1995; Segalat et al., 1995). The monoamine serotonin regulates 
locomotion; treatment with exogenous serotonin causes a reduction in the rate of 
locomotion, whilst mutants which lack serotonin (tryptophan hydroxylase (tph-1) 
mutants) move hyperactively (Horvitz et al., 1982; Segalat et al., 1995). The lethargic 
locomotion caused by exogenous serotonin correlates with a reduction in ACh release, 
both of which are blocked by mutation of goa-1 (Mendel et al., 1995; Nurrish et al., 1999; 
Segalat et al., 1995). Furthermore, mutation of goa-1 causes an increase in ACh 
release, whilst over expression of GOA-1 in the motor neurons causes a reduction in 
ACh release (Miller et al., 1999; Nurrish et al., 1999). The reduction in ACh release is 
rescued by treatment with phorbol esters (Nurrish et al., 1999). Mutation of goa-1 causes 
the recruitment of UNC-13 to sites of release in a DAG binding dependent manner, 
mimicking the recruitment observed in EGL-30 over expressing animals (Lackner et al., 
1999; Nurrish et al., 1999). All this data supports the hypothesis that within the motor 
neurons GOA-1 inhibits ACh release in a DAG and UNC-13 dependent manner (Figure 
1.13).
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Figure 1.13 GOA-1 negatively regulates ACh release
GOA-1 reduces ACh release via DAG and UNC-13. 
Proteins inhibiting ACh release are shown in red.
Proteins stimulating ACh release are shown in blue.
— — — - Indicates an indirect interaction.
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1.7.5. Antagonism between the regulation of ACh release by EGL-30 and 
GOA-1
EGL-30 stimulates ACh release via EGL-8, the production of DAG and the recruitment of 
UNC-13 to sites of release, whilst GOA-1 inhibits ACh release by inhibiting DAG 
accumulation via an as yet unknown mechanism (Lackner et al., 1999; Miller et al.,
1999; Nurrish et al., 1999). These two pathways have an opposing effect upon ACh 
release, whilst both regulate the levels of DAG and UNC-13 localisation. This suggests 
that these pathways are either acting separately and antagonistically to regulate DAG 
and UNC-13 or that one pathway negatively regulates the other to regulate ACh release. 
Double mutants in both egl-30 and goa-1 are lethargic indicating EGL-30 acts 
downstream or in parallel to GOA-1. Animals over-expressing GOA-1 are lethargic and 
this is suppressed by over expression of EGL-30, again indicating that EGL-30 acts 
downstream or in parallel to GOA-1 (Hajdu-Cronin et al., 1999; Miller et al., 1999).
1.7.6. EAT-16 is a negative regulator of EGL-30
The protein EAT-16, which contains a regulator of G protein signalling (RGS) domain, 
inhibits ACh release. RGS proteins negatively regulate the activity of heterotrimeric G 
proteins by functioning as GTPase activating proteins (GAPs) catalysing the intrinsic 
hydrolysis of Ga-GTP to Ga-GDP. eat-16 mutants exhibit hyperactive locomotion 
consistent with EAT-16 having a negative effect upon ACh release, and EAT-16 is 
expressed neuronally including in the cholinergic motor neurons (Hajdu-Cronin et al., 
1999). Over expression of both wild type and constitutively active EGL-30, cause a 
hyperactive locomotion and an increase in ACh release. Over expression of EAT-16 
suppresses the increase in ACh release in animals expressing wild type EGL-30, but 
does not suppress the increase in ACh release in animals expressing constitutively 
active EGL-30 (Hajdu-Cronin et al., 1999). Constitutively active EGL-30 (Q209L) is 
insensitive to RGS proteins, suggesting EAT-16 is acting upstream of EGL-30 as a 
negative regulator of both EGL-30 and ACh release. If EAT-16 is negatively regulating 
EGL-30, the loss of EAT-16 will reduce the inactivation of EGL-30, thereby emulating an 
increase in EGL-30 signalling and rescuing the reduction-of-function egl-30 mutations 
(Hajdu-Cronin et al., 1999). Hypomorphic reduction-of-function mutations of egl-30 
cause lethargic locomotion and an egg-laying defect. Both of these phenotypes are
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(Hajdu-Cronin et al., 1999). eat-16 mutants suppress the lethargy of GOA-1 over 
expressing animals and over expression of EAT-16 suppressed goa-1 mutants 
suggesting EAT-16 does not negatively regulate GOA-1 (Hajdu-Cronin et al., 1999). All 
this data suggests that EAT-16 negatively regulates EGL-30 to decrease ACh release 
(Figure 1.14).
Figure 1.14 EAT-16 negatively regulates EGL-30
The RGS protein EAT-16 negatively regulates EGL-30 preventing the activation of 
EGL-8, thus lowering the production of DAG and decreasing ACh release.
Proteins stimulating ACh release are shown in blue.
Proteins inhibiting ACh release are shown in red.
Adapted from Seifert et al. 2006.
— — — - Indicates an indirect interaction.
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1.7.7. EGL-10 is a negative regulator of GOA-1
Mutations in the RGS protein egl-10 cause a decrease in locomotion, whilst over 
expression of EGL-10 causes an increase in locomotion (Koelle and Horvitz, 1996). A 
correlation with a respective decrease and increase in aldicarb sensitivities has been 
recorded (Miller et al., 1999). Null mutations of egl-10 and goa-1 cause opposing 
locomotory phenotypes; lethargy and hyperactivity respectively (Koelle and Horvitz, 
1996). Animals with mutations in both egl-10 and goa-1 have a hyperactive locomotion 
comparable to animals with the single goa-1 mutation, suggesting EGL-10 acts 
upstream of GOA-1 or in a parallel pathway (Koelle and Horvitz, 1996). EGL-10 contains 
an RGS domain, which act as GAPs for G protein alpha subunits inactivating them 
(Arshavsky and Pugh, 1998; Berman and Gilman, 1998; Hunt et al., 1996; Watson et al.,
1996). This suggests that EGL-10 could negatively regulate the activity of GOA-1 to 
control locomotion (Koelle and Horvitz, 1996). EGL-10 is expressed in the nervous 
system including the dorsal and ventral cord motor neurons, supporting the hypothesis 
that EGL-10 is regulating the activity of GOA-1 in the release of ACh from the motor 
neurons (Figure 1.15) (Koelle and Horvitz, 1996). egl-30 and egl-10 mutants have 
similar phenotypes; a decrease in the rate of locomotion, and aldicarb resistance, 
suggesting EGL-10 does not negatively regulate EGL-30 (Miller et al., 1999). The 
paralysis of egl-30 mutant animals and aldicarb sensitivity are not suppressed by 
mutation of egl-10, suggesting EGL-10 acts upstream of EGL-30 or in a parallel pathway 
(Figure 1.15) (Miller et al., 1999).
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Figure 1.15 EGL-10 negatively regulates GOA-1 to control ACh release
The RGS protein EGL-10 negatively regulates GOA-1 causing a DAG and UNC-13 
dependent increase in ACh release.
Proteins stimulating ACh release are shown in blue.
Proteins inhibiting ACh release are shown in red.
— — — - Indicates an indirect interaction.
1.7.8. GPB-2 is required by EAT-16 and EGL-10
GPB-2 (EAT-11) is the homologue of the mammalian protein Gp5, a beta subunit of 
heterotrimeric G proteins (Chase et al., 2001; van der Linden et al., 2001). G(3 subunits 
classically bind to Gy subunits. However, studies of mammalian Gp subunits has 
revealed that whilst subunits G|31-G|34 dimerise with Gy subunits, Gp5 binds to a 
differing set of proteins containing a GGL (Gy-subunit-like) domain (Chen et al., 2000; 
Makino et al., 1999; Witherow et al., 2000; Zhang and Simonds, 2000). A null mutation
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of gpb-2 causes hyperactive locomotion and an increase in aldicarb sensitivity (van der 
Linden et al., 2001). This is similar to animals over expressing both EGL-3 and GOA-1 
that exhibit a hyperactive locomotion (Hajdu-Cronin et al., 1999). Double mutants of a 
gpb-2 null with mutations in either eat-16 or egl-10 have a similar hyperactive locomotion 
when compared to gpb-2 single mutants (van der Linden et al., 2001). This suggests 
GPB-2 is needed for EAT-16 and EGL-10 to mediate their effects upon ACh release 
(van der Linden et al., 2001). EAT-16 and EGL-10 contain a GGL domain and interact 
with GPB-2 in vitro (van der Linden et al., 2001). Point mutations in gpb-2 can have 
either a positive or a negative effect upon the aldicarb sensitivity of the animals, 
suggesting that interactions with different proteins are responsible for the change in ACh 
release. This supports the hypothesis that GPB-2 regulates EGL-10 and EAT-16 to 
control the EGL-30 and GOA-1 pathways regulating ACh release (Robatzek et al.,
2001).
Mutation of a second G protein p subunit, GBP-1, is lethal (Zwaal et al., 1996). GBP-1 is 
more than 80% identical to mammalian Gpi-Gp4 subunits, suggesting this subunit acts 
as a conventional Gp subunit dimerising with Gy subunits (Zwaal et al., 1996). This 
provides a possible explanation for the differing roles of GBP-1 and GBP-2 in C. elegans 
(Chase et al., 2001).
1.7.9. DGK-1 regulates DAG levels and ACh release
The enzyme diacylglycerol kinase, DGK-1 (also called sag-1), was identified as a 
regulator of ACh release in three different screens (Hajdu-Cronin et al., 1999; Miller et 
al., 1999; Nurrish et al., 1999). It was identified as a suppressor of the lethargic 
locomotion induced by the expression of constitutively active GOA-1 (Hajdu-Cronin et 
al., 1999). Mutations in dgk-1 were also pulled out of a screen looking for the opposing 
phenotype to the loss of egl-30 i.e. hyperactive locomotion (Miller et al., 1999). The gene 
was actually cloned in a screen to identify suppressors of the neuromodulator serotonin; 
mutation of dgk-1 prevented the lethargic locomotion induced by exogenous serotonin 
(Nurrish et al., 1999). Loss-of-function mutations of dgk-1 cause an increase in aldicarb 
sensitivity, suggesting an increase in ACh release (Miller et al., 1999; Nurrish et al., 
1999). Over expression of DGK-1 causes a reduction in locomotion, consistent with 
DGK-1 negatively regulating ACh release (Nurrish et al., 1999). Mutation of dgk-1
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causes a partial suppression of gain-of-function goa-1, and over expression of DGK-1 
reduces locomotion in hyperactive goa-1 mutant animals, suggesting DGK-1 acts 
downstream or in parallel to GOA-1 in the regulation of ACh release (Nurrish et al.,
1999). Expression of DGK-1 in the cholinergic motor neurons in dgk-1 mutant animals 
reduces aldicarb sensitivity to wild type levels (Nurrish et al., 1999). This suggests that 
DGK-1 acts either downstream of GOA-1 or in a parallel pathway in the cholinergic 
motor neurons to negatively regulate ACh release. Regulation of the activity of DGK-1 by 
GOA-1 in transfected cells has not been observed suggesting that DGK-1 acts in a 
parallel pathway to regulate ACh release, or GOA-1 indirectly regulates DGK-1 activity 
(Figure 1.16) (Nurrish et al., 1999).
Mutation of egl-30 results in resistance to aldicarb in the chronic aldicarb assay 
(examining survival over 4 days exposure to differing concentrations of aldicarb) (Miller 
et al., 1999). Mutation of dgk-1 results in a decrease in aldicarb sensitivity (Miller et al.,
1999). egl-30; dgk-1 double mutants exhibit an almost wild type sensitivity to aldicarb, 
suggesting DGK-1 and EGL-30 act in parallel pathways (Miller et al., 1999). dgk-1; egl-8 
double mutants exhibit a similar wild type aldicarb sensitivity, lying between the aldicarb 
resistance of egl-8 mutant animals and the aldicarb hypersensitivity of dgk-1 mutant 
animals (Miller et al., 1999). This suggests DGK-1 and EGL-8 also act in parallel 
antagonistic pathways (Figure 1.16).
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Figure 1.16 DGK-1 negatively regulates ACh release
The enzyme DGK-1 phosphorylates DAG to PA lowering levels of DAG and 
consequently ACh release.
Proteins that stimulate ACh release are shown in blue.
Proteins that inhibit ACh release are shown in red.
— — — - Indicates an indirect interaction.
Mammalian diacylglycerol kinases catalyse the phosphorylation of DAG to phosphatidic 
acid (PA) (van Blitterswijk and Houssa, 2000). This enzyme activity is conserved in 
DGK-1 in C. elegans (Nurrish et al., 1999). The increase in locomotion, aldicarb 
sensitivity and thus ACh release in dgk-1 mutant animals could be caused by either the 
gain of DAG or the reduction of PA. Addition of the DAG analogue phorbol esters causes 
an increase in ACh release, suggesting the increase in DAG levels in dgk-1 mutant 
animals is responsible for the increase in ACh release (Nurrish et al., 1999). The DAG 
binding protein UNC-13S, (the short isoform of UNC-13 containing the M and R regions 
(Figure 1.10) that has been shown to be sufficient to rescue the loss of release in unc- 
13 reduction-of-function mutant animals), is recruited to synapses in response to DAG 
production to stimulate ACh release (Lackner et al., 1999). The increase in DAG levels
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in dgk-1 mutant animals would be predicted to increase in the recruitment of UNC-13 to 
synapses, although this was not observed (Nurrish et al., 1999). UNC-13 recruitment 
was measured by expressing a fluorescently tagged form of UNC-13S, and counting the 
number of puncta with increased levels of fluorescence (Nurrish et al., 1999). DGK-1 is 
expressed throughout neurons, as opposed to being specifically localised to the 
synapses, thus the loss of DGK-1 would lead to an increase in DAG levels throughout 
the neuron (Nurrish et al., 1999). Therefore, an increase in the number of fluorescent 
UNC-13 puncta may not be visible since UNC-13 will be recruited throughout the plasma 
membrane and not specifically at the synapse (Nurrish et al., 1999).
1.7.10. RHO-1 negatively regulates DGK-1 in the control of ACh release
The activity of the mammalian family of DAG kinases can be regulated by the Rho family 
of small GTPases (discussed further in sections 1.14-1.17)(van Blitterswijk and Houssa,
2000). DGK£ has been shown to interact with Rac-1, and DGK0 interacts with RhoA 
(Houssa et al., 1999; Tolias et al., 1998). DGK£ was found in a complex containing Rac- 
1, which also possessed phosphatidylinositol kinase activity (Tolias et al., 1998). The 
Rho family of small GTPases are known to have an important role in the regulation of 
the actin cytoskeleton (Ridley, 1999). It is hypothesised that this complex is regulating 
the cytoskeleton through the production of PA by DGK£, leading to the activation of the 
phosphatidylinositol kinase catalysing the conversion of PIP into PIP2) a known activator 
of Rac-1 (Tolias et al., 1998). The DGK£/ Rac-1 interaction is therefore thought to result 
in the activation of Rac-1.
The interaction between DGK0 and RhoA regulates the activity of the DAG kinase.
DGK0 specifically interacts with active RhoA and the interaction inhibits the activity of 
DGK0 (Houssa et al., 1999). DGK-1 is the homologue of mammalian DGK0 (Nurrish et 
al., 1999). The interaction between DGK0 and RhoA is conserved in C. elegans as 
shown by the interaction between DGK-1 and the worm Rho homologue, RHO-1 
(McMullan et al., 2006). RHO-1 was therefore a candidate upstream regulator of DGK-1 
in the release of ACh; inhibition of DGK-1 by RHO-1 would cause an increase in release 
(McMullan etal., 2006).
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Figure 1.17 RHO-1 stimulates ACh release
RHO-1 stimulates ACh release by two pathways. One involves the inhibition of 
DGK-1 and the recruitment of UNC-13 to sites of release. The second pathway is 
independent of DGK-1 and UNC-13.
Proteins that stimulate ACh release are shown in blue.
Proteins that inhibit ACh release are shown in red.
   Indicates an indirect interaction.
Expression of constitutively active RHO-1 in the cholinergic motor neurons causes an 
increase in ACh release, whilst inhibition of endogenous RHO-1, through the expression 
of the RhoA specific inhibitor C3 transferase, in the cholinergic motor neurons causes a 
decrease in ACh release (McMullan et al., 2006). Therefore, expression of constitutively 
active RHO-1 and the loss of DGK-1 both cause hyperactive locomotion and an increase 
in aldicarb sensitivity (McMullan et al., 2006). Constitutively active RHO-1 also causes 
the recruitment of UNC-13S to release sites, suggesting RHO-1 acts via increasing DAG 
levels to increase ACh release (McMullan et al., 2006). However, expression of a non-
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DAG binding form of UNC-13S does not completely suppress the increase in ACh 
release mediated by RHO-1 (McMullan et al., 2006). This suggests that RHO-1 also 
stimulates ACh release in a DAG and UNC-13 independent manner. Mutation of dgk-1 
only partially suppresses the reduction in ACh release upon the inhibition of endogenous 
RHO-1, also suggesting RHO-1 can stimulate ACh release in a DAG independent 
manner (Figure 1.17) (McMullan et al., 2006). A mutant form of RHO-1, which cannot 
interact with DGK-1, shows no suppression by UNC-13 (H173K), suggesting the 
regulation of ACh release, which is independent of UNC-13, is also independent of DGK- 
1 (McMullan et al., 2006). Thus, in one pathway RHO-1 negatively regulates DGK-1 
causing an increase in DAG levels, the recruitment of UNC-13 to release sites and an 
increase in ACh release. The second pathway also causes an increase in ACh release, 
but the downstream effectors of RHO-1 are not known (Figure 1.17).
1.7.11. GSA-1 (G e ts ):  a third G protein regulating ACh release
A third G protein coupled pathway regulates ACh release, although this pathway is 
independent of DAG and the site of action is currently known. A null mutation of gsa-1 
results in early larval paralysis and lethality caused by an apparent problem in fluid 
balance, suggesting a role in the canal cells (Korswagen et al., 1998). Activating 
mutations in GSA-1 cause hyperactive locomotion and an increase in aldicarb sensitivity, 
both of which are almost completely suppressed by a null mutation in unc-13, suggesting 
UNC-13 acts downstream of GSA-1 (Schade et al., 2005). Mutation of acy-1 (adenylyl 
cyclase I), an enzyme that converts ATP into the second messenger cAMP, causes 
larval paralysis and larval arrest (Schade et al., 2005). ACY-1 is expressed in both 
muscles and neurons and tissue specific rescue experiments have shown that 
expression in either the muscle or the neurons can rescue the larval arrest, whilst only 
neuronal expression can significantly rescue the paralysis (Reynolds et al., 2005). The 
hyperactive locomotion of activating gsa-1 mutations is suppressed by mutation of acy-1, 
these animals are identical to acy-1 mutants, exhibiting larval paralysis and larval arrest 
(Schade et al., 2005). This suggests ACY-1 acts downstream of GSA-1 in the regulation 
of locomotion and larval arrest (Schade et al., 2005). In addressing the rescue of the 
larval paralysis, the production of cAMP by the Gas pathway has been shown to 
contribute to the recruitment of Dunc-13 to synapses in Drosophila, in addition to the 
separate recruitment of Dunc-13 by DAG (Aravamudan and Broadie, 2003; Speese et
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al., 2003). This suggests that GSA-1 activates ACY-1 leading to the production of cAMP 
and the recruitment of UNC-13 to synapses to mediate ACh release and locomotion 
(Figure 1.18).
A gain-of-function mutation of acy-1 causes hyperactivity of the Gas pathway observed 
as an increase in locomotion (Reynolds et al., 2005). This hyperactive locomotion is 
almost completely suppressed by a null mutation of egl-30, suggesting the GSA-1 
pathway acts via the EGL-30 pathway to control locomotion (Reynolds et al., 2005). 
Conversely, the almost complete paralysis in acy-1 null mutants is partially suppressed 
by mutations that activate the EGL-30 pathway or treatment with phorbol esters 
(Reynolds et al., 2005). This suggests that the EGL-30 pathway requires the GSA-1 
pathway to exert its full effects upon locomotion. Animals that have lost signalling via the 
GSA-1 pathway, but have activated signalling by the EGL-30 pathway, have an unusual 
locomotion. They undergo short periods of extreme twisting resulting in a tightly knotted, 
temporarily paralysed posture (Reynolds et al., 2005). Normal posture and locomotion is 
soon recovered accounting for the partial rescue in the rate of locomotion (Reynolds et 
al., 2005).
Inhibition of the G as pathway in acy-1 null animals (the larval arrest of which has been 
rescued by expression of ACY-1 in the muscles) causes no reduction in aldicarb 
sensitivity (using the chronic aldicarb assay that provides a measure of pharyngeal 
pumping as opposed to locomotion), even though these animals are almost completely 
paralysed (Reynolds et al., 2005). This suggests that the G as pathway regulates 
locomotion without changing the levels of overall ACh release. It is thought that the 
GSA-1 pathway controls the EGL-30 mediated release of ACh such that a sustained 
coordinated locomotion is achieved (Figure 1.18) (Reynolds et al., 2005). The GSA-1 
pathway is thought to regulate the specific synapses at which the EGL-30 mediated ACh 
release occurs without altering the total amount of ACh released by the motor neurons, 
hence no change in aldicarb sensitivity is observed. Treatment of gsa-1 mutant animals 
with phorbol esters does not completely rescue the lethargic locomotion of the animals 
suggesting that the GSA-1 pathway interacts with the EGL-30 pathway below DAG to 
control locomotion (Reynolds et al., 2005).
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Figure 1.18 GSA-1 regulates ACh release by the production of cAMP
GSA-1 activates the adenylyl cyclase ACY-1 causing an increase in cAMP, 
activating PKA and resulting in an increase in ACh release.
Proteins that stimulate ACh release are shown in blue.
Proteins that inhibit ACh release are shown in red.
— — — - Indicates an indirect interaction.
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1.7.12. RIC-8 regulates GSA-1 and EGL-30
RIC-8 (synembryn) stimulates locomotion and ACh release; loss-of-function mutants are 
almost completely paralysed and are strongly resistant to aldicarb (Miller et al., 2000; 
Schade et al., 2005). The addition of phorbol esters rescues the paralysis and aldicarb 
resistance of ric-8 mutants suggesting that RIC-8 regulates ACh release via regulation of 
the levels of DAG (Miller et al., 2000). Synembryn is a receptor-independent GEF that 
can exchange the bound GDP for GTP on the alpha subunits of heterotrimeric G 
proteins (Tall et al., 2003). Synembryn, in mammals, has been shown to be a potential 
regulator of Gas and G aq, directly interacting with both proteins in vitro (Klattenhoff et al., 
2003), and is expressed in the nervous system of both developing and adult mice 
(Tonissoo et al., 2003).
Double mutants of goa-1 and ric-8 are completely sterile preventing assessment of their 
sensitivity to aldicarb using the chronic aldicarb assay but they exhibit a near normal rate 
of locomotion, whilst goa-1 mutants have a hyperactive locomotion suggesting that RIC- 
8 is not a negative regulator of GOA-1 (Miller et al., 2000). Over expression of the GOA- 
1 inhibitor egl-10 causes hypersensitivity to aldicarb (Miller et al., 1999). Double gain-of- 
function egi-10 and loss-of-function ric-8 mutants have an almost wild type locomotion 
rate and aldicarb sensitivity (Miller et al., 2000). These results are in contrast with goa-1; 
egl-30 and egl-10; egl-30 double mutants both of which have locomotion rates almost 
unchanged from egl-30 single mutants (Miller et al., 1999). Loss-of-function goa-1 
mutants and over expression of egl-10 are both thought to cause an increase in the 
activity of the EGL-30, explained by the complete suppression of both goa-1 mutants 
and egl-10 over expression by mutation of egl-30 (Miller et al., 1999). The observation 
that ric-8; egl-10 over expression and ric-8; goa-1 double mutants have almost wild type 
phenotypes suggests RIC-8 acts upstream of EGL-30 to regulate ACh release (Figure 
1.18). Examination of egl-30 gain-of-funotion; ric-8 loss-of-function double mutants has 
revealed a partial suppression of the lethargy of ric-8 mutants (Schade et al., 2005). This 
supports the hypothesis that the GEF RIC-8 may positively regulate EGL-30. RIC-8 in 
C. elegans is therefore predicted to have a similar role to synembryn in mammals, which 
has been shown to be a potential regulator of Gaq (Klattenhoff et al., 2003).
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Gain-of-function mutations in gsa-1 and acy-1 suppress the lethargic locomotion and 
aldicarb resistance of ric-8 mutants suggesting that RIC-8 either positively regulates 
GSA-1 and the downstream pathway including ACY-1 to regulate ACh release or acts in 
a parallel pathway (Schade et al., 2005). The almost complete paralysis of ric-8 null 
mutants is completely suppressed by activation of both the GSA-1 pathway via a gain-of- 
function gsa-1 mutation and activation of the EGL-30 pathway by treatment with phorbol 
esters (Reynolds et al., 2005). RIC-8 is therefore predicted to be an activator for both 
GSA-1 and EGL-30 to regulate locomotion and stimulate ACh release, conserving the 
predicted regulation of both Gaq and Gas by synembryn in mammals (Klattenhoff et al., 
2003; Reynolds et al., 2005) (Figure 1.18).
1.7.13. KIN-2
Another class of mutations isolated when screening for suppressors of the paralysis and 
lethality of the ric-8 null mutation were reduction-of-function mutations in the gene kin-2 
(Schade et al., 2005). KIN-2 encodes a regulatory subunit of protein kinase A (PKA). 
KIN-2 is responsible for inactivating PKA in the absence of cAMP, thus in the absence of 
KIN-2 PKA will be active in the absence of cAMP (Schade et al., 2005). PKA and cAMP 
have been shown to have a role in the recruitment of synaptic vesicles into the ready 
releasable pool in mammals, providing a possible mechanism for an increase in 
neurotransmitter release (Kuromi and Kidokoro, 2000). The suppression of the ric-8 
mutants would be expected to be due to an increase in ACh release, which could be 
mediated by PKA and cAMP (Figure 1.18) (Schade et al., 2005).
1.8. Rho GTPases
The Rho family of GTPases is a large family consisting of 22 members in mammals that 
act as molecular switches. They cycle between an active guanosine triphosphate (GTP)- 
bound, and an inactive, guanosine diphosphate (GDP)-bound state (Figure 1.19). The 
innate ability of the Rho GTPase to hydrolyse GTP to GDP allows it to “switch itself off’, 
this is regulated by external proteins. The family of guanine nucleotide activating 
proteins (GAPs) catalyse the hydrolysis of GTP to GDP by the innate activity of the Rho 
GTPase, thus inactivating it. There are more than 70 known GAPs in mammals.
Guanine nucleotide exchange factors (GEFs) promote the release of GDP and
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replacement by GTP, thereby activating the Rho GTPase. There are 85 RhoGEFs in the 
human genome (Jaffe and Hall, 2005). The activity of Rho GTPases is further regulated 
by their association with the membrane. They are prenylated at their C-terminus, 
facilitating association with the plasma membrane, which is required for function. The 
guanine nucleotide dissociation inhibitors (GDIs) inhibit the activation of Rho GTPases 
by stabilising the GDP-bound form and extracting it from the membrane. The importance 
of Rho GTPases is exemplified by the observation that approximately one percent of the 
human genome encodes proteins which are either upstream regulators or direct 
downstream effectors of Rho GTPases (Jaffe and Hall, 2005). Rho activates a wide 
variety of different proteins including serine/threonine kinases, tyrosine kinases, lipid 
kinases, lipases, oxidases, transcription factors and scaffold proteins.
Figure 1.19 Rho GTPases are molecular switches
Rho GTPases are negatively regulated by GAPs and GDIs, and positively 
regulated by GEFs. Rho-GTP, the activated form, goes on to activate downstream 
effectors.
Taken from Etienne-Manneville and Hall 2002.
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1.9. The cellular effects of Rho GTPases
1.9.1. The cytoskeleton
The Rho family of proteins have a critical role in the regulation of the cytoskeleton. Three 
Rho family proteins, RhoA, Rac1 and Cdc42, have been studied in detail and their 
specific roles in the regulation of actin within the cytoskeleton have been assigned. Rac1 
and Cdc42 are responsible for the branching of the actin filaments, producing 
lamellipodia (actin-rich sheet like protrusions) and filopodia (finger-like actin protrusions) 
respectively (Kozma et al., 1995; Nobes and Hall, 1995a; Nobes and Hall, 1995b; Ridley 
and Hall, 1992a; Ridley et al., 1992), whilst RhoA is responsible for the lengthening of 
the actin filaments and the production of the contractile actin:myosin filaments or stress 
fibres (Ridley and Hall, 1992b).
Microtubules are also a key component of the cytoskeleton. Microtubules are dynamic 
structures like actin filaments and are regulated by Rho GTPases. Rho, Rac and Cdc42 
are all thought to have a role in regulating microtubules through the regulation of 
microtubule plus-end binding proteins, which are key in the control of microtubule 
dynamics (Etienne-Manneville and Hall, 2003; Fukata et al., 2002; Wen et al., 2004).
1.9.2. Gene transcription
Rho GTPases regulate several pathways involved in the regulation of gene transcription. 
Many promoters contain a regulatory element called the serum response element (SRE). 
The transcription factors, serum response factor (SRF) and ternary complex factor 
(TCF), are required to initiate transcription at the SRE. SRF requires the cofactor MAL. 
Rho is responsible for the translocation of MAL from the cytoplasm to the nucleus to 
facilitate transcription from the SRE (Miralles et al., 2003).
Rho GTPases also regulate gene expression independently of the actin cytoskeleton. At 
least four MAP kinase kinase kinases (MAPKKKs) are direct targets of Rho GTPases, 
which then go on to regulate gene transcription. The specificity by which the GTPases 
activate the different MAP kinase pathways is achieved with scaffold proteins. Rac 
activation of jun kinase (JNK) in neurons upon neuronal growth factor (NGF) stimulation
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is achieved by the scaffold POSH, whilst Rho activation of JNK upon serum addition 
requires the scaffold CNK-1 (Jaffe et al., 2005; Xu et al., 2003).
1.9.3. Enzyme activity
Rho GTPases regulate enzymatic activity in addition to those enzymes known to be 
involved in the regulation of the actin cytoskeleton and gene transcription. These 
enzymes include lipid kinases, and enzymes responsible for the generation of reactive 
oxygen species (ROS) (Table 1.3). The importance of the regulation of the enzymatic 
activity of many enzymes has not yet been determined, however some of the lipid 
kinases are predicted to have roles in the regulation of cytoskeleton (Tolias et al., 2000; 
Wang et al., 2002).
Enzymatic activity Effector protein GTPase Reference
Lipid metabolism PI4P5 kinase Rho, Rac (Weernink et al., 2004)
PI3 kinase Rac, Cdc42 (Zheng et al., 1994)
DAG kinase Rho, Rac (Houssa et al., 1999)
PLD Rho, Rac, Cdc42 (Hess et al., 1997)
PLC Rac, Cdc42 (lllenberger et al., 1998)
ROS generation NADPH oxidases Rac (Takeya and Sumimoto, 
2003)
Table 1.3. Enzymes regulated by Rho GTPases
1.9.4. Phagocytosis
Pathogenic bacterial cells are removed by phagocytosis by specialised cells called 
phagocytes, a process dependent upon Rho GTPases (Abo et al., 1991; Caron and Hall,
1998). Firstly, phagocytic cells produce ROS, catalysed by NADPH oxidases. These 
enzymes are activated by Rho GTPases (Table 1.3). The phagocytic cells then engulf 
and phagocytose the bacterial cells, both processes involving changes in the 
cytoskeleton and dependent upon Rho GTPases.
81
1.9.5. The cell cycle
The cell cycle is divided into four phases, G1 (Gap 1), S (DNA replication), G2 (Gap 2) 
and M (mitosis). Rho GTPases have roles in the regulation of cyclin-dependent kinases 
in G1, which are responsible for the regulation of the cell cycle, and in the organisation 
of the actin and microtubule cytoskeleton in M phase. Inhibition of Rho, Rac or Cdc42 
blocks progression of the cell cycle through the G1 phase (Jaffe and Hall, 2005). 
Progression through the cell cycle is regulated by cyclins and cyclin-dependent kinases. 
The levels of cyclin D, which are critical for progression through G1, are regulated by the 
enzyme ERK. This in turn is regulated by signal inputs generated by adhesion to the 
extra-cellular matrix, a Rho dependent process. The adhesion-dependence of the cell 
cycle is likely to account for many roles of Rho GTPases in its regulation. However, Rho 
GTPases have also been implicated in the regulation of transcription and/ or translation 
of cyclin D, and possibly cyclin E (Chou et al., 2003; Joyce et al., 1999; Westwick et al.,
1997). Another possible role for GTPases in the regulation of the progression of G1 
phase is the discovery that they can regulate the levels of cyclin-dependent kinase 
inhibitors. Rho inhibits cell cycle progression by lowering the levels of the inhibitor 
p21cip1, either through the inhibition of transcription or by promoting protein degradation 
(Olson et al., 1998; Weber et al., 1997).
During mitosis at least two events are regulated by Rho GTPases. In the first, the 
chromosomes align along the astral microtubules at their kinetochore, before the 
chromatids undergo separation. This attachment and the orientation of the spindle is 
regulated by Cdc42 (Ahringer, 2003; Etienne-Manneville and Hall, 2001; Peterson et al., 
2004; Yasuda et al., 2004). The second event involves the final separation of the two 
daughter cells during cytokinesis. Inhibition or expression of constitutively active RhoA or 
Cdc42 inhibits the formation of the contractile actin-myosin ring, which is required for cell 
separation (Glotzer, 2001).
1.9.6. Cell polarity
Cell polarity is important not only in unicellular organisms but also in epithelial cells to 
form apical and basolateral domains and both of these processes require Rho GTPases. 
In the absence of Cdc42 function, the unicellular organism Saccharomyces cerevisiae
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cannot establish a defined site for daughter cell growth during the budding phase of the 
cell cycle, leading to isotropical growth (Pruyne and Bretscher, 2000). Epithelial cells are 
polarised not only when part of an epithelial membrane but also when migrating. Cdc42 
is required for the epithelial cell polarisation under both of these conditions, interacting 
with the tight junction in an epithelial layer and directing the positioning of the 
microtubule organising centre and the direction of protrusive activity in migrating cells 
(Etienne-Manneville and Hall, 2001; Lin et al., 2000).
1.9.7. Vesicle transport
Cdc42 is involved in vesicle transport from the golgi to the endoplasmic reticulum (ER); 
over expression of wild type or constitutively active Cdc42 inhibits trafficking from the 
golgi to the ER (Luna et al., 2002). It is similarly required in the exo- and endocytosis of 
vesicles at the plasma membrane (Bader et al., 2004; Symons and Rusk, 2003). It is 
thought that stimulation of a branching actin filament network by Cdc42 may assist in 
pinching off vesicles from the membrane and or might drive the vesicle towards the 
target membrane.
RhoA and Rac have roles in endocytosis. Constitutively active RhoA and Rac1 inhibit 
clathrin-mediated endocytosis (Qualmann and Mellor, 2003). In the case of Rac this is 
thought to be via synaptojanin, a protein involved in the uncoating of vesicles (Malecz et 
al., 2000), whilst it has been hypothesised that RhoA may also be inhibiting the 
uncoating of vesicles through the inhibition of endophilin (Kaneko et al., 2005). Rho and 
Rac also both affect clathrin-independent endocytosis, thought to be via changes in 
membrane dynamics by the ARF GTPases and phospholipase D (Jones et al., 1999; Nie 
and Randazzo, 2006).
1.10. The roles of Rho GTPases in the nervous system
One of the initial steps in the development of a neuron is the formation of small 
cylindrical extensions from the cell body called neurites. These subsequently develop 
into the axons and dendrites of the polarised neurons. The Rho GTPases Cdc42, Rac-1 
and RhoA all have a role in the development of neurites (Govek et al., 2005). Cdc42 and 
Rac1 promote the formation of filopodia and lamellipodia and play a role in neurite
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formation, whilst RhoA prevents neurite initiation and induces neurite retraction (Govek 
et al., 2005).
The next stage in the development of the neuron is the formation of the axon and 
dendrites. RhoA, Rac1 and Cdc42 have all been implicated to have a role in axon 
formation in multiple systems: Cdc42 is thought to positively regulate axon formation, 
whilst RhoA is hypothesised to inhibit the formation of axons (Kim et al., 2003;
Ruchhoeft et al., 1999; Schwamborn and Puschel, 2004). All three GTPases are also 
implicated in the growth and maintenance of the axon (Arakawa et al., 2003; Billuart et 
al., 2001; Bito et al., 2000; Brouns et al., 2001; Kim et al., 2003; Penzes et al., 2001; 
Ruchhoeft et al., 1999; Threadgill et al., 1997). RhoA has specifically been identified to 
have a role in axonal growth after injury. Inhibition of RhoA by C3 transferase promotes 
axonal regeneration after injury in mice and rats, suggesting RhoA negatively regulates 
axon regeneration (Dergham et al., 2002; Fournier et al., 2003).
Rho GTPases are also thought to have a role in axonal pathfinding, although distinction 
between pathfinding defects and general formation and growth defects is hard (Allen et 
al., 2000; Hakeda-Suzuki et al., 2002; Kim et al., 2003; Ruchhoeft et al., 1999). All three 
have a role in growth cone morphology, which is indispensable to pathfinding, supporting 
the idea they have roles in axon formation, growth and pathfinding (Govek et al., 2005). 
Axons are guided by many different factors called guidance cues. All the pathways 
downstream of the guidance cue receptors converge upon Rho GTPases to elicit 
changes in the cytoskeleton and determine the direction in which the growth cone will 
turn (Guan and Rao, 2003; Huber et al., 2003).
Rho GTPases have been implicated to have a role in synaptic transmission in the 
nervous system: Rac and Cdc42 regulate synaptic strength in Aplysia (Humeau et al., 
2002; Udo et al., 2005), lysophosphatidic acid (LPA) mediated ACh release from PC12 
cells requires RhoB (Ishida et al., 2004), and as discussed above, in C. elegans RHO-1 
regulates ACh release at the NMJ (McMullan et al., 2006).
In humans, defects in genes that are regulators or effectors of Rho GTPases have been 
associated with mental retardation, highlighting the importance of Rho GTPases in the 
nervous system (Chechlacz and Gleeson, 2003; Ramakers, 2002). Knockout of several
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Rho GTPase effectors in mice causes learning and memory impairments, and inhibition 
of the Rho effector ROCK impairs long-term memory in rats (Dash et al., 2004; Meng et 
al., 2004; Soderling et al., 2003). All these observations support the importance of Rho 
GTPases in the nervous system in living higher organisms.
1.11. The roles of Rho GTPases in C. elegans
There is one Rho (RHO-1), one Cdc42 (CDC-42) and two canonical Rac (CED-10 and 
RAC-2) proteins in C. elegans. MIG-2, another GTPase that is similar to Rac and Cdc42 
and interacts with Racs is also present in C. elegans. The most likely homologue for 
MIG-2 in mammals is RhoG (deBakker et al., 2004). Three other small GTPases have 
been identified in the C. elegans genome; a Wrch1-like protein, a Cdc-42-like GTPase 
that controls the cytoskeleton in response to Wnt signalling and another Cdc42 type 
GTPase of unknown function (Lundquist et al., 2001; Tao et al., 2001).
1.11.1. RHO-1 controls embryonic cytokinesis and elongation
RNAi knockdown of rho-1 and cdc-42 cause embryonic arrest associated with a defect in 
cytokinesis during the M phase of the cell cycle (Jantsch-Plunger et al., 2000; Kay and 
Hunter, 2001; Spencer et al., 2001). Some RHO-1 effectors have also been shown to 
have roles in embryonic development and cytokinesis: LET-502, a Rho binding kinase, 
and MEL-11, a myosin phosphatase, effect the contractile ring during cytokinesis in 
response to Rho signaling (Piekny and Mains, 2002; Wissmann et al., 1999; Wissmann 
et al., 1997). CYK-4, a RhoGAP, which inactivates Rho, Rac and Cdc42, also plays a 
role in cytokinesis and was identified in cytokinesis defect screen (Jantsch-Plunger et al.,
2000).
During development, the embryo undergoes elongation during which actin rings contract, 
squeezing the embryo and causing a lengthening. Both LET-502 and MEL-11 are 
involved in this lengthening, but have opposing roles (Wissmann et al., 1999; Wissmann 
et al., 1997). The Rac-like GTPase MIG-2 and the RHO-1/CED-10/MIG-2 GEF UNC-73 
are both involved in the MEL-11 pathway to control lengthening (Spencer et al., 2001;
Wu et al., 2002).
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1.11.2. RHO-1, CDC-42 and CED-10 regulate cell migration
RHO-1 is involved in cell migration in C. elegans. RNAi knockdown or expression of a 
dominant negative form of RHO-1 cause a defect in the migration of the hypodermal P 
cells (Spencer et al., 2001). UNC-73 acts upstream and LET-502 downstream of RHO-1 
to regulate P cell migration (Spencer et al., 2001; Steven et al., 1998). Two Rac 
homologues, MIG-2 and CED-10, are also thought to act redundantly to regulate the 
migration of the P cells (Spencer et al., 2001).
During development, hypodermal cells in the hypodermis migrate to the midline where 
they completely surround the embryo in a process called ventral closure (Simske and 
Hardin, 2001; Sulston et al., 1983; Williams-Masson et al., 1997). Mutation of wsp-1, a 
downstream effector of CDC-42, causes a defect in hypodermal cell migration and a 
resulting defect in ventral closure, leading to embryonic lethality (Withee et al., 2004).
Defects in cell migration during early development and gastrulation are observed in 
CED-10 null mutants. This is hypothesised to be due to defects in the rearrangement of 
actin required to mediate cell migration (Withee et al., 2004).
1.11.3. RHO-1 controls neuronal morphogenesis
Expression of dominant-negative RHO-1 in the ASE sensory neuron causes a larger cell 
body and ectopic neurite development (Zallen et al., 2000). The protein SAX-1, an Ndr 
kinase, is a downstream Rho effector in other systems and has been identified to have a 
role in neuronal morphogenesis in C. elegans (Zallen et al., 2000).
1.11.4. RHO-1 and CDC-42 control polarity
CDC-42 and RHO-1 are both involved in embryo polarisation in C. elegans, through 
regulation of actin-myosin contraction, and localisation of the PAR proteins (proteins 
involved in the formation of polarity) (Gotta et al., 2001; Schonegg and Hyman, 2006).
The excretory epidermal cells are polarised to possess an apical and basolateral 
surface. EXC-5, a CDC-42 GEF, is involved in the polarisation of these cells; mutation of
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exc-5 causes a loss of the apical surface and a defect in excretory cell development, 
suggesting a role for CDC-42 in cell polarisation (Buechner et al., 1999; Gao et al., 2001; 
Suzuki et al., 2001).
1.11.5. CED-10 controls cell corpse phagocytosis
Mutations in ced-10 were identified in a screen to isolate genes involved in cell corpse 
phagocytosis (Ellis et al., 1991; Reddien et al., 2001). The Rho/Rac/Cdc42 GEF UNC-73 
and the Rac MIG-2 were subsequently shown to act upstream of CED-10 in the 
regulation of phagocytosis (deBakker et al., 2004).
1.11.6. The three Rac proteins are redundantly involved in axon pathfinding
Double mutations of all combinations of the Rac proteins (CED-10, RAC-2 and MIG-2) 
cause defects in axon pathfinding, including defects in axon initiation, axon guidance 
and axon branching (Lundquist et al., 2001; Wu et al., 2002). Constitutively active 
mutants of any of these three Racs also lead to axon pathfinding defects supporting the 
hypothesis that they are involved in this process (Struckhoff and Lundquist, 2003; Zipkin 
et al., 1997).
1.12. RhoGEFs are the major activators of Rho GTPases
Activation of Rho GTPases could be achieved either through the conversion from the 
inactive GDP-bound form to the active GTP-bound form via a GEF, or through the 
inhibition of inactivation by the GAPs or GDIs. Studies in mammals have suggested that 
the activity of RhoGEFs is the rate-limiting step in Rho GTPase signalling. Thus, 
regulation of the activity of the RhoGEF is crucial in the control of Rho GTPase 
signalling.
In mammals, there are currently 85 known RhoGEFs. Until recently all Rho GTPase 
GEFs were characterised by the presence of a Dbl (Diffuse B-cell lymphoma) homology 
(DH) domain and an adjacent pleckstrin homology (PH) domain, which confer their 
GTPase activity (Cerione and Zheng, 1996). Both domains are necessary for GEF 
activity in vivo.
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Recently, another domain has been shown to catalyse the activation of Rho GTPases 
through exchange of GDP for GTP. Two proteins were identified as activators of Rac 
and Cdc42 (members of the Rho GTPase family) that lack a DH domain, these are Dock 
180 and zizimim 1 respectively. Sequence comparison has identified a new conserved 
domain called CZH2 (CDM-zizimim homology) that possesses Rho GTPase GEF activity 
(Brugnera et al., 2002; Cote and Vuori, 2002; Meller et al., 2002; Meller et al., 2005; 
Namekata et al., 2004). In C. elegans, there are currently 21 predicted members of the 
DH family of RhoGEFs (Table 1.4) and three known members of the CZH family of 
RhoGEFs.
Gene name
Mutant
phenotypes
Known functions
ect-2
(T19E10.1a,b)
Lethal
Cell migration 
Cytokinesis 
Embryonic development 
Vulva development 
Locomotion 
(Morita et al., 2005)
vav-1 (C35B8.2) Lethal
Rhythmic behaviours including 
pharyngeal pumping and defecation 
(Norman et al., 2005)
C02F12.4 Viable Unknown
T08H4.1 Lethal Unknown
C11D9.1 Viable Unknown
C14A11.3a/b Viable Unknown
uig-1
(F32F2.1)
Viable Unknown
K11E4.4 Viable Unknown
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uric-73 
(F55C7.7a,b,c,d,e)
RacGEF viable 
RhoGEF lethal
Cell and neuron migration 
Cytokinesis 
Embryonic development 
Vulva development 
Locomotion 
(Steven et al., 1998)
K07D4.7a,b Viable Unknown
Y105E8A.24a/b No mutants Unknown
unc-89
(C 0 9 D l.la ,b )
Viable
Locomotion 
(Fraser et al., 2000)
exc-5 
(C33D9.1a, b)
Viable
Cell morphogenesis 
Locomotion 
(Simmer et al., 2003; Sonnichsen et al., 
2005)
R02F2.2 No mutants
Embryonic development 
(Gonczy et al., 2000; Kamath et al., 
2003)
Y95B8A.12 Viable Unknown
rhgf-1
(F13E6.6)
Viable
Locomotion 
Embryonic development 
Egg-laying 
Touch sensitivity 
(Yau et al., 2003)
gei-18
(Y37A1B.15)
No mutants
Synaptic transmission 
(Sieburth et al., 2005)
sos-1
(T28F12.3)
Lethal
Cell migration 
Embryonic development 
Vulva development 
(Croce et al., 2004; Sieburth et al., 2005; 
Sonnichsen et al., 2005)
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C28C12.10 Viable Unknown
F52D10.6 No mutants
Growth 
Larval development 
(Kamath et al., 2003; Rual et al., 2004)
Y54G2A.32 No mutants Unknown
Table 1.4. DH-PH containing RhoGEFs in C. elegans
Many RhoGEFs have a promiscuous GEF activity activating multiple Rho GTPases, for 
example UNC-73 activates both CED-10 (Rac) and RHO-1 (Stevens et al., 2005). The 
specificity by which a GEF activates a specific GTPase is gradually being elucidated. 
Crystal structures of the GEF-GTPase complexes are being solved and mutagenesis 
studies are pin-pointing crucial residues in the GTPases (Derewenda et al., 2004). 
Scaffold proteins may also be involved in the assignment of a specific GTPase to a 
RhoGEF. Complexes between the GEF, the GTPase and a subset of its downstream 
effectors have been identified (Jaffe et al., 2005).
Activation of Rho GTPases leads to multiple different outcomes as discussed previously 
(sections 1.9, 1.10 and 1.11). There is evidence that the RhoGEFs determine the 
downstream effects of the GTPase activation. Co-expression of Rac or Cdc42 with 
different GEFs has been shown to lead to different outcomes in mammals (Zhou et al., 
1998). In Drosophila DRhoGEF2 is required for the activation of Rho1 leading to 
epithelial sheet folding at multiple stages in development, but is not required for 
cytokinesis, another Rho1 dependent process (Nikolaidou and Barrett, 2004; Zhou et al., 
1998). The mechanism by which a GEF dictates the pathway downstream of the Rho 
GTPase is currently unknown but could partially be due to scaffold proteins (Connolly et 
al., 2005; Daniels et al., 1999; Elion, 2001; Jaffe et al., 2005; Morrison and Davis, 2003). 
For example, serum stimulation of HeLa cells specifically stimulates the JNK pathway 
downstream of RhoA. This specificity is achieved through the binding of the scaffold 
CNK-1 to the RhoGEFs Net1 and p115RhoGEF and the downstream MAP kinase 
pathway components MLK2 and MLK7 (Jaffe et al., 2005).
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1.13. RGS RhoGEFs mediate signalling from heterotrimeric G proteins to Rho 
GTPases
A sub-family of RhoGEFs contains a regulator of G protein signalling (RGS) domain. 
These domains bind to the activated GTP-bound alpha subunit (Ga) of heterotri meric G- 
proteins and act as GAPs catalysing the intrinsic hydrolytic activity converting GTP to 
GDP and inactivating the a subunit. There are three RGS RhoGEFs in mammals, p115 
RhoGEF, PDZ RhoGEF and LARG (Figure 1.20). All these GEFs are specific activators 
of RhoA and upon binding to an active Ga-GTP subunit catalyse the conversion of 
inactive RhoA-GDP to active RhoA-GTP, as well as inactivating the G a subunit 
converting the active Ga-GTP to inactive Ga-GDP (Fukuhara et al., 2000; Fukuhara et 
al., 1999; Hart et al., 1998; Kozasa et al., 1998). There is just one RGS RhoGEF in 
Drosophila called DRhoGEF2 and one in C. elegans called RHGF-1 (Figure 1.20).
The RGS RhoGEFs have been implicated to have many different specific roles, 
including roles in the regulation of the actin cytoskeleton and gene transcription. For 
example, PDZ RhoGEF can induce neurite retraction and increase cortical actin, whilst 
p115 RhoGEF induces stress fibre formation but does not increase cortical actin in 
Swiss 3T3 cells (Togashi et al., 2000).
The RGS RhoGEFs contain domains in addition to the RGS and DH/PH RhoGEF 
domains; a PDZ domain and a C1 domain. PDZ domains commonly have a role in 
protein-protein interactions and C1 domains bind to DAG and phorbol esters. RHGF-1 
and DRhoGEF2 the RGS RhoGEFs in C. elegans and Drosophila respectively contain 
all these domains, whilst the three mammalian RGS RhoGEFs each contain a subset of 
the domains which always includes the RGS, DH and PH domains (Figure 1.20). The 
roles of these additional domains (PDZ and C1) in the RhoGEFs have not been defined 
but are thought to be involved in the regulation of the RhoGEFs.
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Figure 1.20 The RGS RhoGEF family
LARG: leukaemia associated RhoGEF, PDZ: PDZ domain, RGS: RGS domain,
C1: C1 DAG binding domain, DH: DBL homology domain, PH: pleckstrin homology 
domain.
Not to scale.
The specificity of the Ga proteins that activate the RGS RhoGEFs is under debate.
LARG exhibits GAP activity towards Ga12 and Ga13 in vitro and has been shown to be 
activated by Gai2 and more recently by Gaq in vitro (Booden et al., 2002; Chikumi et al., 
2002; Suzuki et al., 2003). p115 RhoGEF that exhibits GAP activity to Ga12 and Ga13 is 
activated by Gai3but inhibited by Ga12 (Hart et al., 1996; Kozasa et al., 1998).
Therefore, the relationship between the Ga subunits and the RGS RhoGEFs is still being 
elucidated. In Drosophila DRhoGEF2 interacts with and is activated by Concertina (Cst) 
a Ga subunit (Figure 1.21) (Barrett et al., 1997).
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Another level of regulation of the RGS RhoGEFs is the discovery that they are capable 
of homo- and hetero-oligomerization. p115RhoGEF is only capable of homo­
oligomerization, whilst LARG and PDZ RhoGEF are capable of homo- and hetero 
oligomerization (Chikumi et al., 2004). The oligomerization appears to decrease their 
GEF activity (Chikumi et al., 2004).
1.14. RHGF-1 and GPA-12 in C. elegans
In C. elegans RHGF-1 has been shown to interact with constitutively active GPA-12 the 
single Ga homologue in the G a12/ G a13 family, which is 50% identical to G ai2 (Jansen et 
al., 1999; Yau et al., 2003). RHGF-1 (also called CeRhoGEF) can activate Rho- 
dependent signalling in vitro suggesting that RHGF-1 is activated by GPA-12 to 
stimulate the activity of RHO-1 (Figure 1.21) (Yau et al., 2003). The knockdown of both 
gpa-12 and rhgf-1 by RNAi causes similar phenotypes including egg-laying defects, 
embryonic arrest, touch insensitivity and a locomotory defect (Yau et al., 2003). 
Examination of the expression patterns has shown overlapping expression in neurons in 
the head and the ventral nerve cord, although GPA-12 is expressed much more strongly 
in other tissues where RHGF-1 is absent (van der Linden et al., 2003; Yau et al., 2003).
GPA-12 has been shown to have a role in pharyngeal pumping (van der Linden et al., 
2003). The loss of GPA-12 has no effect on pumping, but expression of constitutively 
active GPA-12 causes a loss of pharyngeal pumping and a corresponding embryonic 
arrest (van der Linden et al., 2003). The protein kinase C, TPA-1, is involved in the 
regulation of pharyngeal pumping; mutation of tpa-1 suppresses the embryonic arrest of 
animals over expressing constitutively activate GPA-12 (van der Linden et al., 2003).
The DAG analogue phorbol esters also causes a loss of pharyngeal pumping and 
corresponding embryonic arrest that is dependent upon TPA-1, implicating a role for the 
regulation of DAG levels in the regulation of pumping (van der Linden et al., 2003). The 
site of action of GPA-12 and TPA-1 in the regulation of pumping is in the pharyngeal 
muscle, as determined by tissue specific expression of the genes under the myo-2 
promoter (van der Linden et al., 2003).
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Figure 1.21 The Gai2/ RGS RhoGEF/ Rho pathway is conserved in C. 
elegans, Drosophila and mammals
The pathway connecting the heterotrimeric G proteins to Rho GTPases via RGS 
RhoGEFs is conserved in mammals, Drosophila and C. elegans.
1.15. The hypothesis for this thesis
The work in this thesis is based upon the following hypothesis:
The G alpha 12/ RGS RhoGEF pathway in C. elegans leads to the activation of 
RHO-1 to regulate neurotransmitter release.
RHO-1 has been shown to be a key regulator in the release of the neurotransmitter ACh 
at the NMJ in C. elegans (McMullan et al., 2006). The upstream regulators of RHO-1 in
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this context are currently unknown. GPA-12, the homologue of Gai2, has been shown to 
interact with RHGF-1 when activated and RHGF-1 is capable of Rho dependent 
signalling (Yau et al., 2003). Both GPA-12 and RHGF-1 are expressed in the ventral 
cord motor neurons, the site at which expression of RHO-1 is required to mediate ACh 
release (Yau et al., 2003, McMullan, 2006 #171). RNAi knockdown of GPA-12 and 
RHGF-1 have been reported to cause locomotory defects suggesting a possible change 
in neurotransmission (Yau et al., 2003). Regulation of the levels of the lipid second 
messenger DAG is an important factor in the release of ACh at the NJM (Lackner et al., 
1999; Nurrish et al., 1999). The regulation of DAG has been shown to be involved in the 
control of pharyngeal pumping by GPA-12 and the protein kinase C, TPA-1, although 
this pathway is active in the pharyngeal muscle, as opposed to the neurons (van der 
Linden et al., 2003). These observations suggest that GPA-12 and RHGF-1 could be 
upstream regulators of RHO-1, regulating DAG levels in the context of the neuronal 
regulation of neurotransmitter release.
1.16. The aims of this study
In order to prove or disprove the above hypothesis this study looks at the roles of GPA- 
12 and RHGF-1 in the release of ACh at the NMJ in C. elegans. Mutants in gpa-12 and 
rhgf-1 were characterised and the effects of over expressing both of these proteins were 
studied. Epistasis studies were undertaken to genetically determine the roles of the 
proteins in the known pathways regulating ACh release. This is divided into two 
chapters:
Chapter 3: The role of GPA-12 in neurotransmission.
Chapter 4: The role of RHGF-1 in neurotransmission.
Finally, during the characterisation of an rhgf-1 mutation, another mutation was identified 
with a defect in neurotransmission. This mutation is further characterised and discussed 
in chapter 5.
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2. Materials and Methods
2.1. Worm Stocks
Worms were grown on 55mm petri dishes (VWR International) containing specially made 
worm agar. The plates were seeded with streptomycin resistant E. coli OP50 bacteria as 
food for the worms. Worms were manipulated as published using a platinum wire pick to 
transfer worms between plates (Brenner, 1974). Worm strains were cultivated at 22°C.
2.2. Freezing and defrosting worms
At least 10 plates of worms were grown to starvation on 55mm petri dishes. The animals 
were washed into 15ml of M9 buffer and left on ice for 30 minutes. The worms settled to 
the bottom of the M9 buffer and the volume was carefully reduced to 2ml without 
disturbing the worms. 2ml of molten freezing agar was added and the resulting mixture 
divided into two 2ml aliquots and transferred to 2ml cryovial tubes (Corning). These were 
then placed in a polystyrene box and stored at -80°C. When defrosting animals cryovial 
tubes were transferred from the -80°C freezer to dry ice. A small amount of agar was 
scraped onto a seeded plate using a spatula whilst keeping the cryovial on dry ice. The 
plate was incubated for 2 days at 22°C.
2.3. Crossing worms
For standard crosses, 55mm petri dishes containing worm agar were seeded with a very 
small lawn of E.coli OP50 bacteria in the centre of the plate. Five larval stage 4 (L4) 
hermaphrodites of the first strain were transferred onto the lawn and 10 young adult 
males of the second strain were transferred to the perimeter of the lawn. The plate was 
left either overnight at 22°C or for 3 days at 15°C. Occasionally for crosses between 
mutant strains, the plates were left for 2 days at 22°C. The hermaphrodites were then 
each separated to individual plates and the progeny examined after 3 days.
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2.4. Microinjection of worms
Plasmid DNA or PCR products were injected into the gonad of young adult worms (Mello 
and Fire, 1995; Mello et al., 1991). The experimental plasmid was injected at 10ng/pil, 
unless otherwise stated. PCR products were purified using QIAgen PCR purification kit, 
resuspended in 50^ 1 TE and directly injected. Both were co-injected with a marker 
plasmid at 50ng/pil to identify the transgenic animals, unless otherwise stated. The 
markers used were: TTX-3::GFP, which is expressed in the cell bodies and axonal 
processes of bilaterally symmetric head neurons AIY left and right (a gift from Oliver 
Hobert); UNC-122::GFP, which is expressed in the coelomocytes (a gift from Piali 
Sengupta) and p.acr-2::GFP, which is expressed in ventral cord motor neurons VA, DA, 
VB, DB, DA, IL1, RMD, and PVQ (the promoter for acr-2 was a gift from Yishi Jin). The 
total DNA concentration in the injection mix was made up to 150ng/ptl using pBluescript 
(Stratagene) in TE buffer (no additional bluescript was added for PCR product 
injections). Pads for injecting the worms were made from 2% agarose on 22mm X 50mm 
cover slips (Chance Propper Ltd). A small drop of halothane oil (Sigma) was placed on 
the pad and the worm transferred to the oil. The animal was then gently stuck to the 
agarose pad using a platinum wire pick. A Leica DM IRB microscope and Intracel 
picospritzer III injector were used to perform the injections with 0.5mm diameter injection 
needles (Harvard apparatus). Once injected the worms were carefully removed from the 
pad by the addition of a small volume of M9 buffer that released the worm. The animal 
was then transferred by pipette to a seeded agar plate. The F1 generation from injected 
adults was screened for the transgenic marker and any positive animals transferred to 
clean plates. The progeny of these transgenic animals were then screened for the 
transgenic marker and those that contained it were considered a line of transgenic 
animals.
2.5. DNA isolation from worms
10 starved plates of worms were washed into 15ml ice-cold EN solution and spun down 
for 1 minute at 1000rpm at 4°C. They were then resuspended in 2ml clean ice-cold EN 
solution and left on ice for 10 minutes. 2.5ml cold sucrose solution (68% sucrose) was 
added and the tube vortexed to mix. 3ml of EN solution was then carefully layered on top 
of the sucrose solution. The tube was spun at 2500rpm for 10 minutes to allow all the
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bacteria, dead worms and other unwanted material to pellet at the bottom. The worms 
banded in a layer between the solutions and were transferred to a new tube. They were 
washed twice with EN solution to remove any remaining sucrose. The worms were 
suspended in a small volume of EN solution and transferred to a 1.5ml Eppendorf tube. 
500pil lysis buffer, 5^ 1 of p-mercaptoethanol and 5ptl of proteinase K (20mg/ml) were 
added and the tubes incubated at 65°C overnight with mixing every 15 minutes for the 
first 90 minutes. The next morning a further 5pl p-mercaptoethanol and 5\i\ proteinase K 
was added and the tube incubated at 65°C for 4 hours. The DNA was then extracted 
using an equal volume of phenol and chloroform in sequential separations until a clean 
interface was achieved. The DNA was precipitated by adding 1/10 volume 2.5M NaAc, 
and 100% EtOH and centrifuging for 30 minutes at 1300rpm. It was then washed with 
70% EtOH and resuspended in TE buffer. The concentration was calculated by 
measuring the absorbance at 260nm and using the following calculation:
Concentration (mg/ml) = Abs 260nm X dilution factor X 50
1000
2.6. RNA isolation from worms
50 starved plates of worms were washed into 1 ml M9 buffer and flash frozen in liquid 
nitrogen to aid the lysis of the worms. TRIZOL and fJ-Mercaptoethanol were used to 
thoroughly lyse all the cells. The DNA and RNA (nucleic acids) were cleaned using 
chloroform to remove any lipids and proteins and the TRIZOL. The nucleic acids were 
precipitated using isopropanol and washed using 70% ethanol. They were resuspended 
in DEPC treated water and then treated with DNAse to destroy any DNA. The RNA was 
the extracted using equal volumes of phenol and chloroform and finally resuspended in 
DEPC water. The concentration was calculated by measuring the absorbance at 260nm 
and using the following calculation:
Concentration (mg/ml) = Abs 260nm X dilution factor X 40
1000
2.7. Pharyngeal pumping assays
L4 worms were picked the night before assaying. The resulting adults were transferred 
onto clean seeded plates and left for 20 minutes. An individual animal was then
98
observed for 2 minutes and the number of pumps of the pharynx was counted using the 
programme Etho (obtained from Jim Thomas at University of Washington USA). The 
number of pumps per minute was then calculated for each animal. If an animal moved 
off the bacterial food during the assay, it was void and started again. If heatshock was 
required to induce gene expression, before assaying the plates were placed at 33°C for 
1 hour followed by 30 minutes at 20°C, and this was repeated a second time.
2.8. Defecation assays
L4 worms were picked the night before assaying. The resulting adults were transferred 
onto clean seeded plates and left for 20 minutes. An individual animal was then 
observed for 10 minutes and the time recorded everytime the pBoc phase of the 
defecation cycle was observed using the programme Etho. If an animal moved off the 
bacterial food in this time, the assay was void and started again. The length of the 
defecation cycle was calculated as the average time between the pBoc phases for an 
animal over 10 minutes. If an animal did not defecate in 10 minutes, the maximum cycle 
length of 600 seconds was recorded. If heatshock was required to induce gene 
expression, before assaying the plates were placed at 33°C for 1 hour followed by 30 
minutes at 20°C, and this was repeated a second time.
2.9. Embryonic arrest assays
20 adult worms containing many eggs were placed on clean seeded plates and 
bleached using a solution containing 50% bleach and 1M NaOH. This will kill the adult 
worms but leave any unhatched eggs unharmed. The eggs were left to hatch overnight 
at 20°C and the resulting larval stage 1 (L1) worms were transferred to clean seeded 
plates, 20 animals per plate. They were then incubated at 20°C for 4 days. Pictures were 
taken of the plates showing the number and age of any progeny from the original L1 
worms. If heatshock was required to induce gene expression the plates containing 20 L1 
animals were placed at 33°C for 1 hour followed by 30 minutes at 20°C, and this was 
repeated a second time. The plates were then incubated at 20°C for 4 days.
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2.10. Aldicarb assays
Small (35mm) drug plates containing 1 mM aldicarb (Greyhound Chromatography and 
Allied Chemicals Ltd) in the worm agar were made using 100mM aldicarb stock solution 
dissolved in 70% ethanol. They were seeded with 100^1 E. coli OP50 bacteria and left 
overnight to dry with the lids on. The same day, 30 larval stage 4 (L4) worms were 
picked onto clean seeded plates and left overnight at 20°C. The resulting 30 adults were 
transferred to the small drug plates containing aldicarb and observed every 10 minutes 
for 100 minutes to record the number of worms that had paralysed. Paralysis was 
defined as a worm that could not move any body wall muscles upon stimulation with a 
platinum wire. A graph was then drawn showing the percentage paralysis against time. If 
heatshock was required to induce gene expression, before assaying the plates were 
placed at 33°C for 1 hour followed by 30 minutes at 20°C, and this was repeated a 
second time.
2.11. Levamisole assays
Small drug plates containing 100^M levamisole (Sigma) in worm agar were made using 
100mM stock solution dissolved in S. Basal. They were seeded with 100pJ E. coli OP50 
bacteria and left overnight to dry. The same day, 30 L4 worms were picked onto clean 
seeded plates and left overnight at 20°C. The resulting adults were transferred to the 
small drug plates containing levamisole and observed every 10 minutes for 100 minutes 
to record the number of worms that had paralysed. Paralysis was defined as a worm that 
could not move any body wall muscles upon stimulation with a platinum wire. A graph 
was then drawn showing the percentage paralysis against time. If heatshock was 
required to induce gene expression, before assaying the plates were placed at 33°C for 
1 hour followed by 30 minutes at 20°C, and this was repeated a second time.
2.12. Phorbol esters pre-treatment
Plates containing 2jig/ml phorbol-12-myristate-13-acetate (PMA) alone or 2fxg/ml PMA 
with 1 mM aldicarb in the worm agar were made. Plates were left overnight to dry at 
20°C. The same day 30 L4 worms were picked onto clean seeded plates and left 
overnight at 20°C. The resulting adults were transferred to either a plate containing
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2 i^g/ml PMA alone or a control unseeded plate and left for 2 hours at 20°C. Animals from 
the PMA plate were transferred to a plate containing 2jxg/ml PMA and 1 mM aldicarb and 
the control animals were transferred to 1 mM aldicarb plate. The aldicarb assay was 
undertaken as described above.
2.13. Aldicarb assay screening for rescue of mutation nz90
To follow the phenotype of the mutation nz90 a revised aldicarb assay was used. L4 
worms were picked the night before the assay and the resulting adults transferred to 
small drug plates containing 1 mM aldicarb in the worm agar. These plates were not 
seeded with E. coli OP50 bacteria. The plates were left at 20°C for 60 or 130 minutes. 
The number of worms paralysed using the same definition of paralysis was then 
recorded.
2.14. Feeding RNAi
A library of HT115(DE3) E. coli bacteria, genotype F-, mcrA, mcrB, IN(rrnD-rrnE)1, 
rnc14::Tn10(DE3 lysogen: lavUV5 promoter-T7 polymerase) (IPTG-inducible T7 
polymerase) (RNAse III minus), is available containing small inserts of the C. elegans 
genome (GeneService). These bacteria can be used to perform RNAi knockdown of the 
gene that is inserted in the bacterium. The genomic sequence has been cloned into a 
special vector called L4440 that has two T7 promoter sites flanking each side of the 
insert. The bacteria contain a form of IPGT-inducible T7 RNA polymerase so upon 
exposure to IPTG the bacteria will make dsRNA from the insert (Fraser et al., 2000; 
Timmons et al., 2001; Timmons and Fire, 1998). The worms are simply grown on plates 
containing IPTG to induce the bacteria to make the dsRNA and the gene will be knocked 
down. Plates were made containing 20.8g/litre agar, 2.34g/litre bactopeptone, 50mM 
NaCI, 0.25M potassium phosphate, 1mM MgS04,1mM CaCI2,5ng/ml cholesterol, 1mM 
IPTG and 25pig/ml carbenicillin. These plates were seeded with HT115(DE3) bacteria 
containing the insert for the knockdown of a specific gene the night before use. L4 
worms were then transferred to these plates and left overnight at 20°C. The following 
day the resulting adults were singly placed on new plates and left at 20°C for 3 days. 
Single L4 worms from the F1 generation were then transferred to new plates and left for
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3 days at 20°C. Single L4 worms from the F2 generation were then transferred to new 
plates and analysis undertaken on the F2 generation.
2.15. Single Nucleotide Polymorphism (SNP) mapping
Animals with a mutation in a Bristol N2 strain background were crossed with Hawaiian 
CB4856 worms at least 10 times. Single nucleotide polymorphisms, which alter 
restriction sites (snp-SNPs), were then analysed in these animals to determine if the 
DNA of the animal was Bristol N2 or Hawaiian CB4856 at various points throughout the 
entire genome. A SNP which is closely linked to the mutation being mapped will be most 
likely to remain as Bristol N2 whilst those further away and on different chromosomes 
will be likely to be backcrossed out and become Hawaiian CB4856. The protocol and 
primer sets designed in the paper Davis et al 2005 were used to initially define the 
chromosome upon which the mutation was found using a combination of 50 different 
backcrossed animals. The PCR protocol is identical to that for single worm PCR, which 
is described in section 2.20. The annealing temperature was 50°C and the extension 
time 3 minutes. The amplified DNA was digested by the addition of 1.5^1 SM buffer 
(Sigma), 5 units Dral (Sigma) and 3jxl water. The tubes were incubated at 37°C for 2 
hours and the products were run on a 2.5% agarose gel. The same 8 primer sets on the 
selected chromosome were then used on individual backcrossed animals to further 
define the location of the mutation to a region of the chromosome. Additional SNPs 
within the identified region of the chromosome were found using WormBase. These 
were studied to determine if they were Bristol N2 or Hawaiian CB4856 DNA. Snip-SNPs 
were analysed using the same protocol but with the appropriate enzyme following 
manufacturer’s instructions for digestion temperatures and buffers. SNPs that change 
the DNA sequence but do not change a restriction site were amplified by PCR as above 
but then the DNA was purified using QIAgen PCR purification kit and 5^ 1 was sequenced 
by MWG Biotech. This allowed the region within which the mutation occurred to be 
defined to a small region of one chromosome.
2.16. Confocal microscopy: Examining the gross neuronal morphology
A plasmid (KP#307) expressing GFP from the acr-2 promoter (a gift from Yishi Jin) 
which is expressed in the cholinergic motor neurons VA, DA, VB, DB, DA, IL1, RMD,
102
and PVQ was previously made by Stephen Nurrish (Nurrish et al., 1999) and was 
injected into a variety of different strains. A strain of worms expressing GFP from the 
unc-47 promoter, which is expressed in all GABAergic neurons, was a gift from Erik 
Jorgensen (Mclntire et al., 1997). These worms were then crossed into a variety of 
different strains including gpa-12 (pk322), rhgf-1 (ok880), hs::gpa-12 (Q205L)
(pkls1330), hs::gpa-12 (Q205L) (pkls1330); rhgf-1 (ok880) and nz90. Worms were 
mounted on 2% agarose pads in 100mM levamisole to cause paralysis. Pictures were 
taken using a Biorad 2100 upright multiphoton confocal microscope with a Nikon 40X 
objective. Images were obtained using Lasersharp software (Biorad). Images were 
processed to give maximum intensity projections of a z-series using ImageJ (NIH).
2.17. Confocal microscopy: Counting UNC-13 and SNB-1 puncta
Plasmids containing UNC-13S::YFP (KP#291), p.acr-2::SNB-1::CFP (KP#282) and 
UNC-13S(H173K)::GFP (KP#273) had all previously been made by Stephen Nurrish and 
injected into wild type worms. These worms were crossed with various strains including 
gpa-12 (pk322), rhgf-1 (ok880), hs::gpa-12 (Q205L) (pkls1330), hs::gpa-12 (Q205L) 
(pkls1330); rhgf-1 (ok880) and nz90. Worms were mounted onto 2% agarose pads in 
100mM levamisole to cause paralysis. Pictures (8 bit) were taken using a Biorad 2100 
upright multiphoton confocal microscope with a Nikon 60X objective. Images were 
obtained using Lasersharp software and processed to give maximum intensity 
projections using ImageJ (NIH). Images were analysed to determine the fluorescence 
and thresholded to highlight objects containing more than five pixels with an intensity 
greater than 100 (pixels have an intensity between 0 and 255), these were counted as 
puncta. Highlighted objects outside the dorsal cord, usually autofluorescence in the gut, 
were removed from the image. Puncta number and size were calculated using ImageJ. 
Average puncta intensities were defined as the average pixel value within the puncta 
minus the average value across the entire image using ImageJ.
2.18. Polymerase Chain Reaction (PCR)
10pmol each primer, 0.2mM dNTP mix, 2.5 units Taq polymerase and 1mM MgCI2were 
used unless otherwise stated. Sigma Taq Polymerase was used in all PCR reactions
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unless otherwise stated. The same PCR programme was used for all reactions with 
changes in the annealing temperature and extension time for different primer sets.
1 )95°C
2) 95°C 45 seconds 
40 seconds
3 minutes
3) annealing temperature
4) 72°C
5) back to step 2, repeat 35 times
6) 72°C
extension time
10 minutes
7) 4°C hold
The extension time was calculated as 1 minute per 1 kb of DNA being amplified rounded 
up to nearest 30 seconds. The annealing temperature was determined by trial and error 
beginning at 60°C and increasing due to non-specific amplification and decreasing due 
to no amplification until the correct temperature for specific amplification was found.
2.19. Polymerase chain reaction for sub-cloning
To minimise errors when using PCR products for sub-cloning PFX polymerase 
(Invitrogen) was used. 10pmol each primer, 0.3mM dNTP mix, 2.5 units of PFX and 
1 mM MgS04 were used. The same PCR programme was used for all reactions with 
changes in the annealing temperature and extension time for different primer sets.
1)93°C 1 minute
2) 93°C 30 seconds
3) annealing temperature 15 seconds
4) 68°C extension time
5) back to step 2, repeat 30 times
6) 68°C 7 minutes
7) 4°C hold
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2.20. Single worm PCR for screening progeny when crossing strains
A single worm was placed in PCR tube containing 2.5^1 single worm PCR lysis buffer 
with 10jxg proteinase K. The tubes were placed on dry ice for 20 minutes to freeze the 
worm. The tubes were then transferred to a PCR machine and run at 37°C for 1 hour 
followed by 15 minutes at 95°C to inactivate the proteinase K enzyme. The PCR reaction 
mix was now added and the reaction completed as described in section 2.18.
Band sizes
For gpa-12 (pk322) deletion
wild type gpa-12
(pk322)
Annealing
temperature
Extension
time
gpa-12.1 and gpa-12.2 2.5kb 500bp 50°C 2.5 minutes
gpa-12.2 and gpa-12.5 1.2kb No
amplification
50°C 2.5 minutes
For gpa-12 (Q205L) (pkls1330)
wild type hs::gpa-12
(Q205L)
(pkls1330)
Annealing
temperature
Extension
time
hsp16-2.1 and gpa-12.4 No
amplification
1kb 60°C 2 minutes
For rhgf-1 (ok880) deletion
Wild type rhgf-1 (ok880) Annealing
temperature
Extension
time
RB976.2 and RB976.5 1kb No
amplification
60°C 2.5 minutes
RB976.2 and RB976 
inner left
2.6kb 1.5kb 60°C 2.5 minutes
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For rhgf-1 (gk217) deletion
Wild type rhgf-1 (gk217) Annealing
temperature
Extension
time
VC430.2e and RB976 
outer right
810bp 560bp 40°C 1 minute
2.21. RT PCR from RNA extract
To obtain a full-length cDNA library from an RNA extract BD SMART™ RACE cDNA 
amplification kit (BD biosciences Clontech) was used. Initially first strand cDNA is 
synthesised using a primer that binds to polyA tail of RNA sequences (poly dT) and a 
reverse transcriptase enzyme that adds several C bases to the end of the cDNA.
Another primer, which binds to these additional C bases, allows the reverse 
transcriptase enzyme to amplify the entire cDNA (BD SMART II A oligo). The first strand 
cDNA is then used directly in the PCR amplifications of specific genes from the library. 
The BD SMART IIA  oligo is used in combination with the gene specific primer to amplify 
the 5’end of the cDNA, whilst the poly (dT) primer is used in conjunction with a gene 
specific primer to amplify the 3’ end of the cDNA. The cDNA can then be cloned and 
sequenced.
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Figure 2.1. Principle of SMART™ RACE RT PCR
Taken from Clontech website.
2.22. Restriction digestion and ligation of DNA
5^ ig DNA was digested with 10 units of restriction enzyme (New England Biolabs or 
Promega) at 37°C for 2 hours unless otherwise stated. Digests were run on 1% agarose 
gel made with TBE buffer containing ethidium bromide to visualise the DNA. The DNA 
band was cut from the gel, cleaned using QIAquick gel extraction kit (QIAgen) and 
resuspended in 50ptl TE buffer. Ligations were performed using T4 Quick Ligase (New 
England Biolabs) as per manufacturer’s instructions. 5jxg of purified digested vector 
DNA, 15pig of purified digested insert DNA, ligase buffer and 2,000 units of T4 Quick 
Ligase were incubated at 20°C for 15 minutes and then placed on ice ready for 
transformation.
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2.23. Transformation of bacteria
To make chemically competent cells 1000ml cultures of E. coli DH10p were grown until 
the O.D. at 260nm gave a reading of 0.6. The cultures were incubated on ice for 30 
minutes and then centrifuged at 2500rpm for 20 minutes at 4°C. The resulting cell pellet 
was resuspended in 200ml of ice-cold filter sterilised transformation buffer 1 (TBF1) and 
left on ice for 30 minutes. The solution was spun again at 2600rpm for 20 minutes at 4°C 
to pellet the cells, which were then resuspended in 10ml ice-cold filter sterilised 
transformation buffer 2 (TBF2). The cells were then stored in 50^ 1 aliquots at -80°C. A 
50[xl aliquot of the chemically competent E. coli DH10p was defrosted on ice. 450pl of 
ice-cold 100mM CaCI2 was added and the solution divided into 5 10Opil aliquots. 
Approximately 0.1 ng of ligated DNA or 10ng of plasmid were added and the mixture 
placed on ice for 5 minutes. The bacteria were heatshocked for 2 minutes at 37°C and 
briefly returned to ice. 100^1 LB broth was added and the bacteria grown for 1 hour at 
37°C. The bacteria were then plated onto an LB agar plate with the appropriate selection 
antibiotic (ampicillin at lOO^g/ml, kanamycin at 25jig/ml or tetracycline at 50pg/ml) and 
incubated overnight at 37°C.
2.24. Isolation of plasmid DNA from bacteria
Individual bacterial colonies were picked using a sterile inoculation loop and used to 
inoculate LB broth cultures grown at 37°C overnight with the appropriate selection 
antibiotic. For small scale isolation 2ml cultures were grown and the bacteria harvested 
by centrifugation at 1300rpm for 2 minutes. The bacteria were lysed using TENS buffer 
and 3M NaAc pH5.2. The DNA was precipitated, washed and purified using isopropanol 
and 96% EtOH and resuspended in 50^ 1 TE buffer. Large-scale DNA preparations were 
performed using 150ml bacterial cultures and the QIAgen midi filter kit. The DNA was 
resuspended in TE buffer. The concentration of DNA was determined by measuring the 
absorbance of 1 in 100 dilution at 260nm. The following formula was used to calculate 
the concentration:
Concentration (mg/ml) = Absorbance at 260nm X 100 X 50
1000
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2.25. DNA sequencing
200ng of purified DNA in water was dried down overnight at room temperature. This was 
sent to MWG Biotech with 10ng of the desired primer for sequencing. Value read 
sequencing was used.
2.26. Sequencing the gpa-12 (pk322) deletion
The sequence of gpa-12 (pk322) deletion had been previously mapped to encompass 
the majority of the gene as shown by WormBase. To precisely define the deletion the 
DNA encoding GPA-12 was amplified by single worm PCR as described above (section 
2.20) from C. elegans strain NL594 that contains the gpa-12 (pk322) deletion. Primers 
gpa-12.1 (which primes before exon 1) and gpa-12.2 (which primes after exon 8 and the 
STOP codon) were used with an annealing temperature of 50°C and an extension time 
of 3 minutes. The DNA was purified using gel extraction described above (section 2.22) 
and sent for sequencing with primer gpa-12.1 by MWG Biotech.
2.27. Sequencing the rhgf-1 deletion mutant gk217
The deletion mutation allele gk217 in rhgf-1 had previously been mapped to form a small 
deletion within the centre of the gene as shown by WormBase. Primers were designed 
around this prediction to precisely define the deletion. Genomic DNA was extracted from 
strain VC430 that contains rhgf-1 (gk217) deletion. This DNA was used to amplify the 
rhgf-1 gene using primers VC430-2e and RB976 outer right using 40°C annealing 
temperature and 1 minute extension time. The DNA was purified using PCR purification 
kit from QIAgen as per manufacturer’s instructions and sequenced with primer RB976 
inner right by MWG Biotech.
To determine if the deletion mutation was in-frame the RNA from strain VC430 
containing gk217 deletion in rhgf-1 was extracted. The total cDNA library was then 
amplified as described above. This was then used in PCR reactions using primers both 
5’ and 3’ to the gk217 deletion as defined using the genomic DNA. Primers RhoGEF.9 
and RhoGEF.10 were used to amplify the cDNA 5’ to the deletion, primers RB976 inner 
right and RB976.5 were used to amplify cDNA which would encompass the deletion and
109
primers RB976.6 and RB976 inner left were used to amplify cDNA 3’ from the deletion. 
40°C annealing temperature with 3 minute extension time was used.
2.28. Sequencing the rhgf-1 deletion mutant ok880
The mutation allele ok880 within rhgf-1 had previously been mapped as a deletion in the 
middle of the gene possibly encompassing the start of the DH domain. Primers were 
designed around this prediction to precisely map the deletion. Genomic DNA was 
extracted from strain RB976 that contains rhgf-1 (ok880) mutation. This DNA was used 
to amplify rhgf-1 gene using primers RB976.2 (primes in exon 5) and RB976.7 (primes in 
exon 11) using 60°C annealing temperature and 2 minute extension time. The DNA was 
purified using PCR purification kit from QIAgen as per the manufacturer’s instructions 
and sequenced with primer RB976.7 by MWG Biotech.
To determine if the deletion was in-frame the RNA was extracted from strain RB976 
containing ok880 deletion in rhgf-1. The total cDNA library was then amplified as 
described above. This was then used in a PCR reaction to amplify the cDNA 
encompassing the deletion ok880 using primers RB976 inner left and RB976 inner right, 
40°C annealing temperature and 3 minute extension time. The PCR product was then 
purified using gel extraction and sequenced by MWG Biotech using primer RB976 inner 
right.
2.29. Making constitutively active gpa-12 cDNA under neuronal promoter
Yuji Kohara kindly gave us the plasmid yk336c8 that contains the complete cDNA for 
gpa-12. This was used to amplify gpa-12 cDNA using primers gpa-12.3 which primes the 
top strand at the start of the cDNA introducing an Nhel restriction site just before the 
start codon ATG and gpa-12.6 which primes the bottom strand at the 3’ end introducing 
a Sacl restriction site just after the STOP codon (annealing temperature 60°C, extension 
time 1 minute). The PCR product was digested with Nhel and Sacl, purified and cloned 
into an adapted form of Bluescript made by Stephen Nurrish to include Nhel and Sacl 
sites to make SJN294, containing the entire wild type cDNA for gpa-12. Primer gpa-12.4 
primes in middle of gpa-12 cDNA introducing a single base change substitution T to A at
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position 614 which results in an activating amino acid substitution glutamate to leucine at 
amino acid 205 followed immediately by a silent Bglll restriction site (van der Linden et 
al., 2003). gpa-12.3 and gpa-12.4 were used to amplify the 5’ end of gpa-12 cDNA from 
plasmid yk336c8 and introduce the activating base substitution followed by a silent Bglll 
restriction site (annealing temperature 60°C, extension time 1 minute). The product was 
digested with Nhel and Bglll, purified and cloned into a modified form of bluescript made 
by Stephen Nurrish to include Nhel and Bglll restriction sites to make EJH12. Primer 
gpa-12.5 primes immediately after the activating codon substitution in gpa-12 cDNA and 
introduces a silent Bglll restriction site here matching the one introduced by gpa-12.4. 
The 3’ end of gpa-12 cDNA was amplified from plasmid yk336c8 using primers gpa-12.5 
and gpa-12.6 introducing the silent Bglll restriction site, and the product cloned into a 
modified form of bluescript containing Bglll and Sacl restriction sites to make SJN292 
(annealing temperature 60°C, extension time 1 minute). Plasmid EJH12 was digested 
with Nhel and Bglll and plasmid SJN292 was digested with Bglll and Sacl and the two 
resulting small inserts ligated into a vector containing the promoter for acr-2 to make 
EJH14 and also into a plasmid containing the cholinergic specific promoter for unc-17 (a 
3213-base-pair fragment located -1226 to -4439 bp 5' of the unc-17 start codon, a gift 
from Josh Kaplan, Massachusetts General Hospital, Boston, MA) to make EJH15. The 
gene acr-2 is expressed in the ventral cord motor neurons VA, DA, VB, DB, DA, IL1, 
RMD, and PVQ (Nurrish et al., 1999). The gene unc-17 is expressed in cholinergic 
neurons including the dorsal and ventral cord motor neurons (Alfonso et al., 1993). It has 
further been shown that within the motor neurons unc-17 is localised to synapses 
(Sieburth et al., 2005). The specific promoter fragment used for unc-17 has been shown 
not to cause any developmental defects (Josh Kaplan, personal communication).
2.30. Making rhgf-1 complete cDNA under neuronal promoter
To define the extreme 5’ end of rhgf-1 cDNA we used the SMART RACE kit already 
described. A total cDNA library was made from wild type worms. This was then used to 
amplify the 5’ end of rhgf-1 cDNA in a two step nested PCR reaction. The first reaction 
used the general 5’ end primer BD SMART II A oligo and the gene specific primer for 
rhgf-1 rhogef.4, which primes at the end of exon 14. 2.5ptl of the first round PCR mix was 
then used as a template for the second round using primers SLI-Not I (a general primer 
for all genes with an SLI site) and the gene specific primer rhogef.10, which primes at
111
the end of exon 9. For both the rounds of nested PCR 60°C annealing temperature was 
used with 1 minute extension time. The PCR product from the second round PCR was 
digested with Notl and EcoRI (an EcoRI site exists in the rtigf-1 cDNA at base 888 in 
exon 9), purified, subcloned into bluescript (Stratagene) to make SJN290. This was 
sequenced by MWG Biotech with primer T7. Plasmid yk877c07 a gift from Yuji Kohara 
contains a partial cDNA for rhgf-1 (the 3’ end). This was used to amplify the 3’ end of the 
rhgf-1 cDNA using primers rhogef.7, which primes the top strand just 5’ to the unique 
Spel site at base 3062, and rhogef.2, which primes the bottom strand over the STOP 
codon and introduces a Kpnl site immediately after the STOP (annealing temperature 
60°C, extension time 1 minute). The PCR product was digested with Spel and Kpnl, 
purified and cloned into a modified form of bluescript containing Spel and Kpnl sites to 
make SJN293. To make the entire cDNA without the extreme 5’ end plasmid yk877c07 
was digested with EcoRI and Spel and the resulting fragments run on 1% agarose gel. 
The correct size DNA band corresponding to the middle of rhgf-1 cDNA was cut and the 
DNA purified. Plasmid SJN292 was digested with Spel and Kpnl and the insert purified. 
These two fragments where then combined together in a three way ligation in an 
adapted form of bluescript with EcoRI and Kpnl sites to form the majority of rhgf-1 cDNA 
called SJN301. The 5’ end was further modified by PCR amplification using primers 
rhogef.14 and T7 to introduce an Nhel site before the START ATG codon using SJN290 
as a template (annealing temperature 60°C, extension time 1 minute). The product was 
digested with Nhel and EcoRI and purified. SJN301 was digested with EcoRI and Kpnl 
to extract the rhgf-1 cDNA and this was inserted with the modified 5’end into a modified 
form of bluescript containing Nhel and Kpnl sites to make the entire cDNA for rhgf-1 to 
make SJN305. The cDNA was then placed under the neuron specific promoter p.acr-2, 
which is expressed in the ventral cord motor neurons VA, DA, VB, DB, DA, IL1, RMD, 
and PVQ (Nurrish et al., 1999) to make EJH4.
2.31. Preparation of cosmids and fosmids
Fosmids were grown up from the fosmid library (Geneservice) using chloramphenicol as 
the selection antibiotic (35jxg/ml). In duplicate for each fosmid, 150ml cultures from 
single colonies were used to isolate DNA using QIAgen midi filter kit. Fosmids can often 
lose most of their inserts so a restriction digestion with EcoRI using 10 units and buffer 1 
(New England Biolabs) was performed to confirm the presence of multiple bands of
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varying sizes. Cosmids were grown from stock glycerol cultures kindly provided by Alan 
Coulson at the Sanger Centre using the appropriate antibiotic (ampicillin lOOfxg/ml, 
kanamycin 25jxg/ml or chloramphenicol 35ng/ml). 150ml cultures were grown from single 
colonies in triplicate for each cosmid and the cosmid DNA purified using QIAgen midi 
filter kits. The integrity of the cosmid DNA was also confirmed in an identical EcoRI 
digestion.
2.32. Making T02B5.1 genomic construct
Analysis of the sequence for cosmid T02B5 and comparison with the predicted 
sequence for T02B5.1 (both from WormBase) revealed two restriction sites in the genes 
flanking T02B5.1 (Pstl site in T02B5.2 at 5’ from T02B5.1 and Agel site in T02B5.4 3’ 
from T02B5.1) that are not within T02B5.1. These enzymes were used to digest cosmid 
T02B5, the products run on an agarose gel and the correct size DNA band purified and 
cloned into a modified form of bluescript made by Stephen Nurrish containing Pstl and 
Agel sites to make EJH16.
2.33. Amplifying T02B5.3 genomic sequence
Primers were designed that overlapped the two genes flanking T02B5.3 (T02B5.4 5’ to 
T02B5.3 and AH10.2 3’ to T02B5.3) to amplify by PCR the entire genomic sequence for 
T02B5.3, and any upstream or downstream promoter elements or other critical 
sequences. The primers used were T02B5.3for and T02B5.3rev. The standard PCR 
reaction described above was used with 40°C annealing temperature and 5 minute 
extension time.
2.34. Sequencing genes in nz90
Total genomic DNA from strain QT306 was extracted that included nz90 mutation. 
Primers were designed to enable amplification of short fragments of genes by PCR that 
could then be sequenced by MWG Biotech to look for mutations. The single worm PCR 
protocol was used for these PCR reactions with 50°C annealing temperature and 2 
minute extension time.
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2.35. Solutions and buffers
Worm NGM agar
20.8g/litre agar 
2.34g/litre Bacto-peptone 
50mM NaCI 
Autoclave then add:
0.25M potassium phosphate 
1 mM MgS04 
1mM CaCI2 
5 i^g/ml cholesterol 
200jxg/ml streptomycin 
1O^g/ml nystatin
M9 buffer 
0.02M KH2P04 
0.04M Na2HP04 
0.09M NaCI 
0.01 M MgS04
Worm freezing aaar 
0.1 M NaCI 
0.05M KH2P04 
300g/litre glycerol 
0.05M NaOH 
Autoclave then add:
3mM MgS04 
4g/litre Bacto-agar
T.E. Buffer 
10mM Tris/CI 
1mM EDTA
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EN solution
10mM EDTA 
100mM NaCI
Worm Ivsis buffer 
130mM Tris pH8.5 
1 % SDS 
50mM EDTA 
0.1 M NaCI
DEPC-treated ddH.O
0.1% diethyl pryocarbonate in ddH20  left overnight and then autoclaved. 
(stored at -20°C)
S. basal 
0.1M NaCI
0.05M potassium phosphate (pH6)
5mg/litre cholesterol
Single worm PCR Ivsis buffer:
10mM Tris pH8.0 
50mM KCI 
2.5mM MgCI2 
0.45% Igepal 
0.45% Tween 20 
0.01% gelatin 
(Stored at 4°C)
TBE (Tris-Borate EDTA) buffer 
0.089M Tris Base 
0.089M Boric acid 
2mM EDTA
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Transformation buffer 1 (TFB1)
30mM KOAc 
100mM RbCI 
10mM CaCI2 
50mM MnCI2
Transformation buffer 2 (TFB2) 
10mM MOPS 
75mM CaCI2 
10mM RbCI 
15% v/v glycerol
L broth
1 % Bacto-tryptone 
0.5% Bacto-yeast extract 
10mM NaCI 
(Stored at 4°C)
LB agar
1% Bacto-tryptone 
0.5% Bacto-yeast extract 
10mM NaCI 
1.5% Bacto-agar 
(Stored at 4°C)
TENS buffer 
1mM Tris/CI pH7.5 
1mM EDTA pH8 
0.1 N NaOH 
0.5% SDS
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2.36. Strains
strain genotype notes source
N2 wild type Isolated in Bristol. CGC
CB4856 wild type Isolated in Hawaii. CGC
PS2627 dgk-1 (sy428) CGC
RB976 rhgf-1 (ok880) CGC
VC430 rhgf-1 (gk217) CGC
RB781 pkc-1(ok563) CGC
NL4258
pkls1330; tpa-1 (pk1585) dpy- 
20(e1282)
hs::gpa-12 (Q205L) with tpa-1 
(pk1585).
CGC
NL594 gpa-12(pk322) CGC
EG1285
Iin-15(n765); oxls12 [p.unc- 
47::GFP; lin-15(+)]
p.unc-47::GFP
E.
Jorgensen
KP1683 nuls59 [KP#291,KP#282, rol-6] unc-13S::YFP; SNB-1::CFP S. Nurrish
KP3948 eri-1 (mg366); Iin-15(n744) J. Kaplan
QT42 nzEx4 hs::C3 transferase S. Nurrish
QT47 nzls1*4 hs::.rho-1 (GUV) S. Nurrish
QT181 unc-13(s69); nzls23 [KPX273] unc-13S (H173K)::GFP S. Nurrish
QT189 gpa 12(pk332);nzls 1
hs::rho-1 (GUV) with gpa-12 
(pk322)
E. Hiley
QT199 pkls1330 *2 hs::gpa-12 (Q205L) E. Hiley
QT230 rhgf-1 (ok880) *2 E. Hiley
QT311 pkls1330; oxls12
hs::gpa-12 (Q205L) with p.unc- 
47::GFP
E. Hiley
QT317 nz90 E. Hiley
QT318 nz90 E. Hiley
QT319 nz90 E. Hiley
QT330 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
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QT331 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT332 nz90 x CB 4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT333 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT337 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT338 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT339 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT340 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT341 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT342 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type
E. Hiley
QT343 nz90 x CB4856
nz90 backcrossed through CB4856 
wild type E. Hiley
QT365
nzEx121 [EJH4, KP#307], 
pkls1330, rhgf-1 (ok880)
N::rhgf-1 X10 with hs::gpa-12 
(Q205L) and rhgf-1 (ok880)
E. Hiley
QT368
nuls59 [KP#291, KP#282, rol- 
6];pkls1330
hs::gpa-12 (Q205L) with unc- 
13S::YFP and SNB-1::CFP
E. Hiley
QT360 pkls1330; pkc-1 (ok563)
hs::gpa-12 (Q205L) with pkc-1 
(ok563)
E. Hiley
QT369 gpa-12 (pk322); dgk-1(sy428) gpa-12 (pk322) with dgk-1 (sy428) E. Hiley
QT377 nzEx124 [KP#307; EJH14] p.acr-2::gpa-12 (Q205L) E. Hiley
QT397
nz90, nzEx143 [cosmids F47B8, 
F56A12, C15H11, F23B12, 
R02D5]
nz90 with cosmids F47B8, F56A12, 
C15H11, F23B12, R02D5
E. Hiley
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QT398
nz90; nzEx144 [cosmids F47B8, 
F14D7, K02E11, T16A9, ZC376]
nz90 with cosmids F47B8; F14D7; 
K02E11; T16A9; ZC376
E. Hiley
QT399
nz90; nzEx145 [cosmids F47B8, 
F14D7, K02E11, T16A9, ZC376]
nz90 with cosmids F47B8; F14D7; 
K02E11; T16A9; ZC376
E. Hiley
QT400
nz90; nzEx146 [cosmids 
F58D12; D1086; H39E23; 
T02B5; ZC376]
nz90 with cosmids F58D12; D1086; 
H39E23; T02B5; ZC376
E. Hiley
QT401
nz90; nzEx147 [cosmids 
F58D12; D1086; H39E23; 
T02B5; ZC376]
/?z90 with cosmids F58D12; D1086; 
H39E23; T02B5; ZC376
E. Hiley
QT402
nz90; nzEx148 [cosmids 
F58D12; D1086; H39E23; 
T02B5; ZC376]
nz90 with cosmids F58D12; D1086; 
H39E23; T02B5; ZC376
E. Hiley
QT403
nz90; nzEx149 [cosmid F58D12, 
KP#307]
nz90 with cosmid F58D12 E. Hiley
QT404
nz90; nzEx150 [cosmid H39E23, 
KP#307]
nz90 with cosmid H39E23 E. Hiley
QT406
nz90; nzEx152 [cosmid T02B5, 
KP#307]
nz90 with cosmid T02B5 E. Hiley
QT413 gpa-12 (pk322)*2
gpa-12 (pk322)
E. Hiley
QT414
nz90; nzEx153 [cosmid D1086, 
KP#307]
nz90 with cosmid D1086 E. Hiley
QT418 nz90; nzEx156 [T02B5, KP#307] nz90 with cosmid T02B5 E. Hiley
QT419 pkls1330; nzls25 [KP#273]
hs::gpa-12 (Q205L) with unc- 
13S(H173K)::GFP
E. Hiley
QT423
nz90; nzEx161 [T02B5.2, 
KP#307]
nz90 with T02B5.2 E. Hiley
QT424
nz90; nzEx162 [ T02B5.2, 
KPU307]
nz90 with T02B5.2 E. Hiley
QT428
nz90; nzEx164 [T02B5.4; 
KP#307]
nz90 with T02B5.4 E. Hiley
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QT429
nz90; nzEx165 [T02B5.4; 
KP#307]
nz90 with T02B5.4 E. Hiley
QT430
pkls1330; rhgf-1 (ok880); 
nzEx166 [EJH4, KP#307]
N::rhgf-1 with hs::gpa-12 (Q205L) 
and rhgf-1 (ok880)
E. Hiley
QT431
nz90; nzEx185 [T02B5.4, 
KP#307]
nz90 with T02B5.4 E. Hiley
QT432
nz90; nzEx186 [ T02B5.3; 
KP#307]
nz90 with T02B5.3 E. Hiley
QT433
nz90; nzEx187 [T02B5.1; 
KP#307]
nz90 with T02B5.1 E. Hiley
QT434
nz90; nzEx188 [T02B5.1; 
KP#307]
nz90 with T02B5.1 E. Hiley
QT435
pkls1330; rhgf-1 (ok880); 
nzEx189 [KP#291, KP#282; rol- 
6]
hs::gpa-12 (Q205L) with rhgf-1 
(ok880), unc-13S::YFP and SNB- 
1::CFP
E. Hiley
QT457 pkls1330; nzEx4
hs::gpa-12 (Q205L) with hs::C3 
transferase
E. Hiley
QT460 ok880; nzEx166 [EJH4; KP#307] N::rhgf-1 with rhgf-1 (ok880) E. Hiley
QT462 pkls1330; nzEx193 [KP#307]
hs::gpa-12 (Q025L) with p.acr- 
2::GFP E. Hiley
QT468
pkls1330; unc-13 (s69); 
nzEx195 [KP#273]
hs::gpa-12 (Q205L) with unc- 
13S(H173K)::GFP
E. Hiley
QT479
nzEx204 [KP268]; unc-13 (s69); 
pk/s1330
hs::gpa-12 (Q205L) with unc-13S E. Hiley
QT482 nzEx206 [T02B5; KP#307] wild type with cosmid T02B5 E. Hiley
QT483 nzEx207 [T02B5; KP#307] wild type with cosmid T02B5 E. Hiley
QT484 nzEx208 [T02B5; KPU307] wild type with cosmid T02B5 E. Hiley
QT485 nzEx209 [T02B5; KP#307] wild type with cosmid T02B5 E. Hiley
QT492
nz90; nzEx214 [ZK1001; 
KP#307] nz90 with cosmid ZK1001 E. Hiley
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QT493
nz90; nzEx215 [ZK1001; 
KP#307]
nz90 with cosmid ZK1001 E. Hiley
QT494
nz90; nzEx216 [ZK1001; 
KP#307]
nz90 with cosmid ZK1001 E. Hiley
QT495
nz90; nzEx217 [ZK1001; 
KP#307]
nz90 with cosmid ZK1001 E. Hiley
QT496
nz90; nzEx218 [ZK1001; 
KP#307]
nz90 with cosmid ZK1001 E. Hiley
QT497
nz90; nzEx219 [ZK1001; 
KP#307]
nz90 with cosmid ZK1001 E. Hiley
QT498
nz90; nzEx220 [ZK1001; 
KP#307]
nz90 with cosmid ZK1001 E. Hiley
QT499 nzEx221 [T02B5.3; KP#307] wild type with T02B5.3 E. Hiley
QT500 nzEx222 [T02B5.3; KP#307] wild type with T02B5.3 E. Hiley
QT501
nz90; nzEx223 [WRM0626bE02; 
KP#307]
nz90 with fosmid WRM0626bE02 E. Hiley
QT502
nz90; nzEx224 [WRM0626bE02; 
KP#307]
nz90 with fosmid WRM0626bE02 E. Hiley
QT507
nz90; nzEx229 [T02B5.3; 
KP#307]
nz90 with T02B5.3 E. Hiley
QT508 nzEx230 [EJH15; KP#307] p.unc-17::gpa-12 (Q205L) E. Hiley
QT516 nz90; nzEx234 [T23A9; KP#307] nz90 with cosmid T23A9 E. Hiley
QT517 nz90; nzEx235 [ T23A9; KP#307] nz90 with cosmid T23A9 E. Hiley
QT518 nz90; nzEx236 [ T23A9; KP#307] nz90 with cosmid T23A9 E. Hiley
QT519
nz90; nzEx237 [WRM0636bA09; 
KP#307]
nz90 with fosmid WRM0636bA09 E. Hiley
QT520
nz90; nzEx238 [WRM0636bA09; 
KP#307]
nz90 with fosmid WRM0636bA09 E. Hiley
QT521
nz90; nzEx239 /WRM0636bA09; 
KP#307]
nz90 with fosmid WRM0636bA09 E. Hiley
QT522
nz90; nzEx240 [WRM0636bA09; 
KP#307]
nz90 with fosmid WRM0636bA09 E. Hiley
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QT523
nz90; nzEx241 [WRM0636bA09; 
KP#307]
nz90 with fosmid WRM0636bA09 E. Hiley
QT524
nz90; nzEx242 [H39E23; 
KP#307]
nz90 with cosmid H39E23 E. Hiley
QT525
nz90; nzEx243 [H39E23; 
KP#307]
nz90 with cosmid H39E23 E. Hiley
QT526 nzEx244 [T02B5.1; KPU307] wild type with T20B5.1 E. Hiley
QT532
nz90; nzEx250 [WRM0630aH01; 
KP#307]
nz90 with fosmid WRM0630aH01 E. Hiley
QT533
nz90; nzEx251 [WRM0630aH01; 
KP#307]
nz90 with fosmid WRM0630aH01 E. Hiley
QT534
nz90; nzEx252 [WRM0630aH01; 
KP#307]
nz90 with fosmid WRM0630aH01 E. Hiley
QT537
nz90; nzEx253 [WRM0619dD01; 
KP#307]
nz90 with fosmid WRM0619dD01 E. Hiley
QT538
nz90; nzEx254 [WRM0619dD01; 
KP#307]
nz90 with fosmid WRM0619dD01 E. Hiley
QT539
nz90; nzEx255 [WRM0619dD01; 
KP#307]
nz90 with fosmid WRM0619dD01 E. Hiley
QT540
nz90; nzEx256 [WRM0619dD01; 
KP#307] nz90 with fosmid WRM0619dD01 E. Hiley
QT541
nz90; nzEx257 [WRM0619dD01; 
KP#307]
nz90 with fosmid WRM0619dD01 E. Hiley
QT542
nz90; nzEx258 [WRM0619dD01; 
KP#307]
nz90 with fosmid WRM0619dD01 E. Hiley
QT543
nz90; nzEx259 [WRM0612aE07; 
KFW307]
nz90 with fosmid WRM0612aE07 E. Hiley
QT544
nz90; nzEx260 [WRM0612aE07; 
KP#307]
nz90 with fosmid WRM0612aE07 E. Hiley
QT545
nz90; lin-15 (n765); oxls12 
[p.unc-47::GFP; lin-15(+])
nz90 with p.unc-47::GFP E. Hiley
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QT550
nz90; nzEx261 [WRM0612aE07; 
KP#307]
nz90 with fosmid WRM0612aE07 E. Hiley
QT551
nz90; nzEx262 [WRM0612aE07; 
KP#307]
nz90 with fosmid WRM0612aE07 E. Hiley
QT553
nzEx230 [EJH15; KP#307]; rhgf- 
1 (ok880)
p.unc-17::gpa-12 (Q205L) with 
rhgf-1 (ok880)
E. Hiley
QT559
nz90; nuls59 [KPU291; KP#282; 
rol-6]
nz90 with unc-13S::YFP and SNB- 
1::CFP
E. Hiley
QT572 pkls1330; rhgf-1 (gk217)
hs::gpa-12 (Q205L) with rhgf-1 
(gk217)
E. Hiley
QT573
nz90; nzEx268 [WRM0624aA04; 
KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
QT574
nz90, nzEx269 [WRM0622dC05; 
KP#307]
nz90 with fosmid WRM0622dC05 E. Hiley
QT575
nz90, nzEx270 [WRM0622dC05; 
KPU307]
nz90 with fosmid WRM0622dC05 E. Hiley
QT576
nz90, nzEx271 [WRM0622dC05; 
KP#307]
nz90 with fosmid WRM0622dC05 E. Hiley
QT577
nz90, nzEx272 [WRM0622dC05; 
KP#307]
nz90 with fosmid WRM0622dC05 E. Hiley
QT578
nz90; nzEx273 [WRM0624aA04; 
KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
QT579
nz90; nzEx274 [WRM0624aA04; 
KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
QT580
Nz90; nzEx275 
[WRM0624aA04; KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
QT581
nz90; nzEx276 [WRM0624aA04; 
KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
QT582
nz90; nzEx277 [WRM0624aA04; 
KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
QT583
nz90; nzEx278 [WRM0624aA04; 
KP#307]
nz90 with fosmid WRM0624aA04 E. Hiley
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QT584
nz90; nzEx279 [WRM0624cC12; 
KP#307]
nz90 with fosmid WRM0624cC12 E. Hiley
QT585
nz90; nzEx280 [WRM0624cC12; 
KP#307]
nz90 with fosmid WRM0624cC12 E. Hiley
QT586
nz90; nzEx281 [WRM0624cC12; 
KP#307]
nz90 with fosmid WRM0624cC12 E. Hiley
QT594 nz90; nzEx289 [T26F2; KP#307] nz90 with cosmid T26F2 E. Hiley
QT595 nz90; nzEx290 [T26F2; KP#307] nz90 with cosmid T26F2 E. Hiley
QT596 nz90; nzEx291 [T26F2; KP#307] nz90 with cosmid T26F2 E. Hiley
QT597 nz90; nzEx292 [T26F2; KP#307] nz90 with cosmid T26F2 E. Hiley
QT598 nz90; nzEx293 [ T26F2; KP#307] nz90 with cosmid T26F2 E. Hiley
QT601 rhgf-1 (ok880); nzls1*4
hs::rho-1 (G14V) with rhgf-1 
(ok880)
E. Hiley
QT602 gpa-12 (pk322); nzls1*4
hs::rho-1 (G14V) with gpa-12 
(pk322)
E. Hiley
QT603
nuls59 [KP#282, KP#291]; gpa- 
12 (pk322)
gpa-12 (pk322) with unc-13S::YFP 
and SNB-1::CFP
E. Hiley
QT604
nuls59 [KP#282, KP#291]; rhgf- 
1 (ok880)
rhgf-1 (ok880j with unc-13S::YFP 
and SNB-1::CFP
E. Hiley
QT605 nzEx121 [EJH4; KP#307] N::rhgf-1 X  10 E. Hiley
QT606
nzEx121 [EJH4; KP#307]; gpa- 
12 (pk322)
N::rhgf-1 X  10 with gpa-12 (pk322) E. Hiley
QT607
nzEx121 [EJH4; KP#307]; 
nzEx4 [QT#99, ttx3::gfp]
N::rhgf-1 X  10 with hs::C3 
transferase
E. Hiley
2.37. Oligos
oligo name sequence
hsp16-2.1 CCGGGATTGGCCAAAGGACCC
T7 TAATACGACTCACTATAGGG
SL1-Notl CCCCCGCGGCCGCGGTTTAATTACCCAAGTTTGAG
124
poly (dT) T TTTTTTTTTTTTTTTTTTTTTTTTV *N * *
BD SMART II A 
Oligonucleotide
AAGCAGTGGTATCAACGCAGAGTACGCGGG
gpa-12.1 GTATTGTC TGGTCAC TTTGA
gpa-12.2 CTGGTTTCACACCATTCGAT
gpa-12.3 GGGGGCTAGCCCATGGCGGCCGCCGTATGCTGTTTCGGGAAAAAAGATG
gpa-12.4 GACGTTGAGATCTTAGTCCGCCAACATCAATGAACC
gpa-12.5 AAGATCTCAACGTCAAAAATGGTTTCAATG
gpa-12.6 GGGGGAGCTCGAATTCTTACTGCATCATGAGAGTCTTCAAG
VC430-2e TCGGAACGGCCAATTAAA
rhogef.2 GGGGGTACCTAGGCGGCCGCTGTCATTGGTTGAATTGAAGGTAGTCTTGG
rhogef.4 ATGCGATCTGGATACCAAGCC
rhogef.7 AACATGTCGGTTTAACAGAGG
rhogef.9 GGGGGGCTAGCGGTGGCGGCGATGGACATTGATAGTGACGAAGAGG
rhogef.10 TGTGGAGAATATTTCGAACGCCCAACG
rhogef.14 GGGGGCTAGCGGTGGCGGCGATGATAGAACGATGCGTAGTAGTTCAACG
RB976-2 TCATCCTCACTGCACATCAG
RB976-5 TGAACAAC TAGAAGC TGCAC
RB976-6 TTGTGAGGTTTCTAGCCGAG
RB976-7 AGCTGTAGCTTACGACAAAC
RB976innerleft CGTAGTTTGCGCACTCACAT
RB976innerright TGTAGGGATGCTATCTGGGG
RB976outerright GCATTCAAGTCAAAGGGCAT
DraSNP-1.1 ATGCCAGTGATAAGGAACGG
DraSNP-1.2 TCACATCCCTTGTCGATGAA
DraSNP-1.3 TCGAAATCAGGGAAAAATTGA
DraSNP-1.4 ACGATTTTCGGGGAGTTTTT
DraSNP-1.5 GTTTTCACTTTTGCCGGTGT
DraSNP-1.6 TGAAGGCGCATATACAGCAG
DraSNP-1.7 AAAATATCAGGAAAGAGTTTCGG
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DraSNP-1.8 TTTAAAGATTAAGGGTGGAGCG
DraSNP-1.9 ATCTGGCACCAAATATGAGTCG
DraSNP-1.10 AATCTCGATTTTCAAGGAGTGG
DraSNP-1.11 TCCTGGATAATCCCCAAAAA
DraSNP-1.12 CCCTGCCATTGATCTTGTTT
DraSNP-1.13 TTGAAATCCCCTTTAAAATCCC
DraSNP-1.14 ACAC TGGGTAC C TGAC TCATGC
DraSNP-1.15 ATTATTAACGGCCACGGTGA
DraSNP-1.16 CCCACACACTCTCACCTTCA
DraSNP-2.1 CCGAATTTTCAAATGGATGC
DraSNP-2.2 CCATTGGAATTGCACACAAA
DraSNP-2.3 CTGTGCTGTTGACGATATTGG
DraSNP-2.4 ATGTC TCATTGCAAAATTCGG
DraSNP-2.5 TTGTGAGCTTATATCTCAGTTGTCG
DraSNP-2.6 AGATTTGGTTAGAAATATCACCGC
DraSNP-2.7 TCAAAAACTTACAATCAATCGTCG
DraSNP-2.8 CCAGAAAATCTGCACAGAAGG
DraSNP-2.9 TTCTTCAAAAAGTCTAGGTTCAGCA
DraSNP-2.10 GGGGACGAAAACGGAGTTTG
DraSNP-2.11 ACCGTTTAATAGGATTATTTGGG
DraSNP-2.12 AAGTCTGCGGAATAATTGATGG
DraSNP-2.13 TTCCAGGTAATACACATACAACTCC
DraSNP-2.14 AAAAACACAAAGTTCAAAAACCC
DraSNP-2.15 C CAC TGGC TATAAGC TTTTC TAGG
DraSNP-2.16 TAAGGATTTCAGGC TTTTAGGC
DraSNP-3.1 TATCATCGAAATCCCGGAAA
DraSNP-3.2 TTCGGACGGGAGTAGAATTG
DraSNP-3.3 TCCCAATTTCCCTCTAAAAACC
DraSNP-3.4 TTGAATTTGGACCATTTTGAGG
DraSNP-3.5 GAGGAACCAAATCTGGCGTA
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DraSNP-3.6 TGAAAACTTGGAAAATCGGTG
DraSNP-3.7 AATTTGAATCAGTGACTTTTGGC
DraSNP-3.8 TTTCTGCAAACATTTTTCTTCG
DraSNP-3.9 AAAAATACATGTCTACACAACCCG
DraSNP-3.10 TTTCTTATCACTGTGCAGTCTTACC
DraSNP-3.11 AGCGTTAAAGTATCGGTTATTTCG
DraSNP-3.12 TAAATTCATTTCAAACAATCGAGC
DraSNP-3.13 ATCAAGTTTCTGATTGCTCTTTCC
DraSNP-3.14 AAAAACGTGATTTTTCAATTTTGC
DraSNP-3.15 AGCAGGCTCACCATCATCATCA
DraSNP-3.16 GACATTACGGTAGAGGAGATGGA
DraSNP-4.1 CCACCACGAAAACTACAGTATC
DraSNP-4.2 TCGGTGCCTGGAAAAGTTTGAG
DraSNP-4.3 CGCATAAATCCAACGTTCTCTG
DraSNP-4.4 AATCCATAAGTTTCGTGTTGGG
DraSNP-4.5 ACTCGGCATCCTCACGC
DraSNP-4.6 GTTGAAAATTTTTTCATAGC TATCATC
DraSNP-4.7 TGC TGAAATATTGGAAAATTGAGG
DraSNP-4.8 TTATATCGTCGAGGAGGTTAGAGG
DraSNP-4.9 AAAATGGGAAGCGTACCAAA
DraSNP-4.10 TGCTTGTAGCGTTTCCAAGA
DraSNP-4.11 GACACGACTTTAGAAACAACAGC
DraSNP-4.12 TGGTATGGAGTCCCTATTTTGG
DraSNP-4.13 TGTAAATACCCCACATTTCAAGC
DraSNP-4.14 AAATTTCCAATTGTTCAAAGCC
DraSNP-4.15 TCGAATTGTTGTGTTTCTTTTGA
DraSNP-4.16 TTCCAATTTTCTCGGTTTGG
DraSNP-5.1 TTTCGGAAAATTGCGACTGT
DraSNP-5.2 CGCGTTTTGGAGAATTGTTT
DraSNP-5.3 TCATC TGTTATTTC GTC TC TTGC
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DraSNP-5.4 CGGTAATAATATGCTTTGTGGG
DraSNP-5.5 GAGATTCTAGAGAAATGGACACCC
DraSNP-5.6 AAAAATCGACTACACCACTTTTAGC
DraSNP-5.7 AGAAATGATCCGATGAAAAAGC
DraSNP-5.8 CCGATAGTGTTCATAGCATCCC
DraSNP-5.9 CAAATTAAATATTTCTCAAAGTTTCGG
DraSNP-5.10 ACATAAGCGCCATAACAAGTCG
DraSNP-5.11 TAAAGCCGCTACGGAAATACTC
DraSNP-5.12 ATTTTCTCCCTAATTCCAGGTG
DraSNP-5.13 CATTCATTTCACC TGTTGGTTG
DraSNP-5.14 TCGGGAAGATAATCAAAATTCG
DraSNP-5.15 GAAATTCAAATTTTTGAGAAACCC
DraSNP-5.16 TTCAGAC CATTTTTAGAATATTCAGG
DraSNP-X.1 ATATGTGAGTTTACCATCACTGGG
DraSNP-X.2 ACGTTTTGAAAAATTTGGTTGC
DraSNP-X.3 CCAAAACGGCCAAGTATCAG
DraSNP-X.4 TTGCACTCTTTCTCCTTCCG
DraSNP-X.5 AAGTGTTCAATGATTTTGTCTAATTG
DraSNP-X.6 TGACAGGAGAATACTTTTGAAGG
DraSNP-X.7 AGCAACAAACAATGCAACTATGG
DraSNP-X.8 TAAACAAGAGGGTACAAGGTATCG
DraSNP-X.9 TTAAAACCATACAATTCTTCTCAGC
DraSNP-X.10 GAATTCCCAATCAACAGAGAGC
DraSNP-X.11 ACTGTTTACCGCGTCTTCTGC
DraSNP-X.12 CCGTGTATATAAGAAAATGTGTTCG
DraSNP-X.13 GCTGGGATTTTGAAGAGTTGTT
DraSNP-X.14 CAGTGAATCATCCGTTGAATTT
DraSNP-X.15 CAAATACCAAAGTTGATCGTGG
DraSNP-X.16 TTGTTGCAATTAAATCAAACGG
Vs.A-forl AATATTTGTGCCTAATGTGC
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Vs.A-rev1 TACTCCCACCCGAGAAACT
Vs.A-for2 ACAGGTTATCAGTTTTGTG
Vs.A-rev2 CACAATTAACACCTAGCACA
Vs.B-for1 AAAATTAAGAGGAGGATTGA
Vs.B-rev1 GACAACGATTTTATTCAACAC
Vs.B-for2 AATGACCGGATGGGATTGGG
Vs.B-rev2 TTATCCTACCTTTTGTCCAAA
Vs.C-for1 AAAAAAC TTTTTG T AGAAT AA
Vs.C-for2 AAAAAATTGAAAGGTCAAAC T
Vs.C-rev1 AACTAGGTTTACGTAACATGTG
Vs.C-rev2 TTGGAATAAAAATTCAAAAGTTA
Vs.E-for1 AAATAGACTCGAAAAAAATCGAGT
Vs.D-for2 AAGGTTATTTTACACGGCTTGA
Vs.D-rev1 AATTACACTTAGAACCGGTGTT
Vs.D-rev2 AGACCAATCAGAGGGAGTGACT
Vs.E-for1 ACAACTCCTGGGTGCAGGGAGTTA
Vs.E-for2 AATTC C TTAGTCAAGGC TC TT
Vs.E-rev1 T AC C AC AGTC AGC T AAGC TC TC
Vs.E-rev2 ACTTTGTACTAAGGTCGTAAT
Vs.E-rev3 CTCTCGAATCGACTGACACCAT
Vs.E-rev4 TAATGC TGGAATCATGTTTCA
Vs.F-for1 CTTACCGCTTGTCGATCCTTTG
Vs.F-for2 CATAGTAATTACGATAC
Vs.F-rev1 CATTTATGAATAAAC C T
Vs.F-rev-2 CGTGGCAAAACTTCAAAG
Vs.G-for1 GGAC TTACAATTAATAC C TAATTG
Vs.G-for2 C TCAGAATTTCAGC TAAAAG
Vs.G-rev1 GGTGTGAAACTCACAGTTTTG
Vs.G-rev2 GAGAGAAACGTTCCCTAAAAC
V.W-for TGGCCACAGGAATATTCGAC
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V.W-rev AAATAGCACAGGCTGAACGC
V.Y-for GGTGTAGAGAGC TCAC TCAGC
V.Y-rev TTGGATAGGCCTAGCAGAGC
V.Z-for TGGTGCCAGTGGGATGGTGG
V.Z-rev CACTTGTCAAGGGTATGGCC
V.AA-for GTTGTGAAAGTCGCGTTGAG
V.AA-rev TTCGGTGTGTTGTCTGTAGTCG
V.BB-for TGGAATCTCGTGCACCATAG
V.BB-rev CCCTGAGTTTTACGATATCG
V.CC-for CATTCCCAATCCAATAGCC
V.CC-rev TGATATTGCTGCCACAACGG
V.DD-for GTCGCACCTTTTGCTCAATC
V.DD-rev TCGAAAATTGCCCTCCCTAC
V.EE-for TATTTCCCGCAATGCTCTCC
V.E E-rev CAACCTACTCTGCCTTTTGC
V.FF-for CCGCCAGCTATTCCAATTTC
V.FF-rev ACAACGAAGAAGAGCCACAG
V.GG-for TGGC TAAAC TCGTGATTC TC
V.GG-rev AGTATGACCTAGATGCGAAC
V.HH-for ATCGCGAAATTTCGTGGTTC
V.HH-rev TGGTTGGGAAAAAACTCGAC
V.JJ-for TCCGGTGAGAGTAACATTGC
V.JJ-rev ATGCCAAGATGCCATGGAAC
V.KK-for GTTCCAAACAGTCACCACTACC
V.KK-rev C TCAGATTGGAAC CGC TATC
V.LL-for GAGC TTGAGGAATTGTGAGG
V.LL-rev TAAC TTTGC GGATGGTGG
V.MM-for AATATGTTGGCGTGCAGG
V.MM-rev TTGGGGTGTAACAAACGG
V.NN-for GCAATCGAGAAGCTCCAAAG
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V.NN-rev TTGAAAAAGCCCAGTAGCCC
V.OO-for ACAGGTCTGCGAGTTTTGAG
V. OO-rev AGC TGGGCAAATGTCAAG
V.PP-for CTTTAGCTGATGTCATGGTGGC
V.PP-rev CCAGACGGCATTGAACATGT
V.H-for TCATCCTTCCTGTTCTCTGG
V.H-rev ATCGACAAGCTCATTGGG
V.J -for GCACACAAATGATACCACGC
V.J -rev CTTAAAGCGCTGCAGAAAGC
V.P-for ATGC TCAGTC TGTGTGGTTC TC
V.P-rev AGAACACTCGAGTTTATCC
V.Q-for TTTGGCGTATTCTTTGCCAG
V.Q-rev TTCCTTGTCGCTATCAGACTG
T02B5.1 for GGGGGGGATCCGTTTTGTAATAAGCCTTGATGTGACACAC
T02B5.1 rev CCCCCCTCGAGGACTTCTAGATGAGATGTGTGGCGG
T02B5.1 for2 GCTCTAAACTTTATTTGAAG
T02B5.1 rev2 GCTGTCCTATTTATACTAGTATG
T02B5.1 seql GGTAGAGTCATTTGTTTCTACTAC
T02B5.1 seq2 CATATCGTGTCCAGACTTACTTAG
T02B5.1 seq3 GGAGCTTTGAAATTTCAGTTGC
T02B5.1 seq4 CAAAAATGTATCATTTATGTGAC
T02B5.1 seq5 CCCAGATGTAACTTGTTTCCCCAC
T02B5.1 seq6 GGCAAGTTGATTAGCATTTATAAATTAC
T02B5.1 seq7 GTTTCAAAGGTTTCCTGAAAATGC
T02B5.1 seq8 GAAGTTTCAAATATATAAAGTTC
T02B5.1 seq9 GTGTTTTGTTTTGCTCACATGATTTCG
T02B5.1 seq10 CATACTTTTATCAGTTTCAATTAC
T02B5.1 seq11 GAGCATTTTCTAACTGACTATCC
T02B5.1 seq12 CCCTATCAACACTTTGATAGG
T02B5.1 seq13 GCAAATGCAGGATCAATTATGTATG
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T02B5.1 seq14 CATAAGTTTTCAAGCAATTCAAC
T02B5.1 seq15 GATTCCCACACAAGCGGAAATACG
T02B5.1 seq16 GGATTTTTTGCCCACCGTGCTTC
T02B5.1 seq17 GTTGCAC TTCAAAGAAC TC TAGC C
T02B5.1 seq18 CAGGTGGAAAATGTGAGGTTTTG
T02B5.1 seq19 CGAAATCATGTGAGCAAAACAAAACAC
T02B5.1 seq20 GTACTATATGAGGAACCAGAGAC
T02B5.1 seq21 GGTTTATTTGACAAAAACAGTTGTT
T02B5.1 seq22 GGGCGGTCTCTGAGCACCCGTTTCC
T02B5.1 seq23 CATTTCTCACCATTCGTTTCCG
T02B5.1 seq24 CAATGCATGACTAAATCCCTGACG
T02B5.1 seq 25 GAATTGTTGTACAAGGAGGAAG
T02B5.1 seq26 CGTTACTAGTTCCAGACACAAAG
T02B5.1 seq27 CCAGTTGTTGTATTTATATGC
T02B5.1 seq28 CTTTTGGCAGTAGTGGGATACTG
T02B5.1 seq29 GACAGTGATGGC TCAGATGGTTGG
T02B5.2 for GGGGGGGATCCGTTTCAATCATGTCGTCTCAACAG
T02B5.2 rev CCCCCCTCGAGCAACTGGTAATTGGAAGTAGTAGAAAC
T02B5.2 seql GAAGCTGGCTTGATCGATGCG
T02B5.3 for GGGGGGGATCCGTGAAAACTTTTTATTTGAAAAAAAAGC
T02B5.3 rev CCCCCCTCGAGGTAATCAATGATGTTCCAAAAGAAGC
T02B5.3 for2 GACTACATAGAAATTTATGC
T02B5.3 rev2 CGGCCCTGCAACAGTAAGTTT
T02B5.3 seq 1 AAAAACAC TGATAGAGGAGGC
T02B5.3 seq 2 GAATTTTTTAAAGACCCAGCG
T02B5.3 seq 3 CCTGAACATGAAGTTGAACAGG
T02B5.3 seq 4 GCAGGC TTC TTTC GAAGGCAGG
T02B5.3 seq 5 AGAATGTATGATCAATTAAGG
T02B5.3 seq 6 ATATGAGCTGAATAGTTAAGC
T02B5.3 seq 7 TTTTCTTATTAGTTTCAGCG
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T02B5.3 seq 8 GCTCTGATTTCAAAAATGCCG
T02B5.3 seql 1 GGC TGGGCAC TC GGCAGGAGC
T02B5.3 seq12 AGCTGCGTTTACGATCTCTCC
T02B5.3 seq13 GGACATATTAGTCATTGGTCC
T02B5.3 seq15 GACCAAATATCCGAATAGACG
T02B5.3 seq16 GAGTTCTGTCAAATAAACATCG
T02B5.3 seq17 GTTTTCCCTCAATTATACCGGTCC
T02B5.3 seq17b GTGATGGAGGATTTAGTAAGTTC TG
T02B5.3 seq18 CAGGCATCGGCTTACTTTTATTTGG
T02B5.3 seq19 GGAGCTTCCGTATATCTTGGGC
T02B5.3 seq20 CTGTTCTCCTTGAAGAATCAGG
T02B5.3 seq21 TTGAGACGAAGGAAACATTCTT
T02B5.3 seq22 GAGATCTACAAGGAGTCAGAAG
T02B5.3 seq23 GAATGATGAGGTGATTTCAC
T02B5.3 seq24 GCAAAAACTCCTCGGTGAGTTCC
T02B5.4 for GGGGGGGATCCAACAACTGTTTTTGTCAAATAAACC
T02B5.4 rev CCCCCCTCGAGGTCTAGTAATGCGGTCGCAGAGG
T02B5.4 seq 1 CACCTCTCACCCATCTCGTAC
T02B5.4 seq 2 C TTTCAATTGAATTAGGAGAGGAC
T02B5.4 seq 3 CCCGTTCCCACGTAAGAAAACTTTCTCC
T02B5.4 seq 4 GTTTTGCCATCAAAATGGGTTCCG
T02B5.4 seq 5 GATGTGTGCTGATTTATGATGATC
** V = A, C, or G 
* N = A, C, G or T
2.38. Plasmids
Plasmid Selection Description
KP#273 ampicillin unc-13S H(173)K::GFP
KP#282 ampicillin p. acr-2::SNB-1::CFP
KP#291 ampicillin unc-13S::YFP
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KP#307 ampicillin p.acr-2::GFP
SJN290 ampicillin rhgf-1 5’ cDNA
SJN292 ampicillin gpa-12 (Q205L) 3’ cDNA (STOP-Rl-Sacl)
SJN293 ampicillin rhgf-1 3’ cDNA (Notl-STOP-Kpnl)
SJN294 ampicillin full length gpa-12 wild type cDNA
SJN301 ampicillin rhgf-1 cDNA Ri-Sphl-Notl-STOP-Kpnl
SJN305 ampicillin
5’ end of rhgf-1 with an Nhel site-Kozak consensus- 
START ATG
EJH4 ampicillin p.acr-2::rhgf-1 cDNA wild type
EJH12 ampicillin gpa-12 (Q205L) 5’ cDNA
EJH14 ampicillin p.acr-2::gpa-12 (Q205L) cDNA
EJH15 ampicillin p.unc-17::gpa-12 (Q205L) cDNA
EJH16 ampicillin T02B5.1 genomic
yk336c8 ampicillin Yuji Kohara plasmid cDNA for gpa-12 (F18G5)
yk877c07 ampicillin Yuji Kohara plasmid cDNA for rhgf-1 (F13e6.6)
WRM0624cC12 chloramphenicol Fosmid
T26F2 kanamycin Cosmid
WRM0624aA04 chloramphenicol Fosmid
ZK1001 kanamycin Cosmid
F58D12 kanamycin Cosmid
D1086 ampicillin Cosmid
H39E23 ampicillin Cosmid
WRM0619dD01 chloramphenicol Fosmid
T02B5 kanamycin Cosmid
ZC376 ampicillin Cosmid
T16A9 kanamycin Cosmid
K02E11 kanamycin Cosmid
WRM0626bE02 chloramphenicol Fosmid
WRM0630aH01 chloramphenicol Fosmid
F14D7 kanamycin Cosmid
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F47B8 kanamycin Cosmid
F56A12 kanamycin Cosmid
C15H11 ampicillin Cosmid
F23B12 kanamycin Cosmid
F27F7 kanamycin Cosmid
R02D5 ampicillin Cosmid
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3. Results: Regulation of Acetylcholine Release by Gai2
3.1. Introduction
In C. elegans, the small GTPase RHO-1 stimulates acetylcholine (ACh) release at the 
NMJ (McMullan et al., 2006). In mammals, the G a12 family of trimeric G proteins are 
upstream activators of RhoA (the mammalian homologue of RHO-1) (Buhl et al., 1995). 
C. elegans has one member of the G a12 family, the G a12 homologue GPA-12. GPA-12 is 
expressed in the motor neurons amongst other cells and interacts with an activator of 
RHO-1, the guanine nucleotide exchange factor RHGF-1 (called CeRhoGEF), thus 
GPA-12 is a candidate regulator of RHO-1 and ACh release (van der Linden et al., 2003; 
Yau et al., 2003). This chapter will explore the possible role of GPA-12 in the activation 
of RHO-1 at the NMJ to stimulate ACh release.
3.2. Deletion of almost the entire gpa-12 gene had no effect upon ACh release
GPA-12 shows significant similarity to mammalian Gai2, the amino acid sequence for 
GPA-12 is 50% homologous to human Gai2 sequence (Figure 3.1). A deletion mutation 
in gpa-12 (pk322) deleted the entire gene except the first exon and extreme start of the 
second (amino acids 39 to 355 are deleted) (van der Linden et al., 2003). The regions 
required for GTP binding and hydrolysis were deleted (Figure 3.2 A).
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Figure 3.1. Amino Acid sequence alignment of GPA-12 and human Gai2 
Dark boxes indicate conserved amino acids (or those absent in the other protein). 
Light boxes indicate similar amino acids.
To test for a role in ACh release the drug aldicarb can be used as an indirect 
measurement of release at the NMJ. Aldicarb is an inhibitor of the enzyme ACh esterase 
that is responsible for the degradation of ACh within the synaptic cleft (Nguyen et al., 
1995). In the presence of aldicarb, any ACh released by the motor neuron will fail to be 
degraded, leading to continual stimulation of the body wall muscles, resulting in 
hypercontraction. This is observed as paralysis of the animal. The rate of paralysis upon 
exposure to aldicarb corresponds to the rate of ACh release by the cholinergic motor 
neurons (Nguyen et al., 1995). The aldicarb sensitivity of the mutant gpa-12 (pk322) was 
recorded and almost no difference was observed in comparison to wild type animals 
(Figure 3.2 B).
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Figure 3.2. Structure of gpa-12 (pk322) deletion and aldicarb sensitivity of 
mutant animals
(A) gpa-12 consists of 8 exons all of which encode the G protein alpha subunit 
domain. The deletion pk322 deletes from just after the beginning of exon 2 until 
beyond the end of exon 8 (amino acids 39 to 355).
(B) Aldicarb sensitivity of gpa-12 (pk322) deletion mutation.
All subsequent aldicarb sensitivity graphs display percentage paralysis upon 
exposure to 1mM aldicarb for 0-100 minutes. Error bars on all graphs indicate 
standard error of mean (SEM).
3.3. Over expression of constitutively active GPA-12 increased ACh release
A transgenic strain had previously been made expressing the genomic DNA for gpa-12 
under the control of a heatshock inducible promoter. It has substitution mutation at 
amino acid position 205 where glutamine (Q) is changed to leucine (L) fixing it in the 
active GTP bound form (van der Linden et al., 2003) (Figure 3.3 A). The heatshock-
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induced expression of constitutively active GPA-12 (GPA-12 (Q205L)) resulted in an 
increase in aldicarb sensitivity, the animals became paralysed more quickly (Figure 3.3 
B). This implies there was an increase in ACh release at the NMJ in response to active 
GPA-12. There was a small increase in the rate of paralysis in hs::GPA-12 (Q205L) 
transgenic animals that have not been heatshocked suggesting a leaky heatshock 
promoter (Figure 3.3 B). The increase in aldicarb sensitivity of hs::GPA-12 (Q205L) 
animals was sustained 24 hours after heatshock and was even slightly higher (Figure 
3.4).
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Figure 3.3. Structure of hs::GPA-12 (Q205L) transgene and sensitivity to 
aldicarb of transgenic animals
(A) Construct for expression of gpa-12 (Q205L) genomic DNA under the control of 
a heatshock promoter.
(B) Aldicarb sensitivity of animals with hs::GPA-12 (Q205L) transgene.
---------- with heatshock.
—......... without heatshock.
In this and all subsequent figures, GPA-12 (Q205L) is called gpa-12*.
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Figure 3.4. Aldicarb sensitivity of hs::GPA-12 (Q205L) animals 24 hours 
after heatshock
Aldicarb sensitivity of animals with hs::GPA-12 (Q205L) transgene either 
immediately after heatshock or 24 hours after heatshock.
3.4. Loss or gain of GPA-12 had no effect upon the muscle
ACh that is released into the synaptic cleft at the NMJ stimulates cholinergic receptors 
within the muscle leading to contraction of the muscle. Aside from a change in ACh 
release, an alternative possibility for a difference in sensitivity to aldicarb is a change in 
the muscle. Sensitivity to the drug levamisole, an agonist of nicotinic ACh receptors in 
the muscle, can be used to identify muscle defects. Any changes in the body wall 
muscles will result in a change in levamisole sensitivity. Animals with the deletion gpa-12
24 hours after heatshock.
Immediately after heatshock.
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(pk322) and animals expressing hs::GPA-12 (Q025L) transgene were assayed to 
determine their sensitivity to levamisole. No significant differences in levamisole 
sensitivity were observed in animals with either the loss of GPA-12, (gpa-12 ((pk322)), or 
a gain of constitutively active GPA-12, (hs::GPA-12 (Q205L)) (Figure 3.5). Heatshock 
resulted in a small increase in levamisole sensitivity in both wild type and hs::GPA-12 
(Q205L) animals.
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Figure 3.5. Levamisole sensitivity of gpa-12 (pk322) and hs::GPA-12 
(Q205L)
Levamisole sensitivity of animals with gpa-12 (pk322) deletion and hs::GPA-12 
(Q205L) transgene displayed as percentage paralysis upon exposure to IOO i^M 
levamisole.
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3.5. Gross neuronal morphology of animals with GPA-12 (Q205L) was 
unchanged
The motor neurons are found in the dorsal and ventral nerve cords, which run down the 
dorsal and ventral sides of the animal respectively. All the cell bodies are within the 
ventral nerve cord, therefore some of the motor neurons extend processes that cross 
between the dorsal and ventral cords called commissures. There are more than 40 
commissures that cross on the left or right hand side of the animal consisting of either a 
single or pair of neuronal processes. GPA-12 could be affecting the morphology of the 
motor neurons as opposed to or in addition to regulating the release of neurotransmitter 
from them. The use of the heatshock promoter to express GPA-12 (Q205L) in adult 
animals avoids developmental effects, however leaky expression of the heatshock 
promoter was suspected. To confirm the morphology of the motor neurons in hs::GPA- 
12 (Q205L) animals, GFP was expressed under the acr-2 promoter, which is expressed 
in cholinergic motor neurons. The gross morphology of the motor neurons in transgenic 
animals with hs::GPA-12 (Q205L) was examined and no defects were observed in 
animals with or without heatshock. All the commissures cross the body between the 
dorsal and ventral nerve cords similarly to wild type animals (Figure 3.6). hs::GPA-12 
(Q205L) animals examined 24 hours after heatshock also showed no defects.
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Figure 3.6. Gross neuronal morphology of heatshock induced GPA-12 
(Q205L)
p.acr-2::GFP was expressed in animals with the transgene hs::GPA-12 (Q205L) 
and wild type animals. Pictures were taken looking at the commissures travelling 
between the dorsal and ventral nerve cords.
(A) wild type without heatshock
(B) wild type with heatshock
(C) hs::gpa-12 (Q205L) without heatshock
(D) hs::gpa-12 (Q205L) with heatshock
(E) hs::gpa-12 (Q205L) 24hrs after heatshock
► Cell body in ventral nerve cord.
— ► Commissure linking dorsal and ventral nerve cords
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3.6. Expression of GPA-12 (Q205L) in cholinergic motor neurons increased 
ACh release
The promoter for the gene unc-17 can be used to specifically express proteins within 
cholinergic cells. UNC-17 encodes the vesicular ACh transporter (VAChT), which is 
responsible for the transport of ACh into synaptic vesicles in C. elegans. UNC-17 is 
expressed in cholinergic motor neurons with a small level of expression in the 4 
hindmost gut cells (Jim Rand personal communication). The promoter that expresses 
unc-17 was a gift from J. Kaplan, enabling the expression of proteins specifically in the 
cholinergic neurons. Transgenic animals expressing GPA-12 (Q205L) under the unc-17 
promoter have increased sensitivity to aldicarb in comparison with wild type animals 
albeit less than hs::GPA-12 (Q205L) animals (Figure 3.7). No mis-wiring of the 
cholinergic motor neurons was observed by the co-expression of p.acr-2::GFP (Figure 
3.8). This suggests GPA-12 acts post developmentally and pre-synaptically in the 
cholinergic motor neurons to stimulate ACh release.
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Figure 3.7. Structure of p.unc-17::gpa-12 (Q205L) transgene and aldicarb 
sensitivity of transgenic animals
(A) Construct for expression of GPA-12 (Q205L) under control of the unc-17 
promoter expressed in cholinergic motor neurons.
(B) Aldicarb sensitivity of transgenic animals with p.unc-17::gpa-12 (Q205L).
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Figure 3.8. Gross morphology of p.unc-17::gpa-12 (Q205L) animals
p.unc-17::gpa-12 (Q205L) was co-expressed with p.acr-2::GFP. Pictures show 
commissures crossing between the ventral and dorsal cords.
(A) wild type
(B) p.unc-17::gpa-12 (Q205L)
► Cell body in ventral nerve cord 
— ► Commissure between dorsal and ventral cord
3.7. Inhibition of RHO-1 suppressed GPA-12 (Q205L) mediated ACh release
C3 transferase, an enzyme derived from Clostridium botulinum, is a specific inhibitor of 
mammalian RhoA through ADP-ribosylation of the protein (Aktories and Hall, 1989). This 
enzyme has previously been used to inhibit RHO-1 in C. elegans (McMullan et al.,
2006). Animals expressing C3 transferase under both a heatshock inducible promoter 
and the cholinergic specific promoter p.unc-17 show lethargic locomotion and resistance 
to aldicarb (McMullan et al., 2006).
If GPA-12 is activating RHO-1 to cause an increase in aldicarb sensitivity, the inhibition 
of endogenous RHO-1 by expression of C3 transferase should block this effect. 
Transgenic animals that contain both hs::GPA-12 (Q205L) and hs::C3 transferase (C3T)
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were strongly resistant to aldicarb when heatshocked (Figure 3.9 A). Expression of C3 
transferase almost completely blocked the effect of GPA-12 (Q205L) on ACh release. A 
small increase in aldicarb sensitivity in the absence of heatshock was observed in 
hs::GPA-12 (Q205L) animals with or without the hs::C3T construct, suggesting there is 
no leakiness from the hs::C3T construct (Figure 3.9 B). C3 transferase is extremely 
toxic to the animals, due to the involvement of RHO-1 in many different pathways 
controlling important cellular events such as cell motility and cell division. If C3 
transferase were being expressed at low levels continuously, it would be unlikely the 
worms would survive to adulthood.
3.8. Loss of GPA-12 had no effect upon RHO-1 (G14V) mediated ACh release
Deletion of almost the entire coding sequence for gpa-12 (pk322) had no effect upon 
aldicarb sensitivity (Figure 3.2 B). Expression of active RHO-1 (G14V) leads to aldicarb 
hypersensitivity, suggesting an increase in ACh release (McMullan et al., 2006). The 
data thus far supports a model in which GPA-12 stimulates ACh release by the motor 
neurons in a RHO-1 dependent manner. RHO-1 is known to have a multitude of different 
downstream effectors regulating a wide variety of different pathways. It is possible that 
GPA-12 could itself be regulated by RHO-1. To eliminate the possibility that GPA-12 is 
acting downstream of RHO-1, animals expressing hs::RHO-1 (G14V) in a gpa-12 
(pk322) mutant background, were examined. The aldicarb sensitivity of these animals 
either with or without heatshock was identical to animals with hs::RHO-1 (G14V) alone 
(Figure 3.10 A and B). The loss of GPA-12 had no effect upon the ability of RHO-1 
(G14V) to stimulate ACh release.
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Figure 3.9. Aldicarb sensitivity of hs::C3T co-expressed with hs::GPA-12 
(Q205L)
Aldicarb sensitivity of hs::C3T; hs::gpa-12 (Q205L) transgenic animals.
(A) with heatshock
(B) without heatshock
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Figure 3.10. Aldicarb sensitivity of hs::RHO-1 (G14V) expression in 
presence of gpa-12 (pk322) mutation
Aldicarb sensitivity of transgenic animals expressing hs::RH0-1 (G14V) (RHO-1*) 
in gpa-12 (pk322) deletion mutant background.
(A) with heatshock.
(B) without heatshock.
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3.9. Loss of GPA-12 had no effect upon the increase in ACh release in DGK-1 
mutant animals
One of the pathways downstream of RHO-1 in the stimulation of ACh release, involves 
the inactivation of the enzyme diacylglycerol kinase 1 (DGK-1). Animals that have a 
mutation within DGK-1 showed strong aldicarb hypersensitivity similar to animals 
expressing hs::RHO-1(G14V) (McMullan et al„ 2006; Nurrish et al., 1999). Animals with 
mutations gpa-12 (pk322) and dgk-1 (sy428) have an identical aldicarb sensitivity when 
compared to animals with dgk-1 (sy428) mutation alone (Figure 3.11). Mutation of GPA- 
12 had no effect upon the increase in ACh release upon the loss of DGK-1.
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Figure 3.11. Aldicarb sensitivity of dgk-1 (sy428); gpa-12 (pk322) double 
mutant animals
Aldicarb sensitivity of gpa-12 (pk322); dgk-1 (sy428) animals.
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3.10. GPA-12 (Q205L) increased UNC-13 puncta in the dorsal nerve cord
DAG is a key molecule in the regulation of synaptic vesicle priming. UNC-13 is made in 
many isoforms one of which is UNC-13S, the shortest form. Under normal conditions, 
UNC-13S is diffusely spread throughout the neuron. It is recruited to the synapse in 
response to high neuronal activity to increase synaptic vesicle priming and 
neurotransmitter release (Lackner et al., 1999; Miller et al., 1999; Nurrish et al., 1999). 
Over expression of constitutively active RHO-1 causes the recruitment of UNC-13S to 
the synapse (McMullan et al., 2006; Nurrish et al., 1999).
If GPA-12 is stimulating ACh release via the activation of RHO-1, expression of GPA-12 
(Q205L) might cause the recruitment of UNC-13S to the synapses. UNC-13S::YFP was 
expressed in hs::GPA-12 (Q205L) transgenic animals and the localisation of UNC-13S 
observed both before and after heatshock induction of GPA-12 (Q205L) expression 
(Figure 3.12).
W.T. hs::GPA-12 (Q205L) gpa-12
(pk322)
- hs + hs 24hrs 
after hs
- hs + hs 24hrs 
after hs
- hs
1.86 ± 
0.19
1.94 ± 
0.12
1.89 ± 
0.11
1.83 ± 
0.12
2.29 ± 
0.13
2.21 ± 
0.14
1.85 ± 
0.09
Table 3.1. Quantification of UNC-13S puncta
Average number of puncta per lO^m in dorsal nerve cord ± SEM
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Figure 3.12. UNC-13S::YFP localisation in hs::GPA-12 (Q205L) and gpa-12 
(pk322) mutant animals
UNC-13S::YFP localisation in dorsal nerve cord of wild type, gpa-12 (pk322) and 
hs::GPA-12 (Q205L) transgenic animals before and after heatshock. Pictures have 
been colour coded to show fluorescence intensity black being the least intense and 
white being the most intense.
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Figure 3.13. Graph of UNC-13S puncta
* There is a significant difference between hs::GPA-12 (Q205L) before and after 
heatshock (p=0.01) as determined by a two-tailed t-test.
Number in brackets indicates the number of animals examined.
Error bars indicate SEM.
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The number of puncta was quantified (Table 3.1 and Figure 3.13). There is a 
statistically significant increase in number of UNC-13S puncta in hs::GPA-12 (Q205L) 
transgenic animals with heatshock (n=17) compared to hs::GPA-12 (Q205L) in the 
absence of heatshock (n=18), using two tailed t-test p=0.01 (all subsequent p values 
quoted are using a two tailed t-test). The mutation allele gpa-12 (pk322) has no effect 
upon the number of UNC-13S puncta, comparing wild type (n=11) and gpa-12 (pk322) 
(n=11) in the absence of heatshock (p=0.71). The increase in puncta is maintained 24 
hours after heatshock (n=10), albeit with a decrease in the level of significance, 
suspected to be due to the analysis of fewer animals (p=0.06).
3.11. UNC-13 puncta in GPA-12 (Q205L) animals occurred at synapses
SNB-1 (synaptobrevin), a protein within the synaptic vesicle membrane, can be used as 
a marker for synapses. CFP tagged SNB-1 was placed under the cholinergic motor 
neuron promoter p.acr-2 to visualise synapses in the cholinergic motor neurons. 
Examination of the localisation of UNC-13S::YFP and p.acr-2::SNB-1 ::CFP in hs::GPA- 
12 (Q205L) transgenic animals that have been induced by heatshock, showed co­
localisation of UNC-13S and SNB-1. UNC-13S puncta occurred at SNB-1 labelled 
synapses in GPA-12 (Q205L) expressing animals (Figure 3.14).
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Figure 3.14. Co-localisation of UNC-13S and SNB-1 in hs::GPA-12 (Q205L) 
animals
p.acr-2::SNB-1 ::CFP (in red) and UNC-13S::YFP (in green) in hs::GPA-12 (Q205L) 
animal after heatshock. Merged two images at bottom.
Dorsal nerve cord is shown.
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Figure 3.15. Aldicarb sensitivity of hs::GPA-12 (Q205L) animals expressing 
UNC-13 (H173K)
Aldicarb sensitivity of unc-13 (H173K); hs::gpa-12 (Q205L).
(A) with heatshock induction.
(B) without heatshock induction.
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3.12. Non-DAG binding UNC-13S suppressed GPA-12 (Q205L) mediated 
increase in ACh release
UNC-13 binding to DAG via its C1 domain is thought to be a critical step in the 
stimulation of neurotransmitter release. Expression of UNC-13 (H173K), a non-DAG 
binding form of UNC-13, rescues the paralysis of unc-13 (s69) mutants, but they retain 
an extremely sluggish locomotion and resistance to aldicarb (Lackner et al., 1999). 
Expression of GPA-12 (Q205L) by heatshock induction in animals with just the non-DAG 
binding UNC-13, unc-13 (s69); nzls23 (unc-13S (H173K)), had almost no effect upon the 
aldicarb sensitivity (Figure 3.15 A and B). The animals expressing GPA-12 (Q205L) 
with UNC-13 (H173K) were strongly resistant to aldicarb. The expression of only the 
non-DAG binding UNC-13 mutant blocked the ability of GPA-12 to stimulate ACh 
release.
3.13. Non-DAG binding UNC-13S partially suppressed RHO-1 (G14V) mediated 
increase in ACh release (in collaboration with Dr. R McMullan)
Expression of non-DAG binding UNC-13S (H173K) caused a partial suppression of 
constitutively active RHO-1 (G14V) mediated increase in aldicarb sensitivity (McMullan 
et al., 2006). Animals expressing N::RHO-1 (G14V) (under the control of the unc-17 
promoter) and UNC-13 (H173K) in an UNC-13 null background had a decreased 
aldicarb sensitivity compared to N::RHO-1 (G14V) alone (Figure 3.16). However, 
animals expressing RHO-1 (G14V) with UNC-13 (H173K) are still hypersensitive 
compared to wild type and UNC-13 (H173K) animals. Thus, non-DAG binding UNC-13 
(H173K) partially suppressed the increase in aldicarb sensitivity upon expression of 
RHO-1 (G14V).
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Figure 3.16. Aldicarb sensitivity of animals expressing RHO-1 (G14V) and 
UNC-13 (H173K)
Aldicarb sensitivity of N::RH0-1 (G14V) and N::RHO-1 (G14V); UNC-13 (H173K). 
RHO-1 (G U V) displayed as RHO-1*.
Data courtesy of R. McMullan.
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3.14. Non-DAG binding UNC-13S is not relocalised upon GPA-12 (Q205L) 
expression
Visualisation of UNC-13 (H173K), via a GFP tag, determined that there was no 
recruitment of non-DAG binding UNC-13 to synapses. In wild type animals UNC-13 
(H173K) was generally diffuse along the dorsal nerve cord with few puncta (Figure 3.17 
A and B). When UNC-13 (H173K) is expressed in animals with hs::GPA-12 (Q205L) the 
localisation does not change either before or after heatshock. (Figure 3.17 C and D). 
The number of puncta per 10 microns in the dorsal nerve cord were quantified and no 
statistically significant difference was observed between wild type (n=14) and hs::GPA- 
12 (Q205L) (n=15) animals after heatshock (two tailed t-test p=0.14) or hs::GPA-12 
(Q205L) animals before (n=12) and after heatshock (n=15) (two tailed t-test p=0.40) 
(Table 3.2 and Figure 3.17 E).
W.T. hs::GPA-12 (Q205L)
- hs + hs - hs + hs
0.95 ±0.15 1.16 ± 0.19 1.32 ±0.18 1.53 ±0.14
Table 3.2. Quantification of UNC-13S (H173K) puncta
Number of puncta per 10^m in dorsal nerve cord ± SEM.
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Figure 3.17. UNC-13 (H173K) localisation in hs::GPA-12 (Q205L) animals
(A -  D) Pictures showing UNC-13S (H173K)::GFP localisation in dorsal nerve cord 
of wild type and hs::GPA-12 (Q205L) transgenic animals before and after 
heatshock. Pictures have been colour coded to show fluorescence intensity with 
black being the least intense and white being the most intense.
(E) Quantification of number of puncta per lO^m. No statistically significant 
difference is observed. Error bars show SEM.
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3.15. GPA-12 had no effect upon synapse number or size
The increase in UNC-13S puncta in response to GPA-12 (Q205L) expression could be 
due to an increase in the number of synapses in the motor neurons. The number and 
size of synapses in the cholinergic motor neurons were examined using p.acr-2::SNB- 
1::CFP (Figure 3.18).
No statistically significant difference in the number of SNB-1 ::CFP puncta in hs::GPA-12 
(Q205L) animals with (n=17) or without (n=18) heatshock was seen (p=0.91) (Table 3.3 
and Figure 3.19 A ) . There was no difference in number of puncta in hs::GPA-12 
(Q205L) animals 24 hours after heatshock (n=10) when compared to before heatshock 
(p=0.13). Mutation of gpa-12 (pk322) (n=11) had no effect upon the number of puncta 
when compared to wild type animals without heatshock (n=11) (p=0.97).
The size of the SNB-1 ::CFP puncta in the same animals was calculated and no 
significant difference was seen between hs::GPA-12 (Q205L) before (n=18) and after 
heatshock (n=17) (p=0.42) (Table 3.3 and Figure 3.19 B). No significant difference in 
SNB-1 puncta size was observed between hs::GPA-12 (Q205L) before (n=18) and 24 
hours after heatshock (n=10) (p=0.37) or between hs::GPA-12 (Q205L) immediately 
after heatshock (n=17) or 24 hours after heatshock (n=10) (p=0.23). The spread of the 
data recording the size of the SNB-1 puncta seemed to increase in hs::GPA-12 (Q205L) 
animals immediately after heatshock, but returned to wild type levels 24 hours after 
heatshock. Mutation of gpa-12 (pk322) (n=11) had no effect upon synapse size when 
compared with wild type animals (n=11) without heatshock (p=0.21). Therefore, the loss 
or gain of GPA-12 did not affect the number or size of synapses.
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Figure 3.18. SNB-1 ::CFP localisation
p.acr-2::SNB-1::CFP in wild type, gpa-12 (pk322) and hs::GPA-12 (Q205L) 
animals with and without heatshock. Dorsal nerve cord is shown. Pictures colour 
coded for fluorescence intensity with black being the least intense and white the 
most intense.
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W.T. hs::gpa-12* gpa-12
(pk322)
- hs + hs 24hrs 
after hs
- hs + hs 24hrs 
after hs
- hs
Number
puncta
/10pm
2.51 ± 
0.11
2.48 ± 
0.11
2.38 ± 
0.11
2.56 ± 
0.11
2.50 ± 
0.09
2.30 ± 
0.11
2.51 ± 
0.11
Size
puncta
pm
0.70 ± 
0.05
0.72 ± 
0.05
0.73 ± 
0.06
0.77 ± 
0.06
0.86 ± 
0.10
0.70 ± 
0.10
0.63 ± 
0.02
Table 3.3. Quantification of SNB-1 ::CFP puncta number and size
Number of puncta per 10pm and size of puncta in pm2 in dorsal nerve cord ± SEM.
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Figure 3.19. Graphs of SNB-1 puncta number and size
p.acr-2::SNB-1::CFP puncta in wild type, hs::GPA-12 (Q205L) and gpa-12 (pk322) 
animals with and without heatshock. No statistically significant differences were 
found.
(A) number of puncta
(B) size of puncta
All counts in dorsal cord cholinergic neurons. Error bars show SEM.
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3.16. Expression of GPA-12 (Q205L) in the motor neurons during early 
development affected neuronal wiring
The ACh receptor acr-2 is expressed in the ventral cord motor neurons VA, DA, VB, and 
DB which are all cholinergic neurons (type A and B neurons) (Nurrish et al., 1999). The 
promoter for acr-2 was used as an alternative cholinergic motor neuron promoter to 
express the constitutively active cDNA for GPA-12, p.acr-2::gpa-12 (Q205L) (Figure 
3.20 A). Transgenic animals expressing p.acr-2::gpa-12 (Q205L) are more sensitive to 
aldicarb than wild type animals (Figure 3.20 B). This result is consistent with GPA-12 
increasing the release of ACh from the motor neurons.
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Figure 3.20. Structure of p.acr-2::gpa-12 (Q205L) construct and sensitivity 
to aldicarb of transgenic animals
(A) Construct for expression of gpa-12 (Q205L) cDNA under the control of the 
promoter for acr-2.
(B) Aldicarb sensitivity of animals with p.acr-2::gpa-12 (Q205L) transgene.
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Examination of the wiring of the cholinergic motor neurons revealed dramatic defects in 
p.acr-2::gpa-12 (Q205L) transgenic animals. Neuronal processes or possibly axons were 
found to leave the ventral nerve cord, partially cross the animal, and then continue to 
travel down the animal anterior to posterior outside the dorsal and ventral nerve cords 
(Figure 3.21 B). The defect was observed in at least 50% of transgenic animals.
10 Micron^
Figure 3.21. Gross neuronal morphology of p.acr-2::gpa-12 (Q205L)
p.acr-2::GFP was expressed in p.acr-2::gpa-12 (Q205L) and wild type animals. 
Pictures were taken looking at the commissures travelling between the dorsal and 
ventral nerve cords.
(A) wild type
(B) p.acr-2::gpa-12 (Q205L)
► Cell bodies in the ventral nerve cord.
— ► Commissure crossing animal between dorsal and ventral cords. 
— ► Mis-wired neurons.
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3.17. Other phenotypes associated with expression of GPA-12 (Q205L)
Other phenotypes have been observed in hs::GPA-12 (Q205L) animals in addition to the 
increase in aldicarb sensitivity and re-localisation of UNC-13S. Animals have a very 
strong reduction in the rate of pharyngeal pumping and exhibit growth arrest, 
phenotypes which are likely to be linked (van der Linden et al., 2003). These phenotypes 
were observed in larval animals and suppressed by mutation of the protein kinase C, 
TPA-1. When GPA-12 (Q205L) was expressed in adult animals a reduction in 
pharyngeal pumping was observed and this was suppressed by mutation of TPA-1 
(Table 3.4 and Figure 3.22 A). Another phenotype observed in adult animals 
expressing GPA-12 (Q205L) was an increase in the length of the defecation cycle 
(recorded from pBoc to pBoc phases of consecutive cycles). GPA-12 (Q205L) animals 
were often found not to defecate throughout the entire course of the experiment (600 
seconds) (Table 3.4 and Figure 3.22 B). Mutation of TPA-1 suppressed the increase in 
the length of the defecation cycle (Table 3.4 and Figure 3.22 B).
W.T. hs::gpa-12 (Q205L) hs::gpa-12 (Q205L); 
tpa-1 (pk1585)
- hs + hs - hs + hs - hs + hs
Pumps/min 219 ± 13 260 ±11 166 ±28 15 ± 5 205 ± 28 228 ± 11
Length 
cycle secs
55.6 ±1.1 55.7 ±1.1 67.5 ±1.6 600 ± 0 67.5 ± 16 108.4 ± 
6.1
Table 3.4. Quantification of pharyngeal pumping rate and length of 
defecation cycle
Number of pharyngeal pumps per minute and length of defecation cycle (pBoc to 
pBoc) in seconds ± SEM.
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Figure 3.22. Graphs of pharyngeal pumping and defecation
(A) Pharyngeal pumping rate displayed as number of pumps per minute.
(B) Defecation cycle length displayed as time taken for one defecation cycle (pBoc 
to pBoc).
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3.18. Mutation of TPA-1 did not suppress GPA-12 (Q205L) mediated increase in
ACh release
Mutation tpa-1 (pk1585) suppressed the reduction of pharyngeal pumping and increase 
in the length of the defecation cycle in response to GPA-12 (Q205L) expression in adults 
(Table 3.4 and Figure 3.22 A and B). The aldicarb sensitivity of hs::GPA-12 (Q205L) in 
the presence of tpa-1 (pk1585) mutation showed no difference when compared to 
hs::GPA-12 (Q205L) in a wild type background (Figure 3.23). Mutation of TPA-1 had no 
effect upon the ability of GPA-12 to stimulate ACh release.
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Figure 3.23. Aldicarb sensitivity of tpa-1 (pk1585) mutants with hs::GPA-12 
(Q205L)
Aldicarb sensitivity of hs::GPA-12 (Q205L) with tpa-1 (pk1585) mutation.
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3.19. PKC-1 mutation did not suppress GPA-12 (Q205L) mediated increase in
ACh release
Mutation of another protein kinase C, PKC-1, the homologue of mammalian protein 
kinase C epsilon caused a slight decrease in aldicarb sensitivity (Figure 3.24). The 
aldicarb sensitivity of pkc-1 (ok563) animals expressing GPA-12 (Q205L) was identical 
to the sensitivity of animals expressing GPA-12 (Q205L) in a wild type background 
(Figure 3.24). Mutation of pkc-1 had no effect upon GPA-12 (Q205L) mediated ACh 
release.
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Figure 3.24. Aldicarb sensitivity of pkc-1 (ok563) mutant animals with 
hs::GPA-12 (Q205L)
Aldicarb sensitivity of hs::gpa-12 (Q205L); pkc-1 (ok563).
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3.20. PKC-1 did not suppress GPA-12 (Q205L) mediated reduction in 
pharyngeal pumping, increase in length of defecation cycle or growth arrest
TPA-1, a protein kinase C, is required for GPA-12 mediated reduction in pharyngeal 
pumping and lengthening of the defecation cycle in adult animals (Figure 3.22). The rate 
of pharyngeal pumping is almost identical in pkc-1 (ok563) and wild type animals 
expressing GPA-12 (Q205L) (Table 3.5 and Figure 3.25). The length of the defecation 
cycle is increased to longer than 600 seconds when expressing GPA-12 (Q205L) in both 
wild type and pkc-1 (ok563) animals (Table 3.5 and Figure 3.25). Therefore, mutation of 
a different protein kinase C, PKC-1, does not affect the ability of GPA-12 to reduce the 
rate of pharyngeal pumping or lengthen the defecation cycle.
W.T. hs:: gpa-12 hs::gpa-12; pkc-1 
(ok563)
- hs + hs - hs + hs - hs + hs
Pumps/
min
219 ± 13 260 ± 11 166 ±28 15 ± 5 209 ± 18 15 ± 4
Cycle
length
secs
55.6 ± 1.1 65.7 ± 1.2 55.7 ±1.1 600 ± 0 59.2 ± 
0.77
600 ± 0
Table 3.5. Quantification of pharyngeal pumping and defecation cycle
Number of pharyngeal pumps per minute and length of defecation cycle pBoc to 
pBoc in seconds ± SEM.
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Figure 3.25. Rate of pharyngeal pumping and defecation cycle length in 
pkc-1 (ok563) mutant with hs:.GPA-12 (Q205L)
(A) Rate of pharyngeal pumping displayed as pumps per minute.
(B) Time cycle for defecation displayed as time per defecation cycle (pBoc to
pBoc).
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Expression of GPA-12 (Q205L) causes growth arrest at the L1 (larval 1) stage of 
development (van der Linden et al., 2003). Animals induced to express GPA-12 (Q205L) 
from a heatshock promoter at the L1 stage failed to develop fully to adults after 4 days 
(Figure 3.26). Animals expressing GPA-12 (Q205L) with a mutation in TPA-1 no longer 
underwent a growth arrest, after 4 days L1 animals had fully developed to become 
adults and had progeny (Figure 3.26) (van der Linden et al., 2003). Expression of GPA- 
12 (Q205L) in L1 stage pkc-1 (ok563) mutant animals caused growth arrest, after 4 days 
the animals failed to reach adulthood and have progeny (Figure 3.26). Mutation of the 
protein kinase C TPA-1, but not protein kinase C PKC-1, suppressed GPA-12 mediated 
growth arrest.
Without
heatshock
With I  
heatshock ft
W.T. hs::gpa-12* hs::gpa-12*; hs::gpa-12*;
[pa-1 (pk1585) pkc-1 (ok563)
Figure 3.26. Growth of hs::GPA-12 (Q205L) animals with tpa-1 (pk1585) or 
pkc-1 (ok563) mutations
Pictures taken 4 days after 20 L1 animals, with or without heatshock, were 
transferred to a new plate.
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3.21. Discussion and conclusions
3.21.1. Neurotransmitter release in C. elegans is controlled by G protein 
coupled pathways
Neurotransmitters are released by neurons to transmit signals to other target cells, 
usually neurons or muscles. The neurotransmitter is contained within vesicles called 
synaptic vesicles, which are found within the releasing neuron at the synaptic junction 
with the target cell. Synaptic vesicles undergo a cycle consisting of docking and priming 
at the active zone, fusion with the plasma membrane and exocytosis of the 
neurotransmitter, and finally endocytosis and recycling. The regulation, by 
neuromodulators, of the docking and priming steps of the cycle is critical for the ability of 
the neuron to quickly release high levels of neurotransmitter. These steps are known to 
involve the SNARE proteins syntaxin, SNAP-25 and synaptobrevin although the 
mechanisms of regulation are still being defined.
C. elegans provides a simple model to look at the regulation of synaptic vesicle docking 
and priming. There are homologues of the main proteins known to be involved including 
the t-SNARES UNC-64 (syntaxin) and RIC-4 (SNAP-25) and the v-SNARE SNB-1 
(synaptobrevin). Previous screens looking at the release of ACh at the NMJ have 
identified new proteins involved in the synaptic vesicle cycle including the DAG binding 
protein UNC-13 (Lackner et al., 1999; Maruyama and Brenner, 1991; Miller et al., 1999; 
Nurrish et al., 1999; Sassa et al., 1999; Sieburth et al., 2001). Two G-protein coupled 
pathways regulate levels of the lipid second messenger DAG at the synapse to regulate 
ACh release (Figure 3.27). EGL-30 (Goq) increases levels of DAG causing an UNC-13 
mediated increase in ACh release (Lackner et al., 1999). GOA-1 (Ga0) decreases levels 
of ACh release probably through the regulation of DAG and UNC-13 localisation (Nurrish 
et al., 1999).
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Stimulate Inhibit Stimulate
release release release
GOA-1 (G«0)
RHO-1 (RhoA)
DGK-1 (DAG kinase)EGL-8 (PLC-p)
RHO-1 (RhoA)PAPIP
UNC-13
Acetylcholine Release
Figure 3.27. Three G-protein coupled pathways regulate neurotransmitter 
release at neuromuscular junction
ACh release is regulated by G protein coupled pathways and DAG levels. All 
stimulatory components are shown in blue. All inhibitory components are shown in 
red. Known interactions are shown by bold lines, an indirect or unclear interaction 
is shown by a dotted line.
3.21.2. GPA-12 regulates neurotransmitter release
The results in this chapter support the hypothesis that the release of ACh at the NMJ in 
C. elegans is controlled by the G protein GPA-12 (Figure 3.27). Expression of 
constitutively active GPA-12 under the control of a heatshock promoter leads to an 
increase in sensitivity to the ACh esterase inhibitor aldicarb, suggesting GPA-12 
(Q205L) is increasing ACh release. Expression of GPA-12 (Q205L) under the control of 
the unc-17 promoter, which drives expression in cholinergic cells, causes an increase in
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aldicarb sensitivity consistent with an increase in ACh release. This suggests GPA-12 is 
acting within the cholinergic neurons to increase ACh release, although UNC-17 has 
been observed to be expressed in a few non-neuronal intestinal cells (Jim Ran, OMRF, 
Oklahoma USA). Expression of GPA-12 under the heatshock promoter causes a larger 
increase in aldicarb hypersensitivity compared to the unc-17 promoter. This could be 
due to differences in expression levels from the two promoters or possibly indicate a role 
of GPA-12 in non-neuronal cells such as interneurons or neuropeptide releasing cells.
No changes in the sensitivity of the muscle are observed using the nicotinic ACh 
receptor agonist levamisole in animals expressing GPA-12 (Q205L) suggesting that 
GPA-12 is having no effect upon the muscle. Thus, GPA-12 is affecting the pre-synaptic 
compartment to regulate ACh release. No defects in the wiring of the cholinergic motor 
neurons, in either the dorsal and ventral cord processes or the commissures connecting 
the two cords, are observed when expressing GPA-12 (Q205L) from either a heatshock 
promoter or the unc-17 promoter. All these results combined suggest GPA-12 is 
regulating ACh release from the pre-synaptic motor neuron at the NMJ.
3.21.3. GPA-12 acts upstream of RHO-1 and DGK-1 to regulate release
Regulation of the small GTPase RHO-1, which inhibits the enzyme diacylglycerol kinase 
1 (DGK-1), raising DAG levels and increasing ACh release, has not been determined 
(McMullan et al., 2006). The results in this chapter suggest GPA-12 is acting via RHO-1 
and DGK-1 to regulate ACh release. Expression of C3 transferase, a specific inhibitor of 
RHO-1, almost completely suppresses the ability of constitutively active GPA-12 to 
increase aldicarb sensitivity, suggesting GPA-12 acts via RHO-1 to stimulate ACh 
release (Aktories and Hall, 1989). Expression of constitutively active RHO-1 in a mutant 
that has lost the majority of GPA-12 has an identical aldicarb sensitivity compared to 
expression of constitutively active RHO-1 in wild type animals. This suggests that GPA- 
12 is not required for RHO-1 to stimulate ACh release. It can therefore be hypothesised 
that GPA-12 is acting upstream of RHO-1 in the regulation of neurotransmitter release.
RHO-1 inhibits the enzyme DGK-1, which phosphorylates DAG to PA, raising the levels 
of DAG to stimulate ACh release (McMullan et al., 2006). Mutation of DGK-1 causes a 
significant increase in ACh release (Nurrish et al., 1999). The aldicarb sensitivity of
176
animals with a mutation in DGK-1 causing an increase in ACh release is unaffected by 
mutation of GPA-12. This suggests that mutation of GPA-12 has no effect upon the 
release of ACh in DGK-1 mutants. This suggests DGK-1 could be acting downstream of 
GPA-12 to stimulate ACh release. This genetic data supports the hypothesis that there is 
a new trimeric G protein pathway controlling neurotransmitter release involving the 
activation of RHO-1 by GPA-12, causing the inhibition of DGK-1 and an increase in ACh 
release. An alternative explanation for the lack of effect of the GPA-12 mutant upon ACh 
release in RHO-1 over-expressors and DGK-1 mutants could be that there are two 
pathways controlling release, one involving GPA-12 and one involving RHO-1 and DGK- 
1 .
Mutation of GPA-12, including the loss of the domains required for GTP binding and 
hydrolysis, has no effect upon aldicarb sensitivity, suggesting no effect upon ACh 
release. Inhibition of endogenous RHO-1 causes a decrease in ACh release suggesting 
an additional pathway activating RHO-1 under basal laboratory conditions. The RhoGEF 
UNC-73 has been suggested to regulate ACh release, UNC-73 mutants exhibit a 
lethargic locomotion, although this has been reported to be independent of changes in 
aldicarb sensitivity and ACh release (Steven et al., 2005). Higher sensitivity assays 
appear to show a slight defect in aldicarb sensitivity, suggesting a possible decrease in 
ACh release in UNC-73 mutant animals (see chapter 4 figure 4.24). Therefore, it could 
be hypothesised that UNC-73 is a second potential activator of RHO-1 in the regulation 
of ACh release.
3.21.4. GPA-12 recruits UNC-13 to synapses in a DAG-dependent manner
Recruitment of the DAG binding protein UNC-13 to release sites is associated with the 
increase in ACh release in DGK-1 mutant and constitutively active RHO-1 over 
expressing animals (McMullan et al., 2006; Nurrish et al., 1999). The localisation of 
UNC-13 is also regulated by GPA-12. Expression of constitutively active GPA-12 causes 
UNC-13 to be relocalised from a diffuse distribution to punctate structures, co-localising 
with the synaptic vesicle marker SNB-1; GPA-12 is recruiting UNC-13 to sites of release.
In mice hippocampal neurons and C. elegans, the stimulation of neurotransmitter 
release by the DAG analogue phorbol esters is substantially blocked by a mutation in
177
UNC-13 (H173K), which prevents binding to DAG (Lackner et al., 1999; Rhee et al., 
2002). This non-DAG binding form of UNC-13, UNC-13 (H173K), fails to be relocalised 
to the synapse by constitutively active GPA-12 expression, suggesting the production of 
DAG is required to facilitate GPA-12 mediated UNC-13 relocalisation. No change in the 
number or size of SNB-1 puncta is observed in response to constitutively active GPA-12 
expression, suggesting GPA-12 has no effect upon the number or size of synapses. 
These results suggest GPA-12 regulates ACh release via the recruitment of UNC-13 to 
existing synapses in a DAG dependent manner.
3.21.5. GPA-12 activates one of multiple RHO-1 pathways controlling ACh 
release
Expression of the non-DAG binding form of UNC-13 (H173K) in the absence of wild type 
UNC-13 causes a strong reduction in aldicarb sensitivity and ACh release. Expression of 
constitutively active GPA-12 has no effect upon the aldicarb sensitivity of these non- 
DAG binding UNC-13 mutant animals. In the absence of DAG-UNC-13 interaction GPA- 
12 has lost the ability to stimulate ACh release, suggesting UNC-13 binding to DAG is 
essential for GPA-12 to stimulate ACh release. The complete loss of GPA-12 mediated 
effects upon ACh release in UNC-13 (H173K) mutant suggests GPA-12 is acting in an 
entirely UNC-13 and DAG dependent manner.
The ability of constitutively active RHO-1 to stimulate ACh release is not entirely blocked 
by the non-DAG binding UNC-13 mutant suggesting RHO-1 activates ACh release in 
two ways, one is DAG dependent and the other DAG independent (McMullan et al., 
2006). GPA-12 (Q205L) stimulated ACh release is blocked entirely by the non-DAG 
binding UNC-13 mutant suggesting two possibilities. The first is that the levels of active 
RHO-1 activated by expression of GPA-12 (Q205L) are far lower than those in the RHO- 
1 (G14V) expressing animals. The affinities of the downstream effectors for RHO-1 may 
not to be identical. In the presence of lower levels of active RHO-1, the effector 
stimulating the DAG-UNC-13 dependent pathway may be triggered. Higher levels of 
active RHO-1 may be required for the activation of the second DAG and UNC-13 
independent pathway, by an effector with a lower affinity for active RHO-1. The second 
explanation for the difference in the suppression of GPA-12 (Q205L) and RHO-1 (G14V) 
by non-DAG binding UNC-13 is that GPA-12 activates only one downstream pathway by
178
which RHO-1 stimulates ACh release, the UNC-13-DAG binding pathway. This suggests 
the possibility of two pools of RHO-1 controlling neurotransmitter release, one that is 
activated by GPA-12 and acts via DGK-1 and DAG mediated UNC-13 relocalisation, and 
the second of which is independent of GPA-12 and the DAG-UNC-13 interaction.
Scaffold proteins have been shown to regulate the activity of RhoA (the mammalian 
homologue of RHO-1) and allow the activation of one specific downstream effector and 
pathway in response to different conditions (Jaffe et al., 2005). It is therefore possible 
that in the regulation of neurotransmitter release RHO-1 can activate two separate 
pathways using scaffold proteins.
3.21.6. Possible long term effects of constitutively active GPA-12
An interesting observation involves the long term effects of GPA-12 (Q205L) expression. 
24 hours after heatshock induction of constitutively active GPA-12 (Q205L) animals are 
still hypersensitive to aldicarb. The maintenance of aldicarb hypersensitivity could be 
due to a variety of factors. Firstly, GPA-12 signalling could be causing relatively long 
term changes to the regulation of neurotransmitter release by the motor neurons. A 
second possibility is the GPA-12 (Q205L) protein that is induced has a long lifespan in 
the motor neuron, and continues to affect neurotransmitter release a long time after the 
initial heatshock. A third possibility is that the heatshock promoter is still active and 
promoting the expression of new GPA-12 (Q205L) to continue its effect upon 
neurotransmitter release. Use of an antibody to stain for GPA-12 protein in animals 
before and after heatshock might help to determine between these possibilities, although 
background levels of endogenous wild type GPA-12 are unknown potentially obscuring 
observation of the levels of over expressed constitutively active protein. After 24 hours, 
no defects in the commissures of the motor neurons are observed and the number of 
UNC-13S to puncta remains increased to levels comparable with the number 
immediately after heatshock. Therefore, no evidence has been found supporting the 
model in which an alternative pathway becomes activated 24 hours after heatshock.
3.21.7. Leakiness of the hs::GPA-12 (Q205L) construct
hs::GPA-12 (Q205L) transgenic animals have a small increase in aldicarb sensitivity in 
the absence of heatshock. This could be due to leakiness of the promoter causing a low
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level of expression of GPA-12 (Q205L) at all times. This has been previously observed 
when using this transgenic strain (van der Linden et al., 2003). In hs::GPA-12 (Q205L) 
animals GPA-12 genomic DNA containing the Q205L activating mutation is being 
expressed under the heatshock promoter. It is possible that there are promoter elements 
within the introns causing low level expression in the absence of heatshock as opposed 
to the promoter being leaky. Animals expressing constitutively active GPA-12 under the 
unc-17 promoter were made using the cDNA for GPA-12. The difference in the increase 
in aldicarb sensitivity and ACh release when comparing these animals with hs::GPA-12 
(Q205L) animals could also be due to the presence of promoter elements within the 
heatshock induced genomic GPA-12 (Q205L) DNA and not in the neuronal GPA-12 
(Q205L) cDNA.
3.21.8. GPA-12 regulates feeding but not ACh release through TPA-1
Constitutively active GPA-12 had previously been shown to lead to a reduction in 
pharyngeal pumping causing a loss of feeding and a resulting growth arrest (van der 
Linden et al., 2003). Significant extension of the defecation cycle in GPA-12 (Q205L) 
expressing animals is also observed. Mutation of the protein kinase C, tpa-1 suppresses 
all these effects of GPA-12 (Q205L). Mutations of tpa-1 have also been found to 
suppress growth arrest induced by the DAG analogue phorbol esters (PMA). Exposure 
to PMA causes an increase in ACh release as determined by an increase in aldicarb 
sensitivity, suggesting the possibility that TPA-1 is also regulating ACh release. Animals, 
with a mutation in tpa-1, expressing constitutively active GPA-12 have an identical 
aldicarb sensitivity compared to animals expressing GPA-12 (Q205L) in a wild type 
background. This suggests that TPA-1 has no role in the increase in ACh release by 
GPA-12. It is therefore predicted that there are at least two pathways activated by GPA- 
12 (Q205L) expression: the first regulates feeding via the protein kinase C TPA-1; the 
second regulates ACh release via RHO-1 and UNC-13.
3.21.9. PKC-1 has no role in GPA-12 regulation of ACh release or feeding
Another protein kinase C, PKC-1, an epsilon protein kinase C, has been suggested to 
have a role in the regulation of ACh release. In mammals, protein kinase C epsilon is 
activated by an interaction with DAG resulting in targeting to the membrane (Akita,
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2002). Mutation of pkc-1 causes a slight decrease in aldicarb sensitivity suggesting a 
decrease in ACh release. Expression of GPA-12 (Q205L) in pkc-1 mutant animals 
causes an identical increase in aldicarb sensitivity when compared to expression in wild 
type animals. This suggests that PKC-1 is not involved in GPA-12 mediated ACh 
release. The reduction in pharyngeal pumping, growth arrest and increase in length of 
the defecation cycle caused by GPA-12 are also unaffected by mutation of pkc-1. This 
suggests that PKC-1 has no role in the GPA-12 mediated pathways controlling these 
behaviours. Thus, the protein kinase C, PKC-1, is not required for GPA-12 mediated 
ACh release or feeding whilst the protein kinase C, TPA-1, is specifically required for 
GPA-12 regulated feeding but not ACh release.
3.21.10. GPA-12 controls neuronal wiring during development
It has previously been observed that altering neurotransmitter release at NMJs can alter 
the morphology of the axons of the motor neurons (Troemel et al., 1995). In C. elegans, 
mutations that alter the release of ACh, or the function of the nicotinic ACh receptors in 
the muscle during development cause ectopic sprouting of the three SAB neurons 
innervating the muscles in the head. The degree of blocking of neurotransmission was 
directly correlated with the degree of abnormal axonal sprouting. Analysis of temperature 
sensitive mutants indicated that the levels of neurotransmission are critical at a specific 
time period during development to ensure correct neuronal growth.
Expression of GPA-12 (Q205L) under the cholinergic motor neuron promoter acr-2 
causes a defect in the wiring of the cholinergic motor neurons, indicating a cell 
autonomous effect. Expression of GFP under the acr-2 promoter has revealed the 
promoter to be active early during the development of the animal (before hatching). It is 
possible that changes in ACh release caused by expression of GPA-12 (Q205L) at the 
critical point in development from the acr-2 promoter could be causing the neuronal 
wiring defects. GPA-12 could also have a role in controlling neuronal wiring during 
development that is entirely separate from the role in adult animals regulating ACh 
release. The lack of defects in the wiring of the cholinergic motor neurons in animals 
expressing GPA-12 (Q205L) under the unc-17 promoter (at the light microscope level) 
supports the idea that GPA-12 expression specifically from the acr-2 promoter as 
opposed to expression in the cholinergic neurons is causing these defects. No defects
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have been observed in adult animals expressing GPA-12 (Q205L) under the heatshock 
promoter both immediately after heatshock and 24 hours after heatshock supporting the 
theory that GPA-12 has a role in the development of the animal to control neuronal 
wiring as opposed to in the adult animal. Examination of the wiring of the nervous 
system at the EM level as opposed to the light microscope, might provide further insight 
into the defects in neuronal wiring.
3.21.11. GPA-12 pathways are not active under basal laboratory conditions
Mutation of GPA-12 deleting the majority of the G protein domain including the GTP 
binding and hydrolysis domain does not lead to any observed changes in ACh release 
thus far, either alone or in combination with other mutations. This suggests that while 
GPA-12 is not essential for ACh release, activated GPA-12 has a role in controlling ACh 
release. The pathway involving GPA-12 may not be active under basal laboratory 
conditions, being stimulated by an external cue. Expression of constitutively active GPA- 
12 activates this pathway to stimulate ACh release. Two other phenotypes have been 
recognised upon expression of constitutively active GPA-12. Animals have a strong 
reduction in pharyngeal pumping and undergo an associated growth arrest (van der 
Linden et al., 2003). No defects in pharyngeal pumping are observed in GPA-12 mutant 
animals and expression of wild type GPA-12 also has no effect, suggesting that this 
pathway is also inactive under basal laboratory conditions, resulting in a lack of 
phenotype in GPA-12 mutant animals (van der Linden et al., 2003). The possibility that 
the loss of GPA-12 has been overcome in mutant animals by replacement activation of 
downstream pathways cannot be discounted. Mutation of the Concertina, the GPA-12 
homologue in Drosophila, causes embryonic lethality, as does mutation of Ga13 (a 
member of the Ga12 family that has no homologue in C. elegans) in mice (Offermanns et 
al., 1997; Parks and Wieschaus, 1991). This replacement would be required to activate 
at least two pathways; one controlling the release of ACh by the motor neurons and the 
other controlling the rate of pharyngeal pumping. These pathways are distinct since 
mutation of TPA-1 can suppress the reduction in pharyngeal pumping, but is unable to 
suppress the increase in ACh release associated with constitutively active GPA-12 
expression.
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RNAi knockdown of GPA-12 has been published to result in phenotypes including 
locomotory defects, although these were not quantified, and embryonic arrest (Yau et 
al., 2003). Changes in ACh release often result in locomotory defects, and growth arrest 
was observed after both RNAi knockdown of GPA-12 and/ or over expression of 
constitutively active GPA-12 (van der Linden et al., 2003; Yau et al., 2003). Since no 
defects have been observed in the gpa-12 mutant, which has lost the domains for GTP 
binding and hydrolysis, it is possible that the defects observed after RNAi knockdown 
were caused by non-specific RNAi. However, it is also possible that the loss of GPA-12 
in the short term by RNAi does not result in the stimulation of replacement pathways to 
restore normal levels of ACh release and pharyngeal pumping, causing the observed 
locomotory defects and embryonic arrest.
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4. Results: The Guanine Nucleotide Exchange Factor linking GPA-12 and RHO-1
4.1. Introduction
RHO-1 is a member of the family of small Rho GTPases, consisting of at least 22 
members in mammals (Jaffe and Hall, 2005). One subfamily is the Rho proteins 
themselves. In mammals there are three Rho isoforms: RhoA, RhoB and RhoC. In C. 
elegans, there is only one member of the Rho subfamily, RHO-1. Rho GTPase proteins 
act as molecular switches and exist in two forms: firstly, in an inactive form bound to 
GDP and secondly, converted by Rho guanine nucleotide exchange factors (GEFs), to 
an active GTP bound form (Schmidt and Hall, 2002). The active protein is inactivated by 
the intrinsic hydrolysis of GTP to GDP, which is catalysed by GTPase activating proteins 
(GAPs) (Bernards, 2003). In mammals, more than 85 RhoGEFs have been identified 
that are activated by many different types of proteins (Jaffe and Hall, 2005).
In C. elegans, RHO-1 has been shown to be involved in the regulation of acetylcholine 
(ACh) release at the neuromuscular junction (NMJ) (McMullan et al., 2006). In chapter 
three it was shown that activation of the trimeric G protein alpha subunit GPA-12 causes 
an increase in ACh release at the NMJ through the activation of RHO-1. In mammalian 
systems, the homologous G protein alpha subunits Ga12 and Gai3 activate RhoA via a 
sub-family of RhoGEFs. These RhoGEFs are characterised by the presence of a 
regulator of G protein signalling (RGS) domain (Fukuhara et al., 2000; Fukuhara et al., 
1999; Kozasa et al., 1998). This chapter explores the possibility that GPA-12 is 
stimulating ACh release through the activation of RHO-1 via an RGS-containing 
RhoGEF.
4.2. rhgf-1 cDNA has an additional exon at 5’ end
In C. elegans, RHGF-1 is the only RhoGEF known to contain an RGS domain. Activated 
GPA-12 has been shown to bind to RHGF-1 (Yau et al., 2003). RHGF-1 contains 
multiple other predicted domains including a PDZ domain, a C1 domain and the 
RhoGEF domain consisting of a DH and PH domain. Amplification of the cDNA for 
RHGF-1 using the SMART RACE kit designed to start at the extreme 5’ end of the cDNA 
has lead to the discovery of an additional exon at the extreme 5’ end immediately
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preceding the start of the PDZ domain compared to the published sequence from the 
Yau clone (Figure 4.1). The cDNA was amplified using a primer for the SL1 sequence 
suggesting that this is the true 5’ end of the gene.
ATGCGATCGTACGAGTTTGTAACCAATACACCACTCAAACTTGATCGGCACAAAGTATACCTCGTCGACGATGTGGCTGTCACAAGGACTGTACCCTTAT 
--------------------------------------------------------------------------------------------------ATGATAGAACGATGCGTAGTAGTTCAACGACAACCAGATGGTTTCGGTCTGACGGTGAA
I I I I II I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I
CGCAGCCATTATCCCCATCAACCGCATCATCCAGTTACAATATGATAGAACGATGCGTAGTAGTTCAACGACAACCAGATGGTTTCGGTCTGACGGTGAA
CAGCGAGTTTCCAGTTTATGTGCATACTCTGAAACAGGATGGAGCTGCTTACTGTGCGGGTGTTCGTCAAGGAGATCGGATAGTCAAGGTCAATGGAATG
I I I I I I I I I I I I I I I I I I I I I II I I I I I I II I II II I I I I I I I I II I II I I I I I I II I I I I I I I I I I I I I II II I II I I I I II I I II I I I I I I I I I II I I
CAGCGAGTTTCCAGTTTATGTGCATACTCTGAAACAGGATGGAGCTGCTTACTGTGCGGGTGTTCGTCAAGGAGATCGGATAGTCAAGGTCAATGGAATG
TCGGTGTCGCCCAATAACCATAAGGAAGTGCTCCAAATGATATCGAATGGCCACAACGTTGCATTGACTCTACTTGGAAAACCACCGGACCCCATATCCA
I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I II I I I I I I I I I II II I I II I I II I II I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I II I I I
TCGGTGTCGCCCAATAACCATAAGGAAGTGCTCCAAATGATATCGAATGGCCACAACGTTGCATTGACTCTACTTGGAAAACCACCGGACCCCATATCCA
ATATTTCTTTTCCGAATCAACAAGTTGAGCAAAAAATACATATCGCTGATCCAGTGCTCATCGAGGCCAGCTCAAAGAGTTGGCGACAACGACGCAACGA
I I I I I I I I I I I I I I I I I I I I I I II I I II I I II I II I II I I I I I II II I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
ATATTTCTTTTCCGAATCAACAAGTTGAGCAAAAAATACATATCGCTGATCCAGTGCTCATCGAGGCCAGCTCAAAGAGTTGGCGACAACGACGCAACGA
ATTACTTGGCCAGATGGTAGCTGAAGAAAGACGAAACGTTGAG
I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I
ATTACTTGGCCAGATGGTAGCTGAAGAAAGACGAAACGTTGAG
Figure 4.1. rhgf-1 gene includes one new exon
Alignment of part of the sequence of previously published rhgf-1 cDNA shown in 
black with the newly amplified cDNA using the SMART RACE kit shown in blue.
The additional new 5’ exon in the SMART RACE amplified cDNA is shown in red.
Only the first 6 exons are shown.
4.3. Mutation of RHGF-1 had a small effect upon ACh release
A deletion mutation in rhgf-1 called rhgf-1 (ok880) was obtained from the C. elegans 
knockout consortium. Genomic DNA and cDNA were made from rhgf-1 (ok880) mutant 
animals and sequenced. The mutation rhgf-1 (ok880) is an in-frame deletion beginning 
at amino acid 599 at the end of the predicted C1 domain until amino acid 804 within the 
DH domain (Figure 4.2). The DH domain has previously been shown to be critical for 
RhoGEF activity in mammalian RhoGEFs, so it is likely this mutation results in a protein
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unable to activate RHO-1 (Kristelly et al., 2004). After four rounds of backcrossing, the 
deletion mutation rhgf-1 (ok880) caused a slight increase in the rate of paralysis upon 
exposure to aldicarb (Figure 4.3). Mutation of a RhoGEF is likely to reduce the levels of 
active RHO-1, therefore it might be expected that the loss of a RhoGEF would cause a 
similar phenotype to the inhibition of endogenous RHO-1. However, this was not 
observed (Figure 3.9).
PH
DH
C1 ■ a
RGS
PDZ ■ at
rhgf-1 (F13e6.6) 0------
Figure 4.2. Deletion mutation rhgf-1 (ok880)
Structure of rhgf-1 gene showing the location of domains PDZ, RGS, C1 and 
DH/PH and the region deleted in rhgf-1 (ok880).
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Figure 4.3. Aldicarb sensitivity of rhgf-1 (ok880) mutant animals
Aldicarb sensitivity of rhgf-1 (ok880) mutant animals upon exposure to 1mM 
aldicarb for 0-100 minutes. Error bars show SEM.
All subsequent aldicarb graphs show percentage paralysis upon exposure to 1 mM 
aldicarb for 0-100 minutes. Error bars show SEM.
4.4. Mutation of RHGF-1 had no effect upon the muscle
The nicotinic ACh receptor agonist levamisole was used to analyse the sensitivity of the 
ACh receptors in the muscle in rhgf-1 (ok880) mutant animals. There was no difference 
in sensitivity to levamisole between rhgf-1 (ok880) mutant and wild type animals (Figure
4.4). This suggests that RHGF-1 is not having any effects upon the muscles response to 
ACh.
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Figure 4.4. Levamisole sensitivity of rhgf-1 (ok880) mutant animals
Levamisole sensitivity displayed as percentage paralysis upon exposure to 100^iM 
levamisole.
Error bars show SEM.
4.5. Mutation of RHGF-1 suppressed GPA-12 (Q205L) mediated aldicarb 
hypersensitivity
Expression of constitutively active GPA-12 (Q205L) from either a heatshock promoter 
(Figure 3.3) or a cholinergic neuronal promoter p.unc-17 (Figure 3.7) caused an 
increase in sensitivity to aldicarb. In C. elegans RHGF-1 has been shown to interact 
specifically with active GPA-12 (Yau et al., 2003). It is possible that GPA-12 is activating 
RHO-1 via RHGF-1 in this pathway. When GPA-12 (Q205L) was expressed from the 
heatshock promoter, in the presence of deletion mutation rhgf-1 (ok880), strong 
suppression in aldicarb hypersensitivity was observed although it remained above wild 
type levels (Figure 4.5 A). The heatshock promoter had been shown to be slightly leaky 
such that there was a small increase in aldicarb sensitivity even in the absence of
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heatshock (Figure 3.3). This small hypersensitivity to aldicarb was also blocked by rhgf- 
1 (ok880) mutation (Figure 4.5 B).
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Figure 4.5. Aldicarb sensitivity of hs::GPA-12 with rhgf-1 (ok880) mutation
Aldicarb sensitivity of hs::gpa-12 (Q205L); rhgf-1 (ok880) in the presence (A) or 
absence (B) of heatshock.
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Expression of GPA-12 (Q205L) under the control of the unc-17 promoter, which is 
expressed in cholinergic cells, caused an increase in aldicarb sensitivity (Figure 3.7). 
This increase in sensitivity was suppressed by the rhgf-1 (ok880) mutation (Figure 4.6). 
The mutation rhgf-1 (ok880) alone caused a slight hypersensitivity to aldicarb that is 
comparable to that seen in p.unc-17::gpa-12 (Q205L); rhgf-1 (ok880) animals, 
suggesting rhgf-1 (ok880) completely suppressed the effect of neuronally expressed 
GPA-12 (Q205L) (Figure 4.6).
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Figure 4.6. Aldicarb sensitivity of neuronal GPA-12 (Q205L) with rhgf-1 
(ok880) mutation
Aldicarb sensitivity of p.unc-17::gpa-12 (Q205L); rhgf-1 (ok880).
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4.6. RHO-1 acted downstream of RHGF-1
If RHGF-1 regulates ACh release by activating RHO-1, then the loss of RHGF-1 in 
animals expressing constitutively active RHO-1 would be predicted to have no effect 
upon the release of ACh. Expression of constitutively active RHO-1 (G14V) from a 
heatshock promoter increased aldicarb sensitivity (McMullan et al., 2006). Expression of 
RHO-1 (G14V) in rhgf-1 (ok880) mutant animals caused an identical hypersensitivity to 
aldicarb when compared to RHO-1 (G14V) in a wild type background (Figure 4.7 A). In 
the absence of heatshock induced RHO-1 (G14V) expression rhgf-1 (ok880); hs::rho-1 
(G14V) animals had a small increase in aldicarb sensitivity comparable with animals 
containing the hs::RHO-1 (G14V) transgene in a wild type background (Figure 4.7 B).
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4.7. RHGF-1 was required in cholinergic motor neurons to mediate GPA-12 
(Q205L) induced hypersensitivity to aldicarb
To determine the site of action of RHGF-1 we used a cell specific promoter to rescue the 
rhgf-1 (ok880) mutation (Mello and Fire, 1995; Mello et al., 1991). The increase in 
aldicarb sensitivity caused by expression of GPA-12 (Q205L) under the control of the 
heatshock promoter was partially suppressed by the mutation rhgf-1 (ok880) (Figure
4.5). This suppression was rescued by expressing wild type RHGF-1 solely within the 
cholinergic motor neurons using the acr-2 promoter (N::RHGF-1) (Figure 4.8 A). A small 
increase in aldicarb sensitivity in hs::GPA-12 (Q205L) animals in the absence of 
heatshock was observed, which was entirely suppressed by mutation rhgf-1 (ok880) 
(Figure 4.5). An interesting observation is that expression of RHGF-1 in the cholinergic 
motor neurons fails to rescue this suppression of leaky GPA-12 (Q205L) by rhgf-1 
(ok880) (Figure 4.8 B).
4.8. Expression of RHGF-1 in cholinergic motor neurons was sufficient to 
increase ACh release
Expression of RHGF-1 in the cholinergic motor neurons at low levels (10ng/pJ) rescued 
the increased aldicarb sensitivity in response to GPA-12 (Q205L) in the presence of 
mutation rhgf-1 (ok880) (Figure 4.8 A). Microinjection of neuronally expressed RHGF-1 
at 10 times higher concentration (100ng/nl) (10 X N::RHGF-1) caused a constitutive 
increase in aldicarb sensitivity (Figure 4.9). 10 X N:::RHGF-1 caused an increase in 
aldicarb sensitivity in both the presence and absence of heatshock induced GPA-12 
(Q205L) expression (Figure 4.9 A and B). This suggests that there was a dose- 
dependent response between RHGF-1 levels and aldicarb sensitivity.
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Figure 4.9. Aldicarb sensitivity of neuronal RHGF-1 expressed at high 
levels
Aldicarb sensitivity of high level neuronal RHGF-1 (10 X N::RHGF-1) in the 
presence and absence of hs::GPA-12 (Q205L) induction.
(A) with heatshock.
(B) without heatshock.
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4.9. RHO-1 was required for RHGF-1 to increase aldicarb sensitivity
The increase in aldicarb sensitivity observed upon heatshock induced expression of 
GPA-12 (Q205L) is entirely blocked by inhibition of endogenous RHO-1 using heatshock 
expressed C3 transferase (Figure 3.9). If the effect of RHGF-1 upon ACh release were 
through regulation of RHO-1, expression of C3 transferase would be predicted to 
suppress N::RHGF-1 mediated aldicarb hypersensitivity. Expression of high levels of 
RHGF-1 in the cholinergic motor neurons (10 X N::RHGF-1) had no effect upon animals 
expressing C3 transferase under the control of a heatshock promoter (hs::C3T) (Figure 
4.10 A). RHGF-1 mediated aldicarb hypersensitivity was almost entirely suppressed by 
the inhibition of endogenous RHO-1.
4.10. Mutation of GPA-12 partially suppressed high level neuronal RHGF-1 
mediated aldicarb hypersensitivity
Expression of RHGF-1 in the cholinergic motor neurons at high levels (10 X N::RHGF-1) 
in the presence of the gpa-12 (pk322) mutation has a smaller effect upon aldicarb 
sensitivity than expression of 10 X RHGF-1 in hs::GPA-12 (Q205L) animals in the 
absence of heatshock (Figure 4.11). The ability of RHGF-1 to increase aldicarb 
sensitivity was reduced in gpa-12 (pk322) mutant animals, suggesting a requirement for 
GPA-12 to mediate the full effects of RHGF-1 upon ACh release.
The suppression of the increase in aldicarb sensitivity induced by 10 X N::RHGF-1 
expression in gpa-12 (pk322) animals compared to hs::GPA-12 (Q205L) animals could 
be caused by two differences. First, the difference could be caused by loss of the 
hs::GPA-12 (Q205L) transgene alone. Alternatively, it could be caused by the 
combination of the loss of the hs::GPA-12 (Q205L) transgene and the loss of wild type 
GPA-12 in gpa-12 (pk322) mutant animals. Comparison of expression of 10 X N::RHGF- 
1 in gpa-12 (pk322) animals or hs::C3T animals (which retain wild type GPA-12 but also 
lacks hs::GPA-12 (Q205L)) shows they have an almost identical aldicarb sensitivity 
(Figure 4.12). This suggests the difference in aldicarb sensitivity is due to the loss of the 
hs::GPA-12 (Q205L) transgene.
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Figure 4.10. Aldicarb sensitivity of animals expressing C3 transferase and 
high levels of neuronal RHGF-1
Aldicarb sensitivity of animals expressing high levels of RHGF-1 in cholinergic 
motor neurons (10 X N::RHGF-1) with C3 transferase under a heatshock promoter 
(hs::C3T).
(A) with heatshock.
(B) without heatshock.
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Figure 4.11. Aldicarb sensitivity of high levels of neuronal RHGF-1 in gpa- 
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Aldicarb sensitivity of high level of neuronal RHGF-1 (10 X N::RHGF-1) in the 
presence of GPA-12 null mutation gpa-12 (pk322).
All assays are without heatshock.
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4.11. RHGF-1 was needed for GPA-12 (Q205L) induced UNC-13 relocalisation
Expression of constitutively active GPA-12 caused relocalisation of YFP tagged UNC- 
13S to SNB-1 labelled sites of release, as shown by an increase in UNC-13S puncta 
(Figures 3.12 and 3.14). The mutation rhgf-1 (ok880) blocked the increase in UNC- 
13S::YFP puncta in response to heatshock induced GPA-12 (Q205L) expression 
(Figure 4.13 E and F). There is a statistically significant (p=0.01) decrease in UNC-13S 
puncta when GPA-12 (Q205L) is expressed in an rhgf-1 (ok880) mutant background 
(n=26) as opposed to wild type background (n=17) (Table 4.1 and figure 4.14). This 
result is consistent with activated GPA-12 altering UNC-13 localisation to sites of release 
via RHGF-1.
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rhgf-1 (ok880); 
UNC-13S::YFP - hsS microns
Figure 4.13. UNC-13 localisation in rhgf-1 (ok880) mutants with hs::gpa-12 
(Q205L)
(A -  G) Pictures showing UNC-13S::YFP localisation in dorsal nerve cord of wild 
type (A and B), hs::gpa-12 (Q205L) (C and D) and hs::gpa-12 (Q205L); rhgf-1 
(ok880) (E and F) before and after heatshock and rhgf-1 (ok880) (G) animals. 
Pictures have been colour coded to show fluorescence intensity with black being 
the least intense and white the most intense.
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Figure 4.14. Graph showing quantification of UNC-13S puncta
The number of puncta per 10pm was calculated by thresholding the pixel intensity 
of fluorescence and counting the number of spots above the threshold.
* indicates there is a significant difference between hs::gpa-12 (Q025L) before and 
after heatshock (p=0.01), and between hs::gpa-12 (Q205L) and hs::gpa-12 
(Q205L); rhgf-1 (ok880) both after heatshock (p=0.01) as determined by a two 
tailed t-test.
Numbers in brackets indicate the number of animals examined.
Error bars display SEM.
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without heatshock with heatshock
number puncta n number puncta n
wild type 1.85 ±0.19 11 1.94 ±0.12 11
hs::gpa-12 (Q205L) 1.84 ±0-12 18 2.29 ±0.13 17
hs::gpa-12 (Q205L); rhgf-1 
(ok880)
1.97 ±0.09 18 1.86 ±0.11 26
rhgf-1 (ok880) 1.77 ±0.08 10
Table 4.1. Quantification of UNC-13 puncta in animals with hs::GPA-12 
and rhgf-1 (ok880) mutation
Number of puncta per lO^m in the dorsal nerve cord ± SEM. 
n is the number of animals counted.
Mutation rhgf-1 (ok880) had no effect upon the number of UNC-13S puncta compared to 
wild type (p=0.98) (Figures 4.13 G, 4.14 and table 4.1). This mimics gpa-12 (pk322) 
mutation, which had no effect upon the number of UNC-13S puncta (Figure 3.12).
These results are consistent with the lack of changes in aldicarb sensitivity observed in 
these mutants (Figures 3.2 and 4.3).
4.12. Mutation of RHGF-1 had no effect upon synapse number or size
Expression of active GPA-12 caused UNC-13 to be relocalised to release sites labelled 
with a marker for synaptic vesicles, SNB-1 ::CFP (Figures 3.12 and 3.14). There was no 
change in the number of SNB-1 puncta or size of the puncta in response to constitutively 
active GPA-12 (Q205L) expression suggesting that GPA-12 increased ACh release at 
existing synapses (Figures 3.18 and 3.19). SNB-1 localisation was examined in animals 
expressing constitutively active GPA-12 (Q205L) with mutation rhgf-1 (ok880) and 
animals with mutation rhgf-1 (ok880) alone. CFP tagged SNB-1 was expressed under 
the acr-2 promoter to visualise the cholinergic motor neurons (Figure 4.15).
202
---- ,
Figure 4.15. SNB-1 localisation in rhgf-1 (ok880) mutant animals with 
hs::GPA-12 (Q205L)
Pictures showing p.acr-2::SNB-1::CFP localisation in the dorsal nerve cord of wild 
type (A and B), hs::gpa-12 (Q205L) (C and D) and hs::gpa-12 (Q205L); rhgf-1 
(ok880) (E and F) before and after heatshock and rhgf-1 (ok880) (G) animals. 
Pictures have been colour coded to show fluorescence intensity with black being 
the least intense and white the most intense.
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The number and size of SNB-1 puncta in rhgf-1 (ok880) mutant animals with and without 
hs:.GPA-12 (Q205L) were determined (Table 4.2 and figure 4.16). There was no 
significant change in the number of puncta in rhgf-1 (ok880) mutant animals containing 
hs::GPA-12 with (n=26) and without heatshock (n=18) (p=0.80) suggesting rhgf-1 
(ok880) did not suppress GPA-12 (Q205L) by decreasing the number of release sites. A 
reduction in the number of puncta in rhgf-1 (ok880) mutant animals was observed which 
is bordering on significance (p=0.05). Mutation rhgf-1 (ok880) (n=10) had no effect upon 
SNB-1 puncta size in wild type animals (n=11) (p=0.21). The increase in variability in 
puncta size upon expression of GPA-12 (Q205L) was lost in rhgf-1 (ok880) mutant 
animals.
Number of puncta /10jxm Size of puncta pm2
without
heatshock
with
heatshock
without
heatshock
with
heatshock
wild type 2.51 ±0.10(11) 2.48 ±0.11 
(12)
0.70 ±0.05 (11) 0.72 ± 0.05 
(12)
hs:: gpa-12* 2.56 ±0.11 (18) 2.49 ± 0.09 
(17)
0.77 ±0.06 (18) 0.86 ±0.10  
(17)
hs::gpa-12*; 
rhgf-1 (ok880)
2.54 ±0.09 (18) 2.58 ±0.10 
(26)
0.79 ±0.03 (18) 0.67 ± 0.03 
(26)
rhgf-1 (ok880) 2.27 ±0.04 (10) 0.72 ±0.07 (10)
Table 4.2. Quantification of number and size of SNB-1 puncta in rhgf-1 
(ok880) mutant animals
Table showing the number and size of SNB-1 puncta in the dorsal nerve cord of 
animals with rhgf-1 (ok880) mutation ± SEM.
Number of animals counted in brackets.
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Figure 4.16. Graphs of SNB-1 puncta number and size in rhgf-1 (ok880) 
mutant animals with and without hs::GPA-12 (Q205L)
Quantification of the number (A) and the size (B) of p.acr-2::SNB-1::CFP puncta.
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4.13. RHGF-1 expression did not cause or suppress GPA-12 (Q205L) mediated 
neuronal wiring defects
Examination of the cholinergic motor neurons using p.acr-2::GFP in animals expressing 
low levels of RHGF-1 under the acr-2 promoter revealed no defects in the gross 
morphological structure of these neurons at the light microscope level (Figure 4.17 C 
and D). Expression of RHGF-1 at high levels from the acr-2 promoter also caused no 
defects in the wiring of the cholinergic motor neurons (Figure 4.17 E and F).
To further test the site of action of GPA-12 transgenic animals expressing GPA-12 
(Q205L) under the promoter for acr-2 were made. These animals had defects in their 
motor neurons (Figure 4.18 B). Expression of GPA-12 (Q205L) under the acr-2 
promoter in the presence of rhgf-1 (ok880) mutation still caused defects in the 
cholinergic motor neurons (Figure 4.18 C). The motor neuron processes left the ventral 
nerve cord and failed to reach the dorsal nerve cord, travelling down the animal anterior 
to posterior outside the two nerve cords. Thus, the rhgf-1 (ok880) mutation failed to 
suppress the neuronal wiring defect in p.acr-2::gpa-12 (Q205L) animals.
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Figure 4.17. Gross morphology of the cholinergic motor neurons in animals 
expressing RHGF-1 under acr-2 promoter
p.acr-2::GFP\Nas used to visualise the cholinergic motor neurons in adult animals. 
Pictures were taken looking at the commissures travelling between the dorsal and 
ventral nerve cords.
(A and B) wild type without and with heatshock respectively.
(C and D) p.acr-2::rhgf-1 at low levels with hs::GPA-12 (Q205L) and rhgf-1 (ok880) 
without and with heatshock respectively.
(E and F) p.acr-2::rhgf-1 at high levels with hs::GPA-12 (Q205L) and rhgf-1 
(ok880) without and with heatshock respectively.
► Cell bodies in the ventral nerve cord.
—► Commissures crossing between dorsal and ventral cords.
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Figure 4.18. Cholinergic motor neurons in rhgf-1 (ok880) mutant animals 
expressing p.acr-2::gpa-12 (Q205L)
p.acr-2::GFP was used to visualise the cholinergic motor neurons in adult animals. 
Pictures were taken looking at the commissures travelling between the dorsal and 
ventral nerve cords.
(A) wild type
(B) p.acr-2::gpa-12*
(C) p.acr-2::gpa-12*; rhgf-1 (ok880)
► Cell bodies in the ventral cord.
 ► Commissures between dorsal and ventral cords.
 ► Mis-wired motor neurons.
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4.14. GPA-12 (Q205L) induced reduction of pharyngeal pumping, growth arrest 
or lengthening of the defecation cycle did not need RHGF-1
Expression of constitutively active GPA-12 or constitutively active RHO-1 (G14V) under 
the control of a heatshock promoter caused a reduction in pharyngeal pumping, growth 
arrest and a lengthening of the defecation cycle (Figures 3.22 and 3.26) (van der 
Linden et al., 2003) (Rachel McMullan personal communication). TPA-1, a protein 
kinase C, has been shown to be required for GPA-12 to cause all these phenotypes 
(Figures 3.22 and 3.26) (van der Linden et al., 2003). A protein potentially linking GPA- 
12 and RHO-1 in the regulation of pharyngeal pumping and defecation could be RHGF- 
1. The rhgf-1 (ok880) mutation did not cause a reduction in pharyngeal pumping in 
adults (Table 4.3 and figure 4.19 A). The reduction in pharyngeal pumping and 
extension in the length of the defecation cycle in response to GPA-12 (Q205L) 
expression was not suppressed by the rhgf-1 (ok880) mutation (Table 4.3 and figure 
4.19 A and B).
Constitutively active GPA-12 expression in larvae caused growth arrest which is thought 
to be directly linked to a reduction in feeding caused by reduced pharyngeal pumping 
(Figure 3.26) (van der Linden et al., 2003). Expression of GPA-12 (Q205L) in larval 
animals with the rhgf-1 (ok880) mutation caused growth arrest (Figure 4.20). The rhgf-1 
(ok880) mutation did not suppress the growth arrest induced by GPA-12 (Q205L).
Wild type
hs::gpa-12
(Q205L)
hs::gpa-12 
(Q205L); rhgf-1 
(ok880)
rhgf-1 (ok880)
Heatshock - + - + - + - +
Pumps/
min
219 ± 
13
260 ± 
11
166 ± 
29
15 ± 5
177 ± 
46
71 ±33
191 ± 
18
214 ± 
18
Defecation 
cycle (secs)
56 ±1 66 ±1 56 ±1 600 ± 0 60 ±1 600 ± 0
Tab
defe
Nurr 
to pE
e 4.3. Quantification of pharyngeal pumping rate and length of 
^cation cycle
tber of pharyngeal pumps/min and length of defecation cycle in seconds (pBoc 
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Figure 4.19. Rate of pharyngeal pumping and length of defecation cycle in 
hs::GPA-12 (Q205L) animals with mutation rhgf-1 (ok880)
(A) Rate of pharyngeal pumping displayed as pumps per minute.
(B) Length of defecation cycle displayed as seconds between pBoc phases of
consecutive cycles.
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Figure 4.20. Growth of hs::GPA-12 (Q205L) animals with rhgf-1 (ok880) 
mutation
Pictures taken 4 days after 20 L1 animals were transferred to a new plate either 
with or without heatshock.
211
4.15. An additional deletion mutation in RHGF-1
A second mutation in rhgf-1 allele gk217 had been isolated in strain VC430 by the C. 
elegans Vancouver knockout group. The genomic DNA and cDNA from strain VC430 
were made and gene rhgf-1 sequenced. The mutation rhgf-1 (gk217) was identified as 
an in-frame deletion beginning at amino acid 519 and ending at amino acid 549. This 
deletion encompasses the majority of the predicted C1 domain (Figure 4.21). C1 
domains are known to bind diacylglycerol (DAG) and phorbol esters. The significance of 
C1 domain in RHGF-1 is currently not known. The Drosophila melanogaster homologue 
of RHGF-1, DRhoGEF2, also contains a putative C1 domain the function of which is 
unknown.
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Figure 4.21. Structure of rhgf-1 (gk217) deletion mutant
rhgf-1 (gk217) deletion mutation is an in-frame deletion encompassing the C1 
domain.
Before backcrossing, strain VC430 had a strong resistance to aldicarb. This was lost 
upon backcrossing and is further characterised in chapter 5. After back crossing four 
times animals with the rhgf-1 (gk217) mutation had a decreased sensitivity to aldicarb 
contrasting with the slight increase in aldicarb sensitivity in rhgf-1 (ok880) mutant 
animals (Figure 4.22). This is consistent with the resistance to aldicarb observed by the 
inhibition of RHO-1 through the expression of C3 transferase. The transgene expressing
DH
PH
Ml
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wild type RHGF-1 under the acr-2 promoter (N::RHGF-1), which rescued the rhgf-1 
(ok880) mutation, failed to rescue the aldicarb resistance in animals with the rhgf-1 
(gk217) mutation (Figure 4.22). This suggests either a different mutation and not rhgf-1 
(gk217) is causing the observed resistance to aldicarb or that a there is a defect outside 
the motor neurons.
Figure 4.22. Aldicarb sensitivity of rhgf-1 (gk217) with and without wild type 
RHGF-1
Aldicarb sensitivity of rhgf-1 (gk217) with and without p.acr-2::rhgf-1.
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The sensitivity of the ACh receptors in the muscles in rhgf-1 (gk217) animals was tested 
using levamisole. Animals with mutation rhgf-1 (gk217) showed no difference in 
levamisole sensitivity, when compared to wild type animals (Figure 4.23). This suggests 
that the mutation causing the reduction in aldicarb sensitivity is not causing any change 
in the sensitivity of the ACh receptors in the muscle.
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Figure 4.23. Levamisole sensitivity of rhgf-1 (gk217) mutant animals
Levamisole sensitivity of rhgf-1 (gk217) animals displayed as percentage paralysis 
upon exposure to 100jxm levamisole.
4.16. Other RhoGEFs in the nervous system
There are 18 predicted RhoGEFs in the C. elegans genome. Most of them have not 
been studied and the majority are still not named. The aldicarb sensitivities of animals 
with the mutations in three different RhoGEFs have been assayed. Mutations in two 
RhoGEFS, uig-1 and tag-25 had no effect upon aldicarb sensitivity (Figure 4.24). 
Mutation of RhoGEF UNC-73, which exists in multiple isoforms, is lethal but this can be 
overcome through the expression of one isoform D1 that is expressed solely in the
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pharynx (Steven et al., 2005). Mutant animals expressing only the D1 isoform of UNC-73 
were resistant to aldicarb (Figure 4.24).
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Figure 4.24. Aldicarb sensitivity of other predicted RhoGEFs
Aldicarb sensitivity of animals with mutations in other predicted RhoGEFs.
4.17. Discussion and conclusions
4.17.1. RHGF-1 is required for GPA-12 to stimulate neurotransmitter release
In the previous chapter, the heterotrimeric G protein subunit G ai2 (GPA-12) was shown 
to stimulate neurotransmitter release. GPA-12 is hypothesised to activate RHO-1, 
leading to an increase in DAG levels at release sites through the inhibition of the enzyme
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diacylglycerol kinase 1 (DGK-1) (Figure 4.25). UNC-13 is then recruited to sites of 
release leading to an increase in ACh release. In mammalian systems, the activation of 
RhoA by Gai2 is achieved via the RGS RhoGEFS, which have an RGS domain, 
enabling an interaction with heterotrimeric G proteins. In C. elegans there is only one 
RhoGEF with an RGS domain called RHGF-1.
In this chapter RHGF-1 is shown to be required for GPA-12 to fully stimulate ACh 
release (Figure 4.25). The rhgf-1 (ok880) mutation strongly suppresses the increase in 
aldicarb sensitivity caused by the expression of GPA-12 (Q205L) under the control of 
both the heatshock promoter and the cholinergic unc-17 promoter. This suggests RHGF- 
1 is required for GPA-12 stimulated ACh release. Expression of GPA-12 (Q205L) causes 
a DAG-binding specific recruitment of UNC-13 to sites of ACh release. Expression of 
GPA-12 (Q205L) in rhgf-1 (ok880) mutants does not cause the relocalisation of UNC-13. 
No change in the number or size of SNB-1 labelled synapses in rhgf-1 (ok880) mutants 
is observed with or without GPA-12 (Q205L). The loss of UNC-13S relocalisation in 
response to GPA-12 (Q205L), with no change in the number or size of synapses in rhgf- 
1 (ok880) mutants, suggests RHGF-1 is required for GPA-12 to both recruit UNC-13 to 
synapses, and to increase ACh release. Expression of constitutively active RHO-1 
(G14V) causes identical increases in aldicarb sensitivity in the presence or absence of 
mutation rhgf-1 (ok880), suggesting that RHGF-1 is not needed for RHO-1 stimulated 
ACh release. This is consistent with RHGF-1 acting as an upstream activator of RHO-1 
to mediate ACh release.
The direct interaction between Ga12 and the RGS RhoGEF p115 RhoGEF observed in 
mammalian proteins is conserved in C. elegans (Yau et al., 2003). The interaction 
between GPA-12 and RHGF-1 (called CeRhoGEF) is dependent upon GPA-12 being 
activated (Yau et al., 2003). The activation of RHO-1 by RHGF-1 has been 
demonstrated, the DH-PH domain of RHGF-1 is sufficient to activate RHO-1 dependent 
signalling (Yau et al., 2003). Demonstration of the GPA-12/ RHGF-1 interaction and the 
activation of RHO-1 by RHGF-1 support the conservation of the Gai2/ RGS RhoGEF/ 
RhoA pathway in C. elegans. All these results support a model in which GPA-12 
activates RHO-1 via RHGF-1 causing an increase in DAG levels through the inhibition of 
DGK-1, relocalisation of UNC-13 and the release of ACh (Figure 4.25).
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Figure 4.25. RHGF-1 mediates the activation of RHO-1 by GPA-12
RhoGEF RHGF-1 activates RHO-1 in response to GPA-12 activation causing an 
increase in ACh release via the inhibition of DGK-1, an increase in DAG levels and 
the relocalisation of UNC-13 to sites of release.
The RHGF-1 homologue DRhoGEF2 in Drosophila is essential (Barrett et al., 1997). 
Mutation of DRhoGEF2 causes a defect in gastrulation during development resulting in 
lethality (Barrett et al., 1997). The survival of animals with the rhgf-1 (ok880) mutation 
suggests that DRhoGEF2 and RHGF-1 have different roles in Drosophila and C. elegans 
respectively.
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4.17.2. RHGF-1 is needed only within the cholinergic motor neurons to 
stimulate neurotransmitter release
Suppression of increased aldicarb sensitivity caused by GPA-12 (Q205L) expression 
from a heatshock promoter is rescued by the expression of RHGF-1 within the 
cholinergic motor neurons under the acr-2 promoter. This suggests that RHGF-1 is 
required in the cholinergic motor neurons to mediate the increase in ACh by GPA-12. 
Expression of RHGF-1 in the cholinergic cells at higher levels causes an increase in 
aldicarb sensitivity in the absence of heatshock induced GPA-12 (Q025L) expression, 
suggesting high level expression of RHGF-1 is causing constitutive ACh release. A 
dose-dependent relationship appears to exist between the level of expression of RHGF- 
1 and the resulting level of ACh release. The constitutive release by high levels of 
RHGF-1 is blocked by the inhibition of endogenous RHO-1, as shown by the complete 
suppression of the RHGF-1 mediated increase in aldicarb sensitivity by the expression 
of C3 transferase. This suggests that RHGF-1 is acting via RHO-1 to stimulate ACh 
release in the cholinergic motor neurons. Induced expression of constitutively active 
GPA-12 from the heatshock promoter slightly reduces the increase in aldicarb sensitivity 
in animals expressing high levels of RHGF-1. This could be caused by an auto-inhibitory 
feedback mechanism activated above certain threshold levels of GPA-12/ RHGF-1 
signalling inhibiting ACh release. The published co-expression of GPA-12 and RHGF-1 
in the motor neurons (Yau et al., 2003) and the above results support the hypothesis that 
at least one site of action of the GPA-12/ RHGF-1/ RHO-1 pathway controlling ACh 
release is within the cholinergic motor neurons.
There is a reduction in aldicarb sensitivity in animals expressing high levels of neuronal 
RHGF-1 in gpa-12 (pk322) animals compared to animals with the hs::GPA-12 (Q205L) 
transgene. Animals expressing high levels of RHGF-1 with the hs::C3T transgene and 
wild type GPA-12 have the same aldicarb sensitivity without heatshock as animals 
expressing high levels of RHGF-1 in gpa-12 (pk322) mutant background. This suggests 
that loss of hs::GPA-12 (Q205L) transgene is reducing the ability of RHGF-1 to stimulate 
ACh release. The hs::GPA-12 (Q205L) transgene is suspected to be leaky, thus even in 
the absence of heatshock low levels of GPA-12 (Q205L) may be being expressed (van 
der Linden et al., 2003). This suggests that the loss of GPA-12 (Q205L) reduces the 
increase in ACh mediated by RHGF-1 over expression, thus RHGF-1 requires GPA-12
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(Q205L) to have its full effects upon ACh release. Wild type RHGF-1 is being over 
expressed as opposed to a constitutively active form, therefore the requirement of 
additional proteins to activate RHGF-1 such as GPA-12, which is known to directly 
interact with RHGF-1, would not be unexpected. In mammals, the RHGF-1 homologue 
p115RhoGEF has been shown to interact with the GPA-12 homologue Ga13 via the RGS 
and DH domains. This interaction is critical for the GEF activity of the protein (Hart et al., 
1998; Kozasa et al., 1998; Wells et al., 2002). However, the ability of RHGF-1 to 
increase ACh release in gpa-12 (pk322) mutant suggests RHGF-1 has some RhoGEF 
activity even in the absence of GPA-12.
In the absence of heatshock, hs::GPA-12 (Q205L) animals exhibit a small increase in 
aldicarb sensitivity, possibly due to a leaky heatshock promoter, which is not rescued by 
expression of RHGF-1 under the acr-2 promoter. This could be due to leaky expression 
of GPA-12 (Q205L) outside the cholinergic motor neurons being able to increase ACh 
release. The difference in the ability of low and high levels of neuronal RHGF-1 to 
stimulate ACh release suggests a dose dependency between RHGF-1 and ACh release. 
It is possible that the low level of neuronal RHGF-1 is insufficient to rescue the small 
amount of GPA-12 (Q205L) being expressed by the leaky heatshock promoter. 
Potentially, a higher level of neuronal RHGF-1 would rescue the aldicarb hypersensitivity 
of GPA-12 (Q205L) in the presence and absence of heatshock.
4.17.3. Mutation rhgf-1 (ok880) does not completely suppress GPA-12 
(Q205L) mediated ACh release
The aldicarb hypersensitivity observed in response to hs::GPA-12 (Q205L) is not entirely 
suppressed by the rhgf-1 (ok880) mutation. It is not known if the rhgf-1 (ok880) deletion 
mutation is a null mutation. In the mammalian RGS RhoGEF, p115RhoGEF, the region 
N-terminal to the DH domain that contains the RGS domain has been shown to be 
important to facilitate the GEF activity of the protein (Hart et al., 1998; Kozasa et al.,
1998). Both the RGS domain and the DH domain are required for the binding and 
activation of p115RhoGEF by Ga13 (a member of the Ga12 family in mammals) (Wells et 
al., 2002). The rhgf-1 (ok880) mutation deletes the start of the DH domain and the region 
immediately preceding it, but all other domains remain intact including the RGS domain. 
The role and importance of these domains is currently unknown. It is possible that the
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truncated form of the protein is still able to signal via these other domains in response to 
high levels of GPA-12 (Q205L) to stimulate ACh release. The lack of complete 
suppression by rhgf-1 (ok880) on GPA-12 mediated ACh release suggests that GPA-12 
(Q205L) may be acting via additional pathways, independent of RHGF-1, to increase 
ACh release. Such pathways would not be suppressed by mutation of RHGF-1 
explaining the incomplete suppression observed. It would have been interesting to 
examine ACh release in rhgf-1 (gk217) mutant animals (which have an in-frame deletion 
of the C1 domain), but the presence of an additional closely linked mutation prevented 
this. It would also be interesting to examine ACh release in a true rhgf-1 null animal.
4.17.4. RHGF-1 is not involved in neuronal wiring
Expression of GPA-12 in the cholinergic motor neurons from the acr-2 promoter caused 
an increase in aldicarb sensitivity but also defects in the gross morphology of the 
cholinergic motor neurons. These defects were not suppressed when expressing p.acr- 
2::gpa-12 (Q205L) in rhgf-1 (ok880) mutant animals. Expression of RHGF-1 at low levels 
from the acr-2 promoter restores the GPA-12 (Q205L) mediated increase in ACh release 
suppressed by rhgf-1 (ok880), but does not lead to defects in the cholinergic motor 
neurons. Expression of RHGF-1 from the acr-2 promoter at high levels causes a 
constitutive increase in ACh release similarly to the expression of GPA-12 (Q205L) from 
the acr-2 promoter. However, expression of RHGF-1 at high levels does not cause the 
motor neuron defects observed in animals expressing constitutively active GPA-12 from 
the acr-2 promoter. The lack of defects in the gross morphology of the motor neurons 
after over expression of RHGF-1 from the acr-2 promoter, and lack of suppression of the 
GPA-12 (Q205L) induced defects in rhgf-1 (ok880) mutant animals, suggest RHGF-1 is 
not involved in the pathway by which GPA-12 regulates neuronal wiring. It should be 
remembered that an important dose-dependent response between the levels of RHGF-1 
and the levels of ACh release has been observed. It is possible higher levels of RHGF-1 
expression under the acr-2 promoter could cause neuronal wiring defects or conversely 
lower levels of GPA-12 (Q205L) under the acr-2 promoter might not cause these 
defects. An important difference between the proteins being expressed is that GPA-12 
(Q205L) is constitutively active whilst RHGF-1 is wild type. However, the higher level of 
expression of RHGF-1 under the acr-2 promoter is sufficient to cause constitutive ACh
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release suggesting the levels of wild type protein being expressed are capable of the 
induction of RHGF-1 signalling pathways.
4.17.5. RHGF-1 is not involved in the regulation of pharyngeal pumping or 
the length of the defecation cycle by GPA-12
Expression of GPA-12 in all cell types under the control of a heatshock inducible 
promoter causes a reduction in pharyngeal pumping, a lengthening of the defecation 
cycle and growth arrest (van der Linden et al., 2003). The growth arrest is hypothesised 
to be caused by a lack of feeding resulting from the reduction in pharyngeal pumping 
(van der Linden et al., 2003). Neither the reduction in pharyngeal pumping and related 
growth arrest nor the lengthening of the defecation cycle is suppressed by the mutation 
rhgf-1 (ok880). This suggests that RHGF-1 is not involved in the pathways controlling 
pharyngeal pumping and defecation, thus GPA-12 activates different pathways in 
different cell types. GPA-12 activates ACh release via RHGF-1 in the cholinergic motor 
neurons, whilst activating pumping via TPA-1 in the pharyngeal muscle (van der Linden 
et al., 2003). It would be interesting to test if TPA-1 is required for the neuronal 
morphology defect caused by p.acr-2::gpa-12 (Q205L).
4.17.6. Mutation rhgf-1 (gk217) is not the cause of aldicarb resistance
Another mutation in RHGF-1 has been identified, called rhgf-1 (gk217), which deletes 
the C1 domain but retains the DH and PH domains known to be required for GEF 
activity. Animals with rhgf-1 (gk217) have a decrease in aldicarb sensitivity compared to 
wild type animals, suggesting a reduction in ACh release. However, the decrease in 
aldicarb sensitivity of rhgf-1 (gk217) mutant animals was not rescued upon expression of 
wild type RHGF-1 in the motor neurons. This suggests either an additional closely linked 
mutation in rhgf-1 (gk217) animals is causing the resistance to aldicarb, or RHGF-1 has 
a role in cells other than the cholinergic motor neurons to regulate ACh release. All other 
experiments using rhgf-1 (ok880) mutant animals have pointed to an important role in 
the cholinergic motor neurons to regulate ACh release. Therefore, it is more likely an 
additional mutation in a gene other than rhgf-1 is causing the aldicarb resistance in strain 
VC430.
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4.17.7. Other RhoGEFs regulate ACh release
Similarly to mutation gpa-12 (pk322), rhgf-1 (ok880) mutant animals exhibit no changes 
in ACh release. The gpa-12 (pk322) mutation removes the majority of the gene resulting 
in a predicted null mutation, whilst rhgf-1 (ok880) only removes part of the DH domain, 
although this is likely to result in the protein being unable to fulfil its GEF activity to 
activate RHO-1. This suggests that the GEF activity of RHGF-1 is not required under 
normal laboratory conditions to mediate ACh release. The inhibition of endogenous 
RHO-1 through the expression of C3 transferase causes a decrease in ACh release.
This suggests that RHO-1 is being activated by alternative mechanisms under laboratory 
conditions.
One potential additional activator of RHO-1 is the RhoGEF UNC-73. The unc-73 gene 
encodes at least 8 different protein isoforms expressed in a variety of different tissues. It 
has two GEF domains; one of which is a Rac-specific GEF (RhoGEFI), and the other a 
Rho-specific GEF (RhoGEF2). The null mutant is lethal, but rescue with different 
isoforms has allowed study of these RhoGEF domains. Crucial to survival is the 
expression of isoform D1 or D2, which are required in the pharynx. Studies using 
animals expressing the D1 isoform have determined that isoforms C1, C2, E and F act 
redundantly in the nervous system to control locomotion (Steven et al., 2005). Animals 
expressing only the D1 isoform of UNC-73 have a reduction in their sensitivity to 
aldicarb. This is consistent with the previously observed lethargic locomotion (Steven et 
al., 2005). A large scale RNAi screen for regulators of ACh release has also suggested 
RhoGEF GEI-18 is required for ACh release (Sieburth et al., 2005).
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5. Results: Identification of a New Mutation Affecting Acetylcholine Release
5.1. Introduction
Two classes of motor neurons mediate stimulation of the body wall muscles enabling 
locomotion in C. elegans. First, the stimulatory neurons that release ACh into the 
synaptic cleft, activating ACh receptors in the muscle, and causing contraction. The 
second class of motor neurons is the inhibitory GABAergic neurons, which release 
GABA into the synaptic cleft, activating GABA receptors in the muscle, causing 
relaxation. Antagonistic activation and relaxation of the body wall muscles, by the 
cholinergic and GABAergic motor neurons respectively, facilitate the bending of the body 
and thus normal locomotion (Mclntire et al., 1993b). Many proteins involved in the 
release of ACh and GABA by the motor neurons have been identified through screens 
looking at the locomotion and aldicarb sensitivity of the animals (Brenner, 1974; Lackner 
et al., 1999; Maruyama and Brenner, 1991; Miller et al., 1996; Nguyen et al., 1995; 
Nurrish et al., 1999; Sieburth et al., 2001). Exposure to aldicarb, an inhibitor of ACh 
esterase, causes hyper contraction of the muscles observed as paralysis and eventual 
death of the animals (Nguyen et al., 1995). Changes in sensitivity to aldicarb are 
observed in animals with defects in the release of ACh and GABA by the motor neurons 
and defects in neuropeptide release and muscle sensitivity (Loria et al., 2004; Miller et 
al., 1996). Therefore, genes, which when mutated cause a change in aldicarb sensitivity, 
are extremely interesting and are likely to have roles in neurotransmission.
5.2. An additional mutation in strain VC430 causes strong aldicarb resistance
Mutations in strain VC430 were generated by exposure to trimethylpsoralen (TMP) and 
UV, which typically cause multiple short deletions, including a mutation in RhoGEF rhgf- 
1 called gk217. The strain showed strong resistance to aldicarb. After backcrossing 
through wild type animals four times following the aldicarb resistance phenotype, to 
remove additional mutations, the mutation rtigf-1 (gk217) was lost. This indicated an 
alternative mutation was causing the aldicarb resistance phenotype, which we named 
nz90 (Figure 5.1). Animals with rhgf-1 (gk217) mutation were slightly resistant to 
aldicarb, whilst those with both nz90 and rhgf-1 (gk217) were strongly resistant, and 
those with nz90 alone even more resistant. Further analysis of rhgf-1 (gk217) mutant
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animals has shown the slight reduction in aldicarb sensitivity is probably caused by 
another mutation in a gene closely linked to RHGF-1 (Figure 4.22).
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Figure 5.1. Aldicarb sensitivity of rhgf-1 (gk217) and nz90 mutations
Aldicarb sensitivity of strain VC430 backcrossed with wild type animals containing 
mutations rhgf-1 (gk217), nz90 or both. Displayed as percentage paralysis upon 
exposure to 1mM aldicarb for 0-100 minutes.
Error bars on all graphs display standard error of mean (SEM).
5.3. Mutation nz90 caused resistance to trichlorfon
Aldicarb acts as an ACh analogue to inhibit ACh esterases (Figure 5.2). An alternative 
drug which also inhibits ACh esterases and has been used to examine ACh release at 
the NMJ in C. elegans is trichlorfon (Figure 5.2) (Nguyen et al., 1995). Exposure to 
trichlorfon will cause a build up of ACh in the synaptic cleft at the NMJ, which will lead to 
enhanced stimulation of the ACh receptors in the muscles, hypercontraction and
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eventual paralysis (Nguyen et al., 1995). Mutations that reduce the release of ACh 
confer resistance to both aldicarb and trichlorfon, such as unc-13 and unc-17 (Nguyen et 
al., 1995). Animals with mutation nz90 are resistant to trichlorfon, as are animals with a 
null mutation in egl-8, a gene known to be involved in the release of ACh (Figure 5.3) 
(Lackner et al., 1999; Miller et al., 1999). This suggests mutation nz90 did not 
specifically alter the effects of aldicarb upon ACh esterases.
Figure 5.2. Chemical structure of ACh, aldicarb and trichlorfon
The chemical structure of aldicarb is very similar to ACh, whilst trichlorfon has a 
different chemical structure.
Taken from Nguyen et al 1995.
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Figure 5.3. Trichlorfon sensitivity of animals with nz90 mutation
The percentage of animals paralysed upon exposure to 1mM trichlorfon over 0-80 
minutes was recorded.
The error bars show SEM
5.4. Levamisole sensitivity was unchanged in nz90 mutant animals
Changes in the sensitivity of the ACh receptors in the muscle could cause changes in 
aldicarb sensitivity. The sensitivity of animals to the drug levamisole, an agonist of 
nicotinic ACh receptors, can be used as a measure of the sensitivity of the ACh 
receptors in the muscle, as measured by percentage paralysis over time. An increase in 
the sensitivity of the receptors in the muscle would cause an increase in the rate of 
paralysis, conversely a decrease in receptor sensitivity would cause a decrease in the 
rate of paralysis. No change in the rate of paralysis and levamisole sensitivity was 
observed in nz90 mutant animals (Figure 5.4).
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Figure 5.4. Levamisole sensitivity of nz90 mutant animals
Levamisole sensitivity of nz90 mutant animals displayed as percentage paralysis 
upon exposure to 100pM levamisole for 0-100 minutes.
5.5. Treatment with phorbol esters caused aldicarb hypersensitivity in nz90 
mutant animals
Phorbol esters (phorbol-12-myristate-13-acetate (PMA)) are an analogue of 
diacylglycerol (DAG). They directly bind to C1 domains, activate DAG-binding proteins, 
and have been shown to enhance neurotransmitter release at many synapses (Malenka 
et al., 1986; Segal, 1989; Stevens and Sullivan, 1998). Phorbol esters strongly stimulate 
ACh release in C. elegans, thus causing a strong aldicarb hypersensitivity phenotype 
(Lackner et al., 1999). Phorbol esters were still able to cause aldicarb hypersensitivity in 
the nz90; rhgf-1 (gk217) double mutant animals, although there was a slight reduction in 
the aldicarb hypersensitivity compared to wild type animals (Figure 5.5).
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Figure 5.5. Aldicarb sensitivity after treatment with phorbol esters
Aldicarb sensitivity after treatment with 2ng/ml PMA for 2 hours.
5.6. Mutation nz90 did not affect neuronal wiring
Defects in neuronal wiring are a potential cause of resistance to aldicarb (Loria et al., 
2003; Loria et al., 2004). The excitatory cholinergic motor neurons in nz90 mutant 
animals were visualised using p.acr-2::GFP transgene. The commissures connecting the 
dorsal and ventral nerve cords were examined and no defects were found (Figure 5.6 
B). The inhibitory GABAergic motor neurons were visualised using p.unc-47::GFP. UNC- 
47 is a transmembrane vesicular GABA transporter that is expressed in all GABAergic 
neurons including the dorsal and ventral cord motor neurons (Mclntire et al., 1997).
Thus, the promoter for unc-47 can be used to express proteins in the GABAergic
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neurons. No defects in the GABAergic motor neurons and their commissures are visible 
in nz90 mutant animals (Figure 5.6 D).
D
nz90
Figure 5.6. The gross neuronal morphology of nz90 mutant animals
Pictures showing the commissures between the dorsal and ventral cord for 
cholinergic (A and B) and GABAergic (C and D) motor neurons.
Ventral nerve cord is on the left-hand side
► Cell body in ventral nerve cord.
 ► Commissure linking dorsal and ventral nerve cords.
5.7. Mutation nz90 caused no defect in the defecation cycle
Defecation is another behaviour controlled by motor neurons. Mutations in genes 
involved in neurotransmission such as egl-8 cause defects in defecation, egl-8 mutants 
have an absent or very weak pBoc phase, and in some cases a defect in Exp, but there 
is no increase in the overall length of the cycle (Thomas, 1990). The defecation cycle, 
defined as the time taken between pBoc phases (contraction of the posterior body wall
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muscles) of consecutive cycles, is unchanged in nz90 mutant animals, the average cycle 
length is 53.4 ± 0.7 (SEM) for nz90 mutant animals and 55.6 ±1.1 (SEM) for wild type 
animals (Figure 5.7).
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Figure 5.7. Length of defecation cycle in nz90 mutant animals
Length of defecation cycle quantified as time taken between pBoc phases in
consecutive cycles.
Error bars display SEM.
5.8. UNC-13 localisation is changed in nz90 mutant animals
The DAG binding protein UNC-13, which is involved in neurotransmission, exists in 
many isoforms. The longest form UNC-13L is constitutively localised to synapses. Under 
normal conditions, the shortest form UNC-13S is found diffusely spread throughout the 
neuron. It is recruited to synapses in response to high neuronal activity to increase 
synaptic vesicle priming and neurotransmitter release (Lackner et al., 1999; Miller et al.,
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1999; Nurrish et al., 1999). Increases in ACh release caused by mutation of GOA-1 
(Ga0) or constitutively active RHO-1 (G14V) expression lead to a change in the 
localisation of the DAG-binding protein UNC-13S (McMullan et al., 2006; Nurrish et al., 
1999). The localisation of UNC-13 in nz90 mutants was determined using an YFP 
tagged form of UNC-13S. Over expression of UNC-13S has been shown to be sufficient 
to restore wild type levels of ACh release in UNC-13 mutant animals (Nurrish et al.,
1999). UNC-13S localisation in the dorsal cord motor neurons was examined (Figure 
5.8 A and B). Quantification of UNC-13 puncta revealed a significant decrease in the 
number of puncta (two tailed t-test p=0.008) (Table 5.1 and Figure 5.8 C).
5.9. Mutation nz90 caused a decrease in the number of SNB-1 puncta
Changes in aldicarb sensitivity could be caused by changes in the number of synapses. 
SNB-1 is a membrane-bound protein found in the synaptic vesicle membrane, p.acr- 
2::SNB-1::CFP was used to examine the synapses in the cholinergic motor neurons in 
nz90 mutant animals (Figure 5.9 A and B). There was a significant decrease in the 
number of SNB-1 puncta in nz90 animals compared to wild type animals (p=0.001) 
(Table 5.1 and figure 5.9 C). The ratio of UNC-13S:SNB-1 puncta is almost identical in 
wild type and nz90 mutant animals, suggesting a decrease in synapse number as 
opposed to a specific change in UNC-13 localisation (Table 5.1).
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Figure 5.8. UNC-13S puncta in nz90 mutant animals
(A and B) Pictures of UNC-13S::YFP localisation in dorsal nerve cord.
(C) Quantification of number of puncta per 10 microns calculated by thresholding 
the pixel intensity of fluorescence and counting the number of spots above the 
threshold. * a significant difference is observed (two tailed t-test p=0.008).
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Figure 5.9. Number of SNB-1 puncta in nz90 mutant animals
(A and B) Pictures of p.acr-2::SNB-1 ::CFP localisation in dorsal nerve cord.
(C) Quantification of number of puncta per 10pm, calculated by thresholding the 
pixel intensity of fluorescence and counting the number of spots above the 
threshold. * a significant difference is observed two tailed t-test p=0.001.
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wild type nz90
UNC-13S puncta/IO^im 1.84 ±0.12 (18) 1.32 ± 0.12 (11)
SNB-1 puncta/10pm 2.51 ±0.10(11) 1.84 ± 0.15 (11)
Ratio UNC-13S:SNB-1 
puncta
0.73 0.72
Table 5.1. UNC-13S and SNB-1 puncta in nz90 mutant animals
Quantification of the number of UNC-13S and SNB-1 puncta in animals with 
mutation nz90.
Number of animals counted shown in brackets.
5.10. Partial co-localisation of UNC-13 and SNB-1 was observed in nz90 mutant 
animals
SNB-1 is a membrane bound protein enriched within the synaptic vesicle membrane. 
The localisation of UNC-13S is altered in response to DAG levels. Under normal 
conditions it is found diffusely spread along the neuron and is recruited to the synapse in 
response to increased DAG levels (Nurrish et al., 1999). In wild type animals there is a 
partial co-localisation between UNC-13S::YFP and p.acr-2::SNB-1 ::CFP in the dorsal 
cord. At some synapses they are found together whilst at other synapses, defined by 
SNB-1 puncta, no UNC-13S is found and conversely UNC-13S is found in other non- 
synaptic regions of the neuron. The same partial co-localisation is found in nz90 mutant 
animals (Figure 5.10).
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Figure 5.10. Co-localisation of UNC-13S::YFP and SNB-1::CFP
UNC-13S::YFP (green) and p.acr-2::SNB-1 ::CFP (red). Merged two images at 
bottom. Dorsal nerve cord is shown.
► UNC-13S ► SNB-1 UNC-13S and SNB-1
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5.11. No defects in the post-synaptic compartment have been identified in nz90 
mutant animals
Two ACh receptors have been identified in the body wall muscles. The first is levamisole 
sensitive and is composed of five subunits, including three essential ones, UNC-38, 
UNC-63 and UNC-29, and two non-essential ones, LEV-1 and LEV-8 (Culetto et al., 
2004; Fleming et al., 1997; Richmond and Jorgensen, 1999; Towers et al., 2005). The 
second ACh receptor is levamisole insensitive and includes the essential subunit ACR- 
16, but the remaining structure is unknown (Touroutine et al., 2005). Both receptors are 
ligand-gated ion channels. Changes in the clustering of the UNC-38, LEV-1, UNC-29 
AChR have been identified in mutants where an extremely small change in sensitivity to 
the nicotinic AChR agonist levamisole has been observed (Gaily et al., 2004).
The clustering of the levamisole sensitive AChR has been examined in nz90 mutant 
animals. An UNC-38 specific antibody was used to examine the localisation of the AChR 
in the body wall muscles. Double immuno-labelling was performed using an UNC-17 
specific antibody, labelling the synaptic vesicles in the presynaptic motor neurons. No 
change in the localisation and clustering of UNC-38 was observed in nz90 mutant 
animals, co-localisation with UNC-17, the pre-synaptic marker, was retained (Jean-Louis 
Bessereau, personal communication).
5.12. snip-SNP mapping of mutation nz90
Two strains of C. elegans have been isolated, one called N2 collected in Bristol, UK and 
the other called CB4856 collected in Hawaii, USA. They are the same species but have 
been isolated from each other for a long period of time and thus have accumulated 
single nucleotide polymorphisms (SNPs) in their genomes. These can be used to map 
mutations (Koch et al., 2000). In certain cases the SNP will remove or create a 
restriction site in CB4856 compared to N2: these are called snip-SNPs. Thus, by 
amplifying the DNA surrounding the snip-SNPs by PCR, and digestion with the 
respective restriction enzyme, the origin of the DNA in that region of the genome can 
quickly be determined to be from an N2 or CB4856 strain. Mutation nz90 was generated 
in an N2 background. Thus, crossing nz90 mutant animals with strain CB4856 and 
following the nz90 mutant phenotype of aldicarb resistance will retain snip-SNPs of an
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N2 background in the region close to the mutation nz90, following the theory of genetic 
linkage.
The genotypes of 8 snip-SNPs on each chromosome were determined using pooled 
DNA isolated from 30 different homozygous nz90 strains that had been crossed with 
CB4856 at least 4 times (Figure 5.11). Chromosomes IV and V had 4 and 3 snip-SNPs 
with an N2 genotype respectively as shown in the gel in Figure 5.12.
Figure 5.11. snip-SNP locations
Diagram showing location of snip-SNPs taken from (Davis et al., 2005). 
Roman numerals indicate chromosomes.
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Figure 5.12. Analysis of 8 snip-SNPs on all chromosomes
Picture of agarose gel and interpreted genotypes of snip-SNPs on all 
chromosomes. nz90 loaded in first lane, CB4856 control loaded in second lane for 
each pair. The chromosome is indicated by roman numerals. 
snip-SNP genotypes: N2 - blue
CB4856 - red 
N2 and CB4856 - purple 
*snip-SNPs in black could not be genotyped.
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Upon repeated examination of the snip-SNPs 7 out of 8 on chromosome IV were either 
CB4856 or both N2 and CB4856 (Figure 5.13). On chromosome V snip-SNPs V4to V8 
were N2, suggesting mutation nz90 is on chromosome V between V4 and V8 (Figure 
5.13).
5.13. Mutation nz90 lies within a small region in the centre of chromosome V
To more precisely define the location of mutation nz90 DNA extracted from 80 nz90 
animals, which had been crossed with CB4856 at least 8 times, was not pooled but 
tested individually. The use of individual animals enables the proportion of animals with 
each genotype to be determined. snip-SNPs closely linked to the mutation nz90 will 
have a very low proportion of animals with CB4856 DNA, whilst those further away will 
have a high proportion of animals with CB4856 DNA. An example of the agarose gel run 
after analysis of a single snip-SNP when analysing individual animals is shown in Figure
5.14.
snip-SNPs between positions V:4.64 and V:6.89 gave the lowest proportion of animals 
with CB4856 DNA (Figure 5.15 B). 8 different strains were identified to have CB4856 
DNA in this region (Figure 5.15 C). snip-SNP AH10 [6], at position V:6.24, gave a 
surprisingly high proportion of strains with CB4856 DNA (7 from 76) but further analysis 
of the strains revealed that 4 strains had N2 DNA flanking this region on both sides, 
suggesting that this snip-SNP was giving incorrect results (Figure 5.15 C). Further 
verified snip-SNPs and one SNP (CE5-217), which was analysed by sequencing, were 
tested in the region between V:4.64 and V:6.62 using the only four strains that contained 
CB4856 DNA within this region. A short region between V:5.84 and V:6.41 was N2 in all 
four strains suggesting that mutation nz90 lay within this section of chromosome V 
(Figure 5.15 C).
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Figure 5.13. Repeated analysis of snip-SNPs on chromosomes IV and V
Picture of agarose gel and interpreted result from snip-SNP mapping on 
chromosomes IV and V. Each snip-SNP was done in triplicate pairs. nz90 loaded 
in first lane, CB4856 control in second lane for each pair. 
snip-SNP genotypes: N2 - blue
CB4856 - red 
N2 and CB4856 - purple 
*snip-SNPs in black could not be genotyped.
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a a
Figure 5.14. Gel showing snip-SNP pkP5129 using individual animals
All lanes used DNA from different individual nz90 backcrossed animals. 
Band sizes: N2 475bp
CB4856 288bp and 127bp
11 out of 76 animals have CB4856 DNA.
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A  -17  -13  .5 0 .55  5.84 9 .96  13 18
v  I I 1-------------1---------------i-----------  ---------- 1----------- 1---------
N2 N2 ? N2 N2 N2 N2 N2
C B 4856  C B 4856
B  0 .55  3.37  4 .64  5 .84  6.24  6.41 6.62  6.89  9.96
PKP5097 pKP5067 pkP 5089  pkP 5125  A H 10[6] pkP5086 pkP 5085  pkP 5084  pkP 5129
1 3 / 6 9  1 2 / 6 2  7 / 7 2  2 / 6 9  7 / 7 6  3 / 3 3  3 / 7 4  3 / 6 3  8 / 7 4
4 .64  4 .73  5.11 5.84 6 .24  6.28 6 .30  6.41 6 .62  6.89
pkP 5089  p kP 5090  pkP 5069  pkP 5125  A H 10(6] p kP 5087C E 5-217  pkP 5086  pkP 5085  pkP 5084
Strain 1 C B 4856 C B 4 8 5 6 C B 4856 C B 4856 C B4856 N2 N2 N2 ♦
C B 4856
N2 ♦  
C B 4856
N2 ♦
C B 4856
Strain 2 C B 4856 C B 4 8 5 6 C B 4856 C B 4856 C B4856 N2 N2 N2 ♦
C B 4856
N2 ♦  
C B 4856
N2 ♦
C B 4856
Strain 3 C B 4856 N2 N2 + 
C B 4856
C B 4856 N2 N2
Strain 4 N2 N2 N2 N2 N2 ♦  
CB 4856
N2 ♦ 
C B 4856
N2 ♦
C B 4856
Strain 5 N2 ♦ 
C B 4856
N2 C B 4856 N2 N2
Strain 6 N2 N2 CB 4856 N2 N2
Strain 7 N2 N2 CB 4856 N2 N2 N2
Strain 8 N2 N2 C B 4856 N2 N2 N2
Figure 5.15. Mutation nz90 lies between positions 5.85 and 6.41 on 
chromosome V
(A) snip-SNPs on chromosome V suggest mutation nz90 lies between positions 
V:0.55 and V:18.
(B) Analysis of individual strains at positions V:0.55, V:5.84 and V:9.96 suggests 
mutation nz90 lies within this region. Further snip-SNPs are analysed and the 
region with the lowest proportion of strains with CB4856 DNA is between V:4.64 
and V:6.89.
(C) The genotypes of individual strains at the snip-SNPs between V:4.64 and 
V:6.89 are determined. Two strains have CB4856 DNA throughout this region and 
further snip-SNPs and SNPs are examined to define a region between V:5.84 and 
V:6.41 in which these strains have N2 DNA. Mutation nz90 is therefore predicted 
to lie within this region (shown in pink).
* Data suggests AH10[6] snip-SNP was not reliable.
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5.14. Cosmid and fosmid rescue of nz90 aldicarb resistance
The genetic map distance V:5.85 to V:6.43 represents 563kb of DNA. Small fragments 
covering almost the entire C. elegans genome have been cloned into plasmids called 
cosmids or fosmids. Twenty one cosmids and fosmids covering the entire region defined 
as the location for mutation nz90 by snip-SNP mapping (V:5.85 to V:6.43) were identified 
and their DNA purified (Figure 5.16).
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Figure 5.16. Cosmids and Fosmids covering the location of nz90 
determined by snip-SNP mapping
Over-lapping cosmids and fosmids covering the genome between snip-SNPs 
pkP5125 and pkP5086.
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Figure 5.17. Aldicarb sensitivities of nz90 animals injected with cosmids 
and fosmids
Aldicarb sensitivity displayed as percentage paralysis upon exposure to 1mM 
aldicarb for 130 minutes.
Error bars show SEM
All cosmids and fosmids were injected into nz90 animals either in small groups or 
individually, and the aldicarb sensitivity of the transgenic animals recorded. 
Microinjection of cosmid T02B5 into nz90 animals restored the aldicarb sensitivity to 
almost wild type levels (Figure 5.17). No strong rescue was seen with any other 
cosmids or fosmids (Figure 5.17).
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5.15. Rescuing cosmid T02B5 encodes 4 genes
Cosmids and fosmids contain more than one predicted gene. Cosmid T02B5 contains 
DNA predicted to encode 4 genes. T02B5.1, T02B5.2, T02B5.3 and T02B5.4 (Figure 
5.18).
T02B5.4 T02B5.2
T02B5.3 srf-26  T02B5.1 ocam-1..... - * ,--L 1 ....... .
Cosmid T02B5
Figure 5.18. T02B5 encodes 4 genes
Structure of cosmid T02B5 that encodes four genes.
The genomic DNA for all the predicted genes was individually amplified or subcloned 
from the cosmid and injected into nz90 animals. No restoration to wild type aldicarb 
sensitivity was observed after injection of genes srd-26 (T02B5.4) and ocam-1 (T02B5.2) 
(Figure 5.19). A significant increase in aldicarb sensitivity was observed after injection of 
T02B5.1 in one of two lines, only slight rescue was seen in the second transgenic line. 
The difference in the degree of rescue between the two lines could be due to differences 
in the level of expression of the transgene. Significant rescue was also seen in nz90 
mutant animals injected with T02B5.3 (Figure 5.19). The rescue by T02B5.1 and 
T02B5.3 suggests mutation nz90 affects one of these genes.
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Figure 5.19. Aldicarb sensitivity of nz90 mutant animals expressing 
individual genes on cosmid T02B5
Aldicarb sensitivity displayed as percentage paralysis upon exposure to 1mM 
aldicarb for 130 minutes.
All assays for animals with T02B5.3 had 80% paralysis.
Error bars show SEM.
* no significant paralysis was observed.
5.16. T02B5.1 and T02B5.3 encode predicted carboxylesterases
Genes T02B5.1 and T02B5.3 are both predicted to contain carboxylesterase domains. 
Examination of the predicted amino acid sequence has shown they are very similar with
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60% of amino acids identical between the two proteins (Figure 5.20). This may explain 
why both genes rescue mutation nz90.
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Figure 5.20. Amino acid alignment between T02B5.1 and T02B5.3
Proteins T02B5.1 and T02B5.3 are 60% identical.
Identical residues are shown in dark shaded boxes.
Similar amino acids are shown in light shaded boxes.
All predicted exons and introns comprising genes T02B5.1 and T02B5.3 were 
sequenced using genomic DNA extracted from nz90 mutant animals, and no mutations
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were found compared to the published wild type sequence. No mutations in the DNA 
between the START or STOP codon and the neighbouring gene were found. The DNA 
composing both the introns and exons of srd-26 (T02B5.4), which lies between T02B5.1 
and T02B5.3, was sequenced and no mutations were found.
5.17. RNAi of T02B5.1 and T02B5.3 had no effect upon aldicarb sensitivity
Knockdown of specific genes by RNAi is achieved by feeding the animals with bacteria 
producing double stranded RNA of the desired gene (Fraser et al., 2000; Timmons et al., 
2001; Timmons and Fire, 1998). RNAi has been shown to be ineffective in the neurons 
of wild type animals (Kamath and Ahringer, 2003; Tavernarakis et al., 2000; Timmons et 
al., 2001). Two strains have been identified with an enhanced sensitivity to RNAi in the 
neurons. The first has a mutation in the gene eri-1. eri-1 has been shown to degrade 
siRNAs in vitro. It is highly expressed in the nervous system and thought to be part of 
the reason for the poor penetrance of RNAi in the nervous system. A predicted null 
mutation in eri-1 (mg366) has been shown to have enhanced RNAi sensitivity within the 
nervous system (Kennedy et al., 2004). Mutation of a second gene, rrf-3, has also been 
shown to enhance RNAi sensitivity (Simmer et al., 2002). rrf-3 belongs to a family of 
putative RNA-directed RNA polymerases [RdRP]. Recently, a third strain has been used 
in an RNAi screen specifically aimed at analysing genes required for synapse structure 
and function (Sieburth et al., 2005). This screen used a strain with enhanced sensitivity 
to RNAi in the neurons, which had mutations in both eri-1 and lin-15B. Iin-15B is a 
Tam3-transposase. Mutation of lin-15B appears to enhance RNAi by an as yet unknown 
mechanism (Boxem and van den Heuvel, 2002).
Using bacteria from the Ahringer RNAi library (Geneservice) the sensitivity to aldicarb for 
eri-1; lin-15B mutant animals after RNAi knockdown of T02B5.1 or T02B5.3 was 
recorded. The aldicarb sensitivity was also recorded after RNAi knockdown of egl-8, 
which has been reported to reduce aldicarb sensitivity (Sieburth et al., 2005). RNAi of 
both T02B5.1 and T02B5.3 in eri-1; lin-15B mutant animals had no significant effect 
upon aldicarb sensitivity (Figure 5.21). RNAi of egl-8 strongly reduced the aldicarb 
sensitivity of eri-1; lin-15B mutant animals (Figure 5.21).
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Figure 5.21. Aldicarb sensitivity after RNAi knockdown of T02B5.1, T02B5.3 
and egl-8
Aldicarb sensitivity after 2 generations of RNAi treatment. Displayed as percentage 
paralysis upon exposure to 1mM aldicarb for 100 minutes.
All assays for knockdown of T02B5.1 had 100% paralysis.
Error bars show SEM.
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5.18. Over expression of T02B5.1 and T02B5.3 in wild type animals had no 
effect
Expression of T02B5.1 and T02B5.3 might be increasing aldicarb sensitivity 
independently of mutation nz90, leading to non-specific rescue. To address this 
possibility, cosmid T02B5 and genes T02B5.1 and T02B5.3 were independently 
expressed in wild type animals. No large change in aldicarb sensitivity was observed 
(Figure 5.22). Expression of T02B5.3 in wild type animals does lead to a slight increase 
in aldicarb sensitivity. This increase is small especially when compared to the change in 
sensitivity when rescuing nz90 animals.
60 minutes 130 minutes
Figure 5.22. Aldicarb sensitivity of wild type animals with cosmid T02B5 or 
genes T02B5.1 or T02B5.3
Aldicarb sensitivity displayed as percentage paralysis upon exposure to 1 mM 
aldicarb for 60 or 130 minutes.
Error bars show SEM.
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5.19. Discussion and conclusions
5.19.1. Strain VC430 contains an additional mutation reducing aldicarb 
sensitivity
An unknown mutation in strain VC430 is responsible for the resistance to aldicarb 
phenotype observed, which we have named nz90. Resistance to aldicarb, an ACh 
esterase inhibitor, suggests a decrease in ACh release. The resistance could however 
be due to a reduction in the ability of aldicarb to inhibit the ACh esterase, thus another 
ACh esterase inhibitor was tested, trichlorfon. Animals with mutation nz90 are also 
resistant to trichlorfon, supporting the hypothesis there is a reduction in ACh release in 
nz90 mutant animals. Resistance to ACh esterase inhibitors can be caused by a 
reduction in the sensitivity of the ACh receptors in the muscle. Levamisole, an agonist of 
the nicotinic ACh receptors in the muscle, sensitivity is unchanged in nz90 mutant 
animals suggesting there is no change in the sensitivity of the receptors in the muscle. 
The lack of resistance to levamisole suggests the hypothesis of a defect in the cuticle 
preventing the uptake of exogenous drugs to be the cause of the resistance to aldicarb 
and trichlorfon is unlikely. All this data suggests that mutation nz90 causes a reduction in 
ACh release, however, a change in the release of the inhibitory neurotransmitter GABA 
cannot be discounted.
It is interesting to note that animals with both nz90 and rhgf-1 (gk217) mutations have a 
weaker resistance to aldicarb than animals with mutation nz90 alone. This suggests the 
possibility of an additional mutation causing a slight increase in aldicarb sensitivity in 
VC430 animals that is lost in nz90 animals.
5.19.2. Mutation nz90 alters the synapse
The number of synapses in nz90 mutant animals was quantified using the transgene 
p.acr-2::SNB-1 ::CFP as a marker. There is a significant reduction in the number of SNB- 
1 labelled synapses in nz90 mutant animals. There is also a significant reduction in the 
number of UNC-13S puncta; UNC-13 is recruited to sites of release in response to high 
level neuronal activity to increase synaptic vesicle priming and neurotransmitter release 
(Lackner et al., 1999; Miller et al., 1999; Nurrish et al., 1999). UNC-13 is a DAG-binding
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protein that is thought to facilitate neurotransmitter release in multiple ways including 
regulating the formation of the SNARE complex (Brenner, 1974; Kohn et al., 2000; 
McEwen et al., 2006; Nguyen et al., 1995; Richmond et al., 1999; Richmond et al.,
2001). Addition of the DAG analogue phorbol esters to wild type animals strongly 
stimulates ACh release, causing a strong hypersensitivity to aldicarb (Lackner et al.,
1999). The induction of hypersensitivity to aldicarb by phorbol esters is conserved in 
nz90 mutant animals, suggesting everything downstream of DAG production in 
mediating neurotransmitter release is functioning correctly. This suggests the reduction 
in UNC-13S puncta may be due to the reduction in SNB-1 containing synapses in nz90 
mutant animals. The ratio of UNC-13S puncta and SNB-1 puncta is the same in wild 
type and nz90 animals also suggesting the decrease in UNC-13S puncta is caused by a 
decrease in SNB-1 labelled synapses. There is no change in the gross neuronal 
morphology of either the cholinergic nor GABAergic neurons suggesting there is a 
specific defect in the number of SNB-1 containing synapses. Co-localisation of the 
nicotinic ACh receptor subunit UNC-38 in the muscle and the pre-synaptic marker UNC- 
17 suggests there is no defect in the formation of ACh receptors adjacent to synaptic 
terminals. Unfortunately, the density of UNC-17 and UNC-38 puncta were not quantified 
by our collaborators. All this data suggests there is a reduction in the number of SNB-1 
containing synapses in nz90 mutants causing a reduction in neurotransmitter release.
5.19.3. SNB-1 localisation defects in synaptogenesis mutants
The defects in SNB-1 ::CFP localisation in nz90 mutant animals could be due to a 
developmental defect. SNB-1 ::GFP has been used as a maker in mutagenesis screens 
to identify proteins involved in synaptogenesis (Crump et al., 2001; Schaefer et al., 2000; 
Shen and Bargmann, 2003; Zhen and Jin, 1999). Defects in both the number, the size 
and the intensity of SNB-1 ::GFP puncta have been identified.
The protein RPM-1 (regulator of presynaptic morphology) has been shown to have a 
positive role in synapse formation or maintenance (Schaefer et al., 2000). It is expressed 
in the nervous system and mutation of rpm-1 causes a reduction in SNB-1 ::GFP 
accumulations (Schaefer et al., 2000). There is an increase in active zones in the 
GABAergic neurons in rpm-1 mutants, but this is thought to be caused by a reduction in 
synaptic activity (Schaefer et al., 2000). The cholinergic motor neurons in the head of
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rpm-1 mutants sprout, which has previously been associated with a decrease in synaptic 
activity (Schaefer et al., 2000). Examination of the ultra-structure by EM has shown there 
is a decrease in the number of vesicles per synapse and the presence of multiple 
densities at one synapse (Nakata et al., 2005; Zhen et al., 2000).
Another protein identified to have a role in synaptic formation or maintenance is SAD-1 
(Crump et al., 2001). sad-1 encodes a serine-threonine kinase that is expressed in the 
nervous system (Crump et al., 2001). Mutation of sad-1 results in the presynaptic 
vesicles clusters, in both sensory and motor neurons, being diffuse and disorganized, 
and failure of the axons to terminate, although no change in the presynaptic density is 
observed (Crump et al., 2001). Over expression of SAD-1 causes ectopic SNB-1 ::GFP 
localisation in dendrites (Crump et al., 2001). SAD-1 is predicted to have a role in the 
clustering of vesicles at the synapse (Crump et al., 2001).
A screen looking for defects in the localisation of SNB-1 :.GFP in the GABAergic motor 
neurons pulled out mutations in syd-2. Mutation of syd-2 results in SNB-1 ::GFP to 
becoming more diffuse, which corresponds to longer presynaptic densities (active 
zones) (Zhen and Jin, 1999). No significant change in the total number of synaptic 
vesicles at the terminal have been reported (Zhen and Jin, 1999). SYD-2 is a member of 
the liprin family of proteins that interact with LAR-type receptor proteins having tyrosine 
phosphatase activity (Serra-Pages et al., 1998). SYD-2 is required to localise PTP3A, a 
LAR-type receptor, to the synapse where it is required for synaptogenesis (Ackley et al.,
2005). SYD-2 is hypothesised to have a role in the recruitment of proteins to form the 
presynaptic density (Jin, 2006).
Mutation nz90 could be affecting the formation of the synapse, by regulating the 
formation of the presynaptic density like SYD-2 and RPM-1, or vesicle clustering like 
SAD-1. There could alternatively, or in addition, be a defect in the maintenance of the 
synapse. The localisation of SNB-1 ::CFP has only been examined in adult animals in 
this thesis, therefore examination of SNB-1 localisation at earlier stages of development 
would help to determine between these possibilities. Closer examination of the synapse 
at the ultra-structural level using EM would provide significant information to further 
characterise the defects in nz90 mutant animals, such as examination of the clustering 
of vesicles, and the size of the presynaptic density.
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5.19.4. SNB-1 specific localisation
p.acr-2: .SNB-1 ::CFP has been used as a synaptic marker in this study. SNB-1 has been 
found to be localised to not only to the synaptic vesicle membrane but also at low levels 
to the plasma membrane (Taubenblatt et al., 1999). SNB-1 found in the plasma 
membrane derives from fused synaptic vesicles. It diffuses along the axon to provide a 
source of SNB-1 at extra-synaptic locations. The rates of exo- and endocytosis have 
been shown to be involved in the proportion of SNB-1 in the plasma membrane as 
opposed to the synaptic vesicle membrane (Dittman and Kaplan, 2006).
It is possible that in nz90 mutant animals there is a defect in the localisation of SNB-1 as 
opposed to there being a reduction in the number of synapses. Expression of other 
fluorescently tagged synaptic vesicle proteins such as SNT-1 or immunostaining of 
known synaptic proteins such as UNC-17 could aid the distinction between these 
scenarios.
This study has focussed upon the localisation of SNB-1 in the cholinergic motor neurons. 
Expression of SNB-1 ::CFP under the control of other neuron specific promoters, such as 
unc-47 for GABAergic SNB-1 ::CFP expression, would provide information on the 
synapses in neurons other than the cholinergic motor neurons, to determine if the SNB-1 
defect in nz90 mutant animals is specific to the cholinergic motor neurons or more widely 
spread.
5.19.5. Mutation nz90 may have an indirect effect upon the cholinergic motor 
neurons
Changes in aldicarb sensitivity can be due to defects not only in the cholinergic motor 
neurons but also in; the GABAergic motor neurons, the interneurons stimulating the 
motor neurons, and the muscles. Any defects in the muscle are unlikely; no change in 
levamisole sensitivity was observed in nz90 mutants, and clustering of the postsynaptic 
ACh receptor looked like wild type animals. Defects in the GABAergic motor neurons 
have not been discounted, therefore examination of SNB-1 localisation in the GABAergic 
motor neurons would be an important addition to the study. The possibility of defects in 
the interneurons has also not been eliminated. Examination of receptors such as the
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GLR-1 receptor using a GFP fusion protein in the interneurons could provide some 
valuable information upon the signalling of the interneurons (Chang and Rongo, 2005).
5.19.6. nz90 might be a mutation in T02B5.1 or T02B5.3
Genetic mapping and rescue experiments have suggested a defect in gene T02B5.1 or 
T02B5.3 is responsible for the defects in nz90 mutant animals. T02B5.1 and T02B5.3 
are over 60% identical providing a plausible explanation for the rescue by both genes.
No mutations within the genes or the nearby sequences have been identified. The genes 
have not been fully cloned, therefore the gene prediction models may be inaccurate and 
missing exons and introns. Amplification of the cDNA using the SMART RACE and SL1 
primers would identify the true 5’ end of the gene, which could then be used to ensure 
the entire gene is sequenced. The sequences that are responsible for the regulation of 
genes T02B5.1 and T02B5.3 are not known. It is therefore possible a mutation within 
these unknown regulatory sequences is the cause of the neurotransmission defects in 
nz90 animals.
Mutation nz90 was introduced using TMP/UV mutagenesis. This usually introduces short 
deletion mutations. Examination of 14 alleles generated by exposure to TMP/UV 
identified 11 short deletions, 1 insertion and 2 complex rearrangements (Yandell et al.,
1994). It is therefore quite unlikely that the mutation nz90 is a single point mutation that 
could more easily be missed in sequencing. This suggests mutation nz90 is not within 
the area that has been sequenced, unless a complex rearrangement has occurred. DNA 
for sequencing mutation nz90 was extracted from animals with nz90 and rtigf-1 (gk217) 
mutations. The rtigf-1 (gk217) mutation provided a simple control to detect wild type 
contamination in the DNA extracts by PCR amplification and no contamination was 
detected.
Expression of T02B5.1 or T02B5.3 in wild type animals has no effect upon aldicarb 
sensitivity suggesting that the rescue of nz90 is specific. It is possible T02B5.1 and 
T02B5.3 only have a role in basal levels of neurotransmission, and over expression of 
the proteins is unable to induce increased neurotransmission above wild type levels. 
Further confirmation of a specific rescue of nz90 by T02B5.1 and T02B5.3 could be
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obtained by looking for rescue upon expression of T02B5.1 or T02B5.3 in other mutants 
known to be resistant to aldicarb such as egl-8.
No mutation alleles of T02B5.1 or T02B5.3 have been identified. RNAi knockdown of 
T02B5.1 and T02B5.3 had no effect upon sensitivity to aldicarb, whilst knockdown of egl- 
8 a gene known to be involved in ACh release reduced aldicarb sensitivity, suggesting 
the loss of T02B5.1 or T02B5.3 has no effect upon neurotransmission. However, no 
control to confirm knockdown of the proteins was performed. Expression of a GFP 
tagged form of T02B5.1 and T02B5.3 could provide a control to confirm the RNAi 
treatment is knocking down the protein. Attempts to make GFP tagged forms of T02B5.1 
and T02B5.3 were thus far unsuccessful. These fusion proteins would also provide 
significant information upon the expression patterns of T02B5.1 and T02B5.3, which 
have not previously been published.
From the data obtained thus far in this study it cannot be positively concluded that a 
change in T02B5.1 or T02B5.3 is responsible for the aldicarb resistance in nz90 mutant 
animals. Two results support the hypothesis that mutation nz90 is in T02B5.1 or 
T02B5.3. Firstly, aldicarb resistance observed in nz90 animals is rescued by expression 
of T02B5.1 or T02B5.3. Secondly, expression of T02B5.1 and T02B5.3 in wild type 
animals does not increase aldicarb sensitivity suggesting specific rescue. Two other 
observations do not correlate with the hypothesis that nz90 is a mutation in either 
T02B5.1 or T02B5.3. No mutations in the sequence of the genes or the immediately 
flanking regions have been identified and RNAi knockdown of the genes has no effect 
upon aldicarb sensitivity.
Further experiments could help to determine if mutation nz90 effects T02B5.1 or 
T02B5.3. Firstly, isolation of the complete cDNAfor T02B5.1 and T02B5.3 would provide 
confirmation of the predicted gene sequences, allowing comprehensive sequencing of 
the entire genes. Expression of T02B5.1 or T02B5.3 under various neuronal specific 
promoters such as acr-2, unc-47 or the muscle specific promoter myo-3 could provide 
more specific details of the rescue. Identification of the expression patterns of T02B5.1 
and T02B5.3 using GFP tagged proteins could provide further support for the hypothesis 
that mutation nz90 is affecting one of these genes.
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5.19.7. T02B5.1 and T02B5.3 encode predicted carboxylesterases
Genes T02B5.1 and T02B5.3 are predicted to contain carboxylesterase domains. There 
is a multigene superfamily of carboxylesterases (CarbEs) in mammals (Satoh and 
Hosokawa, 1998). Their structure, substrate specificity and function are all tightly 
regulated. They are localised to the endoplasmic reticulum (ER) of many tissues. They 
catalyse the hydrolysis of molecules containing ester- and amide bonds including 
exogenous drugs and toxicants and endogenous compounds such as short and long- 
chain acyl-glycerols, and long-chain acyl-CoA esters (Satoh and Hosokawa, 1998).
A subfamily of carboxylesterases called ACh esterases are known to degrade ACh. Four 
ACh esterase genes (ACE genes) have been identified in C. elegans (Combes et al., 
2000). The ACh esterase inhibitor aldicarb, which is used to measure ACh release at the 
NMJ, acts as an ACh analogue to inhibit the enzyme, and thus could itself be degraded 
by ACh esterases. Trichlorfon is another ACh esterase inhibitor with a different chemical 
structure and is therefore unlikely to be degraded by carboxylesterases (Nguyen et al.,
1995). nz90 mutant animals are resistant to both aldicarb and trichlorfon suggesting 
there is a defect in neurotransmission as opposed to the degradation of aldicarb being 
responsible for the resistance in these animals.
5.19.8. Neuroligins
A family of proteins that possess an ACh esterase-like domain and have a role of 
neurotransmission are the neuroligins (Missler and Sudhof, 1998). They are 
characterised by a cleaved signal peptide, a cholinesterase-like domain, a carbohydrate 
attachment region, a single transmembrane domain and a short C-terminal tail 
containing a PDZ-binding motif (Lise and El-Husseini, 2006).The loss of a crucial amino 
acid in the cholinesterase domain renders it catalytically inactive (Missler and Sudhof, 
1998). Neuroligins have been assigned to the family of cholinesterase-like adhesion 
molecules (Gilbert and Auld, 2005). In this family, the inactive cholinesterase domain is 
thought to mediate receptor-ligand interactions. The cholinesterase domain lies 
extracellularly and the PDZ domain lies intracellularly probably binding to other PDZ 
domain containing proteins (Missler and Sudhof, 1998).
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In vertebrates, neuroligins are important for synaptic function. They have been thought 
to be important in synaptogenesis since expression in non-neuronal cells generates 
functional sites of release (Scheiffele et al., 2000). Over expression of neuroligins in 
cultured neurons increases the number of synapses formed whilst RNAi knockdown of 
neuroligins cause a decrease in synaptic density and a change in synaptic activity (Chih 
et al., 2005). However, recent data examining triple knockdown mice of three neuroligins 
has recorded no reduction in the number of synapses formed, although a reduction in 
synaptic signalling remains (Varoqueaux et al., 2006). This suggests neuroligins are 
regulating the synapses after formation as opposed to regulating synaptogenesis. 
Neuroligins bind to the neurexins, transmembrane proteins found in the plasma 
membrane of the presynaptic neuron (Missler and Sudhof, 1998). The interaction 
between neuroligins and neurexins is required for their role in synaptogenesis. There are 
two hypotheses for the role of neuroligins and neurexins in synaptogenesis (Figure 5.23 
C and D) (Lise and El-Husseini, 2006). The first is that they are required for initial 
synapse formation, recruiting the pre-and post-synaptic proteins to the newly forming ^  
synapse (Figure 5.23 C). The second is that a different set of adhesion proteins initially 
forms the synapse and the neuroligins and neurexins are required for synapse 
maintenance and stability (Figure 5.23 D). In the absence of the neuroligins and 
neurexins the synapse becomes destabilised and eventually eliminated. Different 
members of the neuroligin and neurexin families may be responsible for the formation of 
the distinct excitatory and inhibitory synapses (Figure 5.23 A and B).
Another potential role for neuroligins and neurexins is in the regulation of synaptic 
strength (Figure 5.24) (Lise and El-Husseini, 2006). An increase in neuronal activity 
might lead to the increased formation or stabilisation of the neurexin-neuroligin 
complexes. Trans-synaptic signalling within this complex could then mediate the 
recruitment of critical pre- and post-synaptic elements required for increased signalling. 
Alternatively, a decrease in neuronal activity could lead to destabilisation of the neurexin 
and neuroligin complex and a reduction in synaptic activity.
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Figure 5.23. Regulation of synaptogenesis by neuroligins and neurexins
(A and B) The combination of specific forms of neuroligins and neurexins may 
allow recognition of a particular type of neuron or type of synaptic contact 
(C and D) Neuroligins and neurexins aid synapse formation or stabilise and 
maturate existing synapses.
(C) Initial contact between the dendrite expressing neuroligins and the axon 
expressing neurexins triggers the clustering of neuroligins and neurexins and the 
coordinated recruitment of the pre- and post- synaptic proteins.
(D) Cell adhesion molecules initiate the contact between the dendrite and axon, 
which stimulates the recruitment of neuroligins to the synapse where they are 
involved in synapse stabilisation and maturation. The absence of neuroligins may 
lead to destabilization and synapse elimination.
Taken from Lise and El-Husseini 2006.
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Figure 5.24. Putative role of neuroligins and neurexins in modulation of 
synaptic strength
An increase in synaptic activity may cause an increase in the recruitment or 
stabilisation of the neuroligin/neurexin complex at the synapse, leading to further 
recruitment of the critical pre and post synaptic proteins to sites that modulate 
synaptic activity, and thus enhance synaptic strength. Alternatively, a decrease in 
synaptic activity might result in the loss or destabilisation of the neuroligin/neurexin 
complex from the synapse resulting in a decrease in synaptic strength 
Taken from Lise and El-Husseini 2006.
There is one neuroligin homologue in C. elegans called neuroligin 1 (NLG-1). It is 
expressed in the nervous system including the cholinergic motor neurons in both larvae 
and adult animals (McKay et al., 2004). Mutation of nlg-1 causes a mis-localisation of the 
GLR-1 receptors responsible for receiving signals from the interneurons (Hunter et al.,
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2006). Defects in the localisation of GLR-1 receptors could cause defects in the 
signalling of the motor neurons, although no cholinergic defects have been reported 
(Hunter et al., 2006). It is therefore possible that T02B5.1 and T02B5.3 have a role 
similar to neuroligins in C. elegans.
5.19.9. T02B5.3 homologues are expressed in neurons
Homologues of T02B5.3 have been identified in humans and rats. Both homologues are 
predicted ACh esterases. The enzymatic activity of the rat homologue, Ache, has been 
confirmed to catalyse the degradation of ACh into choline and acetate. It is expressed in 
the nervous system. The loss of an ACh esterase in C. elegans increases levels of ACh 
within the synaptic cleft, causing hypersensitivity to aldicarb (Kolson and Russell, 1985). 
The opposite phenotype is seen in nz90 animals. In rats, the T02B5.3 homologue Ache 
is also thought to be important for growth of both axons and dendrites, and 
synaptogenesis in the nervous system. It is possible that mis-wiring of the nervous 
system in nz90 animals is causing resistance to aldicarb. The gross morphology has 
been examined and looks wild type, but further more detailed analysis would provide 
evidence the nervous system is correctly wired.
5.19.10. Identifying mutation nz90
Further work is needed to confirm the putative identification of mutation nz90 affecting 
either predicted carboxylesterase T02B5.1 or T02B5.3. Proteins with carboxylesterase 
domains have been shown to have roles in neurotransmission including the neuroligins, 
which contain an inactive carboxylesterase domain and regulate synaptic transmission. 
Human and rat homologues of T02B5.3 are predicted ACh esterases and the rat 
homologue has been hypothesised to have a role in the neuronal growth and 
synaptogenesis. nz90 mutant animals have a possible defect in synaptogenesis, as 
determined by the reduction in SNB-1 labelled synapses.
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6. Summary, conclusions and future work
The hypothesis behind this thesis was:
The G alpha 12/ RGS RhoGEF pathway in C. elegans leads to the activation of 
RHO-1 to regulate neurotransmitter release.
This thesis set out with two main goals: to show that Ga12 regulates neurotransmitter 
release, and to show that this regulation is dependent upon the RGS RhoGEF, RHGF-1.
6.1. Summary of results
In chapter 3, the role of Ga12 in the regulation of neurotransmission was investigated. 
Over expression of constitutively active Ga12 in the cholinergic motor neurons increased 
ACh release at the NMJ in C. elegans. This increase in release was dependent upon 
RHO-1 and the ability of UNC-13 to bind to the lipid second messenger DAG; expression 
of either the RHO-1 inhibitor C3 transferase to inhibit endogenous RHO-1, or a non-DAG 
binding UNC-13 mutant, UNC-13 (H173K), both inhibit the increase in ACh release 
mediated by constitutively active GPA-12. The increase in ACh release occurred in 
combination with the recruitment of UNC-13 to sites of release, with no obvious change 
in either neuronal morphology or the total number of release sites. It was concluded from 
the data in this chapter that Ga12 is regulating ACh release in a RHO-1 and UNC- 
13/DAG dependent manner.
In chapter 4, the requirement of RHGF-1 for Gai2 mediated increases in ACh release 
was investigated. Mutation of rhgf-1 strongly suppressed the ability of constitutively 
active Ga12, expressed under both a heatshock and a cholinergic specific promoter, to 
stimulate ACh release. Expression of wild type RHGF-1 in the cholinergic motor neurons 
partially rescued this suppression, and at high levels constitutively increased ACh 
release. ACh release induced by high levels of RHGF-1 was suppressed by the 
inhibition of endogenous RHO-1, suggesting RHGF-1 stimulates ACh release in a RHO- 
1 dependent manner. The recruitment of UNC-13 to release sites by constitutively active 
GPA-12 was suppressed by mutation of rhgf-1, suggesting RHGF-1 is required for Ga12 
mediated UNC-13 relocalisation. It was concluded from the data in this chapter that Gai2
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is, at least in part, stimulating ACh release via RHGF-1, leading to the activation of RHO- 
1, an increase in DAG at sites of release and the subsequent recruitment of UNC-13 to 
release sites.
6.2. The release of ACh in C. elegans is a model system used to identify 
candidate proteins involved in human behaviours and diseases
The neurotransmitters and neuromodulators serotonin and dopamine are associated 
with several behavioural aspects in humans including eating disorders, alcohol 
consumption and aggression (Berman et al., 1997; Crabbe et al., 1996; Saudou et al., 
1994; Tecott et al., 1995). Defects in serotonin signalling have been associated with 
changes in mood including a possible link to depression, whilst defects in dopamine 
signalling have been associated with schizophrenia and Parkinson’s disease.
Serotonin and dopamine control behaviours in the model system C. elegans including 
locomotion, feeding, egg-laying, defecation, chemosensation and thermosensation 
(Brundage et al., 1996; Colbert and Bargmann, 1997; Lackner et al., 1999; Mendel et al., 
1995, Miller et al., 1999; Mori, 1999; Nurrish et al., 1999; Sawin et al., 2000; Segalat et 
al., 1995). Examination of the genes and proteins involved in the regulation of these 
behaviours in C. elegans provides a source of candidate proteins involved in inherited 
mental disease and possible drug targets. Analysis of the behaviour of locomotion has 
identified two G-protein coupled pathways (Gaq and Gao), which antagonistically 
regulate the levels of the lipid second messenger DAG, to be key components of 
pathways regulating synaptic release (Mendel et al., 1995; Nurrish et al., 1999; Segalat 
et al., 1995). The small GTPase Rho also plays a role in the regulation of release in C 
elegans, and mutations in Rho have been associated with mental retardation in humans 
supporting the hypothesis that proteins identified to have a role in neurotransmission in 
C. elegans also have a role in humans diseases (Chechlacz and Gleeson, 2003; 
Ramakers, 2002).
6.3. What acts upstream of GPA-12 to regulate neurotransmission?
Overall, the results in this thesis support the hypothesis that a third pathway regulates 
ACh release at the NMJ in C. elegans. The heterotrimeric G protein alpha subunit, Ga12,
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activates the RhoGEF, RHGF-1, leading to the activation of RHO-1, the recruitment of 
UNC-13 to release sites and an increase in ACh release. This thesis has therefore 
identified two more proteins that are involved in the regulation of the synaptic vesicle 
cycle and neurotransmission.
The lack of phenotypes in gpa-12 and rhgf-1 mutant animals suggests that the pathway 
is inactive under standard laboratory conditions and becomes activated upon a stimulus. 
Assays examining the response of the gpa-12 mutant animals to various stimuli such as 
starvation, mechanosensation, chemosensation and thermosensation might provide 
some clues as to the upstream triggers and use of the GPA-12/ RHGF-1 pathway in a 
natural environment. As discussed above at least three neuromodulators are currently 
known to regulate the release of ACh at the NMJ.
6.3.1. Potential neurotransmitters and neuromodulators regulating the Gai2/ 
RHGF-1 pathway
The neuromodulator dopamine is hypothesised to both positively and negatively regulate 
ACh release via interactions with different receptors, and thus could be an upstream 
regulator of the G a 12 pathway (Chase et al., 2004). Treatment of animals with elevated 
G cx12 signalling with exogenous dopamine could provide some interesting information 
about the possible regulation of Ga12 by dopamine. A second neuromodulator known to 
affect ACh release, serotonin, acts as an inhibitor of ACh release and is therefore 
unlikely to directly regulate the Gai2 pathway. However, the possible effects of serotonin 
upon the Gcx12 pathway could be examined by treating animals expressing constitutively 
active GPA-12 with exogenous serotonin to determine if there is any suppression of the 
effects of exogenous serotonin. It would also be interesting to determine if the increase 
in ACh release caused by the loss of the serotonin pathway, for example by treatment 
with methiothepin a serotonin antagonist, can be suppressed by the loss of Gai2.
The neurotransmitter ACh can stimulate release at the NMJ through activation of the 
muscarinic ACh receptors. Treatment with arecoline, a muscarinic ACh receptor agonist, 
causes an increase in ACh release. The effects of arecoline upon gpa-12 and rhgf-1 
mutants could provide information on the possible activation of the Ga12 pathway by the 
muscarinic ACh receptors.
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The invertebrate neurotransmitter octopamine is also a potential upstream regulator of 
the G ai2/ RHGF-1 pathway. Octopamine positively regulates locomotion although the 
pathway through which it mediates this effect is not known (Horvitz et al., 1982).
Neuropeptides have also been identified to have a role in regulating ACh release and 
locomotion. Mutation or RNAi knockdown of flp-1, a gene that encodes more than seven 
FMRFamide-like peptides, causes a loopy increased locomotion and a decrease in ACh 
release (Sieburth et al., 2005). Analysis of ACh release of animals with RNAi knockdown 
of flp-1 that are also expressing constitutively active GPA-12 and gpa-12 (pk322) mutant 
animals over expressing FLP-1 could provide an interesting indication of a possible role 
for FLP-1 upstream of GPA-12. Other FLP genes have been shown to have roles in the 
regulation of pharyngeal pumping, another behaviour regulated by GPA-12, although 
independent of RHGF-1 (Papaioannou et al., 2005; van der Linden et al., 2003). The 
upstream activator of GPA-12 regulating pharyngeal pumping is also unknown so 
identification of these genes could provide further potential candidates for the stimulation 
of ACh release at the NMJ.
6.3.2. Potential GPCRs upstream of GPA-12
A genome-wide RNAi screen of G protein coupled receptors (GPCRs) predicted to bind 
to small-molecule neurotransmitters or neuropeptides identified seven GPCRs whose 
knockdown results in locomotory defects (Keating et al., 2003). Knockdown of all seven 
resulted in a lethargic locomotion with reduced body bends, suggesting that all mediate 
a stimulatory response for locomotion (Keating et al., 2003). These seven receptors are 
therefore candidate receptors to act upstream of GPA-12 to regulate ACh release. Three 
are predicted neuropeptide receptors: two NPY receptors (NPR-2 and NPR-3) and one 
somatostatin (Keating et al., 2003). The other four are predicted small-molecule 
receptors: two dopamine receptors (DOP-1), one acetylcholine (GAR-1) and one 
melatonin receptor (Keating et al., 2003). RNAi knockdown of these genes, in the 
presence of constitutively active GPA-12, could provide an indication of the possible role 
of these candidate GPCRs upstream of GPA-12.
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An RNAi screen looking for genes involved in synapse function identified the GPCR 
FSHR-1 to be involved in ACh release (Sieburth et al., 2005). Loss of fshr-1 causes 
aldicarb resistance, shown by both RNAi knockdown and a loss-of-function mutation, 
suggesting FSHR-1 is a positive regulator of ACh release (Sieburth et al., 2005). FSHR- 
1 is therefore another candidate upstream activator of GPA-12.
The muscarinic ACh receptor GAR-3 has been identified to have a role in pharyngeal 
pumping (Steger and Avery, 2004). The loss of gar-3 causes hypercontraction of the 
pharynx and subsequently lethality following starvation (Steger and Avery, 2004). In this 
instance GAR-3 is acting via Gctq to regulate the changes in pumping associated with 
starvation (Steger and Avery, 2004).
6.4. Are there any other proteins acting downstream of GPA-12?
Mutation of rhgf-1 does not completely suppress the effects of GPA-12 on 
neurotransmission, suggesting there may be additional downstream pathways regulating 
ACh release. There is only one predicted RGS containing RhoGEF in the C. elegans 
genome, it is therefore unlikely GPA-12 is directly activating a different RhoGEF. It is 
currently unknown if the mutation rhgf-1 (ok880) is a null mutation, although since the 
entire DH domain is critical for RhoGEF activity in mammalian RhoGEFs, this suggests 
this will be a null mutation for RhoGEF activity (Kristelly et al., 2004). Biochemical 
confirmation of a complete loss of RhoGEF activity using an in vitro assay would provide 
further evidence of the presence of additional downstream effectors of GPA-12 
regulating ACh release (Kubiseski et al., 2003).
A second deletion mutation allele of rhgf-1 is available and encompasses the C1 
domain. Analysis of this mutant in this thesis has identified a closely linked mutation 
causing a decrease in ACh release. Further backcrossing to attempt to eliminate this 
second mutation, and subsequent analysis of ACh release could provide information 
upon any roles of the C1 domain in regulating ACh release. Analysis of further mutation 
alleles of rhgf-1, if, and when available, would also provide valuable information on the 
role of RHGF-1 in the regulation of ACh release.
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In mammals, in addition to interacting with RGS RhoGEFs, the Gai2 family members 
Ga12 and Gcxi3 have been shown to interact with a wide variety of other proteins such as 
the serine/threonine phosphatase PP2A, cadherin, and radixin, a member of the ERM 
family of proteins known to connect receptors and ion channels with the intracellular 
microfilaments (Meigs et al., 2001; Vaiskunaite et al., 2000; Zhu et al., 2004). 
Conservation of these interactions in C. elegans has not thus far been explored.
6.4.1. PLC-1
In mammals Gon2 interacts with and activates PLCe, a different class of PLC from EGL- 
8, that also catalyses the hydrolysis of PIP2 to DAG and IP3 (Lopez et al., 2001). PLCe is 
therefore another candidate regulator of ACh release downstream of Gai2, through its 
ability to regulate levels of DAG. PLCe has also been shown to act as a RasGEF 
activating the small GTPase Ras (Lopez et al., 2001). One PLCe homologue has been 
identified in C. elegans called PLC-1. It is expressed in neurons, although the identity of 
the neurons is not defined (Kariya et al., 2004). Further examination of the expression 
pattern, in particular examination of expression in the cholinergic motor neurons, would 
be interesting to confirm if PLC-1 could be a potential downstream effector of GPA-12 in 
the regulation of ACh release.
6.4.2. TPA-1
GPA-12 also regulates pharyngeal pumping via a pathway acting in the pharyngeal 
muscles and requiring the protein kinase C, TPA-1 (van der Linden et al., 2003). The 
mechanism by which GPA-12 stimulates TPA-1 has not been identified, but the data in 
this thesis suggests that this is not through the activation of RHGF-1. It is proposed that 
TPA-1 is activated by the production of the lipid second messenger DAG. EGL-8 
catalyses the production of DAG suggesting GPA-12 may be activating EGL-8, although 
this is unlikely since egl-8 mutants cannot suppress the loss of pharyngeal pumping 
induced by constitutively active GPA-12 (van der Linden et al., 2003). This provides 
evidence for another downstream effector of GPA-12, in addition to RHGF-1 in C. 
elegans.
267
6.5. Does the Gcxi2 pathway regulate the Gaq and/ or Gao pathways to regulate 
ACh release?
An interaction between the G a 12 (GPA-12) pathway and either the Gaq (EGL-30) or G a0 
(GOA-1) pathway may be responsible for the regulation of neurotransmitter release. It 
has been hypothesised that the inhibitory GOA-1 pathway negatively regulates the 
stimulatory EGL-30 pathway to decrease ACh release (Hajdu-Cronin et al., 1999). The 
GOA-1 and EGL-30 pathways are active under standard laboratory conditions, as shown 
by phenotypes observed in EGL-30 and GOA-1 mutants, unlike the GPA-12 pathway. As 
discussed above, the incomplete suppression by mutation of rhgf-1, of the increase in 
ACh release mediated by constitutively active GPA-12, suggests GPA-12 may be 
activating one or more effectors in addition to RHGF-1 to stimulate ACh release. Either a 
positive impact upon the EGL-30 stimulatory pathway, or negative impact upon the 
GOA-1 pathway could be the additional effect of GPA-12.
Genetic epistasis studies could provide an insight into the possible regulation of the 
EGL-30 or GOA-1 pathway by GPA-12. Examining the release of ACh in animals with a 
gain-of-function mutation in egl-30 and either a loss-of-function mutation in gpa-12 or 
rhgf-1 could demonstrate if GPA-12 and/or RHGF-1 are acting downstream of EGL-30 to 
regulate ACh release. Conversely, expression of constitutively active GPA-12 in egl-30 
mutants could determine if EGL-30 is acting downstream or in parallel to the GPA-12 
pathway. Analysis of the release of ACh in animals expressing both constitutively active 
GPA-12 and GOA-1 could help to determine if GPA-12 is acting upstream, downstream 
or independently of GOA-1. All these genetic experiments will provide suggestions for 
possible interactions that could be followed up with biochemical studies.
6.6. Is GPA-12 acting in cells other than the cholinergic motor neurons?
Expression of constitutively active GPA-12 under the control of the heatshock promoter, 
and therefore in all cells, caused a much larger increase in aldicarb sensitivity than 
expression under the control of the unc-17 promoter, which is expressed in cholinergic 
cells. This could be due to differences in expression levels from the two promoters, or 
may suggest that GPA-12 has roles in cells other than the cholinergic motor neurons by 
which it regulates ACh release. Expression of RHGF-1 under the motor neuron specific
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promoter acr-2 failed to completely rescue the increase in ACh release by heatshock 
expressed constitutively active GPA-12 in rhgf-1 mutant animals, again suggesting GPA- 
12 has a role in other cells. GPA-12 is expressed in a wide variety of cells including the 
pharynx, muscle tissue and the hypodermis (van der Linden et al., 2003; Yau et al., 
2003). Constitutively active GPA-12 acts in the pharyngeal muscle to reduce the rate of 
pharyngeal pumping (van der Linden et al., 2003). This would be comparable to a 
situation of starvation for the animals. Starvation results in an increase in locomotion and 
a corresponding increase in ACh release (de Bono and Bargmann, 1998; Sawin et al.,
2000). The action of GPA-12 inhibiting pharyngeal pumping, and thus inducing a 
starvation response, could therefore provide another mechanism by which GPA-12 is 
increasing ACh release.
6.7. Other upstream activators of RHO-1
RhoGEFs are the direct activators of the family of Rho proteins including RHO-1. There 
are multiple RhoGEFs in C. elegans providing many potential upstream activators of 
RHO-1. Inhibition of endogenous RHO-1 by C3 transferase causes extreme lethargy, a 
phenotype not seen in rhgf-1 mutant animals, suggesting additional RhoGEFs are 
activating RHO-1 in the regulation of ACh release under standard conditions.
A second RhoGEF, UNC-73, has been identified to have a role in ACh release in this 
thesis, contradicting a previous study, although different aldicarb assays to measure the 
rate of release were performed (Steven et al., 2005). unc-73 is a large gene containing 
both Rac-specific (RhoGEF-1) and Rho-specific (RhoGEF-2) RhoGEF domains 
(Kubiseski et al., 2003; Spencer et al., 2001; Steven et al., 1998; Wu et al., 2002). The 
Rac-specific RhoGEF-1 domain is involved in regulating axon guidance (Steven et al., 
1998). The Rho-specific RhoGEF-2 domain is involved in the regulation of pharyngeal 
pumping, locomotion and egg-laying, which are all controlled by RHO-1 and 
neurotransmission (Steven et al., 2005). Loss of the RhoGEF2 domain of UNC-73 
results in lethality due to the loss of pharyngeal pumping. Expression of the RhoGEF2 
domain solely in the pharynx rescues the lethality, and the resulting animals exhibit a 
lethargic locomotion that is not suppressed by mutations in goa-1 or dgk-1, suggesting 
UNC-73 acts downstream or in parallel to GOA-1 and DGK-1 to regulate 
neurotransmitter release (Steven et al., 2005). It is unlikely that UNC-73 is directly
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regulated by GPA-12 since it does not possess an RGS domain. It would still, however, 
be interesting to determine if the loss of the RhoGEF2 domain of unc-73 is able to 
suppress GPA-12 mediated ACh release.
A second RhoGEF that has been shown to have a role in regulating behaviour is VAV-1 
(Norman et al., 2005). The RhoGEF activity of VAV-1 is required for the regulation of 
pharyngeal pumping, the defecation cycle and gondal-sheath-cell contractions (Norman 
et al., 2005). All these behaviours are regulated by the effects of VAV-1 in the muscle as 
opposed to neuronal effects, suggesting it is unlikely that VAV-1 is an upstream 
regulator of RHO-1 in neurotransmission (Norman et al., 2005). Furthermore, the 
expression pattern of VAV-1 does not include neuronal expression (Norman et al.,
2005).
A third RhoGEF identified to have a role in ACh release is GEI-18 (Sieburth et al., 2005). 
RNAi knockdown of gei-18 causes resistance to aldicarb, suggesting a decrease in ACh 
release (Sieburth et al., 2005).
In conclusion, this thesis has identified one pathway that acts upstream of RHO-1 to 
regulate neurotransmission. Within the cholinergic motor neurons, Ga12 activates the 
RGS RhoGEF, RHGF-1, leading to the activation of RHO-1, DAG-dependent recruitment 
of UNC-13 to release sites, and an increase in ACh release. Additional pathways that 
activate RHO-1 to regulate release remain to be identified, and the possibility of 
additional effectors of GPA-12 regulating ACh release remains to be explored.
The components of the pathway identified in this thesis are conserved in humans, and 
are therefore likely to be involved in the regulation of neurotransmitter release in 
mammals. They are therefore possible candidate proteins involved in inherited mental 
problems, and provide potential drug targets in the treatment of diseases caused by 
defects in neurotransmission.
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8. Appendix
8.1. Sequence of gpa-12  deletion mutant pk322
gpa-12 genomic sequence is shown in black. Exons for gpa-12 are shown in red. gpa-12 
(pk322) sequence from strain NL594 is shown in blue.
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TGTTATAGTTTTAAGAAGAATTTTTGGTATCGTTTAAAAATAACAAAGAACTGGATGAAAAATTTTTAACA
C G A A A T T A G A T T A T T C G T T C T A A T C A A A A T T C C A C A C T T T T T A G A A A T C A T T C A A A A A A T T A A C T T T T T T T
ATGAAAACTTATTGCACTTAAATACATTAATATTATAGATTTTCTGTCGGCGATTTATTAAAAGGAATTGA
TTTCACCACGTTTGTTGAAGTAGCCCCAATCATCAGTGATTTCTGGAACGACGCTGCGATTAGAAAAACAT
ATGAGCAAAGAAACTTATTCCAAATTGTAAGTTTTTGATTTTTTTAAATTATATATGTTCTGTTTTCAGAG
TGACTCCTGTCAGTACTTCTTTGAGCATATTCCACGAATCGCAATGCCTGATTTTTACCCAACAAACCGTG
ATATCCTTTTCTGCCGAAAAGCGACACGTGGCATTTCTGAACACATTTTCGAGATCAACAAGATTCCATTT
AGGTTTGACTTTTTTCCTCAATGGTCACGGACTTAGTTTGTGAATTATATTGTTTCAGGTTCATTGATGTT
GGCGGACAAAGATCGCAACGTCAAAAATGGTTTCAATGTTTTACAGACATCACAAGTATTTTGTTCATGGT
CGCCAGTAACGAATACGATCAGGTTAGAGATCAAGACACACTTGTTCTGGTGTTTACTATACATTTTTCAG
GTGATTCTCGAAGACAGACGGACGAATCGAGTTGTCGAATCACGGTCTGTTTTTGAGACGATTGTCAACAA
CAGAGCGTTCTCTAATGTCTCCATCATCTTGTTCATGAACAAAAATGATTTATTGCAAGAGAAAGTTCCCA
AATCCGATATCAGACAGTATTTCACGGATTTCACAGGGGATCACACTTTAGTGAGTCTATATTATTGAGAA
A A A A C G T G T T T G A C A A T A G A A A A A T G T A T C T T G T A T C A A G C T A T A T T A A A A G G A A A A T C A T A T T T G G T A A A
307
AATTAGGGGAGTATTACACAGCCGACATGTTTCGGGCATTGGAATTCACGTATTACGGAAATCTTTTTTTC
TTTATTCATTCTTTCACTGGAACTGTGAGGGTACAGTTGGAAATGTTGTGTTTTACTCACGACCTTTTCAA
ATC TC GAAAAATTTC AAT AATT AAC GTT AAAAGTTTTTTTTTC TT AGAGC AAAAAAGTTGTTATTTAAAAA
C T T G T T C T T T T C C A G G T C C G A G A T G T T C A A T T T T T C C T T G T C G A C A A A T T C G A A G C A T C T C G C C G C G A T C G
T G C A C G A C C C T T C T T T T A T C A C T T C A C C A C T G C C G T C G A C A C T G A A A A C A T T A G A A G A G T G T T C C G A G A T G
T A C G T G A A A G T A T T T T A G A G C A A A A C T T G A A G A C T C T C A T G A T G C A G T A A T A T A T T T T C T T G T T G T T G C T C
AAATGTTTCCTTCAACAAAATGGTGATTTAAATCAGTTTAATGATACAAACCTTATTTGTCCATTTAATTC
AGTTCAATGCGATTCTACCAATGTCCCACTTTATTTTTTATACAATATCATTTTTGTGCATATTTATAGTC
ATGATAAAAATTTACACACTTTGACCTAAATGCTTCTCGGATCCGGTGAAATTCACAATGTTTTGCATTCA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = G C T T C T C G G A T C C G G T G A A A T C A C A A T G T T T T G C A T G T C A
AAAAATTT AATAGTGC T AAATTTGAC AGAATTGC AC C AATC T ACTC T AAAAAATGTTGTAAAAAAC TAAAC
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II
A A A A A T T T A A T A G T G C T A A A T T T G A C A G A A T T G C A C C A A T C T A C T C T A A A A A A T G T T G T A A A A A A C T A A A C
CACAGCATTTGAAA
I I I II I II I II II I
C A C A G C A T T T G A A A
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8.2. Sequence of rhgf-1 deletion mutant ok880
rhgf-1 genomic sequence is shown in black. Exons for rhgf-1 are shown in red. rhgf-1 
(ok880) sequence is shown in blue.
C T T C T T G A A G C T T T T C G T C C C C C C C C C C C C T C C T T C A G C A A T A G T T T T T G G T T C T G T C T A T T G A C A G C G T C A
I I I I I I I I I I I I 11 I I 11 I I 1111111111111111111111111111111111111111111111111111
CTTCTTGAAGCTTTTCGTCCCCCCCCCCCCTCCTTCAGCAATAGTTTTTGGTTCTGTCTATTGACAGCGTCA
C T T T G T C A T A T A T A A A C A T T C G T T C C G C A A T C A G C G C A C C A A G C A C T C T T C C T C T C T T C T T C C G C A C A C T T G
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
CTTTGTCATATATAAACATTCGTTCCGCAATCAGCGCACCAAGCACTCTTCCTCTCTTCTTCCGCACACTTG
C T G C G T G T G T G G G C T C G A T T T C T T A A G G A G G A G A G A A T T T A T T C G T C C A T T C A C T C A C A T T C T G T G T C T C C G
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
CTGCGTGTGTGGGCTCGATTTCTTAAGGAGGAGAGAATTTATTCGTCCATTCACTCACATTCTGTGTCTCCG
T G A T T C C G T T G G C A T T T A T A G T T C T T C T C A G T T T G C C A T T A T T G A T A C T T T T T A C A G A A A C T G T A T A T G C G A
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 ! 11111111111111  
TGATTCCGTTGGCATTTATAGTTCTTCTCAGTTTGCCATTATTGATACTTTTTACAGAAACTGTATATGCGA
TCGTACGAGTTTGTAACCAATACACCACTCAAACTTGATCGGCACAAAGTATACCTCGTCGACGATGTGGCT
TCGTACGAGTTTGTAACCAATACACCACTCAAACTTGATCGGCACAAAGTATACCTCGTCGACGATGTGGCT
GTCACAAGGACTGTACCCTTATCGCAGCCATTATCCCCATCAACCGGTGAGCCATTTTTGCACTTTTACAAT
I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I  I I I I I  I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I  I I I I I I
GTCACAAGGACTGTACCCTTATCGCAGCCATTATCCCCATCAACCGGTGAGCCATTTTTGCACTTTTACAAT
T A C C T T G T C C T T C G A A T T G G G T A A A A G G G T T G A A C T T T A A A C T T C A T C A T A A C T C G A A A T A C T G T T G G T T T C
I I I I I I I I I I I I I I I  I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
TAC CTTGTCC TTC G AATTGGGT AAAAGGGTTGAAC TTT AAAC TTC ATC ATAAC TC GAAATAC TGTTGGTTTC
A A T T C G T T C C A T A A T T T T A G A C C T A T G A G T T T T G T T T T T C G T T T T A T T C G G A A C G C A A G A A A A C A A A G T A T T
l l l l l l  I I  M i l l  1111111111I I 111111I I 11  I I I  I I I I  I M i l l  I N I  I I N I  I M M M M M I I M
AATTCGTTCCATAATTTTAGACCTATGAGTTTTGTTTTTCGTTTTATTCGGAACGCAAGAAAACAAAGTATT
C G T T A G A A T A C A C A C A A A G G T A A G T T C T T T T C T T A A A C A C T G A A A A C G T T G A T T T T A G T G T T C A A A G T G C A T
MIIMIII IMI Mi l l  Mi l l  I I M I I I I I I I l l l l ! l lM IM I I I I I I I lM IM  IIMMMIMM
CGTTAGAATACACACAAAGGTAAGTTCTTTTCTTAAACACTGAAAACGTTGATTTTAGTGTTCAAAGTGCAT
A A C  T T T G T  A G T T C  C A T C  A A A A A T T A T T T T G C T T  A A A A G C  A G T G T T T C G T T G T A G C  C T A T C  T A G C T C  A C  T T G C
I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I
AAC TTTGT AGTTC CATC AAAAATTATTTTGC TT AAAAGC AGTGTTTCGTTGTAGCC TATC TAGC TC AC TTGC
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TCTTTTCAACCTCTTCAACAGCATTCAAGATTGAAATCTCAACGGGATATATTGTGTGTATATGTCTTCTTC
111111111111111111111111111111111111111111111111111111111111111111111111 
T C T T T T C A A C C T C T T C A A C A G C A T T C A A G A T T G A A A T C T C A A C G G G A T A T A T T G T G T G T A T A T G T C T T C T T C
CCTTTTCCCACTCATCCCATGTTAAATTTGGCAGAAAGTTATCCCCTTCTCCTGTTATATTCCCAAGAGTCG
I M I M M M I I I I I I 11111111111111111111111111111111111111111111111111111111
C C T T T T C C C A C T C A T C C C A T G T T A A A T T T G G C A G A A A G T T A T C C C C T T C T C C T G T T A T A T T C C C A A G A G T C G
TGTTGCTCTTGTGTTCTCAATAGGCGTTGTTGTGACAATTTTGGCGGGGTGCCTTTTGCAATAGCAACAGAG
T G T T G C T C T T G T G T T C T C A A T A G G C G T T G T T G T G A C A A T T T T G G C G G G G T G C C T T T T G C A A T A G C A A C A G A G
CATCAGTTTACTGGGTTTTCTGAGAATAAAGAAAAAGATGAAACGGAGGAAGAGGATCAAATCTGTTGTGGA
I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
C A T C A G T T T A C T G G G T T T T C T G A G A A T A A A G A A A A A G A T G A A A C G G A G G A A G A G G A T C A A A T C T G T T G T G G A
AATTGTTTAGTCAACTTCTTTGTTGATTGCTGATTCATTTGAATAGAAAACTGAGTGATATTTAAAAACTTT
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  [ 1 1 1 ! 11111111111111  1 1 ! I ! 111111111
A A T T G T T T A G T C A A C T T C T T T G T T G A T T G C T G A T T C A T T T G A A T A G A A A A C T G A G T G A T A T T T A A A A A C T T T
TCTGAATACTTTAAGAGAGATGGGATTGACAGAATGATTTTCTTACAAAACAAGATTAAAATCGTTAGCCTT
) I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I  I I I I I I I
T C T G A A T A C T T T A A G A G A G A T G G G A T T G A C A G A A T G A T T T T C T T A C A A A A C A A G A T T A A A A T C G T T A G C C T T
GAAGTGGATTAAATGCAACTTGAGTGCCAATTGAAAAAAAATCCGCAAACTTCCCATTGAAGAATATATTCA
I I I I I I I I I  I I I I  I I I I I I  I I I I I  I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I
G A A G T G G A T T A A A T G C A A C T T G A G T G C C A A T T G A A A A A A A A T C C G C A A A C T T C C C A T T G A A G A A T A T A T T C A
CAGTTGTTGTTTAAATCTTGTCCTATCGTTACGTTTAACACATTAATTTTACAAGAAACTTTGATCTGAAGT
i i i i m i i i i n i i i m m i i  i i i i m i i i t i i i  i i i i i i m i m i i i i i i i i i i i i i i i r i i i i i
C A G T T G T T G T T T A A A T C T T G T C C T A T C G T T A C G T T T A A C A C A T T A A T T T T A C A A G A A A C T T T G A T C T G A A G T
CGGCAGGGGATGTCAACATTTGCAGTTTGAAAAATTTAATTATTAAATTATTAAAAAATCTGAAGAAAACCA
CGGCAGGGGATGTCAACATTTGCAGTTTGAAAAATTTAATTATTAAATTATTAAAAAATCTGAAGAAAACCA
CGAGCTTTTGGTAATATTCTTCGCATTCTCCATACATTCTATGAAAAGTTGTTGAAAATAGTAATAACTAAT
11111111 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 11 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 111111111111111 M 111
CGAGCTTTTGGTAATATTCTTCGCATTCTCCATACATTCTATGAAAAGTTGTTGAAAATAGTAATAACTAAT
TTCCAGTTCATGAAAGTGATCAACTATTCAGTCTTGTAGTTTATGTTTCATTGAATTTTTGCTTGTTGTCGT
111111111111111111111111111111111111111111111111111111I I 1111111111111111
TTCCAGTTCATGAAAGTGATCAACTATTCAGTCTTGTAGTTTATGTTTCATTGAATTTTTGCTTGTTGTCGT
TCTTGCGCCACACTTAAAAAATTAACCTTCGAATACGCGCAAAACCTTACTACATGTTATTTGAACATTGGC 
111111111111111111111111111111111111111111111111111111111111111111111111 
TCTTGCGCCACACTTAAAAAATTAACCTTCGAATACGCGCAAAACCTTACTACATGTTATTTGAACATTGGC
^
^
T T C A G A G A A T C T G C T T G T T G T C G T G T T A C C G G C A T A C T T T C A G A T A A A A C T T T T T T G A A T T C T G C G C T G A A T
1 1 1 1 1 I I 1 1 1 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
T T C A G A G A A T C T G C T T G T T G T C G T G T T A C C G G C A T A C T T T C A G A T A A A A C T T T T T T G A A T T C T G C G C T G A A T
C C A G T T T G A G A A A T T T C C T T T T T G C A C A T T T G C T A A C A T T A T T T A T T T T T G A A A A A A A A A T G A A T T G C C G C C
C C A G T T T G A G A A A T T T C C T T T T T G C A C A T T T G C T A A C A T T A T T T A T T T T T G A A A A A A A A A T G A A T T G C C G C C
A A A A A C T A T G G T C C C A C T T G C A C T T C T G C T T A G A C A T C A G G A T C A T A A A T T A C A A A T T A A A G T T T T A T T C C A
A A A A A C T A T G G T C C C A C T T G C A C T T C T G C T T A G A C A T C A G G A T C A T A A A T T A C A A A T T A A A G T T T T A T T C C A
T A A T A A T A C A C A A A A C C T A G C A G T T G A A G T T C A T T T T G A T T T T T G G T G G T T T T T G T T A A A C T A A A G T T T G A A
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T A A T A A T A C A C A A A A C C T A G C A G T T G A A G T T C A T T T T G A T T T T T G G T G G T T T T T G T T A A A C T A A A G T T T G A A
T A T G C T T T T C A A A A C A T G G G T C T T A T C T T T T T T C A A A C A C C T C A A A T C T G A T C G A A C A C T C T T C A A C T T T T T
I I I I I I I I I I  I I I I I I I I I I I I  I I I I  I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I  I I  I I I I I I I
T A T G C T T T T C A A A A C A T G G G T C T T A T C T T T T T T C A A A C A C C T C A A A T C T G A T C G A A C A C T C T T C A A C T T T T T
A T A G C T C T G A C T T C C A A A A G A A C A T T C T G A A A A A C A A T T C A A A A T T C A C A C A A G T C C C T T T T G C G C G A A C T A
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I  I I I I I I I I I I I I I I I I I I
A T A G C T C T G A C T T C C A A A A G A A C A T T C T G A A A A A C A A T T C A A A A T T C A C A C A A G T C C C T T T T G C G C G A A C T A
A G G T T T C A T G T G A C T A T A A A T A A T G T T C C G T G C A G G A A A A A A A T T A A T T G A A T T G C A A A T T C A A T T T C C T T G
I I I I I I I I  I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I  I I I I I I I  I I  I I I I I I I I
A G G T T T C A T G T G A C T A T A A A T A A T G T T C C G T G C A G G A A A A A A A T T A A T T G A A T T G C A A A T T C A A T T T C C T T G
T T T T A C A T T A G T A T A T C T A T C A C T C G A T T A T A G A G T G G C A G C A C A T T T T T C A A A A T G A G G C A G C G G T T A T T T
I I I I I I  I I  I I I I I I I I I I  I I I I I  I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I  I I I I  I I I I I I I I I I I I I I I
T T T T A C A T T A G T A T A T C T A T C A C T C G A T T A T A G A G T G G C A G C A C A T T T T T C A A A A T G A G G C A G C G G T T A T T T
G G G A C C A G A T T G G G C C G G C A A A G A G A T T T A T A T C C G T T T T C G G G G C A A A G G A C G A A C A A C G A G C A G A A C G A G
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
G G G A C C A G A T T G G G C  C G G C A A A G A G A T T T A T A T C C  G T T T T C  G G G G C A A A G G A C  G A A C A A C  G A G C A G A A C  G AG  
T G C G T T A C G T T T T T A T T A G T G T T T G C T T A G C A C C C G C A T C A C C C A C A A A A G T C C A T A A A A T T G C G G G T C G T T
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I
T G C G T T A C G T T T T T A T T A G T G T T T G C T T A G C A C C C G C A T C A C C C A C A A A A G T C C A T A A A A T T G C G G G T C G T T
G T T C C C T G T G G T T C T G T G G T T T T T A G A C T T A C T G T G A C A T C T C T C G C T C G C T A G T T T T C C G G G T C A A T C A A G
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G T T C C C T G T G G T T C T G T G G T T T T T A G A C T T A C T G T G A C A T C T C T C G C T C G C T A G T T T T C C G G G T C A A T C A A G
A C A A C T T A T G A T C C A G G T T A T A T G A G A A T T T G G T G A A C A T T A G C A T C A T T G A G G T G A G A C T A A C A C C G C C G T
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A C A A C T T A T G A T C C A G G T T A T A T G A G A A T T T G G T G A A C A T T A G C A T C A T T G A G G T G A G A C T A A C A C C G C C G T
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T A G A A T T A T T C T C T T C T G G G T T G T A A A A T C T C C G G T T C A C A T T T C T C C A T C C A T T T T C T T A T T T A T G G T C A A
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T A G A A T T A T T C T C T T C T G G G T T G T A A A A T C T C C G G T T C A C A T T T C T C C A T C C A T T T T C T T A T T T A T G G T C A A
T T C A C G G T T T T C T A T A G A T A T T T T C A T A G G A G G G T C G A T G A C C A T T G G C G A C A A A A A T A A T G A C A A T T T G A T
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T T C A C G G T T T T C T A T A G A T A T T T T C A T A G G A G G G T C G A T G A C C A T T G G C G A C A A A A A T A A T G A C A A T T T G A T
C C G C T G T T T T A A C C T C A T T T T T T T T G T G A A A T G A A T T C A A T T C A A A G G G T G G T C A C C A C T A C C G C C A T C G C A
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C C G C T G T T T T A A C C T C A T T T T T T T T G T G A A A T G A A T T C A A T T C A A A G G G T G G T C A C C A C T A C C G C C A T C G C A
A C A C T T A A C G G A T A A G G A G G G C T T C T T T T C G G G A A A A G A A G A T T A G G T T G A A G A A T C T G A A T A C C G G T A A A T
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A C A C T T A A C G G A T A A G G A G G G C T T C T T T T C G G G A A A A G A A G A T T A G G T T G A A G A A T C T G A A T A C C G G T A A A T
G A A A T G A A G A G C G C G T C T T G C T G C T G T C T C C T G A T G T G C G T T C A A C T T T C G T T T C A T T T T C C C G G C C G C G C T
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AAAAGCCATTACTTCGAAATACTTGACTACTTGAGCGTTGATGGTGCAGCGCCGAAAATTTTTCGTTCAAGT
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TTTGAC AGTT AAAC TGTTGTTAT AGT AGATTTTTC AATTGTTC AAAATTC AAAAGTTAAATC TGATAAAAAA
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ATAAAACTTTAAGTTGCGTCAAAGAGTTAACCAACATTCTATGTATAAACTTTTCAATTTGATTTAGATGTT
TTCATCTCGTTTTATTAATCTTTTTTTAATTTCAGCATCATCCAGTTACAATATGATAGAACGATGCGTAGT
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TTCATCTCGTTTTATTAATCTTTTTTTAATTTCAGCATCATCCAGTTACAATATGATAGAACGATGCGTAGT
AGTTCAACGACAACCAGATGGTTTCGGTCTGACGGTGAACAGCGAGTTTCCAGTTTATGTGCATACTCTGAA
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AGTTCAACGACAACCAGATGGTTTCGGTCTGACGGTGAACAGCGAGTTTCCAGTTTATGTGCATACTCTGAA
ACAGGATGGAGCTGCTTACTGTGCGGGTGTTCGTCAAGGAGATCGGATAGTCAAGGTTAGTACCCTTGCCTT
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ACAGGATGGAGCTGCTTACTGTGCGGGTGTTCGTCAAGGAGATCGGATAGTCAAGGTTAGTACCCTTGCCTT
TTAGAAATGTCTCACAAGAATGTGCGCACATAAGTAGTTCAACTGAATTGCATTTTACTAAATCGTGTTTAG
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TTAGAAATGTCTCACAAGAATGTGCGCACATAAGTAGTTCAACTGAATTGCATTTTACTAAATCGTGTTTAG
ACACTAGACACCCACGACTTTTCACTCTATTTAGGTCAATGGAATGTCGGTGTCGCCCAATAACCATAAGGA
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ACACTAGACACCCACGACTTTTCACTCTATTTAGGTCAATGGAATGTCGGTGTCGCCCAATAACCATAAGGA
AGTGCTCCAAATGATATCGAGTATGTTGAAAATAAATACAGAAAATCAAAACAAACACTTGAAACTTTAGAT
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AGTGCTCCAAATGATATCGAGTATGTTGAAAATAAATACAGAAAATCAAAACAAACACTTGAAACTTTAGAT
GGCCACAACGTTGCATTGACTCTACTTGGAAAACCACCGGACCCCATATCCAATATTTCTTTTCCGAATCAA
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GGCCACAACGTTGCATTGACTCTACTTGGAAAACCACCGGACCCCATATCCAATATTTCTTTTCCGAATCAA
CAAGTTGAGCAAAAAATACATATCGCTGATCCAGTGCTCATCGAGGTATGCATTAGAGGTCACATAATTATA
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CAAGTTGAGCAAAAAATACATATCGCTGATCCAGTGCTCATCGAGGTATGCATTAGAGGTCACATAATTATA
ATACAGACAGTTTCTCCATCTTTTAGGCCAGCTCAAAGAGTTGGCGACAACGACGCAACGAATTACTTGGCC
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ATACAGACAGTTTCTCCATCTTTTAGGCCAGCTCAAAGAGTTGGCGACAACGACGCAACGAATTACTTGGCC 
AGATGGTAGC TGAAGAAAGAC G AAAC GTTGAGGTC AGTGTC ATTTCC TGC TC TTTCGGTGTTTTCGC AAAC A
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AGATGGTAGCTGAAGAAAGACGAAACGTTGAGGTCAGTGTCATTTCCTGCTCTTTCGGTGTTTTCGCAAACA 
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GCGGTCCTTGTAATCCACTTGTATCCCTTTTTGTGTTTCACTATCCGGGAACATTGCGGATTGTAAGAGTTC
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I I I M M M I I  I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
AAAGAACCTCAATGAACAAAGACAAATTGTACCAATGGTCGGGTTCTGACGTCCTTTGAGCAATTCAGAAAA
T A T A T T G G T T T C G G T G T A G G C C A C C A A T T T T T T C C T T A T T C C C A A G C C C G T T C T T T T G G C T T T C C T G T C C G T
111111II1111 1 11111II1 1111 1111 1 1 1 1111111 1 1 1 1 1 111111111111111111 1 1 1 1111111
TATATTGGTTTCGGTGTAGGCCACCAATTTTTTCCTTATTCCCAAGCCCGTTCTTTTGGCTTTCCTGTCCGT
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TTTCCCGATGGACCTTCAGAGAAGTTGTTTCTGGGTTCCGAAGTCTATTAATAATCGGGTTTGCATAGATCG
G A T T T G T T A G T T T C T G A T T A T A A T T T T T T G T G A C T G A T T C T T T A A A G A A A A C T T A A T C T T G C G T T T A T T G G C
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GATTTGTTAGTTTCTGATTATAATTTTTTGTGACTGATTCTTTAAAGAAAACTTAATCTTGCGTTTATTGGC
T T T C G T A G A A A A T C T T G T A A A A T T T T C G G A T C T T T T C A C C A A A A A G T G A G C A G A A A A T A C A T A T G G T C T G C T
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
TTTCGTAGAAAATCTTGTAAAATTTTCGGATCTTTTCACCAAAAAGTGAGCAGAAAATACATATGGTCTGCT
A G T T T T T G C T G C T C T G C T C T T T T T T T A C G A T T T T T C C T T G T A T A T T T T A A A C A T T G A A A A G T T T C G A A T A T T
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AGTTTTTGCTGCTCTGCTCTTTTTTTACGATTTTTCCTTGTATATTTTAAACATTGAAAAGTTTCGAATATT
A A A A A A T T G A T C T C A A A T T T A T G T A T T T T A A T T A C C A A T C T C T T G A T A G T T T G T T T G T A A A A C A G T C A A G T C
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AAAAAATTGATCTCAAATTTATGTATTTTAATTACCAATCTCTTGATAGTTTGTTTGTAAAACAGTCAAGTC
A A T T A A A T A A A A T T C A T C T G A A A C T T T C A A G C T C A A A A A G T T G C C G T T T A T T T T G C T T C C A T T T T C A T A T T G
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AATTAAATAAAATTCATCTGAAACTTTCAAGCTCAAAAAGTTGCCGTTTATTTTGCTTCCATTTTCATATTG
A T C T T G A T A A A A A A A G A A G A G A G T A G A A G A A C A C T T T T A G T T A A T G C T A T G A A T A C T A C A A T A A A T G A C A A A
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ATCTTGATAAAAAAAGAAGAGAGTAGAAGAACACTTTTAGTTAATGCTATGAATACTACAATAAATGACAAA
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TAATAAATTTTTCAAGTTCATCATATCATAATGCCCAAAACAATCGAAGATTCTTATTGATTAGCATGTTTT
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CTTCCAATTTTTCAATTTAAACCTTTAAAAAGTATTAAAAAAGTATTCTTTAAAAAATAAAAGTGAGGAACC
T G A T T T G A C C C A A A C T T T T T G T T G A T T T C A T C A C G A A G T C C C T T T T T T A T T C T A T T T T A T T T T T A T T C T A T T
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TGATTTGAC C C AAAC TTTTTGTTGATTTC ATC AC GAAGTC CC TTTTTTATTC TATTTTATTTTTATTC TATT
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TATTCTATTCTATGGAAAACGCGACCCACTATTACCAGAACCACCGATTTTTGACAAGTTTTCCGAATAAAC
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TATTCTATTCTATGGAAAACGCGACCCACTATTACCAGAACCACCGATTTTTGACAAGTTTTCCGAATAAAC
ATGCAACGATTTCTTTTTTGACGACGACGACGACGAGGACGCAAGGGATATCTGTTGCTTTCTTTCCCTCCC
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ATGCAACGATTTCTTTTTTGACGACGACGACGACGAGGACGCAAGGGATATCTGTTGCTTTCTTTCCCTCCC
ATTTGAGCTTCTTCTCATCCTTCTTCTTCTCCTTCCCCTTCTTAGAAACTGCACATCGTTTTGTAGCCTTTG
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ATTTGAGCTTCTTCTCATCCTTCTTCTTCTCCTTCCCCTTCTTAGAAACTGCACATCGTTTTGTAGCCTTTG
TGTGCGTTGTCGAATTTCTCCCAATCACAGAGTTTTGTCACTTGTCCCCACCCTTATTCAATGATTCCAAA
1 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 11111
TGTGCGTTGTCGAATTTCTCCCAATCACAGAGTTTTGTCACTTGTCCCCACCCTTATTCAATGATTCCAAA
GCGCTGGGGGTTATCCAATTGCAACCGCCTGTTGTCAACATCCTTCTAGTCCAGACCCGCATTTGCTCTTTT
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GCGCTGGGGGTTATCCAATTGCAACCGCCTGTTGTCAACATCCTTCTAGTCCAGACCCGCATTTGCTCTTTT
TATATATACATCTCTTCTTTTGCCGCCCAATGGTTTTTTTTTTGGGACGCAGTCCTTAGACAGATCTACACT
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TATATATACATCTCTTCTTTTGCCGCCCAATGGTTTTTTTTTTGGGACGCAGTCCTTAGACAGATCTACACT
CCAAAAAGTGGAAATACTACGCTGGGCCAATGCCCTATGAGCATATAAAGATGAATTCATAATTGTTAGAAA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I  I I I I I I I I I I I I I I  I I I I I I  I I I I I I
CCAAAAAGTGGAAATACTACGCTGGGCCAATGCCCTATGAGCATATAAAGATGAATTCATAATTGTTAGAAA
AAGCCATGCGGGGCTCCTCTTCTGTCACACTTATTCATTCTATTTCCGCTTTTTGTCTTCCCTCAATCTTGT
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AAGCCATGCGGGGCTCCTCTTCTGTCACACTTATTCATTCTATTTCCGCTTTTTGTCTTCCCTCAATCTTGT
TTTTGGCACCATGGTCCGAGACAACCAAATGTTTATAATTTTCTCATCAAAAATACACTCCTAGACTCTCAA
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TTTTGGCACCATGGTCCGAGACAACCAAATGTTTATAATTTTCTCATCAAAAATACACTCCTAGACTCTCAA
AGGCTGCCAAAAGTGTTCCATTTATGTTATTCCGCCTTGCTTAAAAAAATGTTTTTAGCGATTCGGTTTTTA
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AGGCTGCCAAAAGTGTTCCATTTATGTTATTCCGCCTTGCTTAAAAAAATGTTTTTAGCGATTCGGTTTTTA
TGAAATTTACTTTTTGAGAAAAATTAAAGCATGATATTTTATACTTTTCACTTGGCTTCACATTTTCAATTC
I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I  I I I I I I I I I I I I I I I I I I I I I I  I I I I I
TGAAATTTACTTTTTGAGAAAAATTAAAGCATGATATTTTATACTTTTCACTTGGCTTCACATTTTCAATTC 
CTAATTTTC AGGGTC TAC GAGAGTC ATC TC AAAATGGCGAAAAAATTGAC AGAGC TTTAAAAC GAATTGTTT
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CTAATTTTC AGGGTCTACGAGAGTCATCTCAAAATGGCGAAAAAATTGACAGAGCTTTAAAACGAATTGTTT
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CATTGCAGTCACAACTGAAACAATTAAAACCAGAATCAATTATCTCGGATAGTCAGAAAAGTTTGGTGAGTC
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CATTGCAGTCACAACTGAAACAATTAAAACCAGAATCAATTATCTCGGATAGTCAGAAAAGTTTGGTGAGTC
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ACAAATTTTTTTTGTCTTACATTTAGAGTGTTATGTTTAAGTATACAAGTAGTATAAGGCTGTAGATTTTTC
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GAGATAAACTTAAATATGCCGAATGACTGTTTCAACTTGAGAACCTGAAGAAATTAATCATGCTAAATATGT
T A A A A A T T T G A A T T C C T G C G T G A A G T C A A T T G T G C G G T A A T T T G A A A A T C A T T T A C T T C C A T T C A C T T T A G C
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TAAAAATTTGAATTCCTGCGTGAAGTCAATTGTGCGGTAATTTGAAAATCATTTACTTCCATTCACTTTAGC 
C T C  T T T T G  A G C  A G C  T C T T T C  T A C  T C  T T T C T T T A A A T G T T A T G T  A A A T C  A A T T C G G T A T  A T C G T A T T T T A T C  T
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CTC TTTTGAGC AGC TC TTTC TAC TC TTTC TTT AAATGTT ATGT AAATC AATTC GGTAT ATCGTATTTTATCT 
A T T A G T A T T G C A C C C C T A A G A G C C A C T C A A A A A T T A T T C T T G C A G T C T C T T T T A G T A T T G C A T T T T C T A A T A
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ATTAGTATTGCACCCCTAAGAGCCACTCAAAAATTATTCTTGCAGTCTCTTTTAGTATTGCATTTTCTAATA
G T C T T C T G A T A C T C T A A T A G T C T G G T T T T G A C A G A C C A A C A C T G C T A C T C G G G A A A G T C A G A A A T G T T T C A T
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GTCTTCTGATACTCTAATAGTCTGGTTTTGACAGACCAACACTGCTACTCGGGAAAGTCAGAAATGTTTCAT
T T T T T G G G T G T A T C A A A T T T A A A A T C G T T C A A A T A A T T G A T A C C A A A T T G A A A A G T A T T A T C A T A G C T T A A A
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TTTTTGGGTGTATCAAATTTAAAATCGTTCAAATAATTGATACCAAATTGAAAAGTATTATCATAGCTTAAA
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CGGTATAAACAAAAATATTATAGAAATAATGGTCAGTTTTCCAAAATTATGGGGTATCCGACAAATATGTAG
T T T T G C A G C T T T T A A T A G C A T T G C A G T C T T A A T T A C T T T T G C A C T G C T A C G G A C C A G A T T C A A A T T A G T C T G
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TTTTGCAGCTTTTAATAGCATTGCAGTCTTAATTACTTTTGCACTGCTACGGACCAGATTCAAATTAGTCTG
A C A T G C A A G A C T A A T A G A G G A A A T A C G G T A T A C A T T C T T A T A G T T T T T T T C A A A T T C C A T A T G A A A T G C T T C
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ACATGCAAGACTAATAGAGGAAATACGGTATACATTCTTATAGTTTTTTTCAAATTCCATATGAAATGCTTC
A A A A A G T A G C C A G A T G T A G T A A A T C T A A G G G T C C T C C C A A C T A C T A G T A T G T G T A A T T G C T C C A G T T T G T C A
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AAAAAGTAGCCAGATGTAGTAAATCTAAGGGTCCTCCCAACTACTAGTATGTGTAATTGCTCCAGTTTGTCA
899999
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11111 M 11111111111111111111! 11111111111111111111111111111111111111111111
TCCATAACTTTCACTTTCACTTAGAGTTATATCTTCTGAATGCATTATATTTTGATTGATGTTTTTGATTAT
TTCTCCAAATTCTACTAATATTTCAGACAAATCTAAACATGGACATTGATAGTGACGAAGAGGAAAATGACG
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TTCTCCAAATTCTACTAATATTTCAGACAAATCTAAACATGGACATTGATAGTGACGAAGAGGAAAATGACG
T T G T C T A T T T G G T A T A T T T A T T T G G T C A T T T A A T T T T A A T A C T T A A C T A T C G A T A T T G T A G C C T G A A T C A C A
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TTGTCTATTTGGTATATTTATTTGGTCATTTAATTTTAATACTTAACTATCGATATTGTAGCCTGAATCACA
AGGAGGCCCATTTTCTAATTTGGCGGAGCTCAAAACCCATCCAGCACATTTGGCGGTGTTCATAAATTATCT
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AGGAGGCCCATTTTCTAATTTGGCGGAGCTCAAAACCCATCCAGCACATTTGGCGGTGTTCATAAATTATCT
TTTACTACACGGAAATCCAAGTAGTTTGGTAAGCGTTCAGCAAAACCCGTGTTATCTATTTTCACTTGTTTT
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TTTACTACACGGAAATCCAAGTAGTTTGGTAAGCGTTCAGCAAAACCCGTGTTATCTATTTTCACTTGTTTT
CAGTTTTTCTATCTAATCACCGATGCATATCAGTCCGCATACGGCACCGCCAAAGAATTCCGACGTTGGGCG
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CAGTTTTTCTATCTAATCACCGATGCATATCAGTCCGCATACGGCACCGCCAAAGAATTCCGACGTTGGGCG
TTCGAAATATTCTCCACATTCATCATTCCTAATTCCCCAATGTGTATTCCCAACTCGAACCAAAGCGTCATT
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TTCGAAATATTCTCCACATTCATCATTCCTAATTCCCCAATGTGTATTCCCAACTCGAACCAAAGCGTCATT
C A G C C G A T T G A C A A G G T T T T T T T G T G A T A T T T C G T G A G A A T A G G G A T A T A A C A G A G G T T A T C T T A C A G A T T A
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
CAGCCGATTGACAAGGTTTTTTTGTGATATTTCGTGAGAATAGGGATATAACAGAGGTTATCTTACAGATTA
TGTGCATGACAGCTGAGCATATTGGAGACAGTGATACTGACACATTAAAACGAATATTTGTGCCAGGACGAC
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TGTGCATGACAGCTGAGCATATTGGAGACAGTGATACTGACACATTAAAACGAATATTTGTGCCAGGACGAC
AAAGAGCTGTAACCGACATCAATATGTATCTGAATGACTTTCGACAGAAAAAGCAACTCGGTGGGCAGGTGT
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AAAGAGCTGTAACCGACATCAATATGTATCTGAATGACTTTCGACAGAAAAAGCAACTCGGTGGGCAGGTGT
CTGAATCGACGAATCAACTGACGCATATGGTTCGAGGTGACATGACAATGGAGCACAGGGTTTGTCGGCTCA
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CTGAATCGACGAATCAACTGACGCATATGGTTCGAGGTGACATGACAATGGAGCACAGGGTTTGTCGGCTCA
TTGACAGGTGAAATTCTAAATTGAAATTTATCGATTTAAGGTTGGAGAGCAGATGCTGTTCCGTTGTCTCGA
M1111111111111111111111111111111111111111111111111111 M 1111111111 M 1111TTGACAGGTGAAATTCTAAATTGAAATTTATCGATTTAAGGTTGGAGAGCAGATGCTGTTCCGTTGTCTCGA
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A A G T G T T A A G G T T C A G T A A A G A A A A C A T T A T T T T C A A T G G A A G T A A G A A T T A A C T G G T A A C T G C T A A A A A G C
T G C A G C T T A T T T T T A G A T A T T T T A A A C G A T A T C C A T T T T C T C A T G T T G C T C T T C A A A T T T T T A T A A A G A T T A
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T G C A G C T T A T T T T T A G A T A T T T T A A A C G A T A T C C A T T T T C T C A T G T T G C T C T T C A A A T T T T T A T A A A G A T T A
G A C A A C T G T A A T T G A A T C T T A A A A A C A A C G G C A A C G A C G T A A C C C G C C G A A T C T C A A T C A A T C A A A A A A G C T
G A C A A C T G T A A T T G A A T C T T A A A A A C A A C G G C A A C G A C G T A A C C C G C C G A A T C T C A A T C A A T C A A A A A A G C T
A G A T G T A A G A T T C T G C T T C G A A A A A A C T A A C C A G T T A A C C T T T C T G A A A A T A G G C T T A A A C A T T T T T G C A G T
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A G A T G T  A A G  A T T C  T G C  T T C  G A A A A A A C  T  A A C C  A G T T A A C  C T T T C  T G A A A A T A G G C T T  A A A C  A T T T T T G C  A G T
C T A A T A A A A A A A A A G T T T C G T T C T G T T T T T T G T T T A A A T A T T C T T G C T A A A A A A T A A C T G A A T A G A A C A C A C
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
C T  A A T  A A A A A A A A A G T T T C  G T T C  T G T T T T T T G T T T A A A T A T T C T T G C  T  A A A A A A T A A C  T G A A T A G A A C  A C  A C
T C A G G A A A A A A A A A C T T A C A A G T T C A A A T G T A T T A C T T T C A A T G A A A A T T C T G T C A T T T T T T T A A A C T C A A C
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T C A G G A A A A A A A A A C T T A C A A G T T C A A A T G T A T T A C T T T C A A T G A A A A T T C T G T C A T T T T T T T A A A C T C A A C
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ACCTCAATACTTCTAAAAAATTAAGCAAAAAAATTCAATAGGTTTTTGTATGTAGAACATAATTGTAATTTT
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  
ACCTCAATACTTCTAAAAAATTAAGCAAAAAAATTCAATAGGTTTTTGTATGTAGAACATAATTGTAATTTT
TTAGATTGTGATGTTAAAGTTCATCCTCACTGCACATCAGCACTTACGGATGCTTGTTACCCGGTAACTCAA
I I I I 1 M M I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
TTAGATTGTGATGTTAAAGTTCATCCTCACTGCACATCAGCACTTACGGATGCTTGTTACCCGGTAACTCAA
TCTAAACAAAAATCTAAGGTTTGCTGCTCCATAACCAATATTAACTGAAAAATTATGTTTTGTTTTTGAAGT
I I 11 >1 1 1 1 1 1 1 1 1 I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
TC T AAAC AAAAATC T AAGGTTTGC TGCTCC AT AAC C AATATTAAC TGAAAAATT ATGTTTTGTTTTTGAAGT 
CTCGTCTATCTGGTTTAATTGGCCGTTCCGATGCTAACGACGATGAAGACTCGGGAAGCAATGCACGGCACG
n i m m m m m m m m m m i m i i m i i m i m m i m m m m m m m i m m m m m m m m i
CTCGTCTATCTGGTTTAATTGGCCGTTCCGATGCTAACGACGATGAAGACTCGGGAAGCAATGCACGGCACG
AGC AGC C T AATGTG AAATC C AC TAGC TC GGAC AGC GGAATTGGC GGTG AAC AT AAC ATGG ATC GTGGC TTGG
I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I || | || | | | | | | | | || | | || | | | | I | | I || I I I I I I I I II I I
AGC AGC C T AATGTG AAAT C C AC TAGC TC GGAC AGC GGAATTGGC GGTGAAC AT AAC ATGGATC GTGGC TTGG
TATCCAGATCGCATAGCATGAGATATCGCGTTGTTAGTTCATTTAAAAAAAACTTAAATATTCAAACTTTTT
T ' TCCAGATCGCA*1
TGTTCAGGCAACTCTCCCACAATCTCTATCTGAAGATAAAGTTTCGATTCCAAGTTCAAAACGAGATAGGTC
GGTCACACCTAGTTGGCAACGATCAACGGGATATGATTTGACGCCGGCTGATGAAATAGACGAAAGTGATAT
TGGTGACAGAAAATCGAAATATCTTGAAAGAAGGTAAGAAAATATATTTCTGATTAGAAATTTATCTTTAAT
GTATGATTGGCAACTGTAGAATTTTTTTTTTAATAACAAAAATTCTCAGAATTTTGGATGTGAAAATTATGT
ATAGCATTATGAC TAGC AC GAAAT AAGT AGAAAT AAAATTGTC C AAC AATT AC TGAAAACGTGAC AAT ATAA
AAATATCGTTTCCGTTATTGAGATATGACGCGTTTTTTACGGTTTTGAATGTTTGGAGTCAAATGGAACTAT
CCTAAATTTCAATTGACCATGACTTTGTTTTCGAGTTGATGTTAAATTTGAATAACATATAGAACTGGTATT
321
GAAATCTTTTGGAGACTTTCTTTCTCTAGTCAGACAGAATTACCACTGGATTTTCACCAAATTAAATGTTAT 
TAATTTTCTTACTTTTAGATCTTTGGAAAGCTCGAGTAGAATGGCCATTGATCTACAAAGTGTCAGTGCAGC 
TTC T AGTTGTTC AC ATC AT AGTGGTTC C GTTGC TATGG ATGAC GAT GT AGGTTTT AGTC T AAAAC AACTTTC 
AAGATATATGGTTACAGATATGTGTTCGACGAACCACAACTCTTCAATTCTCTAGATTTATGGATGGCGATA 
GCGATTTTGAAATTGAAACCGAGGCAACGCCGTTAGAACAACTGATTGGATGGGATGTTATTAGGCATCTGA 
AAC C T AAAGAGAAAAAGC GTC AGGAAGTGATAAATGGC AAGTTGTTGATCGAAGTGTTGATGTTTGAC ATTT
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AATTTTCAGAATTATTTCACACGGAGCGGACTCACGTTAGGAATCTCAAAATATTATATCATGTATTTTATA
AGCCTATTGTCACCAGCAAAATTGTAACTGAAGAACTTGCAAATCTGTTATTTGCCAATCTAGAAGAGCTCT
TGAATTTGCACAAAAGCATGTCTGATGCTATGAGAGCAGAAGTTGAAAAGGTAAGTTTTTGTATACTTAAGA
I I I I I I I I I I I I I I I I 1 I I I I I I I I I I I I I I I I I I I I I I I I
= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = g a g a g c a g a a g t t g a a a a g g t a a g t t t t t g t a t a c t t a a g a
GCATATGTGAGCTTTCAAAATTTTAGTGGAGATCAGCACCGCCTCGTGTGAATGGAGGAATTTATGGGGACA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 1 I I I I I I I I I I 1 I t I I I I 1 I I I I I I I I I I I I I I I I I I
GCATATGTGAGCTTTCAAAATTTTAGTGGAGATCAGCACCGCCTCGTGTGAATGGAGGAATTTATGGGGACA
TTGGTGTGCTGATGGAGAGCATGTTTGATGGTGAAGCAGCCGAAAACCTGATGCGAGTTACGGCAACGTTCT 
TTGGTGTGC TGATGGAGAGC ATGTTTGATGGTG AAGC AGC C G AAAAC C TGATGCGAGTTAC GGC AAC GTTC T
GTCAACACCAACAACACGCGCTCGAGTTTCTCAGAACACGGTGTAAACGAGAAAAAGACGACGCTTTTGTGA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I II I I I I I II I II II I
GTC AAC AC C AAC AAC AC GCGC TC G AGTTTC TC AGAAC AC GGTGTAAAC GAGAAAAAGACGACGCTTTTGTGA
GGTTTCTAGCCGAGGCAGAATCGAATCCCGTTTGTCGTAAGCTACAGCTCAAAGACATGATTCCCGTGGAAA
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I  I I  I I  M M M I
GGTTTCTAGCCGAGGCAGAATCGAATCCCGTTTGTCGTAAGCTACAGCTCAAAGACATGATTCCCGTGGAAA
322
^
TGCAAAGGCTTGTCAAATATCCTTTATTGCTGGAAACCATTGCAAAGTATACAACCGAGCCCAGTGAGGTGA
M M M M I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
TGCAAAGGCTTGTCAAATATCCTTTATTGCTGGAAACCATTGCAAAGTATACAACCGAGCCCAGTGAGGTGA 
G C A T T T  A A A T A A A A T G C  T G G T T T C  T G A C  T G A A A T C T T T T T A A T  A A C  T G C  A C  T G A A C  A T C  A A A A C G T C G T T T A
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GC ATTTAAAT AAAATGC TGGTTTC TGAC TGAAATC TTTTTAATAAC TGC ACTGAAC ATCAAAACGTCGTTTA 
CTTGTATTTCCACAATACATTTTATTATTTAGGAACAAAATTGTTTACTCCGAACGGTAGCATCAGCGAAAC
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CTTGTATTTCCACAATACATTTTATTATTTAGGAACAAAATTGTTTACTCCGAACGGTAGCATCAGCGAAAC
GTATTCTAAGTGCTGTGAATACTGCCAAACGAAATGCTGAAAACTTGAGACGTCTTGAAGAGCTGCAAAAAC
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GT ATTC TAAGTGC TGTGAAT AC TGCC AAACGAAATGC TGAAAAC TTGAGAC GTC TTGAAGAGC TGC AAAAAC 
GAACAGACACGTCGCCGTTTGACAAAGAGTTTGTCGGGCATGACTATACGAACTTGAATTTAACCAAGTGGG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
GAACAGACACGTCGCCGTTTGACAAAGAGTTTGTCGGGCATGACTATACGAACTTGAATTTAACCAAGTGGG
T C C C T A A A T T T T T C A A T T C T T T T C A T C T T C G T G T C T T T C A G A T T T C G G C T T G T G C A C G A T G G T C C T T T A A C A
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TCCCTAAATTTTTCAATTCTTTTCATCTTCGTGTCTTTCAGATTTCGGCTTGTGCACGATGGTCCTTTAACA
TGTCGGTTTAACAGAGGAAAGATGATAGAATTGCATGTTGTTCTTCTTGAGAATATGCTAGTATTGTTCACA
I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I II I I I I II I I II I I I I I I I I I I I I I I
TGTCGGTTTAACAGAGGAAAGATGATAGAATTGCATGTTGTTCTTCTTGAGAATATGCTAGTATTGTTCACA 
AAGAACAGC GATGGGAAC AAAC T AGTGC T T A A G G T T T G T T T A T A C G A G A T G C  T T G A A T T A A A C  A A G C  C A G A T
I I I I I I I I I I I II I I I I I I I I I II I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I II I I
AAGAACAGC GATGGGAAC AAACTAGTGCTTAAGGTTTGTTTATACGAGATGCTTGAATTAAACAAGCCAGAT 
TGTTTAGGCATTGGAACCCTCAAAGGAGACCAGATGGTCACCGATTCTTCCATTAGCTCCTCTGATTGCTAA
I I I II I I II I I I I I I I I I I I I I I I I I I I I I I I II I II I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I
TGTTTAGGCATTGGAACCCTCAAAGGAGACCAGATGGTCACCGATTCTTCCATTAGCTCCTCTGATTGCTAA
AGAAAAAGCCAATGACAAGCGTGCATTTTTCTTAATTTTTAATAGTCAGTATGGTGCGCAAATTTATGAACT
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I II I I I I
AGAAAAAGCCAATGACAAGCGTGCATTTTTCTTAATTTTTAATAGTCAGTATGGTGCGCAAATTTATGAACT 
GGT AGC GGGAAC GGC G AC AGAAC GAAAAAC G T  A A G T T  T C C  T C  T C  A A C  G A T  A G  A A T C  G A A T T  A G G A A A T T C  A A
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GGTAGCGGGAACGGCGACAGAACGAAAAACGTAAGTTTCCTCTCAACGATAGAATCGAATTAGGAAATTCAA
AATTTCAGATGGTTTAAACTAATGGGTGACCAGATAATGAGTGAGAAAAAGAACCAAGCTGCCGGTATCGAT
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AATTTCAGATGGTTTAAACTAATGGGTGACCAGATAATGAGTGAGAAAAAGAACCAAGCTGCCGGTATCGAT
323
9aT^?TTT?aT?T?agtgcgcaaactacgctggattctgatggtgtggccaaagtaaatgtcgttacacat
CATAACTTTGATGTGAGTGCGCAAACTACGCTGGATTCTGATGGTGTGGCCAAAGTAAATGTCGTTACACAT
CCAAGATTGGTGAATGCAAATGAAATTACAATTCAACAACCGACCATTTTGGAGCATGCACAGCCCGTATTA
I I I I I I I I I I M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I
CCAAGATTGGTGAATGCAAATGAAATTACAATTCAACAACCGACCATTTTGGAGCATGCACAGCCCGTATTA 
AC TC C TGC GGAAAAATT AAAAC G AAGC GATGAG ATC ATC ATTC AAAC AC TT ATC AC T AAAC AGAC AAT ACTG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
ACTCCTGCGGAAAAATTAAAACGAAGCGATGAGATCATCATTCAAACACTTATCACTAAACAGACAATACTG
G C T C A A T T C T T G T C A A A C G A T G A C T C G G T A A G T A T G C T C A C A T G G A G C C A T A T G T T G A T T G C T T T C T G T C A C
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GCTCAATTCTTGTCAAACGATGACTCGGTAAGTATGCTCACATGGAGCCATATGTTGATTGCTTTCTGTCAC
T A A T A C T T T T A G A A A T T C A T A A A C T G A A T T T T A T T T A T A T C A A A C C T G T T T T G C T G G C A C G C T A A A A C A T G T
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TAATACTTTTAGAAATTCATAAACTGAATTTTATTTATATCAAACCTGTTTTGCTGGCACGCTAAAACATGT
A C A G G T T A T A T A T T C A T T T A T T G A G A A A A A A A A T G T T G C T G G T T T A A T T C A T T A T T T G C A A A T A C A A T T T C A
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ACAGGTTATATATTCATTTATTGAGAAAAAAAATGTTGCTGGTTTAATTCATTATTTGCAAATACAATTTCA
GAAAGGAAACACGGAAGAACTCGAAAAAATCACTGAAGTGCTTGGAGGTCTTGCAGTTGTTGACTTGAAACA
GAAAGGAAACACGGAAGAACTCGAAAAAATCACTGAAGTGCTTGGAGGTCTTGCAGTTGTTGACTTGAAACA
ACGAGATGGAAAGGAACTTGCAATGTCTGCAATAGTTCATGGAAATCGGCTATTGGATAGTATCAACCAAAG
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
ACGAGATGGAAAGGAACTTGCAATGTCTGCAATAGTTCATGGAAATCGGCTATTGGATAGTATCAACCAAAG
TCTTAACATTCGAAAAGAAATGGGAGAAAATGGATTAGATATCTATATTCTTAATAACCAAGAGCCTAATGT
I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I  I I I I I I I I I I I I I I I I I  I I I I I I I
TCTTAACATTCGAAAAGAAATGGGAGAAAATGGATTAGATATCTATATTCTTAATAACCAAGAGCCTAATGT
G C C G T C A G T T C C G T C T T A T A A A G T G A G T A G A G T T C A G T T T T C G A C T A G A A T T T C C T A T T T T T C T A T T T C A G C
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GCCGTCAGTTCCGTCTTATAAAGTGAGTAGAGTTCAGTTTTCGACTAGAATTTCCTATTTTTCTATTTCAGC
TGACTGCTATCGCCGCACCATTAATGAATCATCTGAAAGCACTAATGCAGGTGATTCAGGACCAACAAAATG
I I I I I I I I I I I I I I I I I I I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I  I I I I I I  I I I
TGACTGCTATCGCCGCACCATTAATGAATCATCTGAAAGCACTAATGCAGGTGATTCAGGACCAACAAAATG 
AAC TT AATC TTGTC AAGC AGC AGCTTTACC AC T AC A A G G T A C  A T T T G A T T T G T C  T C  T  A G C  A T  A T G T T  A C T A A
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 1 1 1 I I I I I 11
AAC TTAATC TTGTC AAGC AGC AGC TTT AC C AC T AC AAGGTAC ATTTGATTTGTC TC TAGC ATATGTTAC TAA
^
^
ATTTAAAAATTTAGAAACTCGCATCTGATGTGGATACTCGCGACAGATCTGTTAGCGAAGAGACTCTTACTG
i i i i i i i i i i i i i i i i m i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i
ATTTAAAAATTTAGAAACTCGCATCTGATGTGGATACTCGCGACAGATCTGTTAGCGAAGAGACTCTTACTG
ATTTGGGAGAAGATCGAAAAATGGTTCCGAAACGACCAAGACTACCTTCAATTCAACCAATGACATAGCATC
l l l l l l l l l l l l l l l l l l l l l l l l l l l i i i i i i i i i i i i i i i i i i i i i i i i i i i i l l l l l l l l l l l l l l l l l
ATTTGGGAGAAGATC GAAAAATGGTTC C G AAAC GACC AAGAC TACC TTC AATTC AACC AATGAC ATAGC ATC 
A C A T T T T T G T T A A A A C A T C A A T A T T T T A A C T T T T T A C A A G C C A T C C C C G T C T G T T T T A T A A A T T A T A A T T T A
I I I I I I I I I I I 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I 1111111111
ACATTTTTGTTAAAACATCAATATTTTAACTTTTTACAAGCCATCCCCGTCTGTTTTATAAATTATAATTTA
T G A G T G A T T G C T A T C A A A C A T C A A T T G A T A T A A T A A C A G T T A A T C T G T C A C C A A A T T T A T A A T T T C A A A C T C
I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I
TGAGTGATTGCTATCAAACATCAATTGATATAATAACAGTTAATCTGTCACCAAATTTATAATTTCAAACTC
T C G C C T C A T A A A A A T C T C C T T T T A C A A A A T T T G T A T T T T G C A T T G A C A C T T C A A C C T T T T T T T G T C G T T C A T
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TCGCCTCATAAAAATCTCCTTTTACAAAATTTGTATTTTGCATTGACACTTCAACCTTTTTTTGTCGTTCAT
G T A T G T T T T A A T T T A C C C G C G T T T C A C G G A T A C T T G T G T T T T T C A T T G C T A T G C T G G A A G A A T G A A A A A T G T
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GTATGTTTTAATTTACCCGCGTTTCACGGATACTTGTGTTTTTCATTGCTATGCTGGAAGAATGAAAAATGT
G T T T C T T T C T C G A A T A A A T A T T C A A C A A T T A A T A A T A G A A A A A A A T T A A A A A T T T T T A A A A G T G A A T C T T C A
I I  I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
GTTTCTTTCTCGAATAAATATTCAACAATTAATAATAGAAAAAAATTAAAAATTTTTAAAAGTGAATCTTCA
A G G A G A A A C T C G T A T C C T A C C C A A G A C A G T A A A A T T G A A T A A A A T A G G A T G G A C A A A A G G T G A A T G G A A A A A
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AGG AG AAAC TC GT ATC C TACCC AAGAC AGTAAAATTGAATAAAATAGGATGGACAAAAGGTGAATGGAAAAA 
C T T T A A A C T A A A A A T A A T G C A A C A T G A A T T T C A A T C G G T
III III 111 INI 111111 III 11111111111111 III
C TTTAAAC TAAAAATAATGCAAC ATGAATTTCAATCGGT
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8.3. Sequence of rhgf-1 deletion mutant gk217
rhgf-1 genomic sequence is shown in black. Exons for rhgf-1 are shown in red. rhgf-1 
(gk217) sequence is shown in blue.
C T T C T T G A A G C T T T T C G T C C C C C C C C C C C C T C C T T C A G C A A T A G T T T T T G G T T C T G T C T A T T G A C A G C G T C A
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CTTCTTGAAGCTTTTCGTCCCCCCCCCCCCTCCTTCAGCAATAGTTTTTGGTTCTGTCTATTGACAGCGTCA
C T T T G T C A T A T A T A A A C A T T C G T T C C G C A A T C A G C G C A C C A A G C A C T C T T C C T C T C T T C T T C C G C A C A C T T G
11111111IIIIIII111111111111111111111111111111111111111111111111111111111
CTTTGTCATATATAAACATTCGTTCCGCAATCAGCGCACCAAGCACTCTTCCTCTCTTCTTCCGCACACTTG
C T G C G T G T G T G G G C T C G A T T T C T T A A G G A G G A G A G A A T T T A T T C G T C C A T T C A C T C A C A T T C T G T G T C T C C G
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CTGCGTGTGTGGGCTCGATTTCTTAAGGAGGAGAGAATTTATTCGTCCATTCACTCACATTCTGTGTCTCCG
T G A T T C C G T T G G C A T T T A T A G T T C T T C T C A G T T T G C C A T T A T T G A T A C T T T T T A C A G A A A C T G T A T A T G C G A
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TGATTCCGTTGGCATTTATAGTTCTTCTCAGTTTGCCATTATTGATACTTTTTACAGAAACTGTATATGCGA
TCGTACGAGTTTGTAACCAATACACCACTCAAACTTGATCGGCACAAAGTATACCTCGTCGACGATGTGGCT
1 1 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1  i 1 1 1 1 1 ! 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1M 1111111 l l  11 M I
TCGTACGAGTTTGTAACCAATACACCACTCAAACTTGATCGGCACAAAGTATACCTCGTCGACGATGTGGCT
GTCACAAGGACTGTACCCTTATCGCAGCCATTATCCCCATCAACCGGTGAGCCATTTTTGCACTTTTACAAT
I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I II I I I I I II I II I I II I I I I I II I I I I I I I
GTCACAAGGACTGTACCCTTATCGCAGCCATTATCCCCATCAACCGGTGAGCCATTTTTGCACTTTTACAAT
T A C C T T G T C C T T C G A A T T G G G T A A A A G G G T T G A A C T T T A A A C T T C A T C A T A A C T C G A A A T A C T G T T G G T T T C
l l l l l l  I I I  I I I I I I  I I I  II II I  Mi l l  l l l l l l l l l l l l  l l l l l l l l l l l l l  l l l l l l l l l l l l l l l l l l l
TAC C TTGTCC TTCGAATTGGGTAAAAGGGTTGAAC TTTAAAC TTC ATC ATAAC TC GAAATAC TGTTGGTTTC 
A A T T C G T T C C A T A A T T T T A G A C C T A T G A G T T T T G T T T T T C G T T T T A T T C G G A A C G C A A G A A A A C A A A G T A T T
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AATTCGTTCCATAATTTTAGACCTATGAGTTTTGTTTTTCGTTTTATTCGGAACGCAAGAAAACAAAGTATT
C G T T A G A A T A C A C A C A A A G G T A A G T T C T T T T C T T A A A C A C T G A A A A C G T T G A T T T T A G T G T T C A A A G T G C A T
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CGTTAGAATACACACAAAGGTAAGTTCTTTTCTTAAACACTGAAAACGTTGATTTTAGTGTTCAAAGTGCAT 
A A C  T T T G T  A G T T C  C A T C  A A A A A T T A T T T T G C  T T  A A A A G C  A G T G T T T C G T T G T A G C C  T A T C  T A G C T C  A C  T T G C
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AACTTTGTAGTTCCATCAAAAATTATTTTGCTTAAAAGCAGTGTTTCGTTGTAGCCTATCTAGCTCACTTGC
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TCTTTTCAACCTCTTCAACAGCATTCAAGATTGAAATCTCAACGGGATATATTGTGTGTATATGTCTTCTTC
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TCTTTTCAACCTCTTCAACAGCATTCAAGATTGAAATCTCAACGGGATATATTGTGTGTATATGTCTTCTTC
C C T T T T C C C A C T C A T C C C A T G T T A A A T T T G G C A G A A A G T T A T C C C C T T C T C C T G T T A T A T T C C C A A G A G T C G
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CCTTTTCCCACTCATCCCATGTTAAATTTGGCAGAAAGTTATCCCCTTCTCCTGTTATATTCCCAAGAGTCG
T G T T G C T C T T G T G T T C T C A A T A G G C G T T G T T G T G A C A A T T T T G G C G G G G T G C C T T T T G C A A T A G C A A C A G A G
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TGTTGCTCTTGTGTTCTCAATAGGCGTTGTTGTGACAATTTTGGCGGGGTGCCTTTTGCAATAGCAACAGAG
C A T C  A G T T T  A C  T G G G T T T T C  T G A G A A T A A A G A A A A A G A T G A A A C G G A G G A A G A G G A T C  A A A T C  T G T T G T G G A
CATCAGTTTACTGGGTTTTCTGAGAATAAAGAAAAAGATGAAACGGAGGAAGAGGATCAAATCTGTTGTGGA
A A T T G T T T  A G T C  A A C  T T C  T T T G T T G A T T G C  T G A T T C  A T T T G A A T  A G A A A A C  T G A G T G A T A T T T A A A A A C  T T T
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AATTGTTT AGTC AACTTCTTTGTTGATTGCTGATTCATTTGAATAGAAAACTGAGTGATATTTAAAAACTTT
T C T G A A T A C T T T A A G A G A G A T G G G A T T G A C A G A A T G A T T T T C T T A C A A A A C A A G A T T A A A A T C G T T A G C C T T
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TCTGAATACTTTAAGAGAGATGGGATTGACAGAATGATTTTCTTACAAAACAAGATTAAAATCGTTAGCCTT
G A A G T G G A T T A A A T G C A A C T T G A G T G C C A A T T G A A A A A A A A T C C G C A A A C T T C C C A T T G A A G A A T A T A T T C A
I I I I I I I I I I I I I I I I I I I I I t t 1 I I tI I I 1 I II I II ) I I II 1(11 I I I I I I I I I I I I I I I I I I I I I I I M I
GAAGTGGATTAAATGCAACTTGAGTGCCAATTGAAAAAAAATCCGCAAACTTCCCATTGAAGAATATATTCA
C A G T T G T T G T T T A A A T C T T G T C C T A T C G T T A C G T T T A A C A C A T T A A T T T T A C A A G A A A C T T T G A T C T G A A G T
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CAGTTGTTGTTTAAATCTTGTCCTATCGTTACGTTTAACACATTAATTTTACAAGAAACTTTGATCTGAAGT
C G G C A G G G G A T G T C A A C A T T T G C A G T T T G A A A A A T T T A A T T A T T A A A T T A T T A A A A A A T C T G A A G A A A A C C A
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CGGCAGGGGATGTCAACATTTGCAGTTTGAAAAATTTAATTATTAAATTATTAAAAAATCTGAAGAAAACCA
C G A G C T T T T G G T A A T A T T C T T C G C A T T C T C C A T A C A T T C T A T G A A A A G T T G T T G A A A A T A G T A A T A A C T A A T
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
CGAGCTTTTGGTAATATTCTTCGCATTCTCCATACATTCTATGAAAAGTTGTTGAAAATAGTAATAACTAAT
T T C C A G T T C A T G A A A G T G A T C A A C T A T T C A G T C T T G T A G T T T A T G T T T C A T T G A A T T T T T G C T T G T T G T C G T
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 I I I I 1 1 I I 1 1 1 I I 1 1 1
TTCCAGTTCATGAAAGTGATCAACTATTCAGTCTTGTAGTTTATGTTTCATTGAATTTTTGCTTGTTGTCGT
T C T T G C G C C A C A C T T A A A A A A T T A A C C T T C G A A T A C G C G C A A A A C C T T A C T A C A T G T T A T T T G A A C A T T G G C
| I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I II I II II M M M I M M
TCTTGCGCCACACTTAAAAAATTAACCTTCGAATACGCGCAAAACCTTACTACATGTTATTTGAACATTGGC
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T T C A G A G A A T C T G C T T G T T G T C G T G T T A C C G G C A T A C T T T C A G A T A A A A C T T T T T T G A A T T C T G C G C T G A A T
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T T C A G A G A A T C T G C T T G T T G T C G T G T T A C C G G C A T A C T T T C A G A T A A A A C T T T T T T G A A T T C T G C G C T G A A T
C C A G T T T G A G A A A T T T C C T T T T T G C A C A T T T G C T A A C A T T A T T T A T T T T T G A A A A A A A A A T G A A T T G C C G C C
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C C A G T T T G A G A A A T T T C C T T T T T G C A C A T T T G C T A A C A T T A T T T A T T T T T G A A A A A A A A A T G A A T T G C C G C C
A A A A A C T A T G G T C C C A C T T G C A C T T C T G C T T A G A C A T C A G G A T C A T A A A T T A C A A A T T A A A G T T T T A T T C C A
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A A A A A C T A T G G T C C C A C T T G C A C T T C T G C T T A G A C A T C A G G A T C A T A A A T T A C A A A T T A A A G T T T T A T T C C A
T A A T A A T A C A C A A A A C C T A G C A G T T G A A G T T C A T T T T G A T T T T T G G T G G T T T T T G T T A A A C T A A A G T T T G A A
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T A A T A A T A C A C A A A A C C T A G C A G T T G A A G T T C A T T T T G A T T T T T G G T G G T T T T T G T T A A A C T A A A G T T T G A A
T A T G C T T T T C A A A A C A T G G G T C T T A T C T T T T T T C A A A C A C C T C A A A T C T G A T C G A A C A C T C T T C A A C T T T T T
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T A T G C T T T T C A A A A C A T G G G T C T T A T C T T T T T T C A A A C A C C T C A A A T C T G A T C G A A C A C T C T T C A A C T T T T T
A T A G C T C T G A C T T C C A A A A G A A C A T T C T G A A A A A C A A T T C A A A A T T C A C A C A A G T C C C T T T T G C G C G A A C T A
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A T A G C T C T G A C T T C C A A A A G A A C A T T C T G A A A A A C A A T T C A A A A T T C A C A C A A G T C C C T T T T G C G C G A A C T A
A G G T T T C A T G T G A C T A T A A A T A A T G T T C C G T G C A G G A A A A A A A T T A A T T G A A T T G C A A A T T C A A T T T C C T T G
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A G G T T T C A T G T G A C T A T A A A T A A T G T T C C G T G C A G G A A A A A A A T T A A T T G A A T T G C A A A T T C A A T T T C C T T G
T T T T A C A T T A G T A T A T C T A T C A C T C G A T T A T A G A G T G G C A G C A C A T T T T T C A A A A T G A G G C A G C G G T T A T T T
I I  I I I I I I I I I I I I I I I I I  I I  I I I  I I I I I I I I  I I I I I I  I I I  I I  I I I I I I I  I I I I  I I I  I I  I I I I I I I I I I I I I
T T T T A C A T T A G T A T A T C T A T C A C T C G A T T A T A G A G T G G C A G C A C A T T T T T C A A A A T G A G G C A G C G G T T A T T T
G G G A C C A G A T T G G G C C G G C A A A G A G A T T T A T A T C C G T T T T C G G G G C A A A G G A C G A A C A A C G A G C A G A A C G A G
G G G A C C A G A T T G G G C C G G C A A A G A G A T T T A T A T C C G T T T T C G G G G C A A A G G A C G A A C A A C G A G C A G A A C G A G
T G C G T T A C G T T T T T A T T A G T G T T T G C T T A G C A C C C G C A T C A C C C A C A A A A G T C C A T A A A A T T G C G G G T C G T T
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T G C G T T A C  G T T T T T  A T T  A G T G T T T G C  T T  A G C  A C  C C G C A T C  A C  C C A C  A A A A G T C  C A T  A A A A T T G C G G G T C G T T
G T T C C C T G T G G T T C T G T G G T T T T T A G A C T T A C T G T G A C A T C T C T C G C T C G C T A G T T T T C C G G G T C A A T C A A G
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G T T C C C T G T G G T T C T G T G G T T T T T A G A C T T A C T G T G A C A T C T C T C G C T C G C T A G T T T T C C G G G T C A A T C A A G
A C  A A C  T T A T G A T C  C A G G T T A T A T G A G A A T T T G G T G A A C  A T T A G C  A T C  A T T G A G G T G A G A C  T A A C  A C C G C C G T
A C A A C T T A T G A T C C A G G T T A T A T G A G A A T T T G G T G A A C A T T A G C A T C A T T G A G G T G A G A C T A A C A C C G C C G T
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T A G A A T T A T T C T C T T C T G G G T T G T A A A A T C T C C G G T T C A C A T T T C T C C A T C C A T T T T C T T A T T T A T G G T C A A
IM111I I1111111111111111111111111111111111111111111111111111111111111111
T  A G A A T T  A T T C T C  T T C  T G G G T T G T  A A A A T C  T C C  G G T T C  A C  A T T T C T C C  A T C C  A T T T T C  T T A T T T A T G G T C  A A  
T T C A C G G T T T T C T A T A G A T A T T T T C A T A G G A G G G T C G A T G A C C A T T G G C G A C A A A A A T A A T G A C A A T T T G A T
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T T C A C G G T T T T C T A T A G A T A T T T T C A T A G G A G G G T C G A T G A C C A T T G G C G A C A A A A A T A A T G A C A A T T T G A T
C C G C T G T T T T A A C C T C A T T T T T T T T G T G A A A T G A A T T C A A T T C A A A G G G T G G T C A C C A C T A C C G C C A T C G C A
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C C G C T G T T T T A A C C T C A T T T T T T T T G T G A A A T G A A T T C A A T T C A A A G G G T G G T C A C C A C T A C C G C C A T C G C A
A C A C T T A A C G G A T A A G G A G G G C T T C T T T T C G G G A A A A G A A G A T T A G G T T G A A G A A T C T G A A T A C C G G T A A A T
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A C A C T T A A C G G A T A A G G A G G G C T T C T T T T C G G G A A A A G A A G A T T A G G T T G A A G A A T C T G A A T A C C G G T A A A T
G A A A T G A A G A G C G C G T C T T G C T G C T G T C T C C T G A T G T G C G T T C A A C T T T C G T T T C A T T T T C C C G G C C G C G C T
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G A A A T G A A G A G C G C G T C T T G C T G C T G T C T C C T G A T G T G C G T T C A A C T T T C G T T T C A T T T T C C C G G C C G C G C T
G T C C T T G A C T T T G C C A C C A G T C T C G A C G A T C A A C G C T T T T A G T T T A G T T A C G C T C A G T T T T T T C C A A C A A A T
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G T C C T T G A C T T T G C C A C C A G T C T C G A C G A T C A A C G C T T T T A G T T T A G T T A C G C T C A G T T T T T T C C A A C A A A T
C A A A A C A T T A C A A A A T A A T A A T T T A T T T A A T C T A G A A A T T T T G T T A T C A G T G T T C G A C T C T C T A A A G T T T T C
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C A A A A C A T T A C A A A A T A A T A A T T T A T T T A A T C T A G A A A T T T T G T T A T C A G T G T T C G A C T C T C T A A A G T T T T C
G A T C C  A A A C  A G A T  A T T T C  A T T A A A A A G A T  A T A A A A C  A C  G T C  T G T A G A G G T T T C  A G T A T T A A A C  T T A C  A A C  T C
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G A T C  C A A A C  A G A T  A T T  T C  A T T  A A A A A G A T  A T A A A A C  A C  G T C  T G T A G A G G T T T C  A G T A T T A A A C  T T A C  A A C  T C
A A C G C A A A G A T C T A T C C G T T T T T G T T C T T T T C T T T A T G C C T T C C A A C A G C T G A G A C T T T C A G A T G A T G G A T G
A A C G C A A A G A T C T A T C C G T T T T T G T T C T T T T C T T T A T G C C T T C C A A C A G C T G A G A C T T T C A G A T G A T G G A T G
T G C A T A C C C C C T C T C G A C A T T G T T T G T T T T C C C C T A T T G A G T T T A C A G A A A A T G G A A A A A A G G C G T G C A A C C
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T G C A T A C C C C C T C T C G A C A T T G T T T G T T T T C C C C T A T T G A G T T T A C A G A A A A T G G A A A A A A G G C G T G C A A C C
T C A T C C G A G T T T T T G T C T A G A A C C C T A T A G A C T T C A A G T T C G C A A T A T A T T T T T T G A A G T A G T T T C A T T G T C
T C  A T C C  G A G T T T T T G T C  T  A G A A C  C C  T  A T  A G A C  T T C  A A G T T C  G C A A T A T  A T T T T T T G A A G T A G T T T C  A T T G T C
T T G C A C A A A A A T T T G A G G T A T C C G C T G A A G A T A G A C T G G A G A A C A T G C G A C G T C T A T C C G T T T T C A T C T C A C
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C T T C G T T T C G T T T T T C T T A T C G T A A T T C C T T G T C G T C A T T T T C G C A T C T T T T T T T T T G C C A C A A T T T C C A T A
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8.4. Sequencing of genes T02B5.1, T02B5.3 and T02B5.4
The sequence of genes T02B5.1, T02B5.3 and T02B5.4 including the introns and 
sequences flanking these genes have been examined in nz90 animals and no mutations 
identified.
Cosmid T02B5 sequence in black.
Exons of T02B5.1 in red.
Exons of T02B5.4 in purple.
Exons of T02B5.3 in blue.
All DNA sequenced in nz90 mutant animals shown in grey boxes.
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T G G C G G A G C T C C A A A G T A G A A T G T C G A G T T T T G A A G C A A C C A A A G T T G A G C A T C A A G T A A C T C T T G A G C A G  
G C T T C T T T C G A A G G C A G G A G T A A A C C T A T A G G A A A T A G T T A A C A C A A A C A T T A A T A T G A A A T T T A C C T G T T  
C A A C T T C A T G T T C A G G A A G T T T A T T A A A A C C A T A T T T C T T T G A A T G A C A A C C A A C T C T T T C A G C C A T T G C T  
G T C A T T C C T T T G A A A T T T G A T T T C T T G G A C A T A T T A G T C A T T G G T C C A C T C A T G A C T A T T T G C T G A T G A A T  
C A A T C C T T T T G T T A A A G G A G A G A T C G T A A A C T G A A A A T T G A A A A A T T G A A A A A A A G G T T C A C C C T T A T A A T  
C A T A C C G C A G C T A C C A C A C C A G C T C C T G C C G A G T G C C C A G C C A A A G T G A T T C T A T C T T T A T T C C C A C C A A A  
T T G T T T T A T T T C T C T T C G T A C C C A T T T C A C A G C T T C C A G G G T A T C T G T A A T T G T C G C C A T A T A C C A A A A A C  
G A A A T A T C G A A G C A A C G A A C C A A A A A T T C C C A C A T T C T T A T C A C C C T C G A A C C C A T T G A G A T G C C C A A A T C  
C A A A A A T T C C A A G G C G A T A A T T T A T A G T G A C G A C T A C A A T A T T C C T G T C T T G C C C C A C A A A A T T A T T C A C T  
A A A A T T T C A T G G T T G A A T G T G G C A G C T G A C T C A A A C A G A T A T C C G C C T C C G T G C A C T A T A A T C A C C A C T G A  
A C A G T T T T T C T G A A T A T C G T C T T G A T G G T T T A G G A A T A G A T T A T G C A G C T T A C A T T T T C C A G G C A A T A T T G  
A T T T G T C A A A A C A T T A A G A T A C A A G C A A T C T T C T G A A A T T G G T C C T C C A A T T C C T C C A T T C T T G T A G G T T T  
T 1  C T G A A A A A G G T A G T T T C A C A T G C C C A A G G C A A A C G A C G C T G G G T C T T T A A A A A A T T C A A C C C A T T T A T T  
T T G A A A C A T T A T A A G T G G G A A A C A C T T T T G G A A T T T T T G C G T T T T T T A A A C T G G A A C A T T A G T A G A G C T C A  
A A A C A A G A A T A C T G T A A A A A T T C A A C A A A T G C A A T G T C C T T A A A A A A A T T T T C T T T A A C T G T T G A T C A A A A  
A C C T T C T A C T C C G T T T A G A G C A G T C G C T G C T T C T T A G T T T T C A A C G A C T T T T C T T A T C A C A A A T G A G C A G A  
C T G T G A T G T G C G T T T G A C A A A A A C G T A G T T T G A A A T G A A A A T C A A A G A G T T T T C C T T G T T C T G A T C A T T G A  
A A T A A A A A A C T A A C G T T G A A T T G C T C A T A C A C G C A G G T T T G A A C T T T T T T G T C T C C A G A A C T C C A C T C C A T  
g t t t t t t g g g g a c g t g g t t t c c g g a a t c g a a g a t c t c c g a t c g g t g g t t c c a c g t a t g g a a t a c c g a g g a a  
T G C A A T A G C A G A T T G A T T T C C A A A T G G A G A A T A T G T A G A A T T C A A T T G T T T T C C C T C A A T T A T A C C G G T C C  
T G A A A A G T T C T T A A G A A A T T T T T G G A A C T A A T T C A A A C A T T C A A A C T C A C G A T A A T T G A A C T T T T G T T G A A  
A T  A G C  A A A C  T G T G C  C G A A A A C  C A A A G A A G C  A C  G A C  A A A T T T  A A A A A T C  A T  G A T T  A A A T T T T  A A A C  T  A A A A G  
T C  T  A G T  A A T G C  G G T C  G C  A G A G G A A T  A A G A A A G T T G T G C  C T C C  T C  T  A T C  A G T G T T T T T C  G A A A A T T T  A T  A T T  
C T A A A T A T T G A T A A A A G A C A A A C A A T T G G A A T T G A C T T G A C C A T G A G A G T C A T A T C A C G A G T C G A C A A A A A  
A C A C A A A T T T C G A A T G A T T T T T G T T C C A A T A A T G C A A A T T T G C G A T T T C A T A A A T T G T G T A A T G T T A C T T G  
A A A G T A A A A G T C A A A G G A A G C C T T A T T T T A T T G G T A T A G T A A A A A T A A A G T A G A T T A A A A A A T C A A A A G A G  
T T C  T G T C A A A T  A A A C  A T C  G T  A A A A T C  C T C  C  A G T  A A A A A C  A A A A A T T A A A A A A A C  A A A T  A C  A T T  A T C  C T T T A  
G T C A T C T T T T T T G C T A A T T T T T T T T T T C A G A A A A T A T A T A A A C A C G T C T A T T C G G A T A T T T G G T C T T T T T G  
G A T T A T T T T T A G T T T T T T A T A A C G G T C A G A A A A A A T A T G C T T C A G A T G T T A C A G A T G C T A T G A T T C A G G G A  
T C A T T T T C T C G T G T A A A A C T T C T G G T T A C C A A T T T G T G A C G G T T G G T T C T A A G A T C A T G T T A T C T C G A T G T  
C T T T G A T G T G T G C T G A T T T A T G A T G A T C A A T T T T A A T A A C T T T G T A C A G T C T G A C A G C T A A A C A T G C G A A A  
A T A T T C T T T A T T T T G C A T A A A T T T C T A T G T A G T C A A T T T T A A A A A T G T T T C A T T T T A T G C T T T T T T T T C A A  
A T A A A A A G T T T T C A C A A A A  ? GC A  T T A G T C  A T  T G T A A C  A G A G A C  A T  T  TG G  A T  T C  T T G A A T G C  T C T A A C  A
G C A C A C A T A T C C G T C G C A C G A T T T T C G G C C G G C T T C T T G T T T C C G G T T A T C A C A T T C A G G T A A T G A G G A A C  
A A A A A G G A T A T A A G A A A A T G G T G A G C A G A T T G G G G A A A A C A T G A A A G C A A T A G A G A C G A G A T A T T G A G C A A  
t a t t c a c a g t a a t a t a a c g a c c g a a c a t t g c t g c a a a t a t g a a g a a t c c c a g a a a g a t g a a g g t t g g a a g a  
A A A C C T G G A A A T A T T T T T G T T C A G T G A A A T G G A A A T A G G A T G A A A A T T G A T T
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TTTACAAGTCGTGCATTTAGATTTTTCACATCGTTTTTATCGGAACCCATTTTGATGGCAAAACTTAGAAG
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t t g t t g a c c g g t a g a c a a t a t g a c c t c c c a a a a t c a a a t g a c t t g a t g c c a a t c c a a a a g a g t c t g g a a c a
a c g a a t g c t t c g t t t g g a t c g t a t g a c c t g a t c c a g g c <5$c c a t a t g g a t g a a g <3At g g g a t t g a t a a g c a
^ g t g c a a c g a a g a c a a g a c t t t t g a t t g a a g g a t c a c g a a c a t a a a g a a t g t a a t a a c g a a a a a t g t a g g
a t g a t a t c a t c c a a a t t a a g t t g c a c t c c a a g a a a c a t a a c a t g a a c a t a t g c c c g a c a t a g c a a g c a g t t
g g g c c g a g a c g a g t g c a t g g t c c a g t t g g a a t g a c c a a a a t g g a a g a t c c a t c a g t g a c g a t t c t g g a a a t
a t a a a t t g a g g g t t a a t g t g g a t a t t t t c t a t a a t t a t t t g t t a a t a t t g a a a t a a g t a a g c t t c a t g g a g
a a a g t t t t c t t a c g t g g g a a c g g g a a a t a t t g t t t t a a a a g a a a t t c a a a a g g a g a a a t t t a a t t c g a t c c
t t c g t a c t g g a t t t g c a a a a c c a a a a a a c t t t c a a t t g a a t t a g g a g a g g a c t a a a t c a a a a a a a t a t a a c
a c t t a g a c g c t g t t t t t c a g g a a t t t g c t t c a a t t g g g a a a c c t t c c a t t a a a a t g t t t g a c t a a c c t
c a t t a c g a a a a a g c t c a t t g c c g a c g t c a a a a t a t c a g t g a a c g t c t t a a t t g t g a t g a t t g c c g a a c a t g
GACGCATAATTTTCG GTG ATTTTGTCAG CG CCAG ATACATCA0S^<K$ftare$(!3SSiiffi*eBK?*^**O$
G A C A A A A C C G T A T G A A G A A G C T G G T A G A G C A T G A C T T C T A G A T G A G A T G T G T G G C G G T G T A G C T G T C C T A T
T T A T A C T A G T A T G T C T A T G G G A A A T A T C A G A A C A G A C T A A T C A T T G T A C T A T A A A G G A G A T T G T A T G A G A C
T T C A A A T T T T C C C A C T A A T G A T T C A T G T A C G A G A T G G G T G A G A G G T G T T C T G A C G C T G A A A A A A A A G A A C G
A G A T T  A T T  A T C  A A A C  T  A T  A A A T T  T C  A A T G C  A T G A C  T A A A T C  C C  T G A C  G T A A A A G A T T T C  A A C G A C  C A G  A C  A
A T G C A A C A A A A A A G A G A C A A A A T G G T G G T T T G A A C T T G G A A A A T A C T C T A G G A A A C G G G T G C T C A G A G A C C
G C C C A T T C T C A T T T C T G A T T T G A A T T T C T G A C A A T A T G C C T T C T C A G T T T C C C C A T C A T A T G A A C A T G A A C
A C A A A T G A T T G T A T C A A A A A A G A A C T T T A A T G T G G T T T A T T T G A C A A A A A C A G T T G T T T A T G A T A G A A G C T
C G T A T C C A T C T C G T G C A C G T T T T T G T A G T A T G A C A T T G G G C A A T G T G A C A T A C A A A A T T C C A C C G A A A A G A
G T T C C A G C A C T G A T G A T A A G G A G A A T A T C T G T A A T T G A A A C T G A T A A A A G T A T G A A T C C A A A A A A T T T G T T
T T T A C G G A A A C G A A T G G T G A G A A A T G T T T T T C T C C A A A A A A A A T A A G A A A C A A C T A A A A A T T G A T T T T A T T
T T G A A A A A C  T T T C  T T  A A A A A T C  T  A T G A G C  T T C  T C  A T T T  A A C  G A C  A G G C  T  A T C  A T  A A T C  T T T  A A A A A T T T G T
G T T T T T T A A G T G T T T T G T T T T G C T C A C A T G A T T T C G A A A A A A T A A A A A T C C A C A G C A A A A A A A A A A C A A A A
A G A T C T A A T T A C C T A G T T T C G A G C T C T C A T C T T C T T C A T C T C C T T C T G T A A T T T C T T T A T T T G C C A A T C C A
T T T T T T C T A T T C T G A A T T C G C A A A G C T T T A T C T C G T C T C T T C G T T T C C A T T T T T A G C T C T T G C G T T C T C T C
C A A T T T T T C T C T T T T C A A A A A A T T A A C T T C C T C C T T G T A C A A C A A T T C A G T T T G C T C A A A A G T T T T A T C A A
A A G C A G T T G T A G T T T G T T T C A T A T G A G A A A C T A G T G G A G A T A T T A C A A G G G C A C A T G T A A A T G T A T C A A G T
G A T G G A G A C C A T T C C T C T T T G A A G G A T T T T T T G C C C A C C G T G C T T C A A A A A T T A T T T A T A G A A T T T A A A T T
C A A A T  A T  A T G A A G T T T C  A A A T  A T  A T  A A A G T T C  T C  A C  C T C  C A A A A C  T C  A T  A A G C  T T C  C G T  A T  A A T  A A T T  A T C
C C T C A T T C C A G G C G T T A T A A A G T T T T T A T C A A A G T T A A T C A A A A A A T G C T C T C G A T T T T C T T T G G T G T A C T
G A T T C C A T T T T T G G T C T C C C G A T G G T A A A G G G T T C T C A A A A T T A A C A A A G T C A G C A A A C A T T C C A C T G T A A
A T T  T T C  T C  T A T  A A T G T  A A T C  T T T T G G C  G C G A A A A T T C  C T C  G A T G  A G T G C  C A A A A A C  A T  A G A T C  A A A T C  T T C
A G  A A T G A T G  A G G G G  A T C  T  A A C  T T C  C A A A T  A T C  T  A T C  G T  A T G C  T G G T C  C T G C  A C  C A C  G A T  A G T C  G T A A C  T G  A
A A T C T G A G C A G T T T C A A A G G T T T C C T G A A A A T G C T T T A C C T A T A C A A G A A T A C T T T C G T A T T T C C G C T T G T
G T G G G A A T C G G C A A A A T C A A T A G C A G G T G T G T A G A A T T C C A T T T C A T T C G A T A A A T T C A T T G A C G A A T T C C
C A T T C A T A T A T T G T T T T T G G C A T T T C T T C G A A A A A G T C T C T G G T T C C T C A T A T A G T A C A T A T C C A A T G T G A
T C A C A T A A G T T T T C A A G C A A T T C A A C T T T T T T G T C A G C A A A T G C A G G A T C A A T T A T G T A T C T G A A C A A T T G
345
TTGTAAACTTAAAATTAATGTTACTCTCACGATGATTCTTCAACTTCTAGAGTTGTAGTACCTATCAAAGT
GTTGATAGGGTAAATTGATTTGGAAGCATATAAATTTTCTGGATAGTCAGTTAGAAAATGCTCATCAATTG
GAGGTGCTCCGAGAAAATATGTAGAATTTTGTAGCAACCATAATTGAGCATCTAGTATTTGTTGAGCAGAT
TTTTTTCGCAGACAAGAGTACGTCTGTAATTTATAAATGCTAATCAACTTGCCTCCCAGATGTAACTTGTT
TCCCCACATTTTTCTTATTGTCTCCATTAAAAAATAAATTACTCAATAAAAATATCAAAACCTCACATTTT
CCACCTGTTCCTCTGACAATTTATTAAACCCAATTTCTTCTGACAGGCATCCAACCATCTGAGCCATCACT
GTCATTCCTTTGAAATTCGATTTCTTTGACATATTCGTCATGGGTGCGCTCATTATAATCTGTTGATGGAC
GAGTCCTTTTGTGAGTGGAGAGCTTGTAAACTGGAAATGGATTAATTTACAAAAATGTATCATTTATGTGA
CCTACCGCTACTATCATACTGGCTCCAGCCGAATGCCCTGCCAATGTAATTCTGTTTTTATTTCCTCCAAA
GTTTTCAATTTCCCTCCTAACCCAATTTACAGATTCAATCATATCTGGAATTTTATCTTGAGAATTTATCT
TATAGTAAAATTGAAAACATACCATAAAGTCCAAAATTCTTGTCTCCTCGATCACCATTAAACTGACCAAA
CGAGAAAAGTCCAAGTCGATAATTGAAAGTAACCACTACAATATTTCTGCCTTGACCCACGAAATTGTTGA
TCAGAATCTCCGGATTGAAAGTTGAAGCTGATTCGGTTAAATACCCTCCACCATGGACAATCATCATAACA
GAACAGTTTTTCTAAACCTTTTCACTTTTCACTCTCAACTATTTGTATTAATTCTCACATTTTCCAAGCAA
TATTCATTTGTGAGGACATTGAGATACAAACAATCTTCAGAAATTGGACCTCCGAATTTATTTTTGTAAGT
T T T C C T G T A A A A T T T G T T C T T T A A A A A A A G C A A C T G A A A T T T C A A A G C T C C T G A A A T T T T T T A A A G G A A A A
A A G A T A T T C T A A A G T A C T T C T C A A T A T T A T A T T T T T T G G T A A A G T T G T T G G T C T G T C C T T T T T C T A C T T T G
A A A G G T A A G C T A G T T T C G T T T C A A C A A T T G T T T T A T T C T G G C T G A A A A T T C T T A T C A A T A A A C G T T G C C G A
A T G A C A T A A A C A A C T T T T G C A A A C A C A A A T A C A C A A C A C T T T T A G T T G C G T C A T T T T C C C A A A A G T G C A G G
AATCAAAACTAACACTGACTATATTGAAATAACTCACGTTGCATTGCTCATACACGCTGATTTATATTCAT
TTGTTACCAAAACTCCTTCCCATGATTTCGGTGGACGGGGTTTTCGATATCGAAGGTCTCCAATTGGAGGT
TCAACAAACGGAATACCCAAAAATACAGTAGCAGATTGATTTCCCAGTGGAGAATATGAAATGTTGAGGAT
TTTGCCTTCTATTGTTCCGGATCTAAAATATTTTCTCAAATATATTTTCTATAACTTCACTTTTTTTCTCT
A A G T A A G T C T G G A C A C G A T A T G T T T T G T T G T T C C T A A T T G A C T G A A A T T A T T G C T T G G T A A A A A A A T C T T C
A A A A A C C A G A G T A A T T T G A A C A T T T T A A T G A G A A T T T T A T C C C C T T T T A A T T G T T G T T T A T T C G G A T A A C C
G G A T  A A T  A T T T  A A C  C A A C  C  A T  A A T  A C  A T G A A A A T  A G T T  A A A A C  G T T  A C  T  A G T T C  C A G A C  A C  A A A G A A T C  T T
T T G A A A T G T A G T A T T G C A G T C T T T G A T G T A C T A G T T T T A C G T T G C G A A G G T A T T T A G A A A T T G G T A T T T C T
T G T C  T T C  C T  A A T  A G A G A A A A T  A C  A G T  A T T T A A A A A G T A A A T G A A C  T T A C G  ATAATTGGAC TC TC TTGC AAA
CATACATTTGTATTAAGAGGAGTACGGTAGCAGGTTTGAGCATTTTAAAACAACTGGTAATTGGAAGTAGT
A G A A A C A A A T G A C T C T A C C T T T T T T A T A T T T A T T C T T G G A G T A C A T G T A A A T A A A A A T G A T A A G A C A A A A A
G G G C A T A G G C T A G A G T T C T T T G A A G T G C A A C A G T T T T G C A A A A T G G T C G T G T A T C G T G T G A A A A C T T T A T T
C A G A G C T T T T G A T A A C T T T G T C G A G A T A T T T A C T T T T G G C A G T A G T G G G A T A C T G A A G C G T A G A G A A C A G T
A C C A A T A A A A C C G G C T C C A A A G C A T A T A A A T A C A A C A A C T G G A A A T T T T C A A A A A A T T T T A A A A A A A C T T A
A G T T T T T T G A A A G A C A T G T G A G C C T A T G G G C T C A T T C A T T T T T A G A G T T T A T T C A T A C A G A A G T A C C A C G G
C A C T A T T T C A A T A T A T A T C T T C A A A T A A A G T T T A G A G C A A A A A T T G T T T T T G T G T G T C A C A T C A A G G C T T A
TTACAAAACAATTAAAAAGCATACATATTTCTCATCAAAAACTTCAAGTAATTCAAGAAATTAATGAGTTT
AGAAACACACAGTTGCTTAAGAAGCTGGCTTGATCGATGCGTTTTCAGATTCATCATTGACGTTTGCTTGA
TCATCAGTCATGGGTTTCACGGGCTCTTTGTTCTGTTCAACATTGCATGGCTCCTCGACAGGATCATGAGT
GACTGTTGTCACAGCTTGGCGTTGTTGCCGGATTACTTGACGTGGATAATTATAGCCATACAACAGAATGC
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CAATGTTGACTCCTTGCGGGACGTCTGATCGAAGAACAATGGGCTCCAGTGTACCTGGCTTGTGCAGTGGC
CGTTTTGGCGTCCAAGTTGACTTTCTGGATGTTGTCGAACTCGAATCCTCGAAAACGCCCTTTAATTGGTA
GTTTTATTTTAATCAAGCTTAGGAAATTAAAAATATAAATTTGCAGTTTATCTGAGTTGTATAAATGGTAA
ACTCACCGATGGTATCTTCCTTGCTTTCTTAACAAGCTCTGCAGAAAGCTTGTTTTGCTGAGAATTCGTGG
TAC TTTCC TCC ATTTC AAGCTAGAAATTTGAAAATTTAGAGAC AATTTTTC AC ATGCGATTTACAAAC AAA
TTTAAAACAATAAATTGAAAAGGATACAATTCTAAAACTTTGACGATGGCATCAGTAGTCGTTTTTGTTTG
GAAATCTATTGAAATTTTAAAAAAACAACTGAATTTTATAAAGGACAAAAGTTTAATTCAAATTGAATATC
ACATTGTGAACATACAAAGCTTGCAGAATGTTGCTTGAATGGGTCTTATTTCAAGAAGATATGTTTAGAAC
GC GGC AC ATGAAAGAAAGTGC C TGC GC AC GAGAAAGC AGAAGGTCGTAAAAC TTTGAATGTT AC ACGAAAA
CCAAAATTAGCGTAATCAGAACTTGGGAAACATGAAACCATTTTTCATCCAACAAAATAAAAAATATAAAA
AACAGTCTTGCATCGGGTCATTGTCGCTTTATTTCATTTCAAAATGGCCAATATCTTATTCCTTTTTAGTA
TTTTGTAGATAACTAAATGCGTTGTTTATAAAATTCTGCCTGGGACAATGTTAAAACTTGTGTGACACAGA
TTCTGTATATTCTCTTTTAATATTGCATGAGAAAATAATTTCCAGCCTCATTTTAAAGGGTAGCGTTAAAT
ATAAGGCCCGAATAGCTTGGCACTTTTTTCATTAGAACACAAACAACACTTATAGTAAGTTTTCTAAAATT
TATAGAATAAGAGATACATTTATTCCAAGTTATTTCAAAAGCTGATATCCTTCCCGAGATTTGTGATGTAG
GCAAAAATGTGAAATAGTGACATAGAGTATTCCACCTAGAAGCGTTCCGCCAAAGATGATTAAGAGGAGAC
CTGGAAAAATATATGTTTTGATAACTATCGACAACTTTCTTTTTCTGAAAACTCACTGACTCCACCTCTAC
TGCCCTTCTTCCCATCTCTCATTTCCATCGGAGCATTTCCTGCTCTCTCTACAATTCTTCCTCCGCCGTTT
CTAATTTTCCTCCATTTTTCCTTCAAAAGTTCCAATTTTCTTTCAGATTTCAAAGTTTTCAGAAACATTTC
TCTTTCCAGGAGCATTTTCTCAAACTGTTCAAATGTTTTATCAGGTCCGGTTGCAACTCCTTTCATATGTG
AAACAATAGGATCAATTAGAATTCCAGTGGTAAATGAGTCGAGTGATGGGGAATAATGCTCAGAAAATGAC
TTGGTACCCGCAGTGCTGTAAAAAGATCTGTTGAGACGACATGATTGAAACAA
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8.5. snip-SNPs: location, primer sequences and name
Taken from Davis et al 2005.
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